-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OjDM+Pr3krW30Jc4/qjBZGTajfknVtMMmfajHskzmHAwM0pxsQwdOOP0EdiBbsLb
 Uzf6i50PWGcfUj8z7SE0ZA==

<SEC-DOCUMENT>0001003297-02-000218.txt : 20021114
<SEC-HEADER>0001003297-02-000218.hdr.sgml : 20021114
<ACCEPTANCE-DATETIME>20021114112714
ACCESSION NUMBER:		0001003297-02-000218
CONFORMED SUBMISSION TYPE:	10QSB
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20020930
FILED AS OF DATE:		20021114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PRO DEX INC
		CENTRAL INDEX KEY:			0000788920
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
		IRS NUMBER:				841261240
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10QSB
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14942
		FILM NUMBER:		02822722

	BUSINESS ADDRESS:	
		STREET 1:		650 S. TAYKOR AVENUE
		STREET 2:		SUITE 20-A
		CITY:			LOUISVILLE
		STATE:			CO
		ZIP:			80027
		BUSINESS PHONE:		3034438165

	MAIL ADDRESS:	
		STREET 1:		1401 WALNUT STREET
		STREET 2:		SUITE 540
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80302
</SEC-HEADER>
<DOCUMENT>
<TYPE>10QSB
<SEQUENCE>1
<FILENAME>prodex10q.htm
<DESCRIPTION>HTML DOCUMENT
<TEXT>
<html>

<head>

<title>Prepared by E-Services, LLC - www.edgar2.net</title>

</head>

<body>

<div align="left">

<table border=0 cellspacing=0 cellpadding=0 width="750" style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=720 valign=top>
  <p align="center"><b>UNITED
  STATES <br>
  SECURITIES
  AND EXCHANGE COMMISSION</b></p>
  <p align=center>Washington,
  D.C. 20549<br>
&nbsp;</p>

  <p align=center><b><font size="5">FORM 10-QSB</font></b></p>
  <p><b>&nbsp;</b></p>
  <p><b>[X]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Quarterly Report Pursuant to Section
  13 or 15(d) of the Securities Exchange Act of 1934.</b></p>
  <p align=center><b>For the quarterly period ended September 30, 2002</b></p>
  <p align=center><b>OR</b></p>
  <p><b>[&nbsp; ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Transition Report Pursuant to Section
  13 or 15(d) of the Securities Exchange Act of 1934.&nbsp;&nbsp; For the transition period from&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>to&nbsp;
  <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .</u></b></p>
  <p><b>&nbsp;</b></p>
  </td>
 </tr>
</table>

</div>

<p><b>&nbsp;</b></p>

<div align="left">

<table border=0 cellspacing=0 cellpadding=0 width=750 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=720 colspan=2 valign=top>
  <p align=center><b>Commission File Number&nbsp;&nbsp;&nbsp; 0-14942 </b></p>
  </td>
 </tr>
 <tr>
  <td width=720 colspan=2 valign=top>
  <p align=center><b>&nbsp;</b></p>
  </td>
 </tr>
 <tr>
  <td width=720 colspan=2 valign=top>
  <p align=center><b><font size="5">PRO-DEX, INC.</font></b></p>
  </td>
 </tr>
 <tr>
  <td width=720 colspan=2 valign=top>
  <p align=center><b>(Exact name of small business issuer as specified in its
  charter)&nbsp;&nbsp;&nbsp;&nbsp; </b></p>
  </td>
 </tr>
 <tr>
  <td width=360 valign=top>
  <p><b>&nbsp;&nbsp; </b></p>
  </td>
  <td width=360 valign=top>
  <p><b>&nbsp;&nbsp;&nbsp;&nbsp;
  </b></p>
  </td>
 </tr>
 <tr>
  <td width=360 valign=top>
  <p align=center><b><u>Colorado </u></b></p>
  </td>
  <td width=360 valign=top>
  <p align=center><b><u>84-1261240 </u></b></p>
  </td>
 </tr>
 <tr>
  <td width=360 valign=top>
  <p align=center><b>(State or Other Jurisdiction of&nbsp;&nbsp;&nbsp; </b></p>
  </td>
  <td width=360 valign=top>
  <p align=center><b>(IRS Employer Identification No.) </b></p>
  </td>
 </tr>
 <tr>
  <td width=360 valign=top>
  <p align=center><b>Incorporation or Organization)&nbsp;&nbsp;&nbsp; </b></p>
  </td>
  <td width=360 valign=top>
  <p><b>&nbsp;&nbsp; </b></p>
  </td>
 </tr>
 <tr>
  <td width=360 valign=top>
  <p><b>&nbsp;&nbsp; </b></p>
  </td>
  <td width=360 valign=top>
  <p><b>&nbsp;&nbsp;&nbsp;&nbsp;
  </b></p>
  </td>
 </tr>
 <tr>
  <td width=720 colspan=2 valign=top>
  <p align=center><b><u>151 E. Columbine Avenue, Santa Ana, California
  92707&nbsp;&nbsp;&nbsp; </u></b></p>
  </td>
 </tr>
 <tr>
  <td width=720 colspan=2 valign=top>
  <p align=center><b>(Address of Principal Executive Offices)&nbsp;&nbsp;&nbsp;&nbsp; </b></p>
  </td>
 </tr>
 <tr>
  <td width=360 valign=top>
  <p><b>&nbsp;&nbsp; </b></p>
  </td>
  <td width=360 valign=top>
  <p><b>&nbsp;&nbsp; &nbsp; </b></p>
  </td>
 </tr>
 <tr>
  <td width=720 colspan=2 valign=top>
  <p align=center><b>Issuer's telephone number: <u>714 241 4411&nbsp;&nbsp;&nbsp; </u></b></p>
  </td>
 </tr>
</table>





</div>





<p align="justify">Indicate by check mark
whether the Registrant (1) has filed all reports required by Section 13 or
15(d) of the Securities Exchange Act of 1934 during the preceding twelve months
(or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past
ninety days.&nbsp;&nbsp;&nbsp; Yes [X] No [ ] </p>



<p align="justify">Indicate the number of
shares outstanding of each of the Registrant's classes of Common Stock
outstanding as of the latest practicable date:&nbsp;
8,747,200 shares of Common Stock, no par value, as of November 1, 2002. </p>



<p align="justify">Transitional Small Business
Disclosure Format:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yes [&nbsp; ]
No [X]</p>



<p align="justify">&nbsp;</p>



<p align="center">-1-</p>

<hr color="#000080"><p style="page-break-after: always"></p>
&nbsp;<p><b>Item 1. &nbsp;&nbsp;&nbsp;&nbsp; Financial Statements</b></p>



<p align=center><b>PRO-DEX,
INC. <br>
CONSOLIDATED
BALANCE SHEETS </b></p>

<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=740 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=456 valign=top>
  <p><b><font size="2">&nbsp;</font></b></p>
  </td>
  <td width=142 valign=top align="right">
  <p align=center><i><font size="2">September 30, 2002</font></i></p>
  </td>
  <td width=142 valign=top align="right">
  <p align=center><i><font size="2">June 30, 2002</font></i></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p align=center><i><font size="2">&nbsp;(unaudited)</font></i></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p align=center><i><font size="2">&nbsp;(audited)</font></i></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><b><font size="2">ASSETS</font></b></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Current assets:</font></p>
  </td>
  <td width=142 valign=top align="right">

  </td>
  <td width=142 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Cash and cash equivalents </font> </p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  179,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  236,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Funds held in escrow, net </font> </p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; 102,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 790,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Accounts receivable, net of allowance for doubtful </font> </p>
  </td>
  <td width=142 valign=bottom align="right">

  </td>
  <td width=142 valign=bottom align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  accounts of $22,000 and $26,000 </font> </p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">1,589,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,620,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Inventories, net </font> </p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">2,715,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,924,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Prepaid expenses </font> </p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 129,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 84,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Deferred taxes</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 454,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 454,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Income tax receivable</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 330,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 330,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top style="border-right-style: none; border-right-width: medium">
  &nbsp;</td>
  <td width=142 valign=top align="right" style="border-left-style: none; border-left-width: medium; border-right-style: none; border-right-width: medium; border-bottom-style: none; border-bottom-width: medium">
  &nbsp;</td>
  <td width=142 valign=top align="right" style="border-left-style: none; border-left-width: medium; border-right-style: none; border-right-width: medium; border-bottom-style: none; border-bottom-width: medium">
  &nbsp;</td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; Total current assets&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </font> </p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: none; border-top-width: medium">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,498,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: none; border-top-width: medium">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,438,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp; </font> </p>
  </td>
  <td width=142 valign=top align="right">

  </td>
  <td width=142 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Equipment and leasehold improvements, net </font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 968,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,025,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Other assets:</font></p>
  </td>
  <td width=142 valign=top align="right">

  </td>
  <td width=142 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Other </font> </p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Deferred tax assets</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,326,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,326,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Patents, net of
  accumulated amortization of $2,692,000 and<br>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  $2,6660,000</font></p>
  </td>
  <td width=142 valign=bottom align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</font></p>
  </td>
  <td width=142 valign=bottom align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Goodwill, net of accumulated amortization
  of $1,683,000 </font> </p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,110,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,110,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; Total other assets&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </font> </p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,494,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,505,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top bgcolor="#C0C0C0">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp; 8,960,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp; 9,968,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><b><font size="2">&nbsp;</font></b></p>
  <p><b><font size="2">LIABILITIES AND SHAREHOLDERS' EQUITY</font></b></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p align=center>&nbsp;</p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p align=center>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Current liabilities:</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
  <td width=142 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Current portion of long term debt to
  shareholders</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 75,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">$&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; 126,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Notes payable</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Credit line payable</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 176,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 638,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Accounts payable</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;442,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;765,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Accrued expenses</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 648,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 801,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Income taxes payable</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 97,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 101,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current
  liabilities</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,446,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,439,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right">

  </td>
  <td width=142 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Long-term debt to a shareholder, net of current
  portion</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;197,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 211,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Total
  liabilities</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,643,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,650,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Commitments and contingencies </font> </p>
  </td>
  <td width=142 valign=top align="right">

  </td>
  <td width=142 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Shareholders'
  equity:</font></p>
  </td>
  <td width=142 valign=top align="right">

  </td>
  <td width=142 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Series A convertible preferred shares; no
  par value; liquidation<br>
&nbsp;preference of $3.60 per share; 10,000,000 shares authorized; 78,129 <br>
&nbsp;shares issued and outstanding</font></p>
  </td>
  <td width=142 valign=bottom align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 283,000&nbsp;</font></p>
  </td>
  <td width=142 valign=bottom align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 283,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Common shares; no par value; 50,000,000
  shares authorized; <br>
  8,735,000 and 8,737,300 shares issued and outstanding, respectively</font></p>
  </td>
  <td width=142 valign=bottom align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; 15,031,000&nbsp;</font></p>
  </td>
  <td width=142 valign=bottom align="right">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; 15,033,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Accumulated deficit </font> </p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7,928,000)</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7,922,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,386,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,394,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right">

  </td>
  <td width=142 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">Receivable for stock purchase</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (69,000)</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (76,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">

  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total shareholders'
  equity</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,317,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,318,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
 </tr>
 <tr>
  <td width=456 valign=top bgcolor="#C0C0C0">
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total
  liabilities and shareholders' equity</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp; 8,960,000&nbsp;</font></p>
  </td>
  <td width=142 valign=top align="right" style="border-top-style: solid; border-top-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp; 9,968,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=456 valign=top>

  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
  <td width=142 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
 </tr>
</table>

</div>

<p><i>See notes to consolidated financial statements.</i></p>



<p><b>&nbsp;</b></p>



<p align="center">-2-</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align=center><b>PRO-DEX, INC.<br>
CONSOLIDATED STATEMENTS OF INCOME<br>
(Unaudited)</b></p>

<p align=center>&nbsp;</p>

<div align="left">

<table border=0 cellspacing=0 cellpadding=0 width=740 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=497 rowspan=2 valign=top>

  </td>
  <td width=243 colspan=2 valign=top>
  <p align=center><i><font size="2">Three Months Ended
  September 30,</font></i></p>
  </td>
 </tr>
 <tr>
  <td width=124 valign=top style="border-bottom-style: solid; border-bottom-width: 1">
  <p align=center><i><font size="2">2002</font></i></p>
  </td>
  <td width=119 valign=top style="border-bottom-style: solid; border-bottom-width: 1">
  <p align=center><i><font size="2">2001</font></i></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>

  </td>
  <td width=124 valign=top style="border-top-style: solid; border-top-width: 1">
  <p align=center>&nbsp;</p>
  </td>
  <td width=119 valign=top style="border-top-style: solid; border-top-width: 1">
  <p align=center>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Net sales&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </font>
  </p>
  </td>
  <td width=124 valign=top align="right">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp; 2,717,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp; 3,170,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>

  </td>
  <td width=124 valign=top align="right">

  </td>
  <td width=119 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Cost of sales (includes rent paid to a director of
  $37,000 in&nbsp; 2001)</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">1,567,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">1,780,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Gross profit</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">1,150,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">1,390,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>

  </td>
  <td width=124 valign=top align="right">

  </td>
  <td width=119 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Operating expenses:</font></p>
  </td>
  <td width=124 valign=top align="right">

  </td>
  <td width=119 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Selling </font> </p>
  </td>
  <td width=124 valign=top align="right">
  <p><font size="2">147,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right">
  <p><font size="2">162,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; General and administrative expenses</font></p>
  </td>
  <td width=124 valign=top align="right">
  <p><font size="2">588,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right">
  <p><font size="2">751,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Research and development costs</font></p>
  </td>
  <td width=124 valign=top align="right">
  <p><font size="2">385,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right">
  <p><font size="2">379,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;
  Amortization</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">32,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">122,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Total operating expenses</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">1,152,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">1,414,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>

  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Income (loss) from operations</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">(2,000)</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">(24,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>

  </td>
  <td width=124 valign=top align="right">

  </td>
  <td width=119 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Other income (expense): </font> </p>
  </td>
  <td width=124 valign=top align="right">

  </td>
  <td width=119 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Other income, net </font> </p>
  </td>
  <td width=124 valign=top align="right">
  <p><font size="2">6,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right">
  <p><font size="2">23,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp; Interest (expense) </font>
  </p>
  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(13,000)</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(16,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Total</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">(7,000)</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p><font size="2">7,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>

  </td>
  <td width=124 valign=top align="right">

  </td>
  <td width=119 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">(Loss) before provision for income tax (credits) </font> </p>
  </td>
  <td width=124 valign=top align="right">
  <p><font size="2">(9,000)</font></p>
  </td>
  <td width=119 valign=top align="right">
  <p><font size="2">(17,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>

  </td>
  <td width=124 valign=top align="right">

  </td>
  <td width=119 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Provision for income taxes (credits)</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(3,000)</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;(6,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top bgcolor="#C0C0C0">
  <p><font size="2">Net income (loss)</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; (6,000)</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (11,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </font>
  </p>
  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p align=right>&nbsp;</p>
  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p align=right>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=top>
  <p><font size="2">Net income
  (loss) per share, basic </font> </p>
  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; (0.00)</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp; &nbsp; (0.00)</font></p>
  </td>
 </tr>
 <tr>
  <td width=497 valign=bottom>
  <p><font size="2">Net income (loss) per share, diluted </font> </p>
  </td>
  <td width=124 valign=bottom align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; &nbsp; (0.00)</font></p>
  </td>
  <td width=119 valign=bottom align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; (0.00)</font></p>
  </td>
 </tr>
 <tr>
  <td width=497>

  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=497>
  <p><font size="2">Weighted average shares
  outstanding - basic</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">8,785,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">8,787,300&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=497>

  </td>
  <td width=124 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=119 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=497>
  <p><font size="2">Weighted average shares
  outstanding - diluted</font></p>
  </td>
  <td width=124 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">8,785,000&nbsp;</font></p>
  </td>
  <td width=119 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">8,787,300&nbsp;</font></p>
  </td>
 </tr>
</table>



</div>



<p><i>See notes to consolidated financial statements.</i></p>

<p align=center>&nbsp;</p><br clear=all>




<p align="center">-3-</p>
<hr color="#000080"><p style="page-break-after: always"></p>




<p align=center><b>PRO-DEX, INC. AND
SUBSIDIARIES <br>
CONSOLIDATED STATEMENTS
OF CASH FLOWS<br>
(Unaudited)</b></p>

<p align=center>&nbsp;</p>

<div align="left">

<table border=0 cellspacing=0 cellpadding=0 width="740" style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=500 rowspan=2 valign=top>

  </td>
  <td width=240 colspan=2 valign=top>
  <p align=center><i><font size="2">&nbsp;Three Months Ended
  September 30,</font></i></p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top style="border-bottom-style: solid; border-bottom-width: 1">
  <p align=center><i><font size="2">2002</font></i></p>
  </td>
  <td width=127 valign=top style="border-bottom-style: solid; border-bottom-width: 1">
  <p align=center><i><font size="2">2001</font></i></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top style="border-top-style: solid; border-top-width: 1">
  <p align=center>&nbsp;</p>
  </td>
  <td width=127 valign=top style="border-top-style: solid; border-top-width: 1">
  <p align=center>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Cash Flows from Operating Activities: </font> </p>
  </td>
  <td width=113 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=127 valign=top>
  <p align=center>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Net&nbsp;
  (loss)</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (6,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (11,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Adjustments to reconcile net (loss) to net cash used in operating activities:</font></p>
  </td>
  <td width=113 valign=top align="right">

  </td>
  <td width=127 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Depreciation and amortization </font> </p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">113,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">223,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Provision for doubtful accounts </font> </p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">(4,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">--&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Non-cash compensation</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">7,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">7,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Deferred taxes</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">--&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">(7,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in:</font></p>
  </td>
  <td width=113 valign=top align="right">

  </td>
  <td width=127 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (Increase) decrease in accounts receivable</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">35,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">(610,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  Decrease in inventories</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">209,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">88,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (Increase) decrease in prepaid expenses</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">(45,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">21,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Increase) decrease in other assets</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">(21,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">6,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (Decrease) in accounts payable and accrued expense</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">(476,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">(11,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  &nbsp;(Decrease) in income taxes payable</font></p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(4,000)</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(10,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Net Cash (used in) Operating Activities</font></p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(192,000)</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(304,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Cash Flows From Investing Activities: </font> </p>
  </td>
  <td width=113 valign=top align="right">

  </td>
  <td width=127 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Proceeds from sale of discontinued
  operations</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">688,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">--&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Net additions to equipment and leasehold
  improvements</font></p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(24,000)</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(78,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Net Cash provided by (used
  in) Investing Activities&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font> </p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;664,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;
  (78,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Cash Flows from Financing
  Activities:</font></p>
  </td>
  <td width=113 valign=top align="right">

  </td>
  <td width=127 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Net
  principal payments on long-term borrowings </font> </p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">(65,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">(7,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Net
  payments on line of credit </font> </p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">(462,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">(20,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">&nbsp;&nbsp;&nbsp; Stock
  repurchases </font> </p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(2,000)</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">--</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Net Cash (used in)
  Financing Activities</font></p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(529,000)</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">(27,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Net (decrease) in Cash and Cash Equivalents</font></p>
  </td>
  <td width=113 valign=top align="right">
  <p><font size="2">(57,000)</font></p>
  </td>
  <td width=127 valign=top align="right">
  <p><font size="2">(409,000)</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>
  <p><font size="2">Cash and Cash Equivalents,
  beginning of period&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font> </p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;
  236,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p><font size="2">&nbsp;
  698,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p>&nbsp;</p>
  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">
  <p>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top bgcolor="#C0C0C0">
  <p><font size="2">Cash and Cash Equivalents,
  end of period&nbsp; </font> </p>
  </td>
  <td width=113 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 179,000&nbsp;</font></p>
  </td>
  <td width=127 valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p><font size="2">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 289,000&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  </td>
  <td width=113 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td width=127 valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=500 valign=top>

  &nbsp;</td>
  <td width=113 valign=top align="right">

  &nbsp;</td>
  <td width=127 valign=top align="right">

  &nbsp;</td>
 </tr>
 <tr>
  <td valign=top>



<p><i>Supplemental
Information</i></p>



<p><i>&nbsp; </i></p>



  </td>
  <td valign=top align="right">

  &nbsp;</td>
  <td valign=top align="right">

  &nbsp;</td>
 </tr>
 <tr>
  <td valign=top>

  <font size="2">Cash payments for interest</font></td>
  <td valign=top align="right">

  <p><font size="2">7,000&nbsp;</font></p>

  </td>
  <td valign=top align="right">

  <p><font size="2">16,000&nbsp;</font></p>

  </td>
 </tr>
 <tr>
  <td valign=top>

  &nbsp;</td>
  <td valign=top align="right">

  &nbsp;</td>
  <td valign=top align="right">

  &nbsp;</td>
 </tr>
 <tr>
  <td valign=top>

  <font size="2">Cash payments for income taxes&nbsp; </font>

  </td>
  <td valign=top align="right">

  <p><font size="2">2,000&nbsp;</font></p>

  </td>
  <td valign=top align="right">

  <p><font size="2">10,000&nbsp;</font></p>

  </td>
 </tr>
</table>



</div>

<p><i>&nbsp;See notes to consolidated financial statements.</i></p>



<b><br clear=all>
</b>

<p align="center">-4-</p>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align=center><b>PRO-DEX, INC. AND
SUBSIDIARIES <br>
</b><b>NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS </b></p>

<p align=center><b>&nbsp;</b></p>

<p><b>Basis of
Presentation</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The accompanying unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for
interim financial information and with the instructions to Form 10-QSB and
Regulation S-B. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. These financial statements should be read in conjunction
with the audited financial statements presented in the Company's Annual Report
for the fiscal year ended June 30, 2002.&nbsp;
In the opinion of management, all adjustments (consisting of normal
recurring accruals) considered necessary for a fair presentation have been
included. The results of operations for such interim periods are not
necessarily indicative of the results that may be expected for the full year.
For further information, refer to the consolidated financial statements and
footnotes thereto included in the Company's Annual Report on Form 10-KSB for
the year ended June 30, 2002. </p>

<p align="justify"><b>Inventories</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inventories are
stated at the lower of cost (the first-in, first-out method) or market and
consist of the following: </p>



<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=498 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=210 valign=top style="border-left-style: solid; border-left-width: 1; border-top-style: solid; border-top-width: 1">

  </td>
  <td width=150 valign=top style="border-top-style: solid; border-top-width: 1">
  <p align=center>September 30, 2002<br>
  <u>(unaudited) </u></p>
  </td>
  <td width=138 valign=top style="border-right-style: solid; border-right-width: 1; border-top-style: solid; border-top-width: 1">
  <p align=right>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
  <p align=right>&nbsp;<u>&nbsp;June 30, 2002</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=210 valign=top style="border-left-style: solid; border-left-width: 1">
  <p>Raw materials </p>
  </td>
  <td width=150 valign=top>
  <p align=right>$&nbsp;&nbsp;&nbsp;&nbsp;
  1,286,000&nbsp;</p>
  </td>
  <td width=138 valign=top style="border-right-style: solid; border-right-width: 1">
  <p align=right>$&nbsp;&nbsp;&nbsp;&nbsp; 1,564,000&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=210 valign=top style="border-left-style: solid; border-left-width: 1">
  <p>Work in process </p>
  </td>
  <td width=150 valign=top>
  <p align=right>337,000&nbsp;</p>
  </td>
  <td width=138 valign=top style="border-right-style: solid; border-right-width: 1">
  <p align=right>291,000&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=210 valign=top style="border-left-style: solid; border-left-width: 1">
  <p>Finished goods </p>
  </td>
  <td width=150 valign=top>
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  1,670,000&nbsp;</u></p>
  </td>
  <td width=138 valign=top style="border-right-style: solid; border-right-width: 1">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  1,661,000&nbsp;</u></p>
  </td>
 </tr>
 <tr>
  <td width=210 valign=top style="border-left-style: solid; border-left-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp; Total </p>
  </td>
  <td width=150 valign=top>
  <p align=right>3,293,000&nbsp;</p>
  </td>
  <td width=138 valign=top style="border-right-style: solid; border-right-width: 1">
  <p align=right>3,516,000&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=210 valign=top style="border-left-style: solid; border-left-width: 1">
  <p>Reserve for slow moving items </p>
  </td>
  <td width=150 valign=top>
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (578,000)</u></p>
  </td>
  <td width=138 valign=top style="border-right-style: solid; border-right-width: 1">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (592,000) </u></p>
  </td>
 </tr>
 <tr>
  <td width=210 valign=top style="border-left-style: solid; border-left-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp; Total inventories, net </p>
  </td>
  <td width=150 valign=top style="border-bottom-style: solid; border-bottom-width: 1">
  <p align=right>$&nbsp;&nbsp; &nbsp; 2,715,000&nbsp;</p>
  </td>
  <td width=138 valign=top style="border-right-style: solid; border-right-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p align=right>$&nbsp;
  2,924,000&nbsp;</p>
  </td>
 </tr>
</table>



</div>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the period ending
September 30, 2002, the Company changed the method of classifying its
inventory.&nbsp; Purchased component parts
previously categorized as &quot;Finished goods&quot; are now categorized as &quot;Raw
materials&quot;.&nbsp; The June 30, 2002 inventory
balances have been adjusted from previous reports for proper comparison.</p>

<p align="justify"><b>Intangible
Assets </b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Intangible assets include
patents and the cost of net assets acquired in excess of fair value, which are
amortized on a straight-line basis over their estimated useful lives ranging
from 7 to 20 years. </p>



<p align="justify">Adoption of FAS 142&nbsp;&nbsp; </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On July 1, 2002
the Company adopted SFAS No. 142 &quot;Goodwill and Other Intangible Assets.&quot;&nbsp; Goodwill and other indefinite-lived
intangible assets will no longer be amortized, these assets will be tested
annually for impairment and assets with finite lives will no longer be limited
to forty years.&nbsp; </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company has
$1,110,000 of goodwill in its Micro Motors reporting unit as of June 30 and
September 30, 2002 and has no other indefinite lived assets or amortizing
intangible assets.&nbsp; The final $32,000 of patent amortization was recorded
in the three months ended September 30, 2002.&nbsp; No further amortization is
expected.&nbsp; The Company is in the process of completing step one of its
impairment analysis on goodwill.&nbsp; </p>



<p align="justify">&nbsp;</p>



<p align="center">-5-</p>



<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>



<p align="justify">This will be completed by December 31, 2002.&nbsp; If the
carrying value of the Micro Motors reporting unit exceeds its fair value, the
Company will complete step two of its impairment analysis by June 30, 2003.&nbsp;
If the implied fair value of goodwill in the Micro Motors reporting unit is less
than its carrying value, an impairment charge will be recorded as a cumulative
effect of a change in accounting principle in the first quarter ending September
30, 2002.&nbsp; Amortization expense related to goodwill for the first three
months ended September 30, 2001 was $21,000.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A reconciliation
of previously reported net (loss) and (loss) per share adjusted for the
exclusion of goodwill as follows:</p>



<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=624 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=375 valign=top>

  </td>
  <td width=249 colspan=2 valign=top>
  <p align=center>Three Months Ended September 30,</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>

  </td>
  <td width=129 valign=top>
  <p align=center>2002</p>
  </td>
  <td width=120 valign=top>
  <p align=center>2001</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>

  </td>
  <td width=129 valign=top>

  </td>
  <td width=120 valign=top>

  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Net (loss)</p>
  </td>
  <td valign=top align="right">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (6,000)</p>
  </td>
  <td valign=top align="right">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (11,000)</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>&nbsp;&nbsp;&nbsp; Add goodwill amortization (net of taxes)</p>
  </td>
  <td valign=top align="right">
  <p><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  --&nbsp;</u></p>
  </td>
  <td valign=top align="right">
  <p><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  13,000&nbsp;</u></p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Adjusted net
  income (loss)</p>
  </td>
  <td valign=top align="right">
  <p><u>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (6,000)</u></p>
  </td>
  <td valign=top align="right">
  <p><u>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,000&nbsp;</u></p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>

  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Basic and
  diluted net (loss) per common share&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </p>
  </td>
  <td valign=top align="right">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>&nbsp;&nbsp;&nbsp; Add goodwill amortization</p>
  </td>
  <td valign=top align="right">
  <p><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</u></p>
  </td>
  <td valign=top align="right">
  <p><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</u></p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Adjusted net
  income (loss) per common share</p>
  </td>
  <td valign=top align="right">
  <p><u>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;</u></p>
  </td>
  <td valign=top align="right">
  <p><u>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</u></p>
  </td>
 </tr>
</table>





</div>





<p align="justify"><b>Stock Repurchase Plan</b></p>



<p align="justify">In September 2002, the Company's Board of Directors
authorized the repurchase on the open market of up to 500,000 shares of the
Company's outstanding Common Stock, subject to compliance with applicable laws
and regulations.&nbsp; There is no requirement that the Company repurchase all
or any portion of such shares.&nbsp; The maximum total value of the repurchase
is not to exceed $500,000.&nbsp; This repurchase is to be financed both with
cash generated by operations and through the utilization of the credit facility.&nbsp;
During the two weeks from the plan authorization date to the quarter end date of
September 30, 2002, the Company repurchased 2,300 shares of Common Stock for
$1,470.&nbsp; Through October 31, the Company has repurchased 40,100 shares of
Common Stock for $20,875. </p>



<p align="justify">&nbsp;</p>



<p align="center">-6-</p>

<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>

<p><b>Net (loss) per share </b></p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The following table reconciles the
weighted average shares outstanding for basic and diluted net income per share
for the periods indicated (unaudited).</p>



<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=650 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=375 valign=top>

  </td>
  <td width=249 colspan=2 valign=top align="right">
  <p align=center>Three Months Ended September 30,</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>

  </td>
  <td width=129 valign=top align="right">
  <p align=center>2002</p>
  </td>
  <td width=120 valign=top align="right">
  <p align=center>2001</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>

  </td>
  <td width=129 valign=top align="right">

  </td>
  <td width=120 valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Net (loss)</p>
  </td>
  <td valign=top align="right">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;(6,000)</p>
  </td>
  <td valign=top align="right">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  (11,000)</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Basic net (loss)
  per common share:</p>
  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>&nbsp;&nbsp; Weighted average of common shares outstanding</p>
  </td>
  <td valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,786,500&nbsp;</p>
  </td>
  <td valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,787,300&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Basic net (loss) per common share</p>
  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;</p>
  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>

  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Diluted net income (loss) per share:</p>
  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>&nbsp;&nbsp; Weighted average of common shares outstanding</p>
  </td>
  <td valign=top align="right">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,785,000&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,787,300&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of potentially dilutive securities
  (options)</p>
  </td>
  <td valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
  <td valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of potentially dilutive securities
  (warrants)</p>
  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=bottom>
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Effect of potentially dilutive
  securities (convertible<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred Shares)</p>
  </td>
  <td valign=bottom align="right" style="border-top-style: solid; border-top-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
  <td valign=bottom align="right" style="border-top-style: solid; border-top-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  --&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top>
  <p>Weighted
  average number of common and shares - Diluted</p>
  </td>
  <td valign=bottom align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,785,000&nbsp;</p>
  </td>
  <td valign=bottom align="right" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,787,300&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=375 valign=top bgcolor="#C0C0C0">
  <p>Diluted net income (loss) per common share</p>
  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--&nbsp;</p>
  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --&nbsp;</p>
  </td>
 </tr>
</table>



</div>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common shares issuable
upon conversion of 78,129 shares of preferred stock have not been included in
the 2002 or the 2001 computation because their inclusion would have been
anti-dilutive.&nbsp; In addition, common
shares issuable upon conversion of 85,674 common stock options have not been
included in the 2002 computation because their inclusion would have been
anti-dilutive.&nbsp; There were no such common
stock options as of September 30, 2001 as none had strike prices below the
average price for the quarter.</p>



<p><b>LINE OF CREDIT </b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The subsidiaries of the
Company entered into a credit facility with Wells Fargo Business Credit Inc.
(WFBCI) in May 2002 for borrowings up to $3,000,000 or 80% of eligible accounts
receivable.&nbsp; The terms of the credit
facility expire May 2004 and require monthly interest payments at the prime
rate (4.75% at September 30, 2002) plus 1.00% to 1.75% based on outstanding
borrowings, with a minimum interest charge of $12,500 per quarter.&nbsp; The outstanding borrowings are secured by all
assets of Micro Motors Inc. (&quot;Micro Motors&quot;) and OMS and guaranteed by the
Company.&nbsp; The outstanding balance under
terms of this credit facility as of September 30, 2002 was $176,000.&nbsp; Available borrowing capacity at September 30,
2002 was $948,000.&nbsp; The bank agreement
requires that certain financial and non-financial covenants be maintained.&nbsp; At September 30, 2002 the Company was in
compliance with all covenants.&nbsp; </p>

<p align="justify">&nbsp;</p>

<p align="center">-7-</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p><b>LONG TERM DEBT </b></p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The following table is a summary of long-term
debt (unaudited): </p>



<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=606 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=288 valign=top>

  </td>
  <td width=152 valign=top>
  <p align=right>September 30, 2002</p>
  </td>
  <td width=47 valign=top>
  <p>&nbsp;</p>
  </td>
  <td width=119 valign=top>
  <p align="right"><u>June 30, 2002</u></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top>
  <p>&nbsp;</p>
  </td>
  <td width=152 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=47 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=119 valign=top>
  <p align=right>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=bottom>
  <p>Unsecured note to a shareholder, bearing interest at 7%, payments of $19,600 quarterly, including
  interest to June 30, 2006</p>
  </td>
  <td width=152 valign=bottom>
  <p align=right>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 272,000</p>
  </td>
  <td width=47 valign=bottom>
  <p align=right>&nbsp;</p>
  </td>
  <td width=119 valign=bottom>
  <p align=right>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 272,000 </p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top>
  <p>Less current portion </p>
  </td>
  <td width=152 valign=top>
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp; 75,000</u></p>
  </td>
  <td width=47 valign=top>
  &nbsp;</td>
  <td width=119 valign=top>
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp; 61,000 </u></p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top>
  <p>Total long-term debt </p>
  </td>
  <td width=152 valign=top>
  <p align=right>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 197,000</p>
  </td>
  <td width=47 valign=top>
  &nbsp;</td>
  <td width=119 valign=top>
  <p align=right>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 211,000 </p>
  </td>
 </tr>
 <tr>
  <td width=288 valign=top>

  </td>
  <td width=152 valign=top>
  <p align=right>=======</p>
  </td>
  <td width=47 valign=top>
  &nbsp;</td>
  <td width=119 valign=top>
  <p align=right>======= </p>
  </td>
 </tr>
</table>

</div>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This debt is subordinated to the line
of credit.</p>

<p align="justify"><b>INCOME TAXES </b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred income taxes are
provided on a liability method whereby deferred tax assets are recognized for
deductible temporary differences and operating losses and tax credit carry
forwards and deferred tax liabilities are recognized for taxable temporary
differences. Temporary differences are the differences between the reported
amounts of assets and liabilities and their tax bases. Deferred tax assets are
reduced by a valuation allowance when, in the opinion of management, it is more
likely than not that some portion or all of the deferred tax assets will not be
realized. Deferred tax assets and liabilities are adjusted for the effects of
changes in tax laws and rates on the date of enactment.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Significant
management judgment is required in determining our provision for income taxes
and the recoverability of our deferred tax asset.&nbsp; It is based on our estimates of future
taxable income by jurisdiction in which we operate and the period over which
our deferred tax assets will be recoverable.&nbsp;
In the event that actual results differ from these estimates or we
adjust these estimates in future periods we may need to establish a valuation
allowance which could result in a tax provision equal to the carrying value of
our deferred tax assets.</p>

<p align="justify"><b>STOCK OPTIONS AND WARRANTS AND SUBSEQUENT EVENT</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the quarter ended
September 30, 2002, the Company granted 60,000 Common Stock Options under the
Director's Plan at the average price of $0.54 (fair market value of $0.32), and
380,000 Common Stock Options under the Employee's Plan at the average price of
$0.66 (fair market value of $0.18) respectively. The options vest after a
period of 6 months for the directors.&nbsp;
200,000 employee options vested immediately, and the remainder for the
employees options vest over the course of four years.&nbsp; Both directors and employee options expire in
ten years from the date of the grant.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the quarter ended
September 30, 2002, 400,000 Common Stock Options under the Employee's Plan
expired unused. </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the quarter ended
September 30, 2002, the Company granted 100,000 Common Stock Warrants at a
price of $1.25 (fair market value of $0.16).&nbsp;
The warrants vest immediately and expire in seven years </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The fair value of each
grant is estimated at the grant date using the Black-Scholes option-pricing
model with the following weighted-average assumptions: no dividend rate for all
years; price volatility of 68% to 72%; risk-free interest rates of
approximately 2.8% to 4.1%; and expected lives of five years for the options
and seven years for the warrants.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In October 2002, the
Company issued 65,000 warrants at the price of $0.54 (fair market value of
$0.15).&nbsp; The warrants vest immediately
and expire in three years.&nbsp; </p>



<p align="justify">&nbsp;</p>



<p align="justify">&nbsp;</p>



<p align="center">-8-</p>

<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>

<p align="justify"><b>FUNDS HELD IN
ESCROW, NET, BUSINESS DIVESTITURES AND DISCONTINUED OPERATIONS</b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; On June 12, 2001, the
Company sold substantially all of the assets of its wholly owned subsidiaries,
Biotrol International, Inc. and Challenge Products, Inc. to Young Colorado,
LLC, for a purchase price of $9 million. The assets sold comprised the
Company's line of infection control and preventive chemical products for the
dental industry. &nbsp;There remained an
unreserved escrow balance of $102,000 as of September 30, 2002 that was collected
in full in October 2002.&nbsp; </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the year ended June
30, 2002, the Company received indemnification notices from Young, to recover
alleged losses and costs as they are incurred for certain alleged breaches of
representations and warranties contained in the Young Asset Purchase Agreement
related to compliance issues with the Food, Drug, and Cosmetic Act (&quot;FDCA&quot;),
Federal Insecticide, Fungicide and Rodentcide Act (&quot;FIFRA&quot;), and other related
laws.&nbsp; In February 2002, the Company
settled a complaint with the Environmental Protection Agency (&quot;EPA&quot;) set forth
in Young's indemnification notice for alleged violations of FIFRA.&nbsp; Pursuant to the settlement, the Company will
pay $150,000 to the EPA, over a 15-month period, commencing March 2002.&nbsp; Through September 30, 2002, an amount equal
to $70,000 has been paid, leaving a remaining amount of $80,000 to be paid.</p>

<p align="justify"><b>SEGMENT INFORMATION </b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company's reportable segments are strategic business units that offer different
products and services.&nbsp; They are managed separately
because each business requires different technology and marketing strategies.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After the 2001 divestiture
of Biotrol and Challenge, there are two reportable segments: Micro Motors, and
OMS. The accounting policies applied to determine the segment information are
the same as those described in the summary of significant accounting policies.
Interest expense is allocated based upon the specific identification of debt
incurred by the individual segment. Corporate overhead, the provision for
income taxes, income from discontinued operations, and gain on disposal of
discontinued operations are included in corporate profit, and are not allocated
to the individual reported segments. Intersegment sales and transfers are
accounted for at amounts that management believes provides the transferring
segment with fair compensation for the products transferred, considering their
condition, market demand, and, where appropriate, a reasonable profit that
recognized which segment will be responsible for marketing costs. Management
evaluates the performance of each segment based on income (loss) before income
taxes. </p>



<p align="justify">&nbsp;</p>



<p align="justify">&nbsp;</p>



<p align="center">-9-</p>
<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>


<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating Segment data (unaudited) for the three
months ending September 30, 2002 and 2001 is as follows (in thousands): </p>



<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=700 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=248 valign=bottom>
  <p align=center>Three months ended <br>
  September,
  2002</p>
  </td>
  <td width=83 valign=bottom>
  <p align=center>Micro<br>
  Motors </p>
  </td>
  <td width=115 valign=bottom>
  <p align=center>Oregon<br>
  Micro Systems </p>
  </td>
  <td width=99 valign=bottom>

  <p align=center>Corporate </p>
  </td>
  <td width=74 valign=bottom>
  <p align=center>Total</p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Sales from external customers </p>
  </td>
  <td valign=top align="right">
  <p align=right>$2,077</p>
  </td>
  <td valign=top align="right">
  <p align=right>$&nbsp;&nbsp;&nbsp; 640 </p>
  </td>
  <td valign=top align="right">
  <p align=right>--&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$2,717&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Depreciation and amortization </p>
  </td>
  <td valign=top align="right">
  <p align=right>70</p>
  </td>
  <td valign=top align="right">
  <p align=right>43</p>
  </td>
  <td valign=top align="right">
  <p align=right>--&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>113&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Interest expense </p>
  </td>
  <td valign=top align="right">
  <p align=right>13</p>
  </td>
  <td valign=top align="right">
  <p align=right>--</p>
  </td>
  <td valign=top align="right">
  <p align=right>--&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>13&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Segment profit (loss) </p>
  </td>
  <td valign=top align="right">
  <p align=right>143</p>
  </td>
  <td valign=top align="right">
  <p align=right>71 </p>
  </td>
  <td valign=top align="right">
  <p align=right>(220)</p>
  </td>
  <td valign=top align="right">
  <p align=right>(6)</p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Segment assets </p>
  </td>
  <td valign=top align="right">
  <p align=right>5,560</p>
  </td>
  <td valign=top align="right">
  <p align=right>1,069 </p>
  </td>
  <td valign=top align="right">
  <p align=right>2,331&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>8,960&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Expenditure for segment assets </p>
  </td>
  <td valign=top align="right">
  <p align=right>15 </p>
  </td>
  <td valign=top align="right">
  <p align=right>9 </p>
  </td>
  <td valign=top align="right">
  <p align=right>--&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>24&nbsp;</p>
  </td>
 </tr>
</table>



</div>

<p>&nbsp;</p>

<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=701 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=248 valign=bottom>
  <p align=center>Three months ended <br>
  September,
  2001</p>
  </td>
  <td width=85 valign=bottom>
  <p align=center>Micro<br>
  Motors </p>
  </td>
  <td width=118 valign=bottom>
  <p align=center>Oregon<br>
  Micro Systems </p>
  </td>
  <td width=95 valign=bottom>

  <p align=center>Corporate</p>
  </td>
  <td width=77 valign=bottom>
  <p align=center>Total</p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Sales from external customers</p>
  </td>
  <td valign=top align="right">
  <p align=right>$2,381 </p>
  </td>
  <td valign=top align="right">
  <p align=right>$&nbsp;&nbsp; 789&nbsp; </p>
  </td>
  <td valign=top align="right">
  <p align=right>--&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$3,170&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Depreciation and amortization </p>
  </td>
  <td valign=top align="right">
  <p align=right>88 </p>
  </td>
  <td valign=top align="right">
  <p align=right>115&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>20&nbsp; </p>
  </td>
  <td valign=top align="right">
  <p align=right>223&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Interest expense </p>
  </td>
  <td valign=top align="right">
  <p align=right>15 </p>
  </td>
  <td valign=top align="right">
  <p align=right>--&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>1&nbsp; </p>
  </td>
  <td valign=top align="right">
  <p align=right>16&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Segment profit (loss) </p>
  </td>
  <td valign=top align="right">
  <p align=right>325 </p>
  </td>
  <td valign=top align="right">
  <p align=right>(62)</p>
  </td>
  <td valign=top align="right">
  <p align=right>(274)</p>
  </td>
  <td valign=top align="right">
  <p align=right>(11)</p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Segment assets </p>
  </td>
  <td valign=top align="right">
  <p align=right>6,313 </p>
  </td>
  <td valign=top align="right">
  <p align=right>2,025&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>3,354&nbsp; </p>
  </td>
  <td valign=top align="right">
  <p align=right>11,692&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=248 valign=top>
  <p>Expenditure for segment assets </p>
  </td>
  <td valign=top align="right">
  <p align=right>55 </p>
  </td>
  <td valign=top align="right">
  <p align=right>23&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>--&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>78&nbsp; </p>
  </td>
 </tr>
</table>

</div>

<p><b>&nbsp;</b></p>

<p align="justify"><b>Item
2. Management's Discussion and Analysis </b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Except for the historical
information contained herein, the matters discussed in this Quarterly Report on
Form 10-QSB, including discussions of the Company's product development plans,
business strategies and market factors influencing the Company's results, are
forward-looking statements that involve certain risks and uncertainties. Actual
results may differ from those anticipated by the Company as a result of various
factors, both foreseen and unforeseen, including, but not limited to, the
Company's ability to continue to develop new products and increase systems
sales in markets characterized by rapid technological evolution, consolidation
within the Company's target marketplace and among the Company's competitors,
and competition from larger, better capitalized competitors. Many other
economic, competitive, governmental and technological factors could impact the
Company's ability to achieve its goals.&nbsp;
Interested persons are urged to review the risks described below, as
well as in the Company's other public disclosures and filings with the
Securities and Exchange Commission.</p>



<p align="justify"><b>Company Overview</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pro-Dex, Inc. (or the
&quot;Company&quot;) is a Colorado corporation, organized in 1978, doing
business through two wholly owned operating subsidiaries, Micro Motors, Inc.
(&quot;Micro Motors&quot;) and Oregon Micro Systems, Inc. (&quot;OMS&quot;).
Micro Motors, headquartered in Santa Ana, California, manufactures electric,
air, and battery driven rotary drive systems for the medical device industry,
electric and air hand pieces for the dental industry, and miniature pneumatic
motors for industrial applications. OMS is headquartered in Beaverton, Oregon,
where it designs and manufactures motion controllers used to control the motion
of servo and stepper motors, predominantly for the semiconductor industries and
medical analysis equipment. </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Over the course
of the past three years, the Company has evolved significantly in response to
changing market conditions.&nbsp; This
evolution includes the strategic refocusing of the Company's subsidiaries, the
development of new products, technologies and customer relationships, the
re-casting of operational infrastructure, the divestiture of segments of the
Company's operations, and the consolidation of the Company's executive offices
and staff.</p>



<p align="justify">&nbsp;</p>



<p align="center">-10-</p>



<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>



<p align="justify"><b>Pro-Dex</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; For the better
part of the past three years, Pro-Dex has investigated several opportunities
with various potential strategic investors.&nbsp;
These activities culminated in the divestiture of the Company's Biotrol
and Challenge subsidiaries in June of 2001.&nbsp;
The proceeds from that transaction were used to retire all of the
Company's existing bank debt at the time, leaving the Company virtually debt
free as of June 30, 2001, but less than half in size.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In response to the
reduction in the Company's operations, the Company's executive operations in
Colorado were consolidated into the Micro Motors facilities in Santa Ana,
California.&nbsp; The executive staff was
eliminated and the corresponding functions were integrated into existing
operational positions at Micro Motors and OMS.&nbsp;
This effort to reduce corporate overhead is hoped to save the Company
approximately $1 million in fiscal year 2003.</p>



<p align="justify"><b>Micro Motors</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Micro Motors designs,
develops and manufactures pneumatic, electric and battery powered rotary drive
systems for use in the medical, dental and industrial markets. Micro
distributes its own line of pneumatic and electric dental hand pieces sold
under the trademarks Dynatorq&trade;, Dynapro&trade;, Dynalite&trade;, Dynasurg&trade;, and Micro
Handpiece&trade;, as well as numerous lines of private label drive systems for use in
dental, cranial, spinal, arthroscopic and orthopedic surgery. Micro Motors also
designs and manufactures miniature pneumatic motors for industrial applications
in the automotive, aerospace, apparel and entertainment industries. </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Significant
aspects of the Micro Motors subsidiary have changed in the last three
years.&nbsp; Historically known as a precision
manufacturer of dental hand pieces, Micro Motors has shifted its focus to the
development and exclusive supply of rotary drive systems for strategic partners
in the medical, dental and industrial segments of the commercial
marketplace.&nbsp; This new approach to the
market has proved to be very effective in generating new revenue streams with
gross margins significantly higher than Micro's historical business.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Internally,
Micro Motors has consolidated its operations and reduced the expenses related
to those operations, while continuing to grow overall sales and develop new
products.&nbsp; This includes reducing its
workforce by 30% and consolidating its manufacturing operations to a 20,000 sq.
ft. facility from a 38,000 facility since 1999.&nbsp;
At the same time, Micro Motors has increased the size of its Engineering
and Product Development group, further enabling it to respond to market demands
for new products and new technologies.</p>



<p align="justify"><b>OMS</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; OMS designs, develops,
manufactures, and markets multi-axis embedded motion controllers. The OMS
controllers are specifically designed for the purpose of controlling servo and
stepper motors to execute desired motion specific to the customer's
application.&nbsp; OMS' motion controllers are
used in a wide range of applications including semiconductor wafer handling
equipment, medical diagnostic equipment, photon accelerators and observatories.
The OMS controllers support a platform for PCI, VME, ISA, cPCI busses as well
as other embedded platforms.&nbsp; Other
products include motors, drivers, cables, software and a variety of accessories
to meet most any embedded motion requirement.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During the past
three years, OMS has both benefited and suffered from the rapidly changing
environment of the semiconductor industry, which is characterized by dramatic
and sometimes volatile changes in demand for products.&nbsp; While recording two of its best operational
performances in its fiscal year 2000 and fiscal year 2001 with revenues in each
year exceeding $7,000,000, OMS has been impacted severely by the downturn in
the semiconductor industry that began in November of 2000 and continues to this
day. </p>



<p align="justify">&nbsp;</p>



<p align="center">-11-</p>

<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In response to
the rapidly changing market conditions, OMS also drastically reduced its number
of employees, made deep cuts in sales and marketing expenses and focused on
maximizing the sales of existing product to existing customers.&nbsp; At the same time, OMS accelerated the development
of a new generation of motion control technology, based on the PowerPC power
chip.&nbsp; This new servo/stepper controller
will be available early in fiscal year 2003 and will be expanded on to create a
full line of new products.&nbsp; OMS is also
developing new customer relationships with companies outside the semiconductor
industry.</p>



<p align="justify"><b>Risk Factors</b></p>

<p align="justify"><b>Competition</b>&nbsp; </p>

<p align="justify"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i>The
markets for healthcare and semiconductor industries are intensely competitive,
and the Company faces significant competition from a number of different
sources.&nbsp; Several of the Company's
competitors have significantly greater name recognition as well as
substantially greater financial, technical, product development and marketing
resources than the Company.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company competes in all of its
markets with other major healthcare and semiconductor related companies.
Competitive pressures and other factors, such as new product or new technology
introductions by the Company or its competitors, may result in price or market
share erosion that could have a material adverse effect on the Company's
business, results of operations and financial condition. Also, there can be no
assurance that the Company's products and services will achieve broad market
acceptance or will successfully compete with other competing products.&nbsp; <b><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i></b></p>

<p align="justify"><b>Fluctuation in Quarterly
Operating Results</b>&nbsp; </p>

<p align="justify"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i>The
Company's revenues have fluctuated in the past, and may fluctuate in the future
from quarter to quarter and period to period, as a result of a number of
factors including, without limitation: the size and timing of orders from
customers; the length of new product development cycles; market acceptance of
new technologies; changes in pricing policies or price reductions by the
Company or its competitors; the timing of new product announcements and product
introductions by the Company or its competitors; changes in revenue recognition
guidelines established by the Financial Accounting Standards Board or other
rule-making bodies; the financial stability of major customers; the Company's
success in expanding its sales and marketing programs; deferrals of customer
orders in anticipation of new products; changes in Company strategy; personnel
changes; and general market/economic factors. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Because a significant percentage of
the Company's expenses are relatively fixed, a variation in the timing of sales
can cause significant variations in operating results from quarter to quarter.
As a result, the Company believes that interim period-to-period comparisons of
its results of operations are not necessarily meaningful and should not be relied
upon as indications of future performance. Further, the Company's historical
operating results are not necessarily indicative of future performance for any
particular period.&nbsp; </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Due
to all of the foregoing factors, it is possible that in some future quarter(s)
the Company's operating results may be below the expectations of public market
analysts and investors. In such event, the price of the Company's Common Stock
would likely be materially adversely affected.</p>



<p align="justify"><b>Dependence on Principal Product
and New Product Development</b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company currently derives a
substantial part of its net revenues from sales of its core healthcare and
motion control products and services. The Company believes that a primary
factor in the market acceptance of its product and services is the value that
is created for its customers by those products and services. The Company's
future financial performance will depend in large part on the Company's ability
to continue to meet the increasingly sophisticated needs of its customers through
the timely development, successful introduction and implementation of new and
enhanced products and services. The Company has historically expended a
significant percentage of its net revenues on product development and believes
that significant continued product development efforts will be required to
sustain the Company's growth. Continued investment in the Company's sales and
marketing efforts will also be required to support future growth. </p>

<p align="justify">&nbsp;</p>

<p align="center">-12-</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There
can be no assurance that the Company will be successful in its product
development efforts, that the market will continue to accept the Company's
existing products, or that new products or product enhancements will be
developed and implemented in a timely manner, meet the requirements of its
customers, or achieve market acceptance. If new products or product
enhancements do not achieve market acceptance, the Company's business, results
of operations and financial condition could be materially adversely affected. </p>



<p align="justify"><b>Technological Change</b></p>

<p align="justify"><b><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i></b>The
healthcare and semiconductor markets are generally characterized by rapid
technological change, changing customer needs, frequent new product
introductions, and evolving industry standards. The introduction of products
incorporating new technologies and the emergence of new industry standards
could render the Company's existing products obsolete and unmarketable. There
can be no assurance that the Company will be successful in developing and
marketing new products that respond to technological changes or evolving
industry standards.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; New product development
depends upon significant research and development expenditures that depend
ultimately upon sales growth. Any material weakness in revenues or research
funding could impair the Company's ability to respond to technological advances
in the marketplace and to remain competitive. If the Company is unable, for
technological or other reasons, to develop and introduce new products in a
timely manner in response to changing market conditions or customer
requirements, the Company's business, results of operations and financial
condition may be materially adversely affected.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In
response to increasing market demand, the Company is currently developing new
products. There can be no assurance that the Company will successfully develop
these new products or that these products will operate successfully, or that
any such development, even if successful, will be completed concurrently with
or prior to introduction of competing products. Any such failure or delay could
adversely affect the Company's competitive position or could make the Company's
current products obsolete.</p>



<p align="justify"><b>Litigation</b></p>

<p align="justify"><i>&nbsp;</i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Company continually faces the possibility of litigation as either a
plaintiff or a defendant.&nbsp; It is not reasonably possible to estimate the
awards or damage, or the range of awards or damages, if any, that the Company
might incur in connection with such litigation. The uncertainty associated with
potential litigation may have an adverse impact on the Company's business. In
particular, such litigation could impair the Company's relationships with
existing customers and its ability to obtain new customers. Defending such
litigation may result in a diversion of management's time and attention away
from business operations, which could have a material adverse effect on the
Company's business, results of operations and financial condition. Such
litigation may also have the effect of discouraging potential acquirers from
bidding for the Company or reducing the consideration such acquirers would
otherwise be willing to pay in connection with an acquisition. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There can be no assurance
that such litigation will not result in liability in excess of its insurance
coverage, that the Company's insurance will cover such claims or that
appropriate insurance will continue to be available to the Company in the
future at commercially reasonable rates.</p>

<p align="justify"><b>Proprietary
Technology </b></p>

<p align="justify"><i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </i>The
Company is dependent on the maintenance and protection of its intellectual
property and relies on license agreements, exclusive development and supply
agreements, confidentiality procedures, and employee nondisclosure agreements
to protect its intellectual property. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There can be no assurance that the
legal protections and precautions taken by the Company will be adequate to
prevent misappropriation of the Company's technology or that competitors will
not independently develop technologies equivalent or superior to the Company's.
Further, the laws of some foreign countries do not protect the Company's
proprietary rights to as great an extent as do the laws of the United States
and are often not enforced as vigorously as those in the United States.</p>

<p align="justify">&nbsp;</p>

<p align="center">-13-</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
Company does not believe that its operations or products infringe on the
intellectual property rights of others. However, there can be no assurance that
others will not assert infringement or trade secret claims against the Company
with respect to its current or future products or that any such assertion will
not require the Company to enter into a license agreement or royalty
arrangement with the party asserting the claim. </p>

<p align="justify"><b>Ability to Manage
Growth</b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company has in the past
experienced periods of growth that have placed, and may continue to place, a
significant strain on the Company's resources. The Company also anticipates
expanding its overall development, marketing, sales, client management and
training capacity. In the event the Company is unable to identify, hire, train
and retain qualified individuals in such capacities within a reasonable
timeframe, such failure could have a material adverse effect on the Company. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In addition, the Company's
ability to manage future increases, if any, in the scope of its operations or
personnel will depend on significant expansion of its research and development,
marketing and sales, management, and administrative and financial capabilities.
The failure of the Company's management to effectively manage expansion in its
business could have a material adverse effect on the Company's business,
results of operations and financial condition.</p>



<p align="justify"><b>Dependence Upon Key
Personnel</b>&nbsp; </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company's future
performance also depends in significant part upon the continued service of its
key technical and senior management personnel, many of whom have been with the
Company for a significant period of time.&nbsp;
The Company does not maintain key man life insurance on any of its
employees. Because the Company has a relatively small number of employees when
compared to other leading companies in the same industry, its dependence on
maintaining its relationship with key employees is particularly significant.
The Company is also dependent on its ability to attract and retain high quality
personnel, particularly in the areas of product development and operations
management. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The healthcare and semiconductor
industries are characterized by a high level of employee mobility and the
aggressive recruiting of skilled personnel. There can be no assurance that the
Company's current employees will continue to work for the Company. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of services of key employees
could have a material adverse effect on the Company's business, results of
operations and financial condition. Furthermore, the Company may need to grant
additional stock options to key employees and provide other forms of incentive
compensation to attract and retain such key personnel.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
Company has experienced changes in some of its key management positions in the
past year as it has streamlined its operations.&nbsp;
In the year ended June 30, 2002, Kent Searl retired as President and
Chief Executive Officer of the Company and was replaced on an interim basis by
Frank Zagar.&nbsp; Mr. Zagar completed a
substantial part of the Corporate reorganization and on September 1 2002,
resigned his operating position, while remaining a Director.&nbsp; Patrick Johnson, Micro Motors President,
assumed the role of the President and Chief Executive Officer of the Company in
addition to his pre-existing role as President of Micro Motors.&nbsp; In May 2002, George Isaac, resigned his
operating position as Treasurer and Chief Financial Officer, while remaining
Corporate Secretary and a Director, to focus on other business opportunities,
and Jeffrey J. Ritchey assumed the role of the Treasurer and Chief Financial
Officer in addition to his pre-existing role as Controller of Micro
Motors.&nbsp; The Company believes that the
new CEO and CFO have the background, and experience necessary to be able to
perform the duties required for these positions.</p>



<p align="justify">&nbsp;</p>



<p align="center">-14-</p>



<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>



<p align="justify"><b>Product Liability</b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company maintains
insurance to protect against claims associated with the use of its products,
but there can be no assurance that its insurance coverage would adequately
cover any claim asserted against the Company. A successful claim brought
against the Company in excess of its insurance coverage could have a material
adverse effect on the Company's business, results of operations and financial
condition. Even unsuccessful claims could result in the Company's expenditure
of funds in litigation and management time and resources.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There can be no assurance that the
Company will not be subject to product liability claims, that such claims will
not result in liability in excess of its insurance coverage, that the Company's
insurance will cover such claims or that appropriate insurance will continue to
be available to the Company in the future at commercially reasonable rates.
Such claims could have a material adverse affect on the Company's business,
results of operations and financial condition. </p>



<p align="justify"><b>Exchange Delisting</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
Company received a notice from the NASDAQ that unless its stock price
maintained a $1.00 per share closing price for ten consecutive trading
sessions, the Company's stock would be delisted on December 3, 2002.&nbsp; Under the current rules, management believes
the delisting will be extended another 180 days if the Company maintains
$5,000,000 of stockholders equity.&nbsp;
Management believes it will maintain the required stockholders equity
level, postponing the delisting deadline.&nbsp;
However, there is no assurance that the Company will meet these exchange
listing requirements in the future or that the Company's shares will maintain a
sufficiently high price to eliminate future delisting notices and subsequent
delisting.</p>



<p align="justify"><b>Critical Accounting Estimates and Judgments</b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Our
consolidated financial statements are prepared in accordance with accounting
principles generally accepted in the United States (GAAP).&nbsp; The preparation of our financial statements
requires management to make estimates and judgments that affect the reported
amounts of assets, liabilities, revenues, expenses and related
disclosures.&nbsp; We base our estimates on
historical experience and various other assumptions that we believe to be
reasonable under the circumstances, the results of which form the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources.&nbsp;
Actual results may differ from these estimates under different
assumptions or conditions.&nbsp; The
significant accounting policies that we believe are the most critical to aid in
fully understanding and evaluating our reported financial results include
inventory valuations for slow moving items, allowances for funds in escrow,
impairment of goodwill, and potentially the most significant, the recovery of
deferred income tax assets.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As
part of the process of preparing our consolidated financial statements we are
required to estimate our income taxes in each of the jurisdictions in which we
operate.&nbsp; This process involves us
estimating our actual current tax liabilities together with assessing temporary
differences resulting from differing treatment of items for tax and accounting
purposes.&nbsp; These differences result in
deferred tax assets and liabilities, which are included within our consolidated
balance sheet.&nbsp; The most significant tax
assets are future deductions from the amortization on intangibles over the next
ten years.&nbsp; Tax assets also result from
net operating losses and research and development tax credits.&nbsp; We must then assess the likelihood that our
deferred tax assets will be recovered from future taxable income and to the
extent we believe that recovery is not likely, we must establish a valuation
allowance.&nbsp; To the extent we establish a
valuation allowance or increase this allowance in a period, the impact will be
included in the tax provision in the statement of operations.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Significant
management judgment is required in determining our provision for income taxes
and the recoverability of our deferred tax asset.&nbsp; It is based on our estimates of future
taxable income by jurisdiction in which we operate and the period over which our
deferred tax assets will be recoverable.&nbsp;
In the event that actual results differ from these estimates or we
adjust these estimates in future periods we may need to establish a valuation
allowance which could result in a tax provision equal to the carrying value of
our deferred tax assets. </p>

<p align="justify"><b>&nbsp;</b></p>

<p align="center">-15-</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify"><b>Results of
Operations</b></p>

<p align="justify"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </b>The
following table sets forth for the periods indicated, the percentage of net
revenues represented by each item in the Company's Consolidated Statements of
Income (unaudited). </p>

<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width="700" style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=471 rowspan=2 valign=top>

  </td>
  <td width=229 colspan=2 valign=top>
  <p align=center>Three Months Ended <br>
  September 30,</p>
  </td>
 </tr>
 <tr>
  <td width=113 valign=top>
  <p align=center>2002</p>
  </td>
  <td width=116 valign=top>
  <p align=center>2001</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>

  </td>
  <td width=113 valign=top>

  </td>
  <td width=116 valign=top>

  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Net Revenues:
  </p>
  </td>
  <td valign=top align="right" width="113">
  <p>100.0%&nbsp;</p>
  </td>
  <td valign=top align="right" width="116">
  <p>&nbsp;100.0%&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>

  </td>
  <td valign=top align="right" width="113">

  </td>
  <td valign=top align="right" width="116">

  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Cost of Goods Sold</p>
  </td>
  <td valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1" width="113">
  <p>&nbsp;57.7&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" style="border-bottom-style: solid; border-bottom-width: 1" width="116">
  <p>&nbsp;56.2&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>

  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1" width="113">

  </td>
  <td valign=top align="right" style="border-top-style: solid; border-top-width: 1" width="116">

  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Gross Profit </p>
  </td>
  <td valign=top align="right" width="113">
  <p>42.3&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" width="116">
  <p>43.8&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Selling, General and Administrative Expenses</p>
  </td>
  <td valign=top align="right" width="113">
  <p>27.0&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" width="116">
  <p>23.7&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Research and Development Costs</p>
  </td>
  <td valign=top align="right" width="113">
  <p>14.2&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" width="116">
  <p>12.0&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Amortization</p>
  </td>
  <td valign=top align="right" width="113" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>1.1&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" width="116" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>3.8&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>

  </td>
  <td valign=top align="right" width="113" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td valign=top align="right" width="116" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Losses from Operations</p>
  </td>
  <td valign=top align="right" width="113">
  <p>(0.0)&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" width="116">
  <p>(0.1)&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>

  </td>
  <td valign=top align="right" width="113" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
  <td valign=top align="right" width="116" style="border-bottom-style: solid; border-bottom-width: 1">

  </td>
 </tr>
 <tr>
  <td width=471 valign=top>

  </td>
  <td valign=top align="right" width="113" style="border-top-style: solid; border-top-width: 1">

  </td>
  <td valign=top align="right" width="116" style="border-top-style: solid; border-top-width: 1">

  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Loss before Provision for Income Taxes</p>
  </td>
  <td valign=top align="right" width="113">
  <p>(0.0)&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" width="116">
  <p>(0.1)&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top>
  <p>Provision for
  Income Taxes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>
  </td>
  <td valign=top align="right" width="113" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>(0.0)&nbsp;&nbsp;&nbsp;</p>
  </td>
  <td valign=top align="right" width="116" style="border-bottom-style: solid; border-bottom-width: 1">
  <p>0.1&nbsp;&nbsp;&nbsp;&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=471 valign=top bgcolor="#C0C0C0">
  <p>Net Loss</p>
  </td>
  <td valign=top align="right" width="113" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p>(0.0%)</p>
  </td>
  <td valign=top align="right" width="116" style="border-top-style: solid; border-top-width: 1; border-bottom-style: solid; border-bottom-width: 1" bgcolor="#C0C0C0">
  <p>(0.0%)</p>
  </td>
 </tr>
</table>

</div>

<p><b>&nbsp;For the
Three-Month periods Ended September 30, 2002 and 2001 </b></p>

<p align="justify"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net Loss.</b>&nbsp; The Company's net (loss) for the three months
ended September 30, 2002 was ($6,000) or ($0.00) per share on a basic and
($0.00) per share on a diluted basis, as compared to a net (loss) of ($11,000)
or ($0.00) per share on a basic and ($0.00) per share on a diluted basis, for
the three months ended September 30, 2001.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b>Net Sales.</b>&nbsp; Consolidated sales decreased 14% for the
quarter ended September 30, 2002, compared to the quarter ended September 30,
2001, primarily due lower sales to dental customers at Micro Motors and to
continued slowness at OMS. At Micro Motors, sales decreased 13% for the quarter
ended September 30, 2002 compared to the quarter ended September 30, 2001.&nbsp; The comparative sales decline was due to the
high incidence of one time stocking shipments made last year.&nbsp; Sales of dental products fell 15% in the
quarter ended September 30, 2002 from the quarter ended September 30, 2001.
Sales to medical customers rose 15% compared to the previous year's quarter.
Sales to industrial customers declined 45% for the quarter. The overall decline
in sales was due to one time stocking orders received for major new product
launches last year.&nbsp;&nbsp; Absent those
accelerated sales associated with initial orders, sales remained flat.&nbsp; Revenue at Oregon Micro Systems decreased 19%
for the quarter ended September 30, 2002 compared to the previous year's same
quarter. The steep decline was caused by the continuing reduction in orders
from customers in the semiconductor fabrication equipment industry. Sales to
customers outside the semiconductor industry were flat for the quarter. </p>



<p align="justify">&nbsp;</p>



<p align="center">-16-</p>

<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>


<p align="justify">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;
Net sales by subsidiary and type of customer were as follows
(unaudited): </p>



<div align="left">



<table border=0 cellspacing=0 cellpadding=0 width=677 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=230 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=15 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=302 colspan=3 valign=top>
  <p align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Three Months Ended September
  30,<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2001</p>
  </td>
  <td width=130 valign=top>
  <p align=center>Increase/<br>
  (Decrease)</p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p>&nbsp;&nbsp; Dental</p>
  </td>
  <td width=15 valign=top align="right">
  <p>$</p>
  </td>
  <td width=138 valign=top align="right">
  <p align=right>1,307,000</p>
  </td>
  <td width=51 valign=top align="right">
  <p>$</p>
  </td>
  <td width=113 valign=top align="right">
  <p align=right>1,531,000</p>
  </td>
  <td width=130 valign=top align="right">
  <p align=right>(15%)</p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p>&nbsp;&nbsp; Medical</p>
  </td>
  <td width=15 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
  <td width=138 valign=top align="right">
  <p align=right>502,000</p>
  </td>
  <td width=51 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
  <td width=113 valign=top align="right">
  <p align=right>436,000</p>
  </td>
  <td width=130 valign=top align="right">
  <p align=right>15%&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p>&nbsp;&nbsp; Industrial</p>
  </td>
  <td width=15 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
  <td width=138 valign=top align="right">
  <p align=right>148,000</p>
  </td>
  <td width=51 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
  <td width=113 valign=top align="right">
  <p align=right>267,000</p>
  </td>
  <td width=130 valign=top align="right">
  <p align=right>(45%)</p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p>&nbsp;&nbsp; Repair &amp;
  Other</p>
  </td>
  <td width=15 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
  <td width=138 valign=top align="right">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 120,000</u></p>
  </td>
  <td width=51 valign=top align="right">
  <p align=center>&nbsp;</p>
  </td>
  <td width=113 valign=top align="right">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 147,000</u></p>
  </td>
  <td width=130 valign=top align="right">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (18%)</u></p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p>Micro Motors </p>
  </td>
  <td width=15 valign=top align="right">
  <p align=right>$</p>
  </td>
  <td width=138 valign=top align="right">
  <p align=right>2,077,000
  </p>
  </td>
  <td width=51 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td width=113 valign=top align="right">
  <p align=right>2,381,000
  </p>
  </td>
  <td width=130 valign=top align="right">
  <p align=right>(13%)</p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>

  </td>
  <td width=15 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td width=138 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td width=51 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td width=113 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td width=130 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top>
  <p><u>Oregon Micro Systems </u></p>
  </td>
  <td width=15 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td width=138 valign=top align="right">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 640,000 </u> </p>
  </td>
  <td width=51 valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td width=113 valign=top align="right">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 789,000&nbsp;&nbsp;
  </u> </p>
  </td>
  <td width=130 valign=top align="right">
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (19%)&nbsp; </u> </p>
  </td>
 </tr>
 <tr>
  <td width=230 valign=top bgcolor="#C0C0C0">
  <p>Total</p>
  </td>
  <td width=15 valign=top align="right" bgcolor="#C0C0C0">
  <p align=right>$ </p>
  </td>
  <td width=138 valign=top align="right" bgcolor="#C0C0C0">
  <p align=right>2,717,000
  </p>
  </td>
  <td width=51 valign=top align="right" bgcolor="#C0C0C0">
  <p align=right>$ </p>
  </td>
  <td width=113 valign=top align="right" bgcolor="#C0C0C0">
  <p align=right>3,170,000&nbsp;&nbsp; </p>
  </td>
  <td width=130 valign=top align="right" bgcolor="#C0C0C0">
  <p align=right>(14%)&nbsp; </p>
  </td>
 </tr>
</table>





</div>





<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b>Gross Profits</b>.&nbsp; The Company's consolidated gross profit for
the quarter ended September 30, 2002 decreased 17% over the same quarter in the
previous year due to reduced sales at both operating divisions. Gross profit as
a percentage of sales decreased to 42% for the quarter ended September 30, 2002
compared to 44% for the quarter ended September 30, 2001 caused by less
absorption of manufacturing overhead and fixed costs over a smaller revenue
base, fewer high margin product launches at Micro Motors partially offset by
higher margins in the remaining OMS sales. </p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Gross profits by subsidiary were as follows (unaudited): </p>



<table border=0 cellspacing=0 cellpadding=0 width="608">
 <tr>
  <td width=168 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=30 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=270 colspan=3 valign=top>
  <p align=center>Three Months Ended September
  30,</p>
  </td>
  <td width=30 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=110 valign=top>
  <p align=center>Increase/</p>
  </td>
 </tr>
 <tr>
  <td width=168 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=30 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=120 valign=top>
  <p align=center>2002</p>
  </td>
  <td width=38 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=112 valign=top>
  <p align=center>2001</p>
  </td>
  <td width=30 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=110 valign=top>
  <p align=center>&nbsp;(Decrease)</p>
  </td>
 </tr>
 <tr>
  <td width=168 valign=top>
  <p>Micro Motors </p>
  </td>
  <td width=30 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=120 valign=top>
  <p align=right>694,000&nbsp;&nbsp; </p>
  </td>
  <td width=38 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=112 valign=top>
  <p align=right>881,000&nbsp;&nbsp; </p>
  </td>
  <td width=30 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=110 valign=top>
  <p align=right>(187,000)&nbsp; </p>
  </td>
 </tr>
 <tr>
  <td width=168 valign=top>
  <p><u>Oregon Micro Systems </u></p>
  </td>
  <td width=30 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=120 valign=top>
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 456,000&nbsp;&nbsp; </u> </p>
  </td>
  <td width=38 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=112 valign=top>
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 509,000&nbsp;&nbsp;
  </u> </p>
  </td>
  <td width=30 valign=top>
  <p align=right>&nbsp;</p>
  </td>
  <td width=110 valign=top>
  <p align=right><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (53,000)&nbsp; </u> </p>
  </td>
 </tr>
 <tr>
  <td width=168 valign=top bgcolor="#C0C0C0">
  <p>Total</p>
  </td>
  <td width=30 valign=top bgcolor="#C0C0C0">
  <p align=right>$ </p>
  </td>
  <td width=120 valign=top bgcolor="#C0C0C0">
  <p align=right>1,150,000&nbsp;&nbsp; </p>
  </td>
  <td width=38 valign=top bgcolor="#C0C0C0">
  <p align=right>$ </p>
  </td>
  <td width=112 valign=top bgcolor="#C0C0C0">
  <p align=right>1,390,000&nbsp;&nbsp; </p>
  </td>
  <td width=30 valign=top bgcolor="#C0C0C0">
  <p align=right>$ </p>
  </td>
  <td width=110 valign=top bgcolor="#C0C0C0">
  <p align=right>(240,000)&nbsp; </p>
  </td>
 </tr>
</table>





<p align="justify">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b>Operating Expenses</b>.&nbsp; Operating expenses decreased to $1,152,000
for the quarter ended September 30, 2002 from $1,414,000 for the quarter ended
September 30, 2001, a decrease of 18.5%. The decrease is mainly due to cost
saving measures implemented at the corporate and divisional level in response
to the lower sales and reduced corporate activity. </p>



<p align="justify">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b>Research and Development Costs</b>.&nbsp; Research and development expenses increased
slightly to $385,000 for the quarter ended September 30, 2002 from $379,000 for
the quarter ended September 30, 2001, an increase of 1.6%. The increase is
mainly due to the maintenance of research work at Micro Motors and OMS to
support new product development. </p>



<p align="justify">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b>Net interest expense. </b>&nbsp;Net interest expense was $13,000 in the first
quarter of fiscal 2002 due to the full quarter use and availability of the
credit line. </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Provision for Taxes</b>. The Company's
effective tax rate on income (loss) from operations is 40% for the quarters
ended September 30, 2002, and 2001. </p>



<p align="justify">&nbsp;</p>



<p align="justify">&nbsp;</p>



<p align="center">-17-</p>

<hr color="#000080"><p style="page-break-after: always"></p>



<p align="justify">&nbsp;</p>

<p align="justify"><b>Liquidity and Capital Resources </b></p>

<p align="justify">The following table presents selected financial statistics and
information for the comparative quarter last year and the last quarter
(unaudited):</p>

<div align="left">

<table border=0 cellspacing=0 cellpadding=0 width=700 style="border-collapse: collapse" bordercolor="#111111">
 <tr>
  <td width=294 valign=top>
  <p><i>&nbsp;</i></p>
  </td>
  <td width=216 colspan=2 valign=top>
  <p align=center>Quarter
  Ended September 30,</p>
  </td>
  <td width=114 valign=top>
  <p align=center>Quarter
  Ending</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td width=108 valign=top>
  <p align=center>2002</p>
  </td>
  <td width=108 valign=top>
  <p align=center>2001</p>
  </td>
  <td width=114 valign=top>
  <p align=center>June
  30, 2002</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td width=108 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=108 valign=top>
  <p align=center>&nbsp;</p>
  </td>
  <td width=114 valign=top>
  <p align=center>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>
  <p>Cash and cash equivalents </p>
  </td>
  <td valign=top align="right">
  <p align=right>$179,000&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$289,000&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$236,000&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>
  <p>Net cash provided by (used
  from) operations </p>
  </td>
  <td valign=top align="right">
  <p align=right>($192,000)</p>
  </td>
  <td valign=top align="right">
  <p align=right>($304,000)</p>
  </td>
  <td valign=top align="right">
  <p align=right>($929,000)</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>
  <p>Working Capital</p>
  </td>
  <td valign=top align="right">
  <p align=right>$4,051,000&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$4,823,000&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$3,999,000&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>
  <p>Credit Line outstanding
  balance </p>
  </td>
  <td valign=top align="right">
  <p align=right>$176,000&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$0&nbsp;</p>
  </td>
  <td valign=top align="right">
  <p align=right>$638,000&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=294 valign=top>

  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
  <td valign=top align="right">

  </td>
 </tr>
 <tr>
  <td width=294 valign=bottom>
  <p>Number of days of sales
  outstanding in accounts receivable at end of quarter </p>
  </td>
  <td valign=bottom align="right">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 58&nbsp;</p>
  </td>
  <td valign=bottom align="right">
  <p align=center>46&nbsp;</p>
  </td>
  <td valign=bottom align="right">
  <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 56&nbsp;</p>
  </td>
 </tr>
</table>

</div>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company's working
capital at September 30, 2002 increased to $4.1 million from $4.0 million at
June 30, 2002 a reduction of $0.8 million from the same period last year.&nbsp; Cash Flow (used from) Operations was ($192,000)
in the quarter ended September 30, 2002 compared to ($304,000) for the quarter
ended September 30, 2001. While the loss from continuing operations was similar
between the periods, the change in working capital components caused an
improvement in cash flow from operating activities.&nbsp; Management believes that the Company's
working capital needs over the next twelve months can be adequately supported
by current operations. Following the sale of the Biotrol and Challenge
operations, management has taken steps to reduce corporate overhead and
consolidate operations for greater efficiency.&nbsp;
These efforts have continued through the present time by eliminating all
corporate headcount and associated expenses and consolidating its operations
with existing Micro Motors and OMS facilities and staff. </p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The subsidiaries of the Company
obtained a $3,000,000 revolving line of credit from WFBCI in May 2002 to fund
their working capital and other general needs.&nbsp;
There was $176,000 outstanding on the line of credit as of September 30,
2002, down $462,000 from June 30, 2002.&nbsp;
The facility has a two year term and is based on Micro Motors and OMS
accounts receivables and secured by those receivables and all other assets of
Micro Motors and OMS.&nbsp; The borrowings of
Micro Motors and OMS are guaranteed by Pro-Dex, Inc. The interest rate on the
facility is based on prime rate (4.75% at September 30, 2002) plus a 1.00% to
1.75% margin based on outstanding borrowings.&nbsp;
There is a minimum interest charge of $12,500 per quarter on the credit
facility.&nbsp; There are certain financial
and non-financial covenants that the Company must meet to be in compliance with
the terms of the credit facility.&nbsp; As of
September 30, 2002, OMS and Micro Motors were in compliance with all covenants.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In September 2002, the Board of
Directors approved, at managements' discretion, the repurchase of up to 500,000
shares of common stock.&nbsp; The maximum
total value of the repurchase is not to exceed $500,000.&nbsp; This repurchase is to be financed both with
cash generated by operations and through the utilization of the WFBCI credit
facility.&nbsp; The Company has repurchased 2,300
shares in the quarter ending September 30, 2002.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
Company believes that its cash and cash equivalents on hand at September 30,
2002, together with cash flows from operations, if any, will be sufficient to
meet its working capital and capital expenditure requirements for the balance
of fiscal 2003.</p>



<p align="justify">&nbsp;</p>



<p align="center">-18-</p>



<hr color="#000080"><p style="page-break-after: always"></p>
<p align="justify">&nbsp;</p>

<p align="justify"><b>Item 3. Controls and Procedures</b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Our Chief
Executive Officer and Chief Financial Officer (our principal executive officer
and principal financial officer, respectively) have concluded, based on their
evaluation as of November 1, 2002 (&quot;Evaluation Date&quot;), that the
design and operation of our &quot;disclosure controls and procedures&quot; (as
defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of
1934, as amended (&quot;Exchange Act&quot;)) are effective to ensure that
information required to be disclosed by the Company in the reports filed or
submitted by us under the Exchange Act is accumulated, recorded, processed,
summarized and reported to our management, including our principal executive
officer and our principal financial officer, as appropriate to allow timely
decisions regarding whether or not disclosure is required.</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There were no
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the Evaluation Date, nor
were there any significant deficiencies or material weaknesses in our internal
controls. As a result, no corrective actions were required or undertaken.</p>

<p><b>&nbsp;</b></p>



<p>&nbsp;</p>



<p align="center">-19-</p>



<hr color="#000080"><p style="page-break-after: always"></p>


<p align=center><b>PART II <br>
OTHER INFORMATION </b></p>

<p align=center>&nbsp;</p>

<p> <b>Item
1 - Legal Proceedings </b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company is a party to
various legal proceedings incidental to its business, none of which are
considered by the Company to be material at this time.</p>

<p> <b>Item 2. &nbsp;&nbsp;&nbsp;&nbsp; Changes in Securities
and Use of Proceeds. </b>&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None.</p>

<p> <b>Item 3. &nbsp;&nbsp;&nbsp;&nbsp; Defaults Upon Senior
Securities. </b>&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None.</p>

<p> <b>Item 4. &nbsp;&nbsp;&nbsp;&nbsp; Submissions of Matters
to a Vote of Securities Holders. </b>&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None.</p>

<p> <b>Item 5. &nbsp;&nbsp;&nbsp;&nbsp; Other Information. </b>&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None.</p>

<p> <b>Item 6. &nbsp;&nbsp;&nbsp;&nbsp; Exhibits and Reports on
Form 8-K. </b>&nbsp;</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Exhibits</u>:</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.32&nbsp;&nbsp;&nbsp; Warrant agreement with Robert Hovee
dated October 2, 2002<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.33&nbsp;&nbsp;&nbsp; Consulting agreement with Robert Hovee
dated October 2, 2002<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.34&nbsp;&nbsp;&nbsp; Warrant agreement with Ronald G. Coss dated October 3, 2002<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Officers' Certification</p>







<p>Pursuant to the requirements of the Securities Exchange
Act of 1934, the Company has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</p>



<table border=0 cellspacing=0 cellpadding=0>
 <tr>
  <td width=309 valign=top>
  <p>Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; November 13,
  2002&nbsp;&nbsp;&nbsp; </p>
  </td>
  <td width=411 valign=top>
  <p>/s/ Patrick L.
  Johnson </p>
  </td>
  <td width=0 valign=top>

  </td>
 </tr>
 <tr>
  <td width=309 valign=top>
  <p>&nbsp;&nbsp; </p>
  </td>
  <td width=411 valign=top>
  <p>_______________________________ </p>
  </td>
  <td width=0 valign=top>

  </td>
 </tr>
 <tr>
  <td width=309 valign=top>
  <p>&nbsp;&nbsp; </p>
  </td>
  <td width=411 valign=top>
  <p>Patrick L. Johnson, Chief Executive Officer and
  President </p>
  </td>
  <td width=0 valign=top>

  </td>
 </tr>
 <tr>
  <td width=309 valign=top>

  </td>
  <td width=411 valign=top>
  <p>&nbsp;&nbsp;&nbsp; </p>
  </td>
  <td width=0 valign=top>

  </td>
 </tr>
 <tr>
  <td width=309 valign=top>
  <p>Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; November 13,
  2002&nbsp;&nbsp;&nbsp; </p>
  </td>
  <td width=411 valign=top>
  <p>/s/ Jeffrey J. Ritchey </p>
  </td>
  <td width=0 valign=top>

  </td>
 </tr>
 <tr>
  <td width=309 valign=top>
  <p>&nbsp;&nbsp; </p>
  </td>
  <td width=411 valign=top>
  <p>_______________________________ </p>
  </td>
  <td width=0 valign=top>

  </td>
 </tr>
 <tr>
  <td width=309 valign=top>
  <p>&nbsp;&nbsp; </p>
  </td>
  <td width=411 valign=top>
  <p>Jeffrey J. Ritchey, Chief Financial Officer </p>
  </td>
  <td width=0 valign=top>

  </td>
 </tr>
</table>

&nbsp;<p>&nbsp;</p>
<p>&nbsp;</p>
<p align="center">-20-</p>
<hr color="#000080"><p style="page-break-after: always"></p>
<p>&nbsp;</p>


<p align="justify">I, Patrick L. Johnson,
certify that:</p>

<p align="justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I
have reviewed this quarterly report on Form 10-QSB of Pro-Dex, Inc.;</p>



<p align="justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report; </p>



<p align="justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this quarterly report; </p>



<p align="justify">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
registrant's other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and we have:</p>



<blockquote>



<p align="justify">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; designed
such disclosure controls and procedures to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which
this quarterly report is being prepared;</p>



<p align="justify">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; evaluated
the effectiveness of the registrant's disclosure controls and procedures as of
a date within 90 days prior to the filing date of this quarterly report (the
&quot;Evaluation Date&quot;); and</p>



<p align="justify">c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; presented
in this quarterly report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;</p>



</blockquote>



<p align="justify">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
registrant's other certifying officers and I have disclosed, based on our most
recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):</p>



<blockquote>



<p align="justify">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; all
significant deficiencies in the design or operation of internal controls which
could adversely affect the registrant's ability to record, process, summarize
and report financial data and have identified for the registrant's auditors any
material weaknesses in internal controls; and</p>



<p align="justify">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls; and</p>



</blockquote>



<p align="justify">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
registrant's other certifying officers and I have indicated in this quarterly
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.</p>



<p>Date: November 13,
2002</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div align="right">
  <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse" bordercolor="#111111" width="400" id="AutoNumber1">
    <tr>
      <td> <u>/s/
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patrick
L. Johnson&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></td>
    </tr>
    <tr>
      <td>Patrick
L. Johnson</td>
    </tr>
    <tr>
      <td>Chief
Executive Officer</td>
    </tr>
  </table>
</div>
<p>&nbsp;</p>
<p align="center">-21-</p>
<hr color="#000080"><p style="page-break-after: always"></p>
&nbsp;<p align="justify">I, Jeffrey J. Ritchey,
certify that: </p>



<p align="justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I
have reviewed this quarterly report on Form 10-QSB of Pro-Dex, Inc.;</p>



<p align="justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based
on my knowledge, this quarterly report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this quarterly
report; </p>



<p align="justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Based
on my knowledge, the financial statements, and other financial information
included in this quarterly report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this quarterly report; </p>



<p align="justify">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
registrant's other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-14 and 15d-14) for the registrant and we have:</p>



<blockquote>



<p align="justify">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; designed
such disclosure controls and procedures to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in
which this quarterly report is being prepared;</p>



<p align="justify">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; evaluated
the effectiveness of the registrant's disclosure controls and procedures as of
a date within 90 days prior to the filing date of this quarterly report (the
&quot;Evaluation Date&quot;); and</p>



<p align="justify">c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; presented
in this quarterly report our conclusions about the effectiveness of the
disclosure controls and procedures based on our evaluation as of the Evaluation
Date;</p>



</blockquote>



<p align="justify">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
registrant's other certifying officers and I have disclosed, based on our most
recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):</p>



<blockquote>



<p align="justify">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; all
significant deficiencies in the design or operation of internal controls which
could adversely affect the registrant's ability to record, process, summarize
and report financial data and have identified for the registrant's auditors any
material weaknesses in internal controls; and</p>



<p align="justify">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any
fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls; and</p>



</blockquote>



<p align="justify">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
registrant's other certifying officers and I have indicated in this quarterly
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.</p>



<p>Date: November 13,
2002</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div align="right">
  <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse" bordercolor="#111111" width="400" id="AutoNumber2">
    <tr>
      <td>&nbsp;<u>/s/
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; JEFFREY J. RITCHEY&nbsp;&nbsp;&nbsp; </u>
      </td>
    </tr>
    <tr>
      <td>Jeffrey
J. Ritchey</td>
    </tr>
    <tr>
      <td>Chief
Financial Officer</td>
    </tr>
  </table>
</div>
<p>&nbsp;</p>
<p align="center">-22-</p>

</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>10QSB
<SEQUENCE>3
<FILENAME>prodex10q.pdf
<DESCRIPTION>PDF DOCUMENT
<TEXT>
<PDF>
begin 644 prodex10q.pdf
M)5!$1BTQ+C,-)>+CS],-"C$@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R
M96YT(#<V(#`@4B`-+U)E<V]U<F-E<R`R(#`@4B`-+T-O;G1E;G1S(#,@,"!2
M(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V
M,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TR(#`@;V)J#3P\(`TO
M4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`X-"`P(%(@
M+U14-"`X."`P(%(@+U14-B`V-R`P(%(@+U14."`V."`P(%(@/CX@#2]%>'1'
M4W1A=&4@/#P@+T=3,2`Y,"`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S4@
M.#<@,"!2(#X^(`T^/B`-96YD;V)J#3,@,"!O8FH-/#P@+TQE;F=T:"`U-C4W
M("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)A%?O;]LX$OWN
MOX(?`IP$V*KX0Q2YW](FNYM%T>PU.N`.N_?!M9U+"M?N.DY;[%]_,T.*HAV-
MD@*UI#>4R#>/PS=ON]F;KE-"BNY^9BMO10W_Z$+;JC:U%497M1/=E]F;=T^-
M6#U11"V>5K,WO]Q)\;^GF8+XNE&B6\UJT7V?%4*(LOL,-PM9>:=@]!4B*T#P
MN53T!OC1LJY:!1_1=67Q&XNZJFO94.Q"+3#Z;%;*5-9D([+WPDI,6(F4,/?P
M$;KJU](:@R_!8?@='+J(5]]G?Q0WQTT),Y+%EW*A*E\(60E\`%?E?[O?LHG[
M>NR%JDUOQ$M\Y<^EU%53/)8U_+];[E:EQ=OE5MP=RZ9JBV7XV7PI)?T2OBN!
M.5D$Z(F^#8NSXXN3OJT:>SJ9+!>1F9ACW[/I\QRW6E<*![X@,JU8J;92-<9*
M#QE(R:HI6?T5+OEWI$P7'TL)D[]=E`N87G%U72Z0B'_/Q<V'=Y4(A"Z:2FI4
M":;\*K[0I1>Z\,)WMQ_NR@7DO;A]CV]QQ<W591>NKL//%7S,%.)MN+LL)=[&
MX,L/[V*4B*_Y%6[[D?&G`]Y5$?$XNX&U!:S(T3QUTO(IO6:,7@.S0'IMZR%#
M)_RZ$*]<U39>P&J5D?1J6+<99"2CC.XV7U$,!G5BBD^;0^F`8M@$<Q"H*B`Q
M2'I;*`'*K;V%R-^>=QNAP^,:]:2+N5`QKE9AB=?=3(I',=,*]&FEL,Y7L%_K
MRL!RZ?_#9G;_.HQ"3+#7E;8Y;J2I3,T.1]BY!#M7>97C30T9XH>_`@]S=U6/
M@CR@7IW-;10>7CX*O^W8O962;QU.:WQ71AE`,5/.XUZ+$D"U])7$!@F(/PNL
M);IXWBV?UX^@5PT%`O_?E!I2NOZS##A(P#2U'0:\%AZ%D(AJVX'',:88/%'%
MX(&KZ8W28$%*M47IQ-@?Q>7='>Q561?=W=GNA.4HY2-YPW$`)X6S;9-M+E_)
M5K8A@D)PU4V8M(52:U^*9QJ%FN&FT-8F5#E=C>N2&=WOJ0#S>VI\>-I3`>;W
MU*OK'DME/O=)J3!X_G5&*HQ`X(AKA_-6IJ/"QZ.BQ-+W#-51%H?#9G<4RZ=X
MB(;3%38:;(,%5(KXZ">LF,K4'J[ATDO8KFVV*2(1C1YHPL/EC(=Q.-$P#B<6
MQF&>!$UBB"08/YP6D06!?^]*7.2RU+!0!R?O0W0RRUVX6(O5\JE_N/GK.5P]
ME@MD\%NXP]%;H,D"<\"9+.+8(ST+[P72I`((?ZV"A,KB`J\CI;+U<RPTOH`L
MP7-M+"SF)$1IFX><,6\4+I:7((,G[AD\D<_@//NP,9U)[.N!?9VQ_S/YB>=@
MA7;A9XVG,$JQ1<H?PD,BMD66>UP\EDT_1&Q"].JP!Q"-RG?TB1:.\ET_7D&^
M("%8TB`#36/@PWCIR5#"E0,F"EFK>1V&A#QHA^]Y&=CZ.@\\RP:<5+!X/AL,
MGK+!X"D;#,YG`R>J4D$PJ2#8+!F7J*ZV6*WV6!D,VFL-:S\^E4#`8;/:/'ZC
MYTMRZ9^V&V07'T!R8!(0*?;W8KG=8A*0J^^E`CX@/L`A>+41]Z%]V(?W'\0Z
M?O#3\3Y<;"E)4&_D5+$!APUKXDEF\$0R@R>2&9PEN?%H?GK%FT'Q)B,9_Y8E
M3*$)1`,3)LB8Y`FT0+TH@,@RE(L+!8($A2UCS)J<[(6R07T&U4=D&2=QOX0_
M&;`Y^?W&A3L_K_LQF;)'!E@5P_(!9^37[9C12]R/PXGZ<3@Q/P[SQ+NV]XY`
MMW:)^;XUHB7>[*#4.ZC9^#]TL,!6>'(L,1O[PR-5$22AQBYH%P.QJX'34%#/
MT'BD(Y*F*"*$MY)N&J0,+UY2G$?[<&.RZ%-^&V\G+06']PQS>$\QA_,<MTUF
M*3)Q9PS_#OKUQ:%<4,7]NGP$8L%"B\T/4%'Q=8,2IKH.!V7X(>EZYV5/$XH;
MGEFK\J*L/*G]M"2/A8?T.!.$.T*K,U,&A8$3J>-PXG0<YBFU)C,H>C`H=6Y0
MKC90"B1Y"X5F;2V.RQ\EF@-\@#22N5!2U09EV_\1-::AR*@S/Z)*/O",N59/
M&@P.3]PQ>"*/P7GV&I49##UT@B=G&FUZ6ZSV7TJEZ*@B[W!<TK8VQ0^"^],-
MKY<4`:<;2M,IY8:J&KG2F@+KP)7E21T)/"/5RDF?P.&)5`9/I#(X3ZJI<U*'
M;5YG9UC<=,%"=>1K-1[F"BW`<BM6S[!:0XT%76!]A9,,6@QR=92#!FU%F_A"
M2^:M'JAN:"062U,83S<NT#AV>MD\6K^(/B.]J8=S_66CR<*AT8PPVV@RP_M&
M,\)LH\E]/4[=^&F],'B:'(.GKS,XZ"6()5.*5KB$H)308*)","-E]WEFX"#%
M(=W5#*Q@J&U%@+),:#<LUJ(.3U<S#J?%C,-I+>,P+WVE\FK<#-)O@O2O_T)=
M-P6>:JKXBHT9*)#JBHXVH2%'`=I&NX87:['=H.Y!_WW$`P'[[1H:F`7XG/X-
M7P^TDWRQ_T81??SX!\([YWU7N8M#@@L_^:/=&O98XU5;M6=%REL:&_=+,^H-
M\?F<7'^MZ*;)HL]VEY8G=?S\A!V'AYR.PD-.1V$^IY)"(:=0QK4)MJ7N*UDI
MF<ZBD>%U7(7@X%@A`LQ7B/'AJ4($F*\0S->'J9LIW\C@^>3&\/SK8SB;`@--
MD:=ME3;3*NTPS,/M\0%L(^D=#^@#G!-/&]I<*/.?T-IHZ15:&[85;*!A\%/F
MA,'3JAD\K9K!^55#1V+2.6J&CD3F'<DM'8Q'6OX#-EK8;F`).%"S81JC*CIJ
M0:A-;G`;%SNSTS[C9:!N\\!3T@RT`&;B,.'PGC0.[TGC<)XT:#'2D<*9C]X/
MRV@C,D=LICW&:34\O1F]6H`C<:=EL#<96M&-Y2W)*]%GJ8#.P:N)5#!X2@6#
MIU0P.)\*:$T&&ZB&3*B3=@_/53+,NCB2V5.@9G1Q3Z6-O2ZP&8!-"!/[>]0C
M&+WE:O7\A9J-9]SZKM@NCYLU[7Q$Z;P+IV.Q/QP?_UX>'_?A5<,[+M3<>C6O
MZ3%TAS`7*+M%"%L'FFM8<B4;:]&,T'8<SG;99.O)TG]1TF&K8!)X]%D;[FT]
MQP_`L4>=J*J5\^<[5%FH>*Y8+.!5`9O8GBINSY&#U$!#U.\>15[K5!+C<%+$
M.)P$,0[S>L`+EP31#H)H!P)_V>_7WTN%QN1QNSWQ)F%#NIA^25N5TD]-&.5?
M8_[1$=D8NQ9+\C[-D'X2AXEO'%YU(>?6Z3D2WF)J`HS,G_04DIZC*-M"AIO8
MFK7,!IZ(/DM64T\>NQR>TL7@*5\,SB=,^3QA+]TLT\BIT,@UU,@AOC\^9-[R
M(**;[3TM&<YPD_5R;6M2W569>Z1.#GYXKYE'-_4K7M-H-^736#CXM`BS/HT9
MWONT"+,^C?OZ,/5)P3!X/KE)P3`X+QC99H(9=2PH$(D5OZ/:[%$JDDH^&I@E
M.9<M7:-*X/M%^#]XFA`5GF"9E!ZF:HL+2KL+'F5.&]_;Z%C&3$Z(]V/Q;L+K
M*#NI%`Z.2@DPKY3QX4DI`>:5PGQ]F/JD4A@\G]RD4A@<E/*FZXR0HKN?!<%D
M:@%#[():4DL%6>T^,^K2OJW4T`28U`1$9_?^YO)MN7!016[PQQ7OR4;$FRZ_
MN::;.W'Y`=2G07Y7XN[7RX_QYOK7V_=7_35%?KS[1W\278=/_!/,B2[^U;_\
M/Z056*L*:X6DMTIY6`+ZA;/E250$K2]<:=O^G_-JV8T;QZ+[_@HM`K0*<&I$
M2J*HR2I(;P88S&+B93;E*L513[G**<M!SWQ&?_'<%ZD7KY*T#=@BS^7KO@](
MDT9*Z?@]S'/"Q9B!-1,WQ-XF\@@PW\*4&BQNR/#*#2?XAH]BWV*CDYFEE_#>
M:*[TZBJ!P:/&:WFB2&E\#4;O4YX<]#6V*<;CRQ;Z2L+3)R?@\>@DK&;(TCNT
M>'1B&YU8FN(/KY#B/#*2"W;&F!BQC&7G_O#`$_VY'WHFMS9G;EL;7W!+Z-NR
M)98[3UUE6Y/+:?&OX4$+&A[4H.&Z'IH*A4*E,&.E,+&UP"=6D*T_4+I_Q:QL
M2#$#4%YXXS.T=/35TU\J)"WT=20GC1V(G1/HHPCQ>JPM-K]1@)?Y$Z?_[-0]
MR$'#=(<,&Y4F_\(['&Z=?%WYG%-W8X$T84Q11RA+#?*!-_3BHITV]TTM]<C,
MZ]=4TF,[:RPP0Q%<5:[23^(V97X%C^97\&A^!=?-[\K85K9C6]FN;/^O71G:
M29.C';"QM]0Y0E`\,\$S^7^1X$'SD#^<6>8[R@^:#Q-X7(RAD6"9@G2+/4&A
M<#`2*8/(0NW-ELY38%1X"HS:3H&ZJNO`NE9!13Z/7M:=>E(;*SAC'?(4TJ06
M]/E#JDZI=JIXC#!;EW,-LOLVZ+YXE*IIDG.EG\@MU.WF_*9:*#P-1Y6GX:CT
M-*RKO0*/CFI'%HFD]/T.7F/SX_$J^?N5WL)*)N):_91OKWPZJ7;6O*D<GC+1
M:559XKNH3-+Z2J)Q]51BH>^JQ2?J'J[@4>,*'E6NX+K.K<?B'XNK7Z43TK\!
M_7.R=Z1_3Q2TS4]9]P<-G[L+&@'B@O\E'3SMX[BM@_?5*=^MV'?]=WP<WCZ1
M6^B\;/")NLX5/.I<P:/.%5S7.5`^;FAFBO['A1X@?HY%U5K*W51",<\@V4,'
MM_D?$QN(PI\#!LZ/TP<"*0#J9<917#[:PYC68A7/$N6U;;"\MG-VN)#D_+1E
M$^NVFRL%CS91\&@3!==M4M1B$PP#&WO,24"`>@KLJN!]KB[@T??$=VHLM7!J
M/AS.V?&5:P2VHIXZ44P$THFB$'>B+S]L#,E$;6$K;+[XQ]#>=UB(?%[QQA7-
M.1X(5/"H($@&,YOACTUL5M)<^P.;+<QJJBG9&8F26%6#F4<)K%(I93G"WD?8
M^WUK4Y1'.WV\^J9'*OCT<IL>J>"J1]H6&T18"3X)21J*8T5.&?QQ!RG0>8JW
MA1$*N]VY*GA\B8+'ERBX_A)O,9),I"YNI"Z.G_//G2GSZ^7Q[8[XQ`"$KB2.
MT1#'0%("Z;#$Z"..@7#&_XACP/P!6`:Z)G$+ARP#P@8`&0/70&G@&G?9A:=X
M?]D,N0\>C2%,*,4P?8D$<2?\ZJ?GB@PF!2R^U;0X&<B5\#"`M69!4J4UAIF(
M2^1*VQJU04MAP8XI+-@PA>GV:^!B/^V&MFGW&U57@>/ETW"\?QK6GU![?@(Y
M7<SN)F3W:4JO.*57DM(Y=U>3W`W,RI26?"+DXX93*/JI8^&*YDH>"%3PJ"!(
M!HE\O-ZLGJ[8W&QA`[!,;`?7^5B%.1\+K.9C97G(QP*K^5@[/5R]V72?-#Q>
M+0F/1R=AW7TJMW?%7\C%MG:;!M!@,0##N@'2RZ,!&-8-H)P>KEYO&B`-CU=+
MPN/125@W`%R*J2&5C=J%"/920#Y`Q$)]:/*GIQYC@:BA<?#_"?I@`[D><BX$
MV66'/>S`(B^P!@K'##I1N8%H/"*UI$Q`XXNLZ67;RV/<4B0#TO$0>CQR!F.H
M[L,O?V%K:@MZ$[1T4N"A<-71H]"A[G^?>A'P@Y'50=%:VD+!HS$4/%I#P75S
M`#,IG=XM?_Q"I1AJ,']<SU!W0=OP\OQ7K(@0*=U7[I5[+-,&38+_@+P4D%C_
M3C72MX9+JQ9=I<%KZ#ZJX%$O"A[UHN"Z7J"$^VKL=&P5->-BKGA;MI!]\H_=
M#8K)CMFLA:>_%\4<KY=O.R0:W6WH'\Y=]GSK/F-S`%X,3<DIPT5?2`(4C(-W
M88L+S1(?<<@(;QGO=`#7KO/S*V_[#FK:5UB!'0A/];L25I\.`Q@#L@5T8C2=
MB0L7\/H]D%1XPV_<P=FQ@[/\,+XD4LY.&B>;'SMJJXB_OH$K%=DS4%;DMK<,
M6:OGYHP<Y=T.HRLS!;)+FBSNPD>QDN9Q=GCEF8$6"WR]]33\7W>2344[C;\S
MEF7:Z<-J%Q]FVV@PP^\"_8+J4-VMJ!N&&>FI$A`<NX9_KR0#]CE<Z.N477EJ
M$($A`&@?D\L>//=(?\--A?;A%:'<U"VD#50VZIKOR0D0%&M*,Q8AC_Z:6U^B
MYHPTD]#0<->I"2QB"G*:#SP%,E2U[#@5/,:4@L>84G`UIDSC8.-)3*U,-,;4
M!VJ&KN3;%C(_IF?^>V6=7V9J7MF6S/0N8RE9$L,(9':&@PC,_(ZME]7HICA3
MC!]9VFD.X@X\#VY*'LK;I-TQ$6?^KBEK=N(Q4K@C1,>C\2D#*?XLF8'`QSJ*
M)%PEECAH>/`B<<7.+'M>8[!!?3,BR9%WV"%U"I)\FY[%+CQZE"M#,8:2&P+X
MF<'NR-OP%;[)V6?>`"J"Y58;[.$,*I)Z[JB$DC\,[[52RKR_7BTKM67SL#"P
M1?!:Z#.*150H<`@*!0XQH<!Z2-3EI/QB!A`G64?$>\RW57XDO4.C`F]L(5.]
MM=0902C"`.ON^2#8`#8_<;WQ5!=\?NR';/ZS,V!$^C.;D4\HE2'EX,^GG#=K
M^-2[UM*)7H8%C8KBTPZ)5>O*[RVTB84+8SD[J]M+8Z7A:*PT'(V5AG5CX8</
MQJJJ,:*K2#XA(Y<-%US\H=BM*%BJO/0\<N*B55ZL..-\0<NC:KI@H2`@NZU3
M:8D*,RT16*4ERO)`2P16:8EV^GCURNL]GX9/+Y?"IZ>G<-V^%H=_@1N:TH_O
M3+U$P>-+%#R^1,'UEQB/Y3BDE=%3"_'4?T/2;B!;=_TWB#UL*S$=8XLJ!96:
M/8.5TX)S4I-'%0*FCO^A)=GS*_V_<2["1G;<"<4[^IHW0K/\LO4%Q72:>2+R
M*7=T3$M)HTIFFXEP0T)N)KRPG6U05;KM%#S:3L&C[11<MUWAQ'8_YX/0*$$4
MJHE`@R41,*PG@O3RF`@8UA.!<OIX]4T3*/CT<ILF4'#5!&TUB9Y$YX8^7=<5
MU.'['6U(C>JBASHS8UGRG4!M&#YU-Q;X4\A5]U5Z,^Z@AM`YT1R>ZR"(9\4B
MM&*EX5$S-D#IZK)<X*<+%DX%&MQR*@T6IV)8=ZKT\NA4#.M.I9P^7GW3J11\
M>KE-IU)PU:F\Q=O^;%BW9GQCXA4*'!ZAP.$-"JP^H2GD"51*?&!O=@P+5V,E
MB!\8'A43,*1QP^&<G?O#`X_Z<S_TW0OR$@<1<.+9[.4+#2E4\$/6GJF:("-I
M(+@ZC#>3WU[^!`968]BPU"LMZ4EVH+I40_`X9@]@,B!09?Y&3L(?3^`=ECF;
MMPPXFBMX()",BBDTAM=TQU;=T?_`CG/K^R*RB77T*2#''H%JY"67AK@C4(VZ
M]*E\W:;==%8%#I=2X'"P`H.S%L%9BZFSNF9?<+,>(PWT>__[+V75[&T-XO>_
MR0SPJV8V,5H`@E*W@`*R!0A4+9!<&BQ`H&J!]*ERW6:BI+V=8V[?J.E2`=W>
M^@!:#Q4OK8?DJ0%,[QRT1*BNIM3.$4SN')5(J*[%U,X13.Z\C8(C_NW^WF=`
M'S[_TG+RS$"!!3IC[8,S8D=1KSJ*CQWD,4QK^#>[7`?^PC8Z&W;0OS3<BD.*
M.!)RQ7[!YA>4N)Y[%CD=8!THML$\2<*?!;D<1)Y7R^R!I<[2W6/7(G(\X$L\
M089JY/O"*P9<L(_9ZO\#`#72NS`*96YD<W1R96%M#65N9&]B:@TT(#`@;V)J
M#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`W-B`P(%(@#2]297-O=7)C97,@
M-2`P(%(@#2]#;VYT96YT<R`V(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W
M.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^
M(`UE;F1O8FH--2`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@
M#2]&;VYT(#P\("]45#(@.#0@,"!2("]45#0@.#@@,"!2("]45#@@-C@@,"!2
M(#X^(`TO17AT1U-T871E(#P\("]'4S$@.3`@,"!2(#X^(`TO0V]L;W)3<&%C
M92`\/"`O0W,U(#@W(#`@4B`^/B`-/CX@#65N9&]B:@TV(#`@;V)J#3P\("],
M96YG=&@@,S,Y."`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(
MB;1738_<-A*]SZ_0P0<*F%;X32FWQ/8&7F3M(.X%%LCLH3VMQ!/8,X.>=F+D
MUV\5BZ38W2PE#K`S@%K28U'%>L57Q6^W5U]MM[I3W?;G*S],OI/P'V^,'Z25
MOK-FD&.W_7CUU?,GU]T^Q1&R>[J]^NJ[MZK[Y>E*PWCI=+>]O9+=]O<KT75=
MO_T5'C9JF$8-UB\0N04$WRL=9X`?H^00-'S$R,'C-S9RD%*Y.'9C-CCZS"MM
M!V\KBVK>*8^<:O^##3B.AL!B+2VV<B(/-&:P=AFKQF$RN`3TYP6Y)J-K^>[W
MJY_$#SVLP8@?>S4$\6;3;\+@Q(N7_<;`[W^NNU>OGP]=_]_M/Z\`D=,R'TZB
M+4ZWR;<XW_,>%BC>]'+0XG6\?]N#C15OOG_U(CY_$Z_;E_34O=WV$\#Y[;]Z
M#Y8OR73[MGOSCUX9>`..Q%?U_&EL#P[`1-')<9#AU$=3>/U)W(C>BW_W#JSN
M=Y_V=T=XG&&24>QO^FB_9)-2$%:*<;PS)F#8?.<GC<^KW,G$B1_!S_&$OY&F
MUX-7UJ&K6MHQ.VM]":CRY/,6_'/B/07QT(_@^SQWN'0C'NZ/L!@CWC_%]]W+
M^_V\[][.O;+`YB.!\\?>#)-XAT3C<C5`-`_X>4UA>[F]4MU==V6T&4:I.A_"
M$&!!`[BVB=?#?/7SG\,65EM@Y:8!TJ(:8$?(*LW:_PE<?QV"2C"0`UOWPKR%
M?UN+Q2EA?H2M@WS!#?$E*SDX8VX<@I+C.761.3<$&S>"T+`E.KBH:`WQ+=Y[
MM[KV-EQ;KZZ=P?_*VJU-:]>P(8.>JHT#@JB5GT;8*25A/,@->N0,.JP]?+/I
M,>%LKA`\GEE;"=M\9*T17IG<2E=/'D8N#]OF7I?)6[&L5];DHG)NE2L&!ZX8
MAHQ&=S$[42L6\55)?%_#3@]QBSN!FU^)#I1![.*+#_$%@?BVJ_Y`728')4F)
M9_%9HUA8<=VCZ`1%3^%:2KJ38*#EY.&6QIMZO`II5#T^)TT*K55+X&'I]BRR
M;;@$EH%S7-LP'U:M!A/#JMTP.=S2=>*K408-.GJQ!HB7\2OIP>!E%1R>E\'@
M_#KD-(RVI(=9TL/DVCQ"!7C`4A(@!0)4!<@2T3W\W"N-J8)O=OUF`ABR)>:*
M30.[&W$'K^ZI7;B-R`?H%L0G>K.?T[C#3!.DD?$#CSNTW=.'.WR5G.AVW1ZA
MPWQ+;Z/-H9?%J6>&WN7D,Y!,E2-$BJ22[WTI^DL=E3XS"6DMH=?P0JJ;OHNS
M4_)?W,5)H2V,^GXV\TF;2%:Y5ZS'-79G&J[JO>)\8V]1(Z.,=O_?CX?QSS<J
M=)&04Y2$D-CR?*<R>$ER#L])SN!LDKL1&A^=D[S!\W>'!\Q$+>C:/1XPDV"'
MB[MCK7@-^I?;"MTH[:"`F"6"F$+7/393RE$^8?SBS:*+C=%FNAA]&FPWN6%D
M2S^'4ATE%,HHR$2C4+:-<YTDE"V3;>/*:2"$E4$.KSUKXM7'6SB?(0$F_F(U
M=_"YE5K/P&41#)S7T(;Y)7B3VU`\6ET<VMX\SH?=\>X>]-R)7^*U`]G%J<7G
M^/@X$_@$YP0L^H31T]?=Z1^`5CL,R2:,8<+)SH,#(5OKA#B\A(?#<WP8G`^0
M4W4G-"UR-U5R]S8>[>;>Q-['I^M=O,;Z,4'PX@\&`1I<.#;AXJ$94@ZK4[\9
M+>2*LB#/-%#66_QRH-?UP+,@0H>\TO,P<`DA`^<(MF$^@%:FGB?*Z+C(Z%@%
M\#OH)S%[%"SH'C1K3/>'W8<^AFI';_?=;O\1U^T@N@C0ZSM(J)AU`:)UC`"D
M;?Q-T&]IT@W8@N+.G^,S)B_^DF%&Z>DT<\]%O-]8[S4Q<L:-&\=K&:==YS`X
M58T[H]!.JRT?AQ<2.3RSR.`\C7I,+5]B[$?8]9FQ%+[=X?9]7,_"UG[^K6*3
MN(2.##:A>$0U@#!\[+6&;9*#3Y;$7:R)\)7;AYK9-7J`;&-",]QF='^)%A,F
MGA:8NS01+5H8O-#"X9D6!N=I4:%N4M2RNU2UN[Z!&&/\'P['NS]`SK$GIJVC
M*``&TJ$*:0JGB0,TTC4)ZB64D/1XT7\D*Z7)J`R_"*'VZU6<P4L(.3R'D,'Y
M$$I7A]`M(4PU<!NS4%/>PG%W]R$N]2&7QBF6QEC-HJS$FHA)"MN#?KK+/ZR3
M)A@T6OHW%_LW1]V>RT%T3+>71UMZL-7HLY`KN];M,6CJ]B+*=WM-X]+M193O
M]IK&E=.K><+@M6>K><+@;)[8R?R=;D_JU6ZO#9=%,'!>0QOFES"J85PYT;RZ
MC\>%VX<HS8ZDV4;Q!GV\$1].#CPW?0_6H:AT.OP<Z.W9'%W:+@_TB2>HGU@H
M&O45RH`>)RS2M30'-XF;O",\J9`%%W`08B>#L<>$P?8Z#98X[I07.ZFE$;S<
M%"Q,NR+![+9@S/.^2#"[,1CSXKI<2RD&7EQKP^7339A/J2#3`>*+MH6%[K_N
MP\]:5`8N:V#@O(8VS*_!06^S=@@ZOH]'G!GDUHM#EXY#<9M@A_^QQW0E%';)
MG`Y&_0;E'4L!G8P0ONF_;N>\=M*OG(NL#^@B3SJ#EXAQ>`X9@_,QLZ%NZ\VB
M):9J/#!RT&A&!;$4.7Q,`C.2.*@$7W?W:3!V@D$<&QW>$K,8-#5I5)'3'LZ@
MW'A2"B.X7L]!HENA337N+.3.K[;@'%Y"SN$YY`S.A]RXU((S\AW#DC3\.!]F
MDFELFDW*2T0>23KG+,0AYBXJ/*CD95==SCO*:.]RPWBJM,J<*"VKR,JO*;*U
MJ[TUAY=X<WB.-X/S\<8/EWB[V%M#%ZV,7_I"W-,/6/`FB#/0(W9PD-5PT'&4
MEY"ATJ`L0!P5$`Y!%@%3#AR(O31:8BP(A&&CP;V`8RXSTIBE96G4+`Y.-8M@
MOF:US4O-(IBO66WSXKI>)Y?!%^<8O'R]C?/D0LM"7?^7U2TX1ZUUI1Q>UL'A
M>1T,SJ]#RJJENY3A&_$]YAKT8UB&)D%7;-U@)[^;L6>C@TT0A[E[/#S\%M7P
MCL91NV9.6KPRO*AYTNOT_D33N^,NH9]IHAMQ>YCW=\?L1T/C2=PUVP1.1;+I
M@^N2$Z[3X);DR&FUDVK#A4L&SE2V899),TY_IY,RT[C623%P7@,'IS4P,+^&
M$*I.JI&./_0;#\IXP/1C4JV=8TO'H.226Y]/&@::Z#+%``9Y]2F/4X+`WXTP
MUSWJ`"0')4E*I:!.ZUP<ZQMCSZ@8_6J3QN&%#`[/;#`X3P<4;*+C)_%Z/JZW
M7^E\M\$:?Z(2<!E'A8;/3C?JC4"J/%'5W)23#G#?-%-J96.:X);>Z++2L3!5
MN@2SE8XQSY4NP6RE8\R+ZW8]"1A\<8[!R]?;."2!B1E@%OH=WB#]N`?5B9Y$
MC;52-&\B&TJ.`^;4]D44I`G-48BVO]9$>;/$0J-6G"Z6@Q-1!!>B@C['H=_2
MEWB)%>!+RZ$NT#@[9+CGC&'R2QA2WQ?KX`?'X-'\$L\\M9=>XJ8&F5DTEPG>
MAFO76W#Y=!/F9<(BT[QH_WWI>)P/';V@<^#N,%]W[W9)\7LK;ND<=WX^>U8?
M/X!]*.3H4-+=K$K>C-A:?Y'5F<ZX,*P<\1BXT,#`F88VS--@(.L+#6JA09W1
MH(@&AR1`$D82=$6"B20$6C,BF880:5!$P_[NPZ?X=)SW50^VF8R=_B(9:OG$
M%]%1VYT18OV2N@WAY^"D%P3SPM\V+\)/,"_\;?/BNEOH-J@-9ZXWX<6U-EP^
MW81;HJ]'5"1,HR+X(JKV&)*:0R*XMIK#V=.O1)^#4_0)YJ/?-B_1)YB/?MN\
M<ET7R0/AO?#\$JT=:Z#5=R_1_Q5>-KD-PD`4WO<4+$'J#QB(R3D:J6L4DA8I
M!:DE/7_?S#,F)3;=)-AO9HS-?/8X3G'1R$UTQM@N&%MB_(935HO6`MMH_PX<
MB*5-IZP">*"Q_='VZ8N7IS*EU0D0PW<V!\7?F96J=KPZ_R?L."D[7:/580;5
M.RG-4'`/#)<\R<T0I,N&+"Z]CG\$P<VR(>=Z\9/[5%6DS:-M:G5FN6=9[FEA
M;39\+'W*E<^*?12+6+GX;AS1_6>,Z?.'C.@AB,"8V6*(+6QXI;GMN)E,L5,M
MAE),=BA1CJ,4=O<H48ZC%';WKUXOZQ2H3<+R\FIAV0\=E.,XY<J<PZFJ/4Y%
M[7`Z]1EF#40*.6,^^#=I'U'2#F5ICP=G!Y:<J6+42+X"(^>LEU3VND:;&=`T
MT*"3PZM..?#`AHLK4!DYV#JJ%[I?_[R6QNK`AY52K8YQIBX"FC[D'.=?TNA5
MKKU6K,E5-E"<S'*>+U_I/D$B:LGDHVIVZ^1=$B@\MM?#X3T;E#?8"(?W>CB\
M9X?R!CN1\+,>";\M(_\1*Z\4`#Z5*#:$`+.'F1:!]]O1R^'0)%#.#WNBLWC9
MO00/<&/(S>L)Z2W'D/PFPSCQ"2=!FDR9%G"C[--(Y:,JHYP62'>Q&"\]3;H6
M?BA"W>$"X[-3AM;9T]OUMK2Z)!)ERN08<'9L\"4^M5;E\T"/21R>F<:8M>&L
M"\,%,UC7>>([W,A,>+F0_[^OUS\V"F5N9'-T<F5A;0UE;F1O8FH--R`P(&]B
M:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@-S8@,"!2(`TO4F5S;W5R8V5S
M(#@@,"!2(`TO0V]N=&5N=',@.2`P(%(@#2]-961I84)O>"!;(#`@,"`V,3(@
M-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^
M/B`-96YD;V)J#3@@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=
M(`TO1F]N="`\/"`O5%0R(#@T(#`@4B`O5%0T(#@X(#`@4B`O5%0X(#8X(#`@
M4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#DP(#`@4B`^/B`-+T-O;&]R4W!A
M8V4@/#P@+T-S-2`X-R`P(%(@/CX@#3X^(`UE;F1O8FH-.2`P(&]B:@T\/"`O
M3&5N9W1H(#0W.#4@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*
M2(FL5]N.V\@1?==7]$,>FL"([CM)O]DS=N)@US;6"A)@)P]:B;9EV*.!I!DG
M^?J<JFXV)0U;WBPR`XADGZJ^U*E;OUS,GBT61FBQ^#@+=1>$PC^_V%`KIX)P
MME:M6'R;/;O>>[':LX02^]7LV9\_:/%I/S.05]Z(Q6JFQ.+[3`HAJL47?,QU
MW;4&VC>$K(#0N#8\`QY6J[HQ6,2J.M`:<U4KI3W+SMV<I,]V95P=W)'&]+QI
M[XWSM2&I*("CNGA4[6K`V)YN:'.\+)T2)TAOWV>_RO>55O*72M=.OIM7\Z9N
MY<VK:F[Q_,>5>//VNA8OWE;SM@[R1E1S"'^HYMB?_!OKO(RB:>S-S9L7O[QY
M=3(&._US\=<9AISEW7@V%;9@'&UF/KS2;JXK4GE7J=K(M_R.67AO/[VYX>\7
M_+MX%;_$AT75`1Y&?ZX"-%]%U<4'\>YUI2U&Q/61<IKR+R*!/U78`U;]^X>X
MU:X&G2<[M9GW7^6MK.CP,+J\6SZL-P=\]EBVE>O;BO5';],:'$7"^,W:ADP/
MTI2M_3FWW>`%_&)5(CATNFY/"&[C[&:8G%^<:>I`<X>V&:7/YO0^^F)HFMJS
MU]#Q7,A$Z!!/N<")O/P<+;6K6IRV[P69U\KMW0''M_+SGL?%J[MUOQ8?^@H>
MU\C["/;?*EMW\C>X5TT&,H#B/#C9533TJ\5,BXV868=I@\;.V?2J=K`__^[Z
MV<??`[<NPSIH.MJ1@%?M)?T?P./J;3V@<)LGRE/HR^/4<TJ%@V&9W::+[*JC
MW'+*L[5U:$-#+NG@08-3,FF^;GT,'FD01@(_FM5AV[SSQI<//8&->HXLF0[%
M5CW3G<9/3FWYR'8\K\=Y)P^L-24R1<=#MFUB@A3Y,#@ICA:"?;K?"Q#203M`
MVIQ!KJS5)BVKNI)UIA0'5P368O@8H_@T;EJ/L-*<A!W-67#M2V8Q(TMVXAB3
M\+BC27A<=Q*&!Q2\W2O*52GO:#-4(YVJT?5R3S7((//0KWC]=8L4A*HHOU<:
M2\D]U2!3:_D1N:1#1L&J6@Y"WRJCI'AW3Y6GE?UN>=A0R8+$'<_W*<Z:IGBQ
M.FP>>61SV/0\V,K]<W'ZAW5E>D-D-YV/,S0M`M?+G,@&:\.]*2N?QT0V=P'/
M]B[@V>`%O&QQVU[.]&\Y3\<$'5.W$+?R*[]M8X:/OZANBM!J;AH7L(C\TVBA
M6QFN5,SU2MU6)(1<A2E/9+2^HI)+,DF81,\LZ)J3K.+.##@-9_M-P]E\TW#9
M>IA6FS%;Q5Z`S(83DC-33X%YK%SC6WZIYOSQ@)Y@?T@?WU`T&TG^Y>"&`49&
M0PA'/FQ)!1M8\0M!*ZJWG=Q\[0<?O>/N@D</1`N+[O<P6U(_$4A*]/2!VB.$
MAZ5ZF/Q4Q;8FA*&&4&N8(O#\7"N$(E=Y1$B38^:!OR*"HK^YB^CVGH/M[E/\
M7*XH\#K,\L@#F^&SCYK/XW:09[U&HAWWA%37&G_<99^E?ZCH@3]C*11.O:.`
M9_<HX-D_"GC9091+5P<.+S.&ETGV9.?']&XT+5YP7MCA!K'G.?:LO(<C;-"?
M=G)YX$?\H-2&M'1'X8+$LTPO:[$DB[:4\A"GNV.5_SR9@"+\[BBEP3W04&!I
MK6T,6X.0Q+@+RF"GQIP,GP6HYMM2.<45\,Q!`<\<%/`B![Y#90C866+!CO<*
MY486QFR>?BP5E/<@A5M3R,-8CWR=V.PK..WVCC_$1XIP+C(&Y.W$>OO`P&^'
MC_'E*QQ^M7V(X@<J8)VD&9Y6$;*\:HCN6^FND`1)0\6).6N&6%;F\[CF$]LK
M3?>&LNT+>+9]`<^V+^!EV[?ZJ*#;=K1\>Y9/GGH_59YD5MRE*O)F/K9'[N&R
M396G@8$^,R8H3^**01G5D,'NHV:?9.,,46/0IT#P'`C^=*&I^L[T-`X=7R,;
MD*-XIQP0Z?.4#-^IB[6^A`]DE/"!C!)>)@-5>:SU4V%0)N.F3VZ.:QR,M=LA
MNQ^6_V('C4-G'GUD/!@677:'64:_G7N#.Z:&GS<3?GYFR*:]5/(+<#;C-)RM
M.`V7C>C;H>37P=N0BQ%GD:HE!Q375?`4Y9\K:L@"_"U8>J(:H\,(:#3C>(^G
MYH))\I1UHMDWD*,L<)?DGN/IAN;*&A]?&Y@5BSPQ5VC&(C7E=P4\&ZR`9XL5
M\++)L'#(;F='M[,_RKY/'?)6OJ$(M7*UZ]&!4%??PV/6_=$WM1TD$M,NO\8!
MY%[*`"1$?56_>>3A)?P7Z1I=U83KMIVBCM3ZZ*96<AT<G#=H=44W#\LM*\$3
M[NM]?2$G%^#,QC2<R9B&RUQ@4V-#8L=^7X7_G8P;=":P=S0]^2],7[ED;LAM
MJ-8UZ>NQBAY/F=>EL0-+;W=1B_)((^-,DS>LHP_J6JRCM&%4=Z5XMIB18S/5
MMI&O()_F9><N-B@E/#-2P#,E!;S,"3K)/]R@%$/$I1!I3@*D&<(#C0M:ROOE
M9LW3]3&5W_<18T&F*DPD]J,[;Z:C48YO@=+YJY3/XT7/-0VE?*-SGG]""!WD
M4H04\$Q(`<^$%/`R(8CHL6MQ\0X47!?.\[Q@6VLUF)H<G`X=B<@VI^$QM3L.
M"2@-0]L#CWVF,6KV-9K(!"WW29V'HUP<H0APSE#$W+)Q27LP>=#4T83)KL3H
MRUU)`<_&+N#9V`6\;&RECKL2/_J^_R.^?Y.-KID+=G8_U@(OXP#WX;$?1#]R
M'SM"+_]=8?^!2T)`28A"/=VK2&E-T^SB-#V+K`5'CD^1X].$_72\H'S'!AYA
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M_A!%'>X])&"5FQ(X"R0X9'<ID`KX2.$T/I(XC9=I#':@,:>U%$VA]KK5,7;@
MN*WQ,=3.PZBQM2N'41'E2&"T'$:3RCF,II6S*:97'C9M+O-0P,>=3>/CXM-X
MF0</GR4:<E.\RITR1=,UJL8<Z0T]%+FX>/V5ZD6+0O.=?*V3>_%Z-PQ]0XU`
M5*!QFP=$PB.KH'S0+6Y_V)!;<X?&Z*<XX1!"J\,FRF\.&ZHXCJ+U.;NQY6U;
MH3LRTOFF]7%91%E1J6W^?[_03@*N/<)P3;Z9F5`W!=<,NK[0"!;@S/$TG"F>
MALL,.X4@R@E3CPE3CTTW=;RP_?O==M6C`W"X;ZPI5>%^\K'2U!?L*B@9250[
MZA7H?BJB"*56([]6CML'>A?;I"76&QZ.@BL&XQ2<:V/CW7*^!)+&'N(C3K46
MVWM.P%&.?FD"K)ZDTS9_D%&Y0YHW\<84Z`X;M?EFVQ@=,.%\GC9]GCQ=1Q8L
M]80%.-,Y#6<ZI^$RG:8CT42G;H>`)9\\8_-M?Q#+-3R8S!@?"*YM?+NK8I/^
M7^:K7<EM(PCF_@H$#L"JTWFQBP6P3EU6E1,E4JB$(J'3E7G@B:94UM^[9V8?
M.'*'*LN)+S@"V_O"/'IZ//6KYSC8S)_EX0NCCQM2E%0%*:_A="/YW-F\`4[(
M[^N#F@/TYOR)Y\3-#[Q;PN'RP)3!FS[+Z(FXPJ<%7WEU.N^)R_@<CY75\?K?
M+:=NZ@+5Q=;*SKW\W%$@66A2VM+(6/QYOY&KK(7J*-#T+Q9?!)*;R'<Z,2AX
M#B4%S[&DX`BFQ*$EC!R*6:W^=A#LMI?R>X/B`(4;*E:'N80*K!?@^O)<@97E
MV0[*Z>7JV4K^*INKZ/IBU^CZW&M43V7$M<FI[*;,S#3(4A8)3.I5&BW46@JO
M`:68E%_S?#I^Y:?'_;QO/G!+%K*R[;F3"Z1L%^A!U&2:*@OFN-O(<K6_%\%Z
MS_*64NU!#EBKVP[D38O.<68\66HU%0;9;=7X>8/J/@PD3BUE"#,M[#A2>XE;
MCE-!>+.*:L47F5OYHN#%6W6\^*N.ZQXS)GGL1U6K`6_=R!L=YL`76,^;^O*<
M-\KR;`_E]'+UF]Y0\/7E;GI#P55ON&FBZV;QFFNAFU;B-2`X2;S:(EZ#B%?4
MCQ3C'S<D`%!^*-+3I*=-ARQX_1CG++S)EK7I%-]VE##4VJVG/,AI%\K6%F6+
MNOLK8&N&@5:3`IG&4"D8+HS%(163:W@RN88GDVNX;G*DK^FSF'1%3+HL/YHW
M&\<ZP3*]>&*JQXT7O>;:'3T_;P\,;+_)($P-P;?0;"(2T-@Q3F\.L(Y(OC%M
M\2!OKZB\TY+Y%&T-->&(7CX<3]R4H,;!U784%V']@VP0SV`764_"8/"B"!WH
MB(CH51\<DU([WIF$R+'7/.6F@:RB"40%SDZJP]E'=5AWT8`NJKC(%Q?YERX2
ML3Z0!2E<HR\\^P(#\R*O9VK72"E2'8IN\>06#FD!XZ#LQ^*?NX#=:1:=MB?+
M496A-?$\,GX0X?V^[0>+:N`PQXBU?2M>2-K+FKLX+OZY<,#8TS?K>:+@V04*
MGGV@X+H3?,]=8G1"\4%QP5N8(7#Y17CO_L3'M=CTF9J?]K3[1#_46$F#(^F4
MGLEVUHO(AVDD0"D\K5AM$#:1?F:\9I7!T>5T:REXMI:"9VLI>$6&NGY*W<P/
MR5#GNWN]FNHH54-!U5I:7YQ*J;(XFZ!^<KETMH^KWKH"K^]5@=<G5V`]4M$S
M%+K`UZ10M;&A?,,"<09A.$Y=\.9O&PJO+0_]]4GH0G3GQ*Q"X]"=/'D1&''Y
M>D/2CQFC2\.R1WS9\4N>@%M,H'K9O6A1"*TX4VX3YW^5B8\QJWA,7F:Y%FTQ
MC#V1B;<!;,,-&Z5.O-^:;<:[.%YEFWZ\S38*GCVHX-F%"E[+'^?^0_)`M.90
MJ62/#G,&"*SG3WUY3B!E>3:"<GJZNB\FJJ10'2Y7J\+EZ"JLIQ")CD$E^S<<
MK,+?0O?(E?V,XKB-U(X0>V1@X2I`+9]+Y,^%H-DRLL\0^JM8"P3__3/7#6[.
M'.5"*AX'WI>;--E=;I#JR,4?":K4P07O*4.0+9P,)@DCEX01]#K5[%BQ:[+(
M6;*+GB<*7MQ4QXN?ZKCN*$Q:2:-0/!5BP[`)0DIB=^(ZMCP>]DT"H6@ZED.^
M39-@?N*:@2V/`=KAP`.S3(^;,"_U<3&,1VL_S`\"R@[+DMYXZD+*J6OCE"BM
MX+GG^23SC_L7KL/TSDP]5C:-=0.+JD`N(GHS86!@"-,:N/":-2_8YU+,UN'L
MLSJ<75:':\QFAJ2@+LG-.'(UDQMYKR-<-!44T&!Z(\\7GX7NTO8ZV>DPLY7`
M.MG5EV>R4Y9GLRBGIZM/]^.@DUT=+E>KPN7H*JSFD$4,6;K5_RN+YGR`DB+4
M#0X>T=?^7!*F&\.+#+$^P!#K&78*-U+%H).9;A"<@A?7U/'BFSH.YYCD'//2
M.98>NEK:4)7RDC4R`)9PXXN1\F4VN!(5U]ER`Z9PC[":+<KRE"W:\F06[?1R
M]6*T>WL!VGLSZ4OK*$5\1AWBS*A6J9R<T?KFV68,W[39]>8%K6Y>+%K??&W1
MZ\T+6MW\._`5@[@!AN,HG9"?%*(2=;^\>S<U"-F//R'$3<\+Y`F&EP6C02TH
MG).;E,Y&RGG[Y?GY,#]M.M93RWE+'!#:0_/'\O$HSZ>G[1F,@:[@N'`>XUP;
MS\6M>S]**ESFS>5'Q"OYU+C*+%BV1\=$Q=H/`^]#[517VJFND&//?8^-O5,'
MJ@(?3KCC-WE_HA\T4HN\,M]9YKLQ=T+,<E-[I#8)'\?=UM3F%3XV8K8]S;)0
MQHCDG!T\)D'6,>EY"`9<J1ONI!GJVBNBL]ZS%32BT_`<G@J>0TC!*[K`XF'Z
M\9[']M!&>N.@P/D[ZG#^C#JLUU*'VC6L:FD)ERZ'R\3A8F.XF!0N0<+%2+B8
M&"Y&PF7D<!E?ADLGX=+%<.DE7&C%CH9[[&,I468^K#GSC'C2WW/<KMHKK+J&
MSKM`.6@O@LMP<)EJ</7F=G`I>'%*'2]>J>-P2Z&>(-XI^4W15(TSPTG>#V-*
M\MX7K]E(1S/W:?*_68YG>8(-R:Z=AR5A<C;SCI$CN<>V"\TX'AYERGZ+=;@'
MGN+DCQ%9MG&^K(ZC6YEU:&B7,[Q(G2+/DQ>YQ--FX(Z0GA=9<:8%]\T%*]:)
MKPNAGG]PZ#\#`)<33=P*96YD<W1R96%M#65N9&]B:@TQ,"`P(&]B:@T\/"`-
M+U1Y<&4@+U!A9V4@#2]087)E;G0@-S8@,"!2(`TO4F5S;W5R8V5S(#$Q(#`@
M4B`-+T-O;G1E;G1S(#$R(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@
M72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE
M;F1O8FH-,3$@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO
M1F]N="`\/"`O5%0R(#@T(#`@4B`O5%0T(#@X(#`@4B`^/B`-+T5X=$=3=&%T
M92`\/"`O1U,Q(#DP(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-2`X-R`P
M(%(@/CX@#3X^(`UE;F1O8FH-,3(@,"!O8FH-/#P@+TQE;F=T:"`S.3<R("]&
M:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)A!?;<IO:]5U?L1\Z
M4^@(PM[<^^;$3L>GK9W:ZF7FN`\$H8@<"51`<?,;_>*N&S<9)?:,@+WN][7?
M;U;O-ANCM-KL5I&;1LJ#?WKQ(]<+O$@%ONLE:G-<O?O0ABIO"<-3;;YZ]Z=G
MK;ZT*P/X7FC4)E]Y:O.ZLI12]N8K?#C:31,#U+<(R0&"Y]H0!WCXVG-C`T)\
MSXU0AN.YGJ=#PG5"![$OM#*!&P43B@E?L"1@2T8)Q@O<.`+\.`B0OI>!)H&Z
M\O:Z^M7Z9&O/>K*U&UB/CNW$;F+=WMF.#\]_K=7]PP=7W3S83N)&UJVR'4!^
MMAU0QOH[T;QG5#F[O[V_>;J_FYV!4_Z]^64%[W&*GD$S;T6;:-`F8FT>'C=(
M'%EW_"`>@:7D]-%V#'!6'QX?;*U'^.-?&'YODYXW<R:W-J*JCV"I:P#'0<7)
MIL"Z>?AP?R/42K@)]067O]H^4,O'`['<S)5D0S6@^:.AWB0_,%J;/\B+8XP;
M3O#`"X;\X?2OZ)#W-W:`OKQ_5H]@@(]R/O'SB2!WSW</]+)AS,T]^`;U&!-<
M&S>*(2\6M'$8AEKX".=3_R).QDB<8GQ#M3;[0F7LP3ROC^R`$T;'6%EEHVW&
M^FYK3*>2H7"J\?0+8ZESE9WE:,M'@MCQHR`7;U5>5VU]X#/!$/RLQ]QR8NYZ
M25F5LVYRD!$KX:%:(1O(1?VBDH,6PFJI??9-U&--U.?^L^A-4:>F.,E[UA3;
M_GBTF#Y'1S4]BFCH][Q)_]>Y`_9"SN7CSU-%:PF)3E(.R1>L"`T,H>!1=`(/
M_FC@5X,3\/T`7C"(]]VF!TMF6"Z_3CCP.=F(U/''5F7Y!+$FV)DE58Q85J(&
MN(:DEA4CEUAUVCH=F%5K>V"\VA%.S2R80)55-U4;"9'R*,C"J&*5>^YB'!#W
M+!&).1R9@E&ZLJZF-E=;]5IV>]7M62AP:#NF.Q./?"!K55=#$XDA)@OLE?8<
MBA04.#<W*1IM/"F:OSV_MR-L7QE(?2IL)X(H?[%3.`(O8F\Z4'I@PF)?(5V?
M'29R&4/=@+,XE4I,0X\J"ED<J.H"K#K\7`L^&N;H:`2H;2UTJJH[L#<_G+=0
MS8>#JG>`+L`"LYB4J9C3KFZ.&:F$ZN_JN@-R,0(J!CS0%/\YEUP&Q!X*QGC4
M!TCNW#NQ>(?>.']3J@<?HTLL8OEJL@,;E[(-?I^U>8[B(<U/7=\#X*P6XG-%
MZ4CXIP;L+"'[6FD5=<,O`_81@%VA=B5VCS([4)O0*#/KBF/!@L@5L=6UKH(.
MV`JZ<,A)62;-V#,)9@?R@-[2JG9?GP_;"S^$4L<!OJ$?/A?@2"2.K6P+X<$&
M^/7,0D(KIPB\<O.0Q%79>5NB!T9M0M+&)VW(3E+I2&I`TVJIUX%U[&+?(D']
MT1ZM#"$#/M3'$W5S_"37A];_;!A;5JMNJNHLHD#&4W&JFPZRHL$5(J2T4XOE
MX`WEL"O;G-0S7I^;!>5]QDG5V#3KBZI/*(9NU2_8$B"\!6Q#:UAU/.,JMO+>
M-DA3#;D_)'-]*BOT7+U#!0%VS*IL6H','#VTIEK(ME_/D@*!Q8Y[L7`6E:VD
M%>@&!5/UU=0P8PIX@#YIBOPLAVS*0#9SC):53/M:5C+(X>9,;2\!7U!7H!*#
M46V]V#00<5+@&$24HL%L2'`,5@6.%;#%6&V;P;E&`#@W09,QZ3-HHX2-C(E+
M`[V,1UE+UD8R"`F#7@@-?`<3L5"?8?S1@*,B!48YJ0<M!"5OJ3#`]/9,Q]U$
M=?16?2J:;,JT):W:<[X7@P?G3'WC)8DD#4V'$+@UM.V41W6:?6/D@>^VA:D[
M'C,*];O*)C%\DM,OOY/#)CP.%->`!V6"@V%;,CYS[LIOPK;>$1VU6CJ8"@5'
M0.IT>R2*T1_($[+ON^T3V\]"4_P7XV*LTZC9@,Y'6YL(6%A-'\U4<-S#S@0[
M2.6+H`*7"M^:>L5EB333TCG'*2,^$E7V1;/<P'32-S"8P?VH6$,F[(`"!B<V
M!%[ERFTV-*M\:)=<8M/1@EXKF@)H949QDP);>0WNNY.>=*??0X'%-(XTC8F9
MIL%PVPA84^QA8_."#/\(WD'?<N2;(P[U/]/4CKA\I*-`2"9]*Z+F$7#?BJC8
MH[%O!0*5O@4.GW>N?EF7.QS>*H,KRSK#<-V(QV7=N[Q4I4CVJW7_\`^ZK*36
MPX:?CW(U2^'&,K\AQ+!'3F2*.#J]N!J\D18-X9<;BX)NX_WTE[LU[Q??(/1U
M4Q8<-HAL1FT3W$JI05V)VEO6]0%`V*%^E2';2%L'K^=UVS'W%PM3;E<V;>>4
MU5K(Y*`^=^K8,Z:+7;>OM]!<:Q$-%=K\UHOJ,"][!CG+Y$G`*Y.,ZWGK&JYR
M6L:='6"-05W6K[PF6W^4*V/JIA&XWU/TXD>X#40J"&%TJ,WQ31Y0#(P7)&-8
MM"%Z>!A/NW&$Y`%D'9+/]PR/R]1ZQJ7I^!F*LT]%9N3&^C+$R2C_Q<)K&VT;
MX"PDN-NLM"K5RN"5+]$J,-!3$A6&H#N01]`!5KO5^\V%D2:!RL"<"0P4T&#E
MI35^#*,UF%ICJ>D?Y6G@ANFESOY@KB]I*>4W7QS(_6`"S%Y71X/V,8Z<N?H3
MG9)$=)JI+@$:]4*VH1LBUS!PHT2AQ<@4?HGK3Z"8!@-44S),P#J%K`VN4B,X
M-B,Y6`Y>G[+W8!`DUZ5[$3M$Z#U_+C[P8*^^KOQ/P!/+C0!-W#M[2OL6.@]%
M7RH:^C9%`NO-C*4G6\,3C#WK%6H:'K@_T$RC_0?OA2'->MAI%XI1>S`;S4S$
M135.2L^'QN]-<:W?43;HM4FB->0B$23D$:K='AQ&P0">I`WT^T@<`"/OTK6+
MT&7W>&9L!-%0&=*P_RD-#0<\3*_?<,J>FCHOVF6/:(C%A.L/_!'U_F!,R_?C
M)2^85"]9C\WYNO6+T$7KJ5XE.:07?X2)3N&'GF559;N'X0(=V;-JW!P7C3;L
ML9'9HL5>PA8/:/-VA;&.8F]J+9-HH(`@)"KUK[8=$W!C7^0-?*.Y%PE]X`N5
M/O(5#_MI>M6_2[!E[\8!-^;QDC?<]_I^N*D[O.B!8G.OQBAKQN-Z+H6^>+;'
MM?RU2?VE?/+7H8X6,LI/PJ&A+%B\"%VV.?*X\5^IJ*>B+1JX*^UJ61K@A@-3
M7QWK;S#Y%4S/XW*6)>F%@!\X!!ITE+Q5Q@S*F.E`&OY>K#!.T#GC_&96X($P
MQ>&7!M#QKF<AU-V"#R[FK74A,C5SD<QF$)F8N<@^8#&L@]<#M@A=#E@0O6W>
M8V:6XPJZ5A6L>V]358>1&WA35E>[_XC![=VL8QT.Z9BZ@3]V?[-.S5+K]\-X
MH;GWP,!WK\[4*T!>)AB(NT08S;<%"$=RC1AW"7]@C:TP2BY7"=]<%0W0Q!NH
M89&8RQ["N6CR`%WD_6/H<BI`F$(S!M"_W!S[6Z+I;XET38FL"N<C7$[P5G&:
MW>R:LM[B=:^LY/B+C9="A2LVW3'@"C';M-?$9')_#?J+I,K["V8V9];?(9'P
M6`S74!`,-Y#\D+5M"5<@&,W("O=2ZU*;LFLIT7':AQ:F.]YT!LFN8"O;>'*3
M<=[X)F;?P%8>LV\^G9O_TUTM2T[C4/17M&#A5$&([3B/9:@"BJD!%LF.E3MV
MB"C;,I;</<-OT#7?.^<^[#@)O>F.Y"O=J_LZYQ[/N0=\\LQUQ)-<@UJ299MW
M4-IVY:-UO0?)0M5O16&J@]06_"L%*0^EK,C8-)*^N89G?\EVR4*8`+WY_6&&
M3,?S&+954/2-AVEKN*.0I7_6L7*-T;%!,]8Y[@7UH_;X5CVX)(L^88*#'>/0
M-YV5YLF*?I&'ZCR4G<TK_SQ'NY&X8>;4:63%TP@;/XYA0S?B<&[$74ED'G)B
MJ2D9'#4@9V:XBS8`-@_#U64C%^;%C]YC4#.GSM6:LALP7^(\$A'##MG0\Z+6
MZ0(1.[F.&&`+I\`+-R_,+BV4PIUWUKMFSK4$&9WB>/GV<%@:,*Z33*SQFA*)
M[DBRD28DF1;9%S#R=738\3]9?`0C0S0^O?O[O9']_?[]`1'*HCU>0SG$ID%/
M(GH(;!/IKK?(^4:^D1TI=]_;ZN?';25\\6(;C\6?(MC-;(&_(6<K4%A;I`,1
M1FS:AZKD;2-?/40Q3)`,)0YM<>4=^6<EAO>%GFGE4)!E`TG5P:4N,G+2L0D^
MH.!G9)(AOMJH@D&W'Q7*AAS]V=N.S\C7@AB^_/R'+Q6I4J\8%<@_N4@O,(^R
MK'J2WD2O^;QY.ENYXRRN4>U3I?<MA0>T^#*KJ<?IZ#:JR4]QY&A00WG:7R5O
M%S/:-:XQ(F9\$`E9VN]4E'%T#EQ=<?2&/U:VD>,H(O[O+5[Y*'MR7KV]Y9D0
M:]WE0I(/%-<4EM1R15"#3._EUXE/])6I[".-F")OIN8A<3;<9-@V>[U$F;(H
M:G5M@D,O$.UHY_09M9CI-2+GT4^&RKQ-=MH:L6R$-?+NKG!ML/`?8(.FH%6T
MFQ%`[4V\3"AX*WIT-D#`-%SW.J8-`31NH;7\M='NACRG3IIQUB=(`H8F],Q8
M6QW#('4U;#H1'3$QD\Z714,W@^%H9GMJ_^MH1QU@20[^XN9DN_G]$</;DZTJ
MPPV:2^@K%'1RGE$\$Q3/4,F#DN_<3ZB(S<ZKU;X,?OX,)-R\#(7*L^-$>/:W
MZ*(>BATKMDW!N+*,3H"K4/Y'J4'5!_6D=R-Z<];+6@W?T#A3.97`-0^E/&E)
M59$0ZG=!@!$,I&`RX>F6RP4X$4KN_=>].QY9^E!L3=/GE80G%8=OU>$$`A;1
ML%T]`CH];=03SD:>)1D/<U)J>](0KI^QU6=4MK9!10M*<B@)=\J3Q;!0T;RC
M9'\QV^]BDXX@G,HS#]=T2Y6A*8&[F%?QZUBWXP5S<=0&68V>JR%%O[2S->4-
M!0"U;3[;8^?,9P><!HR6+86DD4.FAU.(*N":O[0/$<JG"V[9Y,,_]<)L*%&B
MC==\D5.*`T#VPJV7])I$8`P-`I?78XX0$U0*R%>,V;<:LD_2/E&.&3P3%4RO
M5LEK@Q'I59K(F'*53RO-)R+6;#N>W(+P(%\F%H"B<,MAQK1BQI5$Y+6CZX3`
M@=\R*%$_".>N+-E3M6O"V1.SIKJ_\\J<A5#_YM1W[)`_Z"01ZV<;?OZ0/Q.D
M7Z0#T@^`R`#6EA/X#(+9"I[B'<$TSJF!$\1T\%\A!<9Z?8_"O$"A>P%IIPA?
M:Q-J>:7<@I-+;O;*%>0[H%!5.+%<;V2V/QAGY0%B0SU]C?(:1M.-KO*!J"0Q
M5TJR4/0#9'F"7N7:;([8K+H+7E#%L),LW$Y\*%XPE)+W,>'^/P`@<Z@;"F5N
M9'-T<F5A;0UE;F1O8FH-,3,@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R
M96YT(#<V(#`@4B`-+U)E<V]U<F-E<R`Q-"`P(%(@#2]#;VYT96YT<R`Q-2`P
M(%(@#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P
M(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#3$T(#`@;V)J#3P\
M(`TO4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`X-"`P
M(%(@+U14-"`X."`P(%(@+U14."`V."`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@
M+T=3,2`Y,"`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S4@.#<@,"!2(#X^
M(`T^/B`-96YD;V)J#3$U(#`@;V)J#3P\("],96YG=&@@,C@Q-2`O1FEL=&5R
M("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(B8Q727/;R!6^\U>\@P_`E`@#
MC3TWV7(E,\E,4B/F%.<`@4T1-@APL$CV_(S\XKSW>N&BAF2[2@3P]=O7_K!9
MO=]L!$2PV:VRH,P@Q/_\$&=!F(09)'$0%K`YK-Y_'%.H1SX1PEBOWO_U/H+'
M<27P?)@*V-2K$#;/*P\`_,T7?%E'05D(I+XCI$:$OD>".>!/'(5!+E!('`89
MR5B'01A&*9]=9VLZ?:652((L.:-P\]6ZYTD:",LWS%G%($SIZ7GU'^^Y:5MX
MD%#WAV,K)[F%!W]-.GG??5$&L0=W_KH(4D_Z:Q3OU?+P(`=4^P9$&(H`[<3C
MWL^^$'AXY]-?F/92?:ZK8<"'G-E%Q*[I-/M'G[D_5>TLH=\QS:]-/?3P:S_U
MPPB#//;#U'3ZX-PU2"E0A0GD-\VDEG([0C/Y>1!YHT]Z@O_?S2_*\>3%.VUX
MK`T7]$2&[ZIF@"?F$WN5'R,I:G)#>I"ER.@CNJ1"=06=8/5S3YG%3C,>@W&2
M1YB>>\T+S`,Y`RF:"35$3LUPD-T$56=DMLA:H"#->O1)9:\9E8P'?<P(_@7?
M"9\[B9&_,<(P"#$'05`0(I*HY4Y[?4;'`G5H&XPO&\Y.VORTXF03)BF*0OGF
MJ?+9&_@70^,G@?#@T4?QPNO[+>5#H7S0=.PO\CI*P/#AX\#G=1CY>?3#(/%`
MO=#IHP8XNLQ6J8@QG@`=T-*A<62FTYZ4Z7P^1;XD&965,WQ7#$Z<SI2_453G
M##`0?DIN1H&:Q8$>I3TSD:,]%K/G#TK8.D6CM0RVF!R@CAIGJM*-M#=C>B)O
M8G4-F%,YAJ+NARV&@(VM1JB@G@]S6Y'(F(K#7]//DP2YVY&;4:]ZHNI0%%#O
M.7TH#QXE>5]]K^M^[J;&0E@(I0?'H>GJ!G.4PZ1%[%662=@UPSC!'W,U3%JY
M`:U%,MEMKSG=\PGA'2==_>'-I=%AJHR.<GHBHW5SN#U0#?])%95[U=3T'1;O
M478C^:3E@LZY^F*/>L_4*XNHYE/*M>=&G\%DV_4#=PFE^;0?I&(KX:!*#B,X
M[4<R`%G=2ZNM!D-N61$\H^=M_I]:]CL1W:`E`3?2^-0_5&<UM9(80XM,&7K+
M>9U0?TPP0S!M*/L[]=NT3<4/;#G&\6@.T\<G"G'F-?T\MJQC04TWXEI1)U2A
M).@;?MTJ`NC4ZP2?/8:1FHC[$7M(B>^???X,2C:E=6)I7Y"8PT=U0+%68F'<
MJX_5V4<)U?;+/%J56-\=0SV_:-II?\X0U,\W]4UY1^LPC]HY')3UF>LYM=CC
M:_-(+L<JI(;"Z8%Y@>'<]6W;/X]_42S..9R-9`HC`HE@N#S-AE)7+#^1`&JG
ML2A#;X-)AF.IY[SZ9/**8U52HXBIE$Q)L&S<)0JU2\0%3F*'"I\VJP@:6,4X
MO_,L@BS"@T%2P)K_#G*U>P/#%I0H+"JR`-OW&9KBL(T7*%_#3A+S`!<9!6/'
M>$'JA#^<+U&G)21-R:D9I"7.;=Y"1!KD>O/@_>'*9Z+`"6W=9CQV8HW4VJO4
M8"(-&F*-&"];DW!"YJ^8Y(;?,BG'/$[8I#C@`8H6X<!*DS#4$P%52$H6D18E
MV7_M\S?1(EE$4YSLPJ*B0"1QQ7.!W"21AG&M/)<L\G/PA6(B?U5OA,\4Q[^I
M,T/?=@I:=!V5<[,<\+EJ#OA<M`/&D#L"G6%;3TX;=&*;A>Y&OTGJPRUW4II>
M)36.=V#^??8R&BN,B2BYA*+(8%<)DZ>478O6NV%KO1NVUKMAM_5I%(1GU@MK
MO=!5C/]NMUN@B5V<6O)I["=Z['_V.LFKS%2I[9W6J!AG@7);6J2A!R__K=?&
M-3%>:1(<WRGZ".L5PU)R7F4.]?$<EL>%_J<VK/M[>2DOBBD4-@YQ3-/>"BN7
M)*6XYO#^<Y)D&Y`)9A91!BT&TPW;8+IA&TPW[`YF3'6-5BV'\U:-]BU0L'!]
M[`]2)3=ONCK#19(Z,_Q%I/`7:S_+=:3BS%AN<+J;OH"O(IGH2)XI?QW+R[+"
M?\(92ZU.>2[L!+(NY:(BIT"?*?(BU$E!2;`8:C=L0^V&;:C=L#O4.)42K>3E
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M<<I/M.`"SO-3^WE)O(BR8@I]S2]NV19WL[=^4_`K?ELPS>`+VAN_*O@5O[K9
M6]S-_@WX(DESW*`2*I\L"[+BM#^M8Y081-@5[O27]YM-`KB\[#"!"<H)XEJ+
M;!>)=!>YQ\L#-HL-=@/L"O_\^'?<$&(/?O^D/OP++R:Q]V]_33^_?_S;K3ZO
M85#X/]3;[6]JD*-\H>1'0<H:Q*3!=4D9,+7JA;E6+Z8G4N]G7+E00,=WGMR#
M>WF<Y.%!#OXZIW>!N_<-3'M)O:WTU";RL3\<*T/RW8](Q?_YQ$?U1M3[`YO9
MZS/5L`7SO..#<-=H$;*>^F'4F](\[?M!3<K2P]:+@A4RR*.FG_TU_0SUOAI9
MJ\(#;+\G%?NCM.8<*BWEJZ+B.YXVC5UY'MS+2T=D+AWS$:8>1TM(6SNU>6:)
M]\-1\Q(>3'3OP,ODGL0@!,9%@E[9106[J/"0:I[&"9?"1A-UZG9*-#1([J>^
M_GH#X_SP1:HK:LTWT8G4P&%S;)NJJQ4BX;F9]E`=]9T5L;IZ:"6TU;.Z%"DS
M-S]=)4!F$H"6TT&[[I&333NX9>U*7F8CCY:6,0#8&#</'$8)C3Y&TBCP78_L
M_IAM=)GZ(#O4?E_1'QT:$RU7+MF0S_H[!UNGEN((56L4A'X`[>HK#D=:N]"C
M-N3C7._!,-HK.ZM!HF%JP];6%==>*[374GHBKQVJ;ZQ:X36'^>`CZZF?JI8>
MGJIVEBB2<Y=L0.7U64Q8:$9T$8=2^E'L&3:UQ&Q_IY.,_=R,?H$1-BPT+=(]
M2-@U'::`=N&6[$"5'WK,!$P'5&*/@10G([@?F;S."FU#[=--)<7(A92Y\"CQ
MI</*3VA+Q>>)/FSA`54L4,!W7T3$%>L+OP]\@K("Z*FC6E6D_8S++YW<<U%B
M3LQ3TS9_&@(*1\)%HU#20U&R/)](FPEV5@\Z@`PFSF>M1<#'`.YF14II2(7$
M@@WGZ;F'9RF_CIJ9UH])#WPH2I<*)#0%<FRK#BX;DUKAM]4D*1X4YS_F:I@N
M*@,DW?JJ22>ISEI,"VSP46+S6'=;B,,;VVM-A;Q1&_^ONVQ2``2!*'P5%RT,
M+/(/[10=(FE;1/>G\3F)1*T5_)[.O'ERAZ$TDC#*\D8VJ6Q/U7(;QZM*>51I
M]P3>UG_$1EW5:>5"J<8SO^J<NT8L_1`)9,4G]]I!CX.\U!@5+;<OW'3-A"F`
M7*1;>?`&^(UG0T\48Y6&!%Z&$HBFRRN(`'FI>85<V:@PDXK!CSG?_D[OCSAZ
M`VSDA>@*96YD<W1R96%M#65N9&]B:@TQ-B`P(&]B:@T\/"`-+U1Y<&4@+U!A
M9V4@#2]087)E;G0@-S8@,"!2(`TO4F5S;W5R8V5S(#$W(#`@4B`-+T-O;G1E
M;G1S(#$X(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!"
M;W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-,3<@
M,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O
M5%0R(#@T(#`@4B`O5%0T(#@X(#`@4B`O5%0X(#8X(#`@4B`^/B`-+T5X=$=3
M=&%T92`\/"`O1U,Q(#DP(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-2`X
M-R`P(%(@/CX@#3X^(`UE;F1O8FH-,3@@,"!O8FH-/#P@+TQE;F=T:"`S,S4P
M("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)S%=)<^.X%;[[
M5^#0J0*G3#9`$ESFEMZ23LU6W:J:0YR#3%$V9V32(2F[YM_G+2!$RX!\C5TE
MDOBPO/>]%1\V5^\WFU1HL=E?%4E="`7_])(5B<I5(?(L4978/%R]_S@9T4PT
M0XFIN7K_C^]:W$U7*<Q7)A6;YDJ)S?.5%$)$FS_@(]9)7:6P^A,B#2`XKE/:
M`1Z95DF9PB&92@H\(U:)4MK0W+B,<?:95&F>%/EJQ6I?T"1G358G6"W*/,?E
M[HB2I+5OSU?_EK]\CN(\*>6&'^)&_L1OOWZ/8I,8:1\W4:233(K?HCK1TB[Z
M)BSZSRC.DEK^_9L%1/2?S;]6%&N=E!E(MA!B^4+I8\:`,ITA+D\<%@8'2'`T
M!0F>XAL*+J(X+3,E-_>MV`^'P_#<]7=BWMX>6C%&<9E4LFV&*`:J*]DWW:&=
MQ`QSG]L.!C-Y!XJD\GYN=P(GR>U3:Y=MX6'A5DSW=HOM"!L,QWF:M_VNZ^TH
M3^,=]H/=0-QNIZX1,$_LNL,1C^C;671]$\5@30E2X=J'EFDB7?5)5ZV=D33K
M^MB.(,@6MJ^`?-1W)%T>(V0/1J(42!^[83>Q*!V(V&SQX!MY[+?'70?O=C)9
MLI8)'[[YX95%=&(J$JD^T5\O(N';0G^6ULC_V+;BYZ&?[R?QN=_!F=_;1Z*G
MEC/Z!<CW<`L:9.IZ<8N*W2*K_#[Q>7.E12>N,O#VLM"BJ+1020Y2T>_87NW?
MP'22YHSIJD@@(%:HT662!59>PDXGJ@3"GF&=):^6>N$/ZY1S"E1CD-1"%/!2
MIQBHJ4E*&YPB52H]XRRM(`@<;<^G'&"WAM6650FKM067Q1996'8J%04DI+!*
M?O@ME7((X9Q4RA)*DZ"1B+3)E;(9`D3(:S["I*C_.>=OHE4>1(U*LM2A*9@E
MS[WV]"]W3L0P9-'UR6FY!E\)EI87Y09X)7A5H\/XO/!-4D"C<ZNLU?+`:]$\
M\/IH#PPF]QB:U'%%1F4N662VR$#VNY&'89IN(DQ0-2:.=V+U=R.+:YC/</8"
MO9%:+]B9SV05.EB0`#_L"/##C@`_["=`YU!N3U6V<@G<%JL/4!"@,LI&])2%
M*TS9F!USK+@'?#(YF.DI@S?#`X[2S]!3]F]_I/E17.L,`R@N*U\@0:=072#%
M#SM2_+`CQ0_[25$*0N3D%;GSBMR5D!P4^1V+8@&$9$DN.RRH!9?E[1-5D5RV
MXY;GW&'AA&\Q[(6M[4#1P\+/NC[?D>_`%"!).E^JKLNJN#9*D1>6#L'Q\CK#
M\3,VP5CJ`IM^V+'IAQV;?MC+IJG,NI%3QK%IK(M%!31B6V`QD]A]<(=BB-=,
MKN)O[6*.NE4H`M6U/@O/Y2^.<2DTHF'X)7^FQCP9+*5!F%.OA>OS"K[P&UB^
MI%<+!]-K:/DB.A2](FCZ`'P2S0N?CO;"?M.74$<KI=>55-D0"I534Z5T?PCQ
M'H(M[PR'>?<O=[PS'.8]L/PD.@PY:J``OI+=AZ^%\^'KTWVXGWL#+D+70$KG
M2'ULWY#_3]3>1Y`4)?;X],*-/KX-D88FGUXA_*(<$ST0[%(](2.,8PS:CQ@S
M(;[^R',AWJI:A=.]*:K$7#!T"+:&9CAL:/]R9VB&PX8.+#^)KJIP@/GAM6@>
M>'VT!_8;.<]PVO]=I3+8]B!BS-N5RI@</37(IA]V;/IAQZ8?]K.9UBY=G4I5
MO*Y5ED]X0"F6G_=`J)'\B\Z?R89^9PR!4@K@KW83Q.,P\Z0^POHV=UOZ.ARH
MLRKE7U&*XV*'L6G'.M[IB1>*:7W*D;89:?-N[AB:,&!Q9'B<NZ&'>.7#V5+6
M&B!^NC+9J@[29/Z%62DVM/#,E+/CRQEGELS5BP1U;DD_["SIAYTE_;#?DMHD
MN3-C>3+C<CVE/S)?*?D7V3-$K&'S&6N^S$Y8S&?(?*4UGUG,9]A\I62:R8;=
M$R]@LRV['VGY2)M:LYG%;*5\CJ#$2-X:DRJ<SU,A/@T>/K-)R\5\X)&%STBE
MY%\R8WYYQID94T@$53@SAV";F1D.9V;_<I>9&0YGYL#RD^AIV`&]Z%JPU^CZ
MW->HW_N41MW?S,HNB^S;9A9+KMV#`Q3L;3WX&+D7COP5:4S;+CO@&&0'?#RU
MX&'-<41O(D>*2]BHH6P_]$_M.'>WRS;M*G(5J))H2&V?;&^@W?5/KP/EM['=
MM^",5:+E"%7C.U0"_FJQ'UC\D+,+[0S=7F[$B\U5[6BH'0UKCXP#GAJC.C6Q
M57G:"-#J0IL>0*VK$AKV5.]BYZB$AOW4OW@16F/WQBCL5YQ+[85/<GGAT\E>
MV.NJ>9GA1<ZY:N5L5+&-H'/`W)AQUY"^Z!HJ[AI*[AG@2_3'A]L61T9N'ZAO
M@%Z!VD0<!M].P6D$V;1Z[89J=47@%G6'7J%2M2Y7+UJ,3+W=8N05E,8TZ"5!
MF-W$PD$_"2Q?',7"04\)+5]$AV23!UTE`)]$\\*GH[VPWU7R'.\^X:RVV*MO
MZ2(Q/+20B@YT9>"$!!>'<7&*B5)(29VF>)%!(/AUJ>0[3W?".4(7^07XS/`&
MLG8X/01A:WB&PX;W+W>&9SAL^,#R170#,KZN5A;-]86;:!@EN1A-*X5YPDN+
M]V@'^W=WK#%\@36_8@L<D'TAE>$+I'IW=[!_]S?@%P&1%9`R,2"`CH(N7Z>L
M!>Z[^>,J.ZNK,)EC)<,WC)6/P_I*U4W3<7M[:,7Q$08;*MD3-.^81,OJ6E.V
M+61:NSO87CS:04RI$$1[#":H[N-H7Z#,IQ(2[SPT?XK[+;0(_3`+S,X%INH>
M0_1PW-E=(&R[WKYS#,6OE%@"WBP!/]^W`A)S*H91V'>]NC,^'N<M7D'@T&9[
MG%J<TXVBLXU(SQ=-$()4?1Z.AQT+>MNV?!>U4Z""S%V\=-2)311?HS1=S]GM
MH/VQ>P_]M4TT=-5EC38_@/292U=>[FGGAD]_80:H-T69K[0C\Q&Y]J*U)MG1
MV^[L?/@6CJ]%G/ATRR3GL)=,D'S-'4J#[7^&5SY+(^F)99:.61-(YQD['<FT
M`R@3:7=.YN;>LHV>!/-XUG,[MGPPJ"2F8[-L[!+X;&5844`7H4R^U`\[8=M4
MIJS?EASX>_LXM]`NC")3U^0[M#P%4TYP9M\"H>B_8_=G2]Z.V!AI\-ZN:?$L
MF'K;'H9G(A;(YWK"4[;\<1=5U)B\6L]:[JWG_O>X'5$?;)C;,3GYRUE@O]]L
M<@&M\=[V+.4I.DI7#NT=\R<H9$#/5[Y+_O*9/\6O7R+@44OQ\9L=^O1U8[$+
M[9`[/^7S.3HSFH34VL9-IY4E&<UJT/>GX^W4[>"R:LC&.>K/,<,3I@B$&?8$
M(!F\BNB!+/7(ZWIL]U.\XB)_HK6#^#&WO"F/81Z9![$5S>H\"S'WL^"SP$(Y
MW5(0ZP[=;"-E.>.YF^_%[[ST<)C$EPC7T*9WD<8I`TOY@6Q\I-VGKK=:3>*C
M[_`E')<4@C.L<BQ)PA^A)+AD\F+)Y#?8(F-*_4++/T0%;/^1?*F``_`6(.&.
M!.'_,_E@CHIK7$`7.A"%4H+-WP-:!C04M\,X#L\N)V/SG<L)DI0`=M]EU\H"
M2E$?#'Y<J;]A6)%B[:'C%<N]K[(%06P;EK89COT\076SWPQW3Y@*,2E$,?0*
M\I[%@9S3C@\8M?^KN]J5VX:!8)^O0&'/L+`Y(B2&8IDBI29%\@,0S4PP`4F%
M`.W\1_+!N2=?5AH6P!%8'.YV%XQRQ:><$E6#!EZ'=,$4YAJY5KLZ+>/[+?!O
M?FS-Q3&&54).JD7X>-A(VJ\)?^EDU:%//\)N!RA`(*^89HE<$FXQ0/]M,0%,
MB8E8X#9Z\*RRFZ/=$GK84UZ5CWIRB5_8:TOF2G;G@_2AD)N%&K@!4YL"HA[Q
M$@M<U5Q=!.U%C9E23'!:W^/-0?UO*L!F/!J?N"\<`^E\[[NI0^VNN17QW(UX
M:_V)B/R$36X>"OM4ZOMH!GV>BUI>?6C4B1/;Y=7&4K'#:7<XSQF/1K-^[YE(
MZS3XF?BM"(6"TF0/>B]6<QL""$!L$XG$Q3?C8"Y#&L:XDGV;Z79-#A?TA\-H
MGF/_0KH!I`3=%UQ;J.!^N7RE0D/L)2)D"1U!*D4$&2T-4YF5@A;+AEBRI[/,
MLSF>$H(@9:J_N\S!Y-4%U\LT*-+4O\ANX]QO4)<^;MH*I9WD>FFN:L;DM$?+
M_9F5MRIMUW?R:[7EWEP4IH)RJ3XBO\#=?WK5;O*!_-)U4`?ZGJB,L`HWT4WZ
MN[E/!M)-VI6*2>$0/;XA*Y]DO6@>:B6(L\`3%U.MN:DH5(NOKO]I"$5-"(\9
MNYL:M@,:`!I$6L'$540S1<8I*%$1`5_3CLD!A7_WO>L;=E\UH2DR*%<^?`7B
M![[E68)<`*OT*C.\*(PG^3>"=3$=K(GKMB^8X+2U1`3S/U;QH)5+R5D7X:9$
M*6M'\8(1-0BM9?``KQ4>"4$];0EN$0'&7'S(8G;L,2\K>/S<<23//#>;(1[]
M_.W#/]-IC?X*96YD<W1R96%M#65N9&]B:@TQ.2`P(&]B:@T\/"`-+U1Y<&4@
M+U!A9V4@#2]087)E;G0@-S8@,"!2(`TO4F5S;W5R8V5S(#(P(#`@4B`-+T-O
M;G1E;G1S(#(Q(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R
M;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-
M,C`@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\
M/"`O5%0R(#@T(#`@4B`O5%0T(#@X(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O
M1U,Q(#DP(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-2`X-R`P(%(@/CX@
M#3X^(`UE;F1O8FH-,C$@,"!O8FH-/#P@+TQE;F=T:"`S-C8Q("]&:6QT97(@
M+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)I%=;<]O&%7[7K]B'=`;HB`P6
M``&P,WFP+4\F26.G%MUV)NX#2"Q%V"0@`Z"4Y&?D%_<[EP5!2DXS4^F!V-O9
M[]R^<_;EZNKKU2HVUJRV5]E\F9D(__R19/,HC3*3)O.H,*O#U=>O^H79]+PC
M,OWFZNMO;ZVYZZ]B[(\6L5EMKB*S>KP*C#'AZB,&,SM?%C%.W]#*!BLT;V.6
M@)_$1O,\QB5)-,_HCEDTCR*[X+VS8D:[+U#%Z3Q+)R<F<J%)*II,;E`M\C2E
MXW0`-\09G9KYS\>KGX._OWT3IO,B^#8$IC0PJ]?O>/QCF-'PA@>O7ZY,^)_5
M]Q.C+><I7>8U5`,0G!DOP00VH>7@9!-2\$:NCU(^I5\$Q.C?:N?,MMWOV\>Z
MN0N7\RPP0SBS,3[*,`&F]=X93$1!W9O2],?#H>S"68Z57T/+^UM:QG@;TBFS
M;YN[V>!TTR&<\6SEUH/Y$!R;\EC5@ZL^A'\SHN326WXYC8<\6DPL/]'WJ=&S
M93R/B]&OS^@*@'FQB();=S^XP]IU\.NUB>$6K"3LB'"6+.,H^!X3=AX#ISOM
M(92O5U?6U.8JC2P"U>+2B.!F'"XSBI+.76VO7JZ>`Y@7\W0"<#D"7`K`]TWO
M-D>VV#)P,.,RJ$S3#LX,+1E]5]*2#?R.7;NO7'=MUD[FRZYNV`G+@'QH@^<L
M&R>P:'0&YT_8-D,B%)']`^O6#9SM^L&4@\G_<FWN`=9F\+G&AT:`:X9>`JG=
MFJ_L\AI8!.;JKRHZ'D7'(OKSL>P@?`\)L0^X(K@V=;/9(XQ$YYAU+@+#0,@@
M,6R8X$I@@OW8I5.'9GQK;"_SZ>?@*\F).(^O`2*<I8LHNI@4R#.<OLBP1,%;
M^N)4IQ1?,)1%T/<&#F9T"9G"8#&X;[NA;IOGG&7)6>R`)%=B_`-GV4*]-6X.
M\@6K@'V(7-F`H(74'#F6?"EBTSA[(@FZ9U94%VEIG$REI8O_&?\X(`EZLM1H
M-#+5JAW*/1,'V2P)0!_A;(%H[F"\)#@(>SQKI@*2SZ_XHIGBHKC$,[K<+O-G
M7&[MR>7/TU1&;*%VNG!*E,`ZM"5:3K.?\^?GX)MOON%D&'^A<#$=^U\?</$\
M>1)SS[`Z4H4T6.U`UVPU_/;'==LA74KP+F7$`,[?UT@(9.*F<^#C^5AOM+1)
M`<F?*SB7M<5F'H75(O?=FU=O?WP-6Q+QK^3WQ;]UXI8\FP;FLL)%IQIV>6-R
M>:,GBM@J4=RXK9-ZTT$?XH?V`/(L?U$Z=UR:4,"0@06-S7W7/M05]B+_2EBC
M7-?[FBI?PD03%\0H[(&#&W9M91YW8+DUS$ORP$2\H=);MTX%=Z'%O,Y6.(^Y
M"0Y3]KT;"(=#OFQ:G;X+25HCV^O?Y#2P;5L5JT$P,03;(5<[+`I-).!9@&VJ
MXX9_AQK5F[_,(+\'<$[)7Y!L%T@NZ&KG.52IF4T7P7:+)B0/G.XZ?3>$)0E$
MM$SUX8S+C8AL8,U[V>1/S^B*4L$T=\AQ&$".^D,A75_),9B*)W_1X>8)B(JW
MUX/X1M95H<ZKPDMD.SKV&,XR*I$32946HA%U-07MU4>T^@/G``0:2[B`BS#B
M,<=2[4(8&%$7<F$^KW6QE@M4%74=AP29$S@X,)#P"(P<%S=409.@%DB_T64+
M#0]JUE(V@14<?$Q&Z[VL.;_)\?1!!A0(%`-+C@&;^QA()00$2.<:%;G16UE$
M/S<K]V?DB)AM&)'YO';-N2Q.!D6X$TW=,TC&PTZ]MW9Z"!Z.X&'GFDLQ<L]%
MEZ'=%_H^[;XZ1X48]BP/[9&Z%-"BSU,$Q\@-:/6"VLGDL.,^R]6=9C>[>%WV
M#K8A-F(>FBR=)3[R$ZMK7?M56K;2/)3[8WGJ"$;$BY'F%QHKU*^7,(58`M34
M4%/$Q-YJ&M^351;HSD@>-#J434FID'.[)'T)2BMZ$1R5EA^>0[4XM!V5AT]N
MKY/<=A&%[,J&NE+C=^_D"O1]/=&M;V<0E0"(.XG'^!S\R01-72$91B&.:IZ1
M6>[)["*Y9.3I`[9\K'$+X5DKQVF:EOOZ-\U5\L594@M1/.&32]ZYN$OQ]J&X
MTM/&9;I/:4WOT)'<\O&H?#F(X<X0",*6!W*8@FS"2\9KPIPZ8:E4:5"E4OS*
M^0E%[EAN20V6'77W[$V1H_I?1%X^1EXN/MF7CY(`72E1L.1`LG2KQ%]UL4"Q
MYR3TE@!#4P-%W?SD_8MR/]ZN'&D7OD^D[@;/AN"VIAAF8J1VL=[6FQ(]M0_Q
M17#GZ`K&`<-]/%:RGR8IQ#OW^5A+H\"N3:B2X_%P0+8TLM6TQTZ:A+Y6.5"0
M&/>LN8C8/8DXGGD!K)8\B6W_.$@*M2-Y6!QKV4,V:!^<3)8\].V($`3J&C"V
M%`XYNSYA@/)1R;0(V\J/+$UOT5WB:2N1GDLP6XUT>&9N)&J^"RT=Y9!:,BVL
M=2?%S,++)*>/./B@TUT15_R#'.+F(_:1F4BP)\%1,`S'*<X+@&J-O2["^&*M
MT#)[R2PQ:<%,)8;ZJ(8[\BZ17HLJ?56+!*:JNCGWT\BTA3+MXXZW)\'./();
M[QT/N(5*1"VON$Q):=#RQHO^2$B%B4$@RRNM3'"ZK)K)1>U15N6(2*]DWS9,
M1\E=-QE47$N-1$RN8'[16V0D/DY&YER?P?3"9L0<A"3U$;E0:>*#))C+50QK
M$BS2R2V"2_WEYT'GD'\H(X)#;*'H-M.YH\SMQ3GR,DBEZ[76NV:J?G_<0ZVJ
M%ON<66EB1)F7F59Z(4Y8EB`]BIF.-'Y'1R-^5=RC4]AB=Q"[-J07XJ8F^)),
MQ*``.[(L9(/[0M#`<2KQ,/IY9NE1Q8$/7(VL^Y@0]^/%=X;`N[/N=ZK%U,Z3
MY^43]C\U*+X#$5IW$K[\O3.;]KA'@7#D%-*N'+D2WE9*A0AP<+GWS]%-V5$3
MF?MV@_.5JPCS,2#2W2J$'Z[$SY6?X+(B'<92GH"^")6\-%XO;=C_]=Q-Q^=N
M*E;A%VT<K*06OWWU`SI%/'#?_@3@J9_^CEK2.'C[1G>;%V^(2>/@QOSKQ;MW
M+][HOM/RC;GE)UH<O(??BN#EV8;7,OI'.$O@__<Z]%*,CO_))_TB/40*`%+=
M8]$]7LZ+U$3/Z3Z3-3)`0NLRFUS&R6+LJ#4U;XZ=U%'M_CX?M8,JT6=W6BB:
MRDD_6IE;=S^XPQI+271M8CR/KOG<J_9P7S9ZUK>A?%J$=])AHO;#XUETK3L!
MB8X>$&2W(3W!!C(^,FCSR;R]I_CM0RY^;(G9$WVR,>XST><(K!TCNJGYS@QO
MM*'5S]][\],>K7$Y\);R@?4J@"Z&U4L9W'$PZ`JRH-[X5CT#+]%&\Y4.H4)J
M/@3;$H^+@Q[O/KGAE`)9\/0P.I'X0WC-74A21-=B!-TDMAA@`(;Q_(LH2OV+
M2(UD3GJ_/MSO6_:`)27RT\_ON)_:OZD)I"!2^<`6RD'>>1=.3GL3;`EYELD1
MKS0&E+5E2!FL0CY)_58S^).V^!#*6?#-O<I&EPF>?>`'#,E1W'-M9E8[;0\\
ME'-K>.];[_U6K?'@P/+EEB*X!$-WM;=N18(S[G0S/)^:8==SI\CM,/I,"A5P
M#@4VN\61,?4L8^/`L.1G8C)D__1*:E,/!U?5Y?!?RJNFMVT8AM[W*WQ8``=8
MBLAV4G>Y%=AAIQU68)==C-EIA#JQ83L?/W_D(Z7(:5VTES76*$JDR,?W5)+E
M;M<W/5B9YTT@N0:2\R\1NOO"XDFW<CS5%?95_G43)$7^(:IG$%88/Y,"'O$P
M9:CO>KS%EO&8VFP9>S\I'AYM0-R/XG\D8$QH\B[XY&%WS0T"X$OP@\7N;N,+
MB9;PW7M;Q,:CLL1:,>2;N*4CH&^J@Y0).Y6'3PB-Z)VZ9H]AP7GGPH@A81"3
M+^7GKO"")4"+2>&2^<QG-X"X=H"(OE['P$."0H2L^+">0,1LZ;H:[4QH'J.E
M\6NB9=4O4KEV[CF9&</61_$/O5U=M&1;2*?CX=A7)>N%SV9E-<[*&PGQ`\+E
M96)"C+,6C@L?<O"`=&G#*52#8$@@BW]$.A9(3L<;IA)DKL6FU4:X5P2@;IB-
M$)LCL/EJ[I(5HSF3,8(TJ]'M"P_IK_<0KJW_SIT6>Z+\G(M.''0PP>70CX`&
MW6Z9#%#7#8I\*2<A9X\"R-QD%[5UC=%7I^J@:[Y#<@>.*7KDJI%NGC9\]5`^
MI8ZC/RD=5H8K;-,JB3XIRS^.]$(CIE$5ZH)=H#F>Y\;([%]YER(]!M:I[Y'M
M,AI+#\?6H_=\EF.Q=^RYDXU*G5`!/LXYC%I\%W+QE\5OC:"IPYLIDBT0:ZL\
M7RRO[AW+;U3]U:_K$6E/.>T+]Q.RU1*\RNV,)#^%XB$?Q-OM@3-^+YFDVY^E
M\L7:ZG#4_]R)Z:#3%R8E/"W@M<"**$4`?G;=6\E7)#9]?]P+2'V/#@V!_\F6
MXH_J4D9XX)$0.+QVITY(M[HA8U3H&-TAN_M-U,J5Y1M)3=0P.C6UAJ>GV-H.
MN@(-E<H4%P\YCI[!#PN5^T1^;R;XT]+QI\[V+XMMYX@2]1FA6N4T8D<-VO,Q
MTI4M2:*+WH'J=;BE+1$-_!D?G]VIE9EM(M_,O-#2&"5TJXGS]$H,'T`,^?%I
M,1C,GH!A^#E;F1A2D[J$Z7\OW,*!!.C3>.SF'@J59``^,+5S+H<<B$7S7PXS
MPCFH,#!LF?$0ML&,$9?7^T\,6I?YQ&7^Y]QPU`>E>K_D(?^!2`X-SX\WU<6#
M3[:E,F4QL<*H/2MUU7&@]#:DKBO='S#V$-BWRNH?B-6;%6/ZG%YBHH^S:Q]G
M(7X2(3P7^-MQ46>Q?#!`93$&`;YU&N!WR8&ON9F928G](!]B4'N2E1B0*=2B
M^"TCL;F(D];*J7H59E.[<$77=7C`756(`;,^"?;'TY?_`@P`BR`K.PIE;F1S
M=')E86T-96YD;V)J#3(R(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N
M="`W-B`P(%(@#2]297-O=7)C97,@,C,@,"!2(`TO0V]N=&5N=',@,C0@,"!2
M(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V
M,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TR,R`P(&]B:@T\/"`-
M+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@.#0@,"!2
M("]45#0@.#@@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@.3`@,"!2(#X^
M(`TO0V]L;W)3<&%C92`\/"`O0W,U(#@W(#`@4B`^/B`-/CX@#65N9&]B:@TR
M-"`P(&]B:@T\/"`O3&5N9W1H(#(Y,3<@+T9I;'1E<B`O1FQA=&5$96-O9&4@
M/CX@#7-T<F5A;0T*2(ET5]MRV\@1?==7S(.K=I`B:0"\@7F3==G8M99<,IU4
M:C</(#@2D9``@P&IS6]D\\$Y?1D0I.Q2E3B8Z>GIZ^GN#\NK]\ME:A*S?+Z:
MC18S$^./%^/9*)[$,S,9C^+,+'=7[V_\U!2>*6+CBZOW/W]-S(N_2D$?3U.S
M+*YBLWR]LL:8:/E/?`R3T2)+<?N63@J<T'Z2,@?\C)-X-$_QR#@>S>B-83R*
MXV3*M,/%D*@OI$HGH]FD=Z/'%YI,1)/>"ZK%?#*AZ]T3$Y965Z]7O]K[:#&:
MV&_1<#%*[</MUV@XQ<+\Y2X:3G#PB_S<1O$HL^;C@]%]I;N)$CIXXN/'OPW,
M@YXOY6<0P103:S[(YS>FT[L?HV%*;P:.X>G;CW\]?T1Y?=3?;T]W@?3ZX1;D
MG2PLQ$,@5_;?E-FMB?ZQ_"3.(4O?BD7B2>>_7^WC%])G8G%EC)^GZZ4L/CX^
M?"4N>)*9+/]T87^-I#$S'Y^82W!@BU;\0F4^P2:)/50.?AJ8%*X8P`>P;KMQ
M!N_;FWJWSRM0Q7CP/U'"A[[>KHT_K'R;5VV9;[<X3R%:.,>.J9^91^Z]:SU]
ME?AYW=0]XI2)Z]?*";=RK>^4>5,Z/Q#]AN-+*V6J2$HK4N1#-*-;L(^MVZ;>
M&N(#HR=D=`A/OFA=4^5M65?Y=G!YSG%31,.Y'0FQR:NUN=E`#U>]./.EJ=>'
MH@7AV'J*HIGM>*2]-XJ1:6OS]_H0>+Y$%,GFIM[634[\U[5>_"4*_V[(K1D8
M/M>-G.5F?VB*C?+(O:.;9M^4A2-#OEMTCN]'S2A.8LVC7;G=0M.169X\0#Z#
M-#-K"KBT*3V,3@[J.5@=.+,_D3JI]69;5OQD63V[@HR'RQ5;F`RT;]S1(0".
MSA0;MRMAP1ENYUN<L,$\Z03A*>O.15ZHR#-:D<@DRAK,<+FLU@??\KV%2)2(
M7Q8`M:6896')*#AHHA3_G6G<CMR#=8Z=A2TIJ/+*'"IEY+QKCMU=(ED;YXNF
MUKW7*!F-K5GE6[7&PJJY$_V,TP$DASUI]ZO;MVZW<NJR<<S9D\*D>7NAZS3`
M'*U(UU>P*)`(,"F$+"MA\7S8DN[FL6AKXDOL1H3B_217;*=,?Y,6XRXMQO+.
M[:$I*PK!N>;S,(W%H',RWVPTM7EC7"5I-\;>&%MK\XGP(&@TZ**$&:EQQH&/
M8?.&NX5PE0_$!6FW=KNJ?"[UB%/05'6+8$9X-/6.\T6DQ%NULO]![B>:^^DT
MT=QO7%$?H4UF0_8`8":6__'V2Y0AEN%R:,8$?$3O(+F0&UZO(:"+VK=TZ.%D
M1BED"V]LA!K\DHPTSQA]^1KTS^C(E$1(UB'*XM`T;JT?R`)=-:8@D4B8AAGG
M9[?,&]EAP55X(6=(8#DH!&77A%.P1#X&L5U@*:_@D!?\6EUY3M_S*,TZ$,E"
ME#;L6R`0<MQY3OV<\PI12D$1'$?%CT#&?"'88M,11"(*</#2.$E-R-0B3;<Y
M!3U@DF!H6^85LJST_H`'7LMV`\;,T9G[:(HXJ.OUP-PVAS-`'>C7*3<H-!+5
M8)HIIN01^@U+2%[[G>,/A!W_FFOY;<UO%HO$_L&?]Q'%\BV%ZMS>7/^/-W^+
MF&)@Y%08K<GL"_UHF$">.Q4?VJN`*HGUKCA[O3R[/6`:Y7[@CTK.7Z*$OKI;
M0F\ZO9YJW:I:MGEBE9+"-;&!_JVNZ%$2>Z\RRL-/=&=AKT7W<\U%0'V6/U0!
M4R,.>B8P\B-;6[G0JL$NXFT<O!70:IN_>N#=J:S.I:PBB.[=JCGD`B"(R63.
M^),R_C!&!="X*&@G*D1GNZ6*8!2':F&-$$1(MR'TG+FKCB5J`EVJ=E*/4/U;
MK7[7@E,NL"\""L*R#(-_,/+=?4'H\#.P(.]?*)]V4*VM&&4/:B6$0&YU#43*
M\9[9_Z)>9=QYP,0G1.UCJ6`,76D,6PHPLG5RG>!X9D-S98YEO>6K7,CNL3V1
M7BBS]T_7<`'2V!^0])2E9!,(IST;;$A&X9H@CWS?J^D\>/7"&V*M5_0G9@\Q
M$[)1V&7/OTNF2AQSM5418-&!89SG&(`?.[KA#KBT,7O7E(05S.7"R9"YZ"KA
M9TV5G%T5^JPQ1Y(NJ>XN-TU]T&^YN>G#S2PH>&H$NHH9&'9Z:ZG8P:^M<?\^
M(*B@U[MY7]-`"OPT*]7356:O^R)M"06W+C^6@?-+<#8U0(CDTT%TLJD^3+U,
M=FG<E>LW&.@M]GFY'EU,<J/%')/<^0`YY%W"F3F=V-.T*>6:PF$\(_IA6+*Y
M[GXF4)O8SQ&UA7</0/G,+C'-\>*>(&EB'R,B>1*:ZR5&'CX544\C#F)R,>U)
MUNN.AG+6C4!OY#OK0]-%Z$,-`",FNZ4I++?LX4D:G]K1GV!=&042[H'</K21
M39M+8[J2CG5+Z2,[Y)+$[JC=3Z@8H@J'WM2@WT5=[-.50E>8U<&CZ'J/5I9&
M*&DPR:WU\S.B;EUJWXLO;8FIT'(''OK8E@N^?IUG;*B:248K@:+F2,W92)OM
MA`$]@&Z2205B5&NBA*7?Y5675(3;U+9XMS_;(_W0V*3C'IM58%_D!S&F]O7(
M`VIW3KJSP@U2I^1^)^$6?F[U8%V2*4AMGM&H2!>;"D.7\G_1WT[\:JT[$+WY
MEVO+JJ/,WIA(T5JMHXZBG!-TA?T)&LE@9ZWZ#[KT,*QE85B[?L9H2FV/C&".
M,"2!6X]A`YF/EK0MVT/CN._C>8IFWID\/NM/O;W)51F\\-CG!OI)>*I#F1/T
MF/$4-9.9@%K>U]H$"GY\7W-8T^%*`YK6PG@G(E!`_]E\+L-$A8<^AU5;-W[P
M@XX^GFL*SFC%;1LT>/S\5:=7AG+$,$$85R&:[5XX_\R^WI8%M:;Y'JVDM)42
M$`XVW='P*O5+>,BMG7*A<,%<6S<[J:-YH]0<"IA4Y-+.T<37;FK?0\I1.@[2
MKFF(+%>GKM@?=CM)[+G`!00%]/I2GN>>9FY1OU6.@BIM7A2AZ,_1)EXJ..JU
M11V+UNDKY"0TF2@MORN'O:L\M=6(YBE-%=NZX+9[E7O\/^QK$;57S]*@C]^[
M@IH+@W83?;\.;@L=W*"(&GA%UNO&''J4TCF->UK3$^A6RF.YII+GW1L'C("N
M#:(K#ZYU5.2;C7)T^5K&S[UN4)QB)CB6GH2![TB&>J?^_7XODHQ#J6[SW\\F
M7<2D7)<Y=%UZ&G'*Z@`;U>@GI$D:=-@)E:2L:C&&.2JZM:\]U(-I?L!!<7YL
MM:S3J]O#FD(&!6X*?TJM_NX\-@WS6'&R%#@1P.L4]`RCI+9L3X+2)*FSFQ-_
MH4D\A4&@D=X*=+;O)BIFC;Z""6XM]4LGKVZ2.X5D0J]S2&:62YAM^@F'.ZX2
M=@9F<OX$4VTW7WK`=Q@;3Z*S9.=6F:E5%K'V$Y(X%-O,ED("]5$Z'HXI],U2
M,U&D\A=N7]'T`"U(Q,P>(1!,"=V=YU`#OD,<D@"8ULAO(PDYL0HE,H=.!/HR
M1A(>()[S4M^D0`5Y(=,4]Z%`2DI+#@EAUDN_>="'%-#F&A[B*D[ENU5)V%1R
M*$_H/@5T:I$MB#]/@V*/!,(3R[+1WK@6G.&)X/]M5\L*PD`,O/L5/:[0@Q:%
M_H!';QY[643M0F&EJQ;Z]4Z2257PU-*FW3PFR8Q<DGA4<Q-6$!>H34T36Q`M
MQ&9=3;WG@Z#"U!WS?4S`U,<>^(EE.2)B7S"6_T)AY\V)7UW3PTKE[7+./VR6
M<C#-9,>L^=0G4(7"YC)3K8P0:`/!GIK#B36<1-<B4[+.'#@D'I8'?K:H!J:N
M"/"/0!(/,SSIR\LK#D^DHCBU^)ZPQK4(W@V9%@:$KA\E'P$:3OF*]+/0'W&G
M"8Q,;F^&71WA&#P<75T8E/,T(9?2K1&BAM(J0VJ#F]GLV_*ID#MU[7!:O0%T
M"L!0"F5N9'-T<F5A;0UE;F1O8FH-,C4@,"!O8FH-/#P@#2]4>7!E("]086=E
M(`TO4&%R96YT(#<V(#`@4B`-+U)E<V]U<F-E<R`R-B`P(%(@#2]#;VYT96YT
M<R`R-R`P(%(@#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X
M(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#3(V(#`@
M;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14
M,B`X-"`P(%(@+U14-"`X."`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Y
M,"`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S4@.#<@,"!2(#X^(`T^/B`-
M96YD;V)J#3(W(#`@;V)J#3P\("],96YG=&@@-3$T,R`O1FEL=&5R("]&;&%T
M941E8V]D92`^/B`-<W1R96%M#0I(B8Q738_;.!*]]Z_@(<!*"UL1/R11>]M)
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M8RJ>.K]`+\;G!O[O_0H-S;YV[?@\B*8]7]JPQ^O87/]P\RJPT_E.J#Q7XMB>
M\4.*RR".`YA+G)[^Y_#OA[W&B,H"XTD'DN%`TD7^J7MYZ7X,XC&YM.!&]S;`
M<L-C^@_*2#V%LEYFN)+@40BE3^%M/$N=&0Q:E1?+1-5A^]I9'>#@C9A/VYRI
M$+*R7GMN@JEQIE,\>@K#UEM9J*S&6BEKF=G[[BIPT]75RE^7_^3KY=1WS@)&
ME9H]FT.:?.W&KA^8H"F39U6Y<6/C@=59N8V86QS*#NNCRA166-*U/KLR*]0[
M"?[=._\-ZD)G=?(SA=S5R0"A&P0M4V42@C6=:!VB;+V#JLBE3^D>8I9T6.Q0
MCZ\=\"+=&UB\H75OPV!DF17OA\&4)C-F&0::`3[`X.JLE)U#-QY?MG$W5475
MRFWXY?``?!$/N@"G)!0T<,^*/#-6[-W?OGEX>@]%-@04JPVS,>/2VGOFTM9+
M^Q*B6"YQ58#;>=1<P7[*!KBVJ]UUD=\SU[#ZPKR"5GEC;I3-5-P<X7)A+E>[
M%WE^S_P=>!%WXT%LXMNP;M%EU+;H,BA;='GF+;KT>8O^<EC>4KY/EE""Q7R;
M8.D2-_$+N?D-.:238ZK@[TNZU\"DQOT8Q%/?76E$-/]S7;U(QN64OCUZ$W%Z
M&SS4^9G>M,&6A&24)K,%>'=+\0]JEU<5-2T"DP]P5S)=#.FK<G>F.M/N3'@0
MHZD9[/>I5/[269(9DW$3".(@[%O):F*B3W<)B8VRC,`XR7CCB6.$1BG&&T\,
M(S1*L(C;GE^$1NG%&T_L\L8Q<L5V#@&!/!$*K9^)%P,O(\+`RS,S\/)4#+ST
MFX%Y"H&0J!:"3(?K31.%/C>OI)V*Y)1J^'L!>08W)*JBX[7KQ\N?A-(P56B9
ME1LN5#F6(QS`TR0Q^AX-RF*JZ/=I`.DG&H3#$`VDY+:H#<XN%K.3-5,J@YM'
M<\O#(;<\''++PR&W/!QRR\-\;DV-M`CM487VJ"BWOZ;0RVR"8ANDS^@DD$GZ
M9ABGEJB2UZ8=6,$A@^`(V]S1?Q!9=>M3PB5'ZYH>$R4$L^+ROZ_`_4S&2L$J
M7PJW3L%FZQR7.6X0S3$/AQSS<,@Q#X<<\W#(,0_S.88/&>(DG6+;3Y_N"FS2
M`I+Z'5-=XK6%KR(::U,<&L5KGQKX@*O-PNB3^W$9X<GBOE[(I!O@U>(&V&(`
M$:[5K3_Q8E"U+X8P.9'4#6Q63>VADLZLP`=!'C0I%3&\]I3*X9V',ZH%K+2'
M2P\N$F[<)1%-.`^'A/-P2#@/AX3S<$@X#_,)5\KK`XI'%4A=+31/X32,A+3#
M54!B!=X-[4@?\(S%=ZP*T_SX@&^-@D\PS'8O@GG_>PG.?8+#Y*380;-8W0!R
ME\,[%`?+3%L_J'9:2Z9MJXG9\YJ;MTVUF6)W=9FO*T%K++MH)?!PJ`0>#I7`
MPZ$2>#A4`@_SE9#;I?JEU]KTA97P!7LX<A=Z^/DROO6->.IZ,;CKW.)3%^A^
MQ9Q;K`V!LQ,HC68$4;O7UN8)"&E7#`ID]%;>UG>%K,S_NI`-;3N<B=JV,O<N
M\#!Y<X'+FI=7A.;%?(=NA5T$]3J9T#M"F=\ZP/SJ04@3'%?2_.H!YE</2IO@
MN-2.A2V_MWJ0X@3'M3B_>H#YU8-6]ZM'Q3J_>H#YU=^!6=X54'_*S&4'L:U@
MRTS6X1K*Z\#%VC'E\-PWC;AV[?@\"&!C<W:F0,[:F1:SJ0FFQIE^:U['YOI'
MT^\$\(KIC%B+CCQ%"==I^4YKSJ%'6IQ<.>/;[I%\O9SZSIG`*%RFP3<W1]*<
M;NSPV;MQ1!G>D8T/MB"1M_)!4HOXK7="5&&#2J8G!3A2R'6H9`B5I(Y'[L,-
M*/$Z^YE"3<"M!N$;!"T#M0FOW.E,ZRAE>KT#1>53U[]V_1$$,M/N#%#U_3,;
M@,UMW&D*;`BMC-WVT(W'%V9+6$%%PSPWP:*66*>1-A=#J<UY--[F(N93'_,P
M.%BO^ECI$ATQ1]C8``/1--NHHD>C3N1AB%-^VTLT7$EQYQ&VL_-,JU'WS-^!
M0]QS[.V$JBHKUW%EX3EN+#S'A87G<[/P[#@+\TT0;QP[4]<&&6H7,K1,CJG"
M%X1!H9D,XJGOKOAK>E]:E)X$]NW1312GM\$-=GZ&,VCZ@5.E5A)=9G?NM#YI
M?7L*DY,/H#8M/33@FM%>@GZH[%UI4Q0:[B1L.G])W``+E-DZF7S0.UFMQ6E1
M:B1UC)>$WN$E;QYX27"<E[QYX"7!<5Y&G)]X27"<E[QYX*4WC_(RMKN/C(*D
MS0(!1,HJ<CP^AX;'Y[/S^'PX'I^]YW&>?KJZN;UUN`DUT>]S\]H[G5\DIU3#
MW\MQO,!E>FS/XGCM^O'R)Z$T3"7K;L>UR(>*Q0JMYA>:Q%>!>[39:GJT41D7
MBQ%0#ZO*-G9N+UME'(%#^'DX1)^'0_!Y.,2>A_G0*^-O7>I\*G0^1:'_-75M
MJX7V!2)F=&+&)'TSC%/74_@B&QK!=31(0E'>;'.GH^G:=[0P.?&YN5U5PT12
M*?"0H[J9^Q:VK5NM`CZLEJ6&)==)!G"58VW<QK$<\W#(,0^''/-PR#$/AQSS
M,)]C?+N&,$DGQ_;3I[O=FK2`I'['5)=X0X&23VBL37%H%*]]:N`#;C$+HT_N
MQV44CXG[>B&3;A@>4S?`%H,!-]2M/W>*0?NLA<F)5H4G;Z4H972*PJ7S,2G5
M8[K*Z:*H88*JC)]1KF9,2TCI)RR*0,FY#TN\*E=5$,%#&43P4`<1/!1"!`^5
M$,'94C!UB1,"W:M`]VHA=`J4,)F$@K"9QGK`]T?3CO0ACL,`Q%=AFA^'01SC
M^X`B93/O?R?UP%-[.SDI=UIJGWP[=6ZUR]74N_5$8KW3A=DP6^Y*N(%6B87'
MH[%Q=O-P2"L/AZSR<$@J#X><\C"?4JN6VI5>6],7IO0+MFFD)[3I\V5\ZQOQ
MU/5B<!>JQ7<I,/J*R;.89(&S$\AQ,P[P;529)T5!6<7,E)L[U=^-$7EIK)E2
M_KZXM!6)R_E0U*LKNTJ>J75$OQ!<U?,5N!%/,914J4?CJC2V=\#YY2?5ZN&H
M:HTM'W!^^4G5>CBJ:N.1\W@L=*1Z/1Q5O;'E`\XO/ZGB:?F8*HXM'W!^^7=@
M(-;'P\$(>`,]<10K+92E:T2N#'/8.L,[X[,?./R=&%>$JQ4_G7Q"Q51D%1!,
MHG`5*A-?C^WQ^S0,C/O;0)S[?!G@M3B0L$U+0,_BG_"._#E<!B!IE0CB"[BJ
MR%5R1*_XZ%S2LX^WHEI/HMKW!9V<FM?1M83QV8ML\7P9QJZ_G(XOY-JE!?Q*
MZOK4M>/QTC9G;RXFJ[ZYM+O_<UXE.VX<2?0^7Y'0B0600A>7)GF4-1[`AYZV
M+<.#`72IKDJ*"14KR[60H_D,?[%?Q(ODUBT,,)=N5F9D[,N+*R:@'[#INHIV
M*5C,)W9;N="`-O3NE[&P]Y@F:T#,#G!B+J/D6Y:KV;_Z-IJP3O#G0D:.SIH$
M]F>OS#4@FV\>#,C^(U/X\@"\VAU<_C#[Y=,/F33`*0^A3UF/56A4TES[XF:2
ME(?AO8L[L<Y]C'IU:(M$JXIN)G]FTD-[@*58C795#J[R1U]'^VXEXJZMBZ:?
MNI>QAR/[WO5#MD:'[HI!W;,TZ4',7$Y\KYN.6HI4FUUR[4$2U%+M4'1?/0)9
ME`A=#W-V]>B;T@Q:*4NXC!:<E3<OKU3Y%917#\MH7\#/_5@/T+/@S#AIH-8:
M*$1P5L?X]9Y]/\`&L;&'I&*`&L=8'[TK?2=9X[K0?U5S2)YLND$CVXVEZ-B4
M&>'(2O-C*?E1Z$=HAL#C_KW[('KE$Q(/(RD4E$)$9V1B"G+R6P;`M);`[I3?
M3@IQ<2.".<]KGL1,WAQ@DB)@."9[$$RDCQSE-4HS!&H16IX.U(*4E9*X%_`7
M)DF584^FQNZCR3BTB?'LFIKSF3:I%BK_T2ZH[\5D)"UM.I(+'W8ACKWC#4_*
M:VTCN2#RU_%!PV=\!$MI?%[BL`<7`!1X"`T<TN6WUQV@YS_^;?0ZZ:XGE1L;
M>VO/;E],I2+3>I&C#*0XL:,((RF=P35Q<'4XA($O*C=$]A]=033)U0XX<*M5
M*D,&B8YDF2/3J<>+:A;J,&B#6B8R,',4CWX7FM&XXK0B.Z^\CSRO8^L:_CRA
M@"9WQ6K--S\W7VT1Y<#"MAI")^ZL.Q:9#(O>.P'5TC6_Z0#H45IH%D7MI;Z=
M5+R]%+!6\NU>8HA`=V@$":=WX;^\])5DW_Q!\XG=U5HJ1;8!7C0ERGT3Z_A%
M)8>2?0D#P:.@1YD$TR01O3'6H>)XN*GH/`V=S99VGP)Z?F-!VEZ"M&66;\7[
M8N^?.,L1HZ'H]!?BKK-#*,4J?,!\_23!U]<$:++Z64J%ISMGTBK[<;"Q%"6U
ME.V=;EI_.56;7ZM6*E54N8E+>ZU%&")UDS)=(&?/HF^>MF=R<=].7_"=$;CZ
MVM#DB95]3]^>"_/S7'CQ,H9=6;1A*&HFPEH2H81]7K7L%93<S@.'VL8S3_)2
MQT$TDB8>0CD],PA'/W7L_Y$-Y&B$G")=(P,!J2/)/GCFU<W88'JM);UL?JE#
M%W<#8I6&^L9LDZX%M<8:1<1VN;`S[61K1E.^-9H2X=6$9)IO*P95II_NO;WC
MY4LFA]84A(^12?E?2]F3CB(PY0+*\`NEQ.PBJZ8R<#,[X$\9-BE.#/1<ON[X
MK[?/2N]<:Y?9TMK]6JK-=."IV3=V7^RE*'E]=33]3@C&M4=($TRWK[VTM7N/
M+\X>7]/CE3Q&2I?Z3U@LR&*+1-.S2APK4XZ?=3Q-+S.+Q0##3M:/2%.[FTOK
M$'*2JA`_68<6BP5#!L7)/*8'5,FUXTL=J*1B.-.E'SLS0*RUV9U+3>YH2AT:
MZJ]A7)S51=]2Z/3)D]68Y18!/"(4R2U]E-W-X)Q?]H+Y!7P+PBOW!6>:SA.U
M]A`4;KXG"T+\Y5L0_[*RD&A]1K\I;/PE\CX^/_W\X9__=L^__YC-1.=??_\)
MOW+Y^2]IERGP_]]R,3\O%V;?SUV<_=W_QT!O@MB6_+G`Y(9GY7N>?IY<%I"E
M4;[+-I./V6P!LO@:;;_[G,GD$N0.O\-S=>QX(*,,<""22QF[-G8%)U:"X49)
MF$WZAJUQJ4WK<7(>RQ"0;]>;J:OB_7)PQN_#WAC&D5?[]/35>J(HP+PTG*([
M[6-=ZYP6Z#%7ODG+4S:?8-%RL36_W!@X"!Q2^GY\Z4,5BBYX8+:G4':)@WN*
MTDVGY[YSZ_K/$S(43S^E&=_I&A/MJ5S!TW*D_?L9Y6$D-[L*9M>3-.VTM$`'
M]TDS+$\14_AR-Z_2GK8PER`[6.G7J?%.DF`S>7[Z)#6/T&>"X#YG[Y4.!DM.
MSR<T6P[4GP)*9W.9!'*IO\43>U]4?XQ*6'1VZ5'-8M5L:S\1?=Y0%2IBT@NE
M:.QIX3XTQ9142-:57=>\-2Z[#-.\:^PKD2O3@YV1Z;A3U"8G(]6Q_N:-H4_7
M73+:F!5!G8V+J:Y7>OA2&/6]G;G`F7QSCU,WYZ5R8^V^PW#'UA8%B,WR-5YK
M,,%;KPR@/J93&5^`OS`*K5-V1FV:!U^%$K.]\D=),ME/%M+EJ[$?-*7/7+53
M0"U?*Q_`CLG0A5(SCT,D=&XO7VWPI1<1FNDP2B55OK'O052`S.](R;F/W%B_
M-.MS^276BYQ#:$(Q8&RXEJS1(,8#VDEI\=,J45--5(!4ZMJV]@*C2!L0$`"2
M6!K6.0OE&GGH54,VGZ4V'_+X`:G^R$I[G!1'WPW2QO3JN;-C*4!94^S\M+\P
MT_NK831_3+:%`<[J`]]J1UA.N(X<"J0A&10E.8C]O8.I`E%++$0=FI:'V6/O
M%6_8&:--LKASO>^.47DB+Y(O6J!*.FUJ)V\C6/[BLN0K(,ZF:`9VRO49I*K!
M*<UZ`ZL`I[&1]>HJ)EYFL]Z*A9:/15.`X?R*8<]9B`#Y/\9@PEJ!KX+=DAO_
MUSC<F@6K!UM[GA$X5=$FTMAAMV/F;M$<YK9WN-:."AQM44PR6+R\FC]00T'^
MB$R.E.FYZ^H745)CKXV2PO9%KRO;T2Z]LD9$-/0Y0[^=A)U8N\!!:6Y>I,:=
M3\[9B"QHD<5>0DY3]H74J3$AQR#=FDV<AWKW>A+25P95%OF#0179:OT@&54%
MJQGWVYY;:'_9/J%368^5]$?H,9``.3!@U-L":ZNKS"-LLZ[SUBR`WF5P\]JE
M,PD#X?&U-Q?TP1IP<ZYH\W;6&F)9?2>'E^<M#*W/UU$S22HC+5M<D$YT9MM%
MR5IA^^:2E&:!%!0L&.*!A0[IG:_98&QOVH>6VN%F1IJRZ(?0W'"$)O8>"(,0
MJ6#!ISI[8_^:I9_:19J=;A'<)0I;8?@UZ@ISLXZ-MN5,N=UHQ\84L6<!;>9Z
MI=$.8NO4@0R\[6ZZ./42.UGBJ`-#IPY(ZU?:">^7/6Y3W'?$]"OMU8M3=_.N
MNBQ-S'JNG4T?ZU!=GHD[+XK$[PGGIGFW;1$,Y:GUR2_QKT)H:0^^'`<B]\!_
M1TEKG$/HSH[*ZP3IC;S8B:1\LK.%XL??_O;7`#QOP+X*96YD<W1R96%M#65N
M9&]B:@TR."`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@-S@@,"!2
M(`TO4F5S;W5R8V5S(#(Y(#`@4B`-+T-O;G1E;G1S(#,P(#`@4B`-+TUE9&EA
M0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=
M(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-,CD@,"!O8FH-/#P@#2]0<F]C4V5T
M(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#@T(#`@4B`O5%0T(#@X
M(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#DP(#`@4B`^/B`-+T-O;&]R
M4W!A8V4@/#P@+T-S-2`X-R`P(%(@/CX@#3X^(`UE;F1O8FH-,S`@,"!O8FH-
M/#P@+TQE;F=T:"`S.3`T("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E
M86T-"DB)C%?9CN/&%7WOKZB'!""#%LU%ZZ,]D\0VT,@`TV]!'JK)4JLR%"FS
MR-;8GS%O_MN<NQ1;ZL4.!M,JUG;W<T_]<'_SW?U]:0ISO[]99[NUR?&/!]4Z
MRY?YVBRK+-^:^^/-=Q_"RM2!=^0FU#??_?-S81[#38G]^:HT]_5-;N[/-XDQ
M)KW_+SX61;;;ECC]D59JK-!\4?(-^*GR3;8I(:3*LS7)6.19GI,X[%T4Q8*V
MOU"KW&3KY<61-R_>E*+\9KG*2MHE&V#K4FQ=5*1<L2'52&@A0O^=?!K2Q2;I
MTT699]MD@0_\?$P7VVR=.%KZFBX*6C+I?^Y_OO`>6UM4+VP5,:LH)L]7[*8L
MW]'H#('_2%<9"\RS53*8\0`I:\R8!S>.CK3!O#G9883@DA;Z_<6NDPTC/@?]
M=H8T3WY-BQV.Z:0=PJWY-/2L^0I&E?C[41>_ZJPYV&!\]^3"Z!]3.FU'U\3%
MX)YTOVIDTRJKDM;TIU,_C%/G1^^".?OQ8)ZL[O'0A6R;@CAK<>$-<@:YGYQ1
M%MM*G''J1P=_K)(N+7!R]):_6A/&(5V2*?P]NL>TH`U>W%:SXKP41E6YEP,A
M,^;^0/&K$MV1YMD.CI*K:KG0/Y$!LF[JJ3WZ3D6)!%EJ6"L(XP#0C&G\T]7E
MHQ\GD:P;-%H\_M`?3U;M6Q1TZM>TI"N_I8L5ON`G*)_\D&Z?;>O5\IYEM\9>
M^*<1T>+=^[]IBJW%J\6.1N35#P?;MJZCJ"YA>)@>@F^\'2ABGK-J2PJAH!+S
M,[X+;)LZ1ZJ7B%)F4B@%+SIS&OK:N2:8/45XC60HL;<_PD2+-!QL%RRER3:I
M1]]WYNP&9Z;@&C/V9G"C'^0<O-^VT35%]=J&6"9E+!-V7:>QU?3^QHD<C(LY
M[.'^3I+7/,R[OX@C3>,>1D-JPI#1']VM:9U]F@_0=)12BI22%YZ\5A[R'&KK
MA^H@$>.K]X-S\HE*@FWBRHI=6>6WIF0Y<.BM>9A&"`^!`_W"]$)-YQ&9#M]V
MJ,YV3XD7_&_D8,JW"F>S^7!^@;]O(L]2BZVB$=W[4PI#UA+YI1HRN'#JN\"U
MCFQ`U,@M'+4EBUPFS<1^76J(I1C,17R6XILU934="^R'$J5P<H.E0X"C^8Q(
M>G62---RT/!"?CVA4!W?(U=;UHBOA"(I'7T':J)7E]M=3*B6(:+`)4L`0M,C
M6WDDLS(6#6H>0TC?^@:P*`=0@@6!@3A)MM_Y^N*.WMSUHTHAV$&:[R]$RE;?
M,O30D(PPGV6Q&^77?-_)X):*'=\?Y+/U<I5>WWF9SD0KJE8Y+C]?Y;"[D#OQ
M3G*H;`P0N$KD4OEKSMH_5+DW829?19AQK2?81-<PMFLXPG4_(*,44I!8C5<4
M,ONIJR5NC!$O8(@`GK8I7/"=[&C-A365>KI!4G&/P3F]=DXQVYI3'[R(0-'?
MI=3!=7<]:&0"SS[74):#DH@U9,*_[CYS^_#`F/T>?0X%P?)1M(-KIEKK'6:B
M"Y*N&]+5]-(LD08''5"B%@F,".8`'1D/@T4N<QW@DBJ2@$TR%Y*"3*59:$^`
MWZ^ZXH\0)%BTF[?]11<+N<@<?=MRC<)52)%T]QIHES/0*BKL?:CA/"U$*7DM
MTH&KTJ0@&.@+U?O8\\RS\FN:E9=1'H](WAUBLL2U$A,V"!6-T/P9P?HCK-O.
MN;F-4IYCCD80F.*4DF[;!'C4**V#P<F3:_M3X"0^VF[:6^)]-1;0VID#!G/J
MW(0(^/K6N-;5X^!KVA^YX8.-W&TKP0'ZG?JSTDBDCJ)M/Q)7*BZW23\9".=>
M(=EUR+8Q9!%@-69A=$=TZ'Y`Y]45%V'ZR`Z.<6T\0@W;'<"FU23KJ-*:"83+
M8^YHAR]N!(D2!S:>B!A#+Y?2.D$G(Q8QHN.=.]-ZH0VS>V:G+-]C*=4S?*@?
M&RUQTK%,6+6#3EF9:LS)NUJ(!J0#EALS=8U3N)`./R@3:012G'P=!0%@5C`?
MF81ITUDF@*Y^^.7W6Y7U:OE*!Y3B[[=_O`6X[OYL3YA49\$O;(\.6[]'B3:1
M$DE(?L0!>$.0NB:!D8+P[]F!:.&CFXYNZ#4A@`(4*<1,*=*>F13HG7\B_(H<
M1TC^@VL-)Z0^.7!'63!W909TF6YQ"[)-DDJUJ>.K`6T*<^&$/D%K;T+1,N8U
MWCR'H0]U?_*U$I*+=`(<$Y3*`C+9J"^7[$L-.($6U=?,+#)E.W?Q2@$UP0:]
M&A!AV]";*$J*13!CYDLSJ[E0B=!"QWM;CU$?.!J-T5N!#[:#"D1W'J60N%J.
M_3/R23_*9UR&@R\*$\V@1?52?]-[2"'21RO=3F./ZQ`VY)0;^NM=)UO3_.FD
MTT*DKGA>RP"(*++.>)N.UG='?,]J.'I<_;_\LX@%7Q9:\)_IT<-`4J$B'].M
M5H?T:9K;I\7SAMIVHXR0SQ3W#3\S9(H)MXX/'!EZ9-S%HX+]\M&+"+B9'T(R
MV5S)M<B)DKQ!<(W$(<U,O%86`<_U/-/I0&QPO*$Q>IF:=*D=*]=RUX_"0K3M
M>IL\*=!P50NG)&,@U_^H$N+9?HCVBG-L*Y]14K3DG;X2"5T1$?E+1Y@.\+!`
M!E?[0%SBJ+!*?3&F./4T"H`VDL,%AA%0._37JP9\L((3",'![YG<C00A]12(
M&-%SDU*X<=R)*>>8Z\VY)NQLYH)U.P7JEV%"42B1Y,<;H<3>J(J]4DNKWXK'
M#&VQXYC(577Q&=N0[W;4'B)8';FD.0&G(JH[1LPAS/W67??8R_;*-FFK,$$9
MK_8G[(ZJ7*-DL=,H584^9"3QB:]SSH#D1U)ZE&G]<2DM#K673\N?Y"ZF^L?+
M6?1\RGV\#F26O,JKM:.*I]M!BF6.N@%!?N=`;W8T8I[*RA/OY7OJ0]2Q%QU?
MJ7Q4168%=(.6W4X7P+SFNY_T;//R[@?2/C%/Q`>*K?!CTD*?DWMY"^U=K>?4
MDGB?J,Q/$GY9Z:V/KG.#'!5=KD]WCR_:67QQ\H@"!0_AU2"Y5G"F;%!%CE*+
M$ZM*+)+M[,>#H5S8<6O"LS,$+;I*`+I(9-GC92--:2=-";KLI:U5B1[0^5'*
M0GLVC#GHN4/49D"ZVBZVQ2K*_J8T`D\@5"ZELGE`L8$[A/?I_RMD4>I2%I&Z
M_)061#A8NU4R*FT80`J@:%G&E\\JN0(.X1#<P<!@#@"F&J^[OO6-C1@RO_^$
MONL1J4J\UT2.D\>IXL<J.;DNH$</KK6C,A\]06@$EC'SFG>0LU3[2AIQ3<YJ
MW)KSP;>.-!U]-WE^J!+,]T9&Y&AI2K@@.:>`.3P?!W@"#T02BT[LQ!K%0RHU
ME`&95B8]K")^+J]4WP$+&[(E910D,]9DN.]4@(HG7[U)+XM5C-&Y'[[LH]/Q
MTGV@/H0A(RO(8I6K^_[*RCV'0FQ<B9#X@&)VRDY%SYAW*']#Z#5H<(LU97X+
MA4SX)3/[$?]M[<&E-3)1_%XUZX\X46WIA-SY]C-C%9O:Y6W;N0D@I6%BL=OM
MX,KO1\Z/8(]X1OBCFY,PW5[T$6ED[//!V:!)%?QO_`(2=!\%S8/Y>W?5-#KG
M!A][AJRP$S\-',__45XMNVT;473?K^"B"PI0TDBB+6M9)%DZ+F"C771%B4.8
M*%\9DE+0S^@7]YS[D!@K*M!%'&H>=V;NX]QS;C#_#QZ:3Y?&J.6I[HS"XKNI
M7R;E9,$!249MAS;?UW;@77H.#]T=P]!WUJ_O)"]5\R';$+N"W<]-)6Y`JX-)
MJ.DG=W\[Z55M//NU[>I.3Q;B>`L\?GEYR1(@9HE!EMF69<;';[CPS_3I<<$>
M_*P&L'H]7[V1U5QY!47B0.^>V<Y`^>GQ&2]=9&0CP$2\@&#*O\/2)X[Z'SP^
MF)X!'F>"WB4>RWZ0R4/Y=U1X(M47HPO"*ZBV;B@2VQIEXU]LF4!?%LI4C]4[
M,[?BDF\ZB;)64XU:WNNOPBY74#20F.GQ@!DUW<DCZCK,CM/+O`=6<!0P@-<O
M;L/:@SGKCE]T%D$L=K`9K2WD[%R4A#WH8<F.N0%/KX5P:FVMK>MJ@@DBI8,N
M9#*LM0<\$)-EG2$.$1+5U$^Q[VSGP+JR.;\(@`3,*1Y]32)(LZ.?0=WZ/K@Q
M$U8DE\(!OOEU#M-(HCE4MI+W\[O^&$KTB^XPQ]OC#]HL`/63%39:9A,B6NA,
MK`%>GD@BLO21X<S2YW_.`9QY%XY-)F(*>&2N=SY517`NJZSQ>P"!>^QW"1S(
MTOFI/^:29\Q_<&#1_G&&9]VVL9)N*MR0]>Y-(3GEY;S!^C#Y_Q7:A*]3U3?>
M7MMQZ=S8AI*BLC:A&]IN&.%3#9?LE4W]*R+9)K..DJ$YN1%V7<39KIWD%US[
M_N&9-6SYDH:]9QIQLX#3B_(B.I4`,8\,14871VHBT`6D:R/ZX+>/(K(R4!OP
ME_MTR;2&PW]__&R8(9SGGJHW0^Q^72:'V1Z9(K4B$4%3.3%'UN)7]/^:0QV1
MG!Z^"J.#VNZ#28+0[`/PH;`KREM`)QORA*=1#@7U1E\0`+=IXKCQ!V2D#=*;
M2Y%(@1\'Y9^YD,-]36$W=*5;/#%K%1=0@+FN38XY?,I&R"6""1AT^TS55>IK
MS3P$XR"!D'K][U;8!+2J!KF"8%NLC3I:ZI@K/`^LUB)3*@;FU/_@L5L]?7//
M+VG$PF44JN2$K90F5!$IA-+ZLR"3>[&89-"0BCU[DWI?8;*14^P1;!W90W64
MU>CP2,<.DU3=5IP'>U%_V1NWI$8@1;B3GI#$O*\*Y=4[OX1)Q%?'2V:K5MY&
M.<K.T(6#,G>K262N1[V40GNL8M<*.:$V)2D*,^Q`DA43-(^FLMSG4BX@R\X7
M$C0^7##FAQ%DZ6\=A1^4AV9*!%$TA94J/0ED;'+"AO@)Z$OZ-B3'KE[P,$R1
MBK]:JF3RX'NK,D6-]2W4WSGJ`Y&5&DG=.P5"9?W!*SY04A&$<=)B191&KAVZ
M6+RE>^.I$YZ(JMN'812Z>)$OT%GX+!7M@3$YZ"G+4]:7U4`A=DFJ+#6NE4>0
M9U!G`M_N"BA,D:XVQGW>VJ$57D.MK%2*1AL\!FA5N4+(#TS.]=4FZ:I6Q<"N
MH&\6N9HF/V])T>6?T(YW0D`DV4/`NYJ>@4;4SN=%POJ:+I1S)/`K"3O)@5@.
M;X*U/L.#";&B.[40'"WO/<M$$T/7":EG*?W(1QXI"X,*,15/ILK$YA=H-2!,
M9"C%\UJEMJ)PV:=0-E*B%39IY[QGMCA)TM=\?OGIWP$`B)F]T`IE;F1S=')E
M86T-96YD;V)J#3,Q(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`W
M."`P(%(@#2]297-O=7)C97,@,S(@,"!2(`TO0V]N=&5N=',@,S,@,"!2(`TO
M365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@
M-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TS,B`P(&]B:@T\/"`-+U!R
M;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@.#0@,"!2("]4
M5#0@.#@@,"!2("]45#8@-C<@,"!2("]45#@@-C@@,"!2(#X^(`TO17AT1U-T
M871E(#P\("]'4S$@.3`@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,U(#@W
M(#`@4B`^/B`-/CX@#65N9&]B:@TS,R`P(&]B:@T\/"`O3&5N9W1H(#0U,3<@
M+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(F,5\MRXS86W?LK
ML`LY9:E%4A2ER:K34SV5F4IUIJU=:A8T"5GHYD,A2#N=SY@OGG,?H"G;2:5<
M91'`Q7T_#GXXWKP['E.3F./I9K<^[,P&?_R1[=:;[69GMMEZLS?']N;=!Y^;
MRC/%QOCJYMT_[Q+SX&]2T&_RU!RKFXTY/MU$QICX^`6+5;(^[%/<_@>=5#BA
M_21E#OC)-L6Z2"$DVZQW)&.U66\V)`ZTJR1=$?D+M=)BO=LNKKS-6)4OMODZ
M):I(5,I(I20GA434CK5>)WOZ>KKY)?HQ3M+U-NIBG._`=I5LHL'Z2]]Y:\;>
MC&?:PI$U0WEQM:X:_*;K??0M3@ZX;JI`5G;Z\1#3@8M71-8]F+8<OMI1!%1]
MH*I%KAL=!-Z:3S_=F;+QO:F'TH^N*IN7@E3!>JIL;=SH33>U]W8P_2E>%6S!
M?X__NEDM#(?=AV"M;2]-KZ*5HXU7._"W<;9.(ZC0EL%&V3)UH+B82KXF41K"
M76=\V5AORJXVK:I:\CVRUNF.>E=<(B;8WU3*Q<+3PH`/3GTU>1MT,'T'C0*M
M:UU<@/?OHL?L7.$[GBUIHS)5:P_/F%F8@U,#.3OJ^#=-C%P3(Z4O<M5EZ.'D
MD7)`K^?/UW-$?/)CK_LM*5)$=O!K8]Z/(6GRB!1J69,"^KGPJ8&N9%79Q@X4
MO3PJ1T1U<;L.7W!I%CW:IK^TMALUVM"B--V"9!L]B1,?5%!GAY)2BYQP;>]6
M[$WYB^QM>R9$:HY#WYC15N>N;_H'9K^5;-E%MQ1)..^^]#A($`N16U.@*``_
M]T]BS#;Z.5YM0?#!7&@/)>(N<,_Q[)"T]LEX.SSV[_QH+Q?6=A<-03J'D(N,
M?G#WR36-N;=QDKV.W%XLV>SHBRPI'TO7E/>-->!;4#I&`['*Q`BD--+VY#RJ
M2[REVTJ-?T.<$AF<DSTGINH0LF$?77!DQ?#>5&PTT@XA%/K2G":R)",[LL@T
MKK,4![)=DXO2A6DI'>`6*OV8-;PV,543^8M,K"WG@B3C/M(DD&#LD`2<G))M
M6[8&-(-M.!<\XN#AT?$,=[<PPJ'\^FGTKK920[9U5:\<.]*S'^"R&CS9R%0<
MMH_6E`P+93>+D4#=%Z-F*Z.&1T-2S'TX2=2BA+[(HL\_WE&Z'*)_QUPL'V%8
M$;W_<*3=)/KT^8ZE@.5.6"+#"C3_,&K>%+MB(HC>A4ZHB?]+]`$&4D*WDE,7
MA(B;(67LR"GM]`>]6B7KW,S76;:0',8?"/8JEBE(;$94LU9Z7R]+:`]SWSF(
M(XZ(@,P*;TX2A0,JXVS+9CQ7Y/\$29K2IN7DE$)$]^%-"MT<,\H^D$OH*,PE
M[KANI);+%8%#CF42&67=4TS!YH+N/;I'>\LR*"T^<+*H0M]BOO1JV%Q-V4T1
MYLZIK*SHB?+U82Q((];AX$X8=]T\(%D!I>/&=!KZUI32U'7HZ<1#3=6!]'0*
MVS*]P-#WDVY!A[7P-W<H(-V5<:6M`+R6MJ:+0?F=M+[9#-91](&K^L&;<_EH
MGXN!TER[[";;JR.\>XCY>A?3?W="PN&GBH%;H`G]EY.Q8>DT^--DGIIZ>>!;
M5NA'RS^R1YU@ST;17BM'1NEY(:)Z(;M6AOTL-WW,T_=)[J#Q76U[JIUM--W[
M474>7:F4VAR_Q=E"[3]16#U`SL4H#RY@[435P/G6C$L+SMV5UQIA<(O6R@S1
M7Y=,1CDF,$/+1[6+QNG2Z:K\=1!YP*S")T\8W-E%!'GDBT3NHZ_@L6<O`QLY
MMB$5#W/WY7U.1B*N=(UT4VY\F[*/EY*">L*<.!&HZ2:SAIOGWB:%5V@WV=$7
M:0K_I_EAPUUE4<"%)'46+<M-*S3G^0CD285%"#-T(QX9/10<L/6E7_0D('4N
MHR3BFBJX^-`>N#W994M2^"H3/EPBT/-LSVO4.H^I-=N@G0F1MMY/@X)'4DRJ
M<3`G[1,D$I#63]79E'XY>;7:!]X+6&=&[E<`F1KF$,[H+LU0<_^"Z"IC0O_;
M[A5<252WSU'=2E2W$E5J8I06^"6'5TS0QPG/)X7)O!(NW&Z8G.J1DKXM`Y]!
M2/S4C!3&B]`Y8:E*!%FM:"*KKTL!^AKRYU(.]:*55>\=H[WRBIA$Y%$_-;71
MDT>])JL@;IR?%\_"G?`HF46C#(6\?K1+6Y7EVQ`P"Q#08@X0D$.@%9<NDG_/
MTRM%0Z?(>4F%^\D#GWED"Q(*SN-W0W\!?B8^$G-*LY/KRJYR@(Z4U&YD@.<(
MX/7=VKP'@+LE>9BSF&::)?RZ"B!M+R,6)5Q2]H(9";`O+`JP8!-@`;P]OC6&
M>7C_#Z,_@24!5FKA#8\.(T_`<ZGS_>PP^<S]T)=U>)*6<E)5[+++")4`5!5T
MHW;`PRN4!5GX1<()!%@T$&'TPI1L!J^9F++H(SKG&<8"]%W8K(P1:Q'UNIJ1
M\C4`3!1'`?OD"P3X$@(F@L2*``"E.%?ADQ3Z&*,9;4/>396F*27=1$\0S!A9
M4=JCJ/XSH2R>:4(BY\)#VH+Y=%GNEUQ=XS+9NP?S^;E8-<6OD6:R7^>[UR#W
M%=X4N@7@?!MQ+FLE20_I##BE'4AOVLK$.<C$H43]+DY"E0SHU_M(Z!_EIYN$
MV!+^61Y@LA,Q>82P0L6;XR0THZ(H(:VYM,FU8U"&Q:DZ?@0*%6$\<E=)+IV3
M;_UU,<)T*47N3BQ^G);6Z9%L]4S0FE_55F$N9]<B9`\/PG@!)%X#Y%`3::B)
M7Y%2H]7Y2-6+SN/ZFEZ6%P&JW&52ZK#U+0VS4AL5]:F2`;&6"\W>'$,0^R>Y
M6/(<A'NK9JI=IW12<[?FB091`O1WQB,0K]0V+G#?C?Q8_+N\"!WO_4Y3-5<!
M\BYP[5R\UU6O2"2;D0BUTZ&VT(.1O+0->:8._GL6TUCFE474'TXF0!4!$ZPF
MQ(8!7J./,7Z;WPPR\Q78Z(I0-/JDA83G;D=PI6*F2B42T/GDC%\D&!Z6M0!`
MN#8MF5\W^G8-^(&4/T3R%)$X%!$$5V?MUTGT8"D,NH`IKII7<ME<^@:;(.MU
M?^!G'=$JWXKY,M;):-XO(4FZ"2^Z`T%)92%#0Q>S+H$L("%"'LO'%^6,Q&6.
M,JB#6B=1Z]HSN7HFIR_RS(RX^%9.\[CLNG[JV/&PHF6C\-'IU'I!S=AKL;'`
M7KE8D,^&YM'5P^WYO-=C<F6N$&MIXQR@'`$2Q2A,\.VC[8)L&V/L70&]9!/,
M'&P59)";<LF@7%]4^G*C_4GW:]L0VC`*N9'QY7WC_!E`^$^,8T8?,3(*Z05%
MQ%A$74A8.L,[]GU5P<&CZZXT,G>8ZW4IU@UUD&M^B*FD>]&+CW?JIYIPXJI@
M!_*PE@DP-7;5*N%7-:=3&?=]C=3]7A6ZQL3:\M+]OEABXD1>@)E,Q8.\`).H
MJ_C'R0HP9)2O^YBT=HT;9P24LAW\H"TBX250,XF^,-+-!)LF\#Z1<LOAM1QJ
MD@=DG@@R+P)G3#^8Y@D(\2DR=TL=A1>>\T2^?Y-K@4E-7A$?4\)YM43OF2M1
M=5!8-/K*>@HE@:,_J+(Y_5`S#T/9PI#:GB1DEI-AT`"6#</9*N2R=-W0CUT7
MQLZ(UG/AOA\ZWW4Y2JU([#7%)?(BCEF]68%^#)HPX:A5]J#G<\9<].#_?%=-
MD^)&#+WOK_`M4+5D,1\#7)/-(9?45F6.>_&8)CCC#\HVS/S\O/>DM@TSE0O8
MW6JU)$M/3VW7U+5/B1]:RW[PW]G^4+][F;,2W8:MQ!,KOE!;$]W3`*03>H&]
MOAH7#_TWE'#=8%35\+BST3&23LVE3V/_7L5DUA--P#VK[78Y^RWDUJ<RI<VU
M"VC.'4MTHV#M6+2L724\UT[SI=4S7S`S]/8D+FQMA(K:/'!'6C*[P939-C^7
M'SR;=B3T?+'%0V/OE>U>[$WQX@,^`+7\PF6F97CWC4NH.P!4AD&F)>F)AI2F
MQ]SS*]WXF]]<NIVN&R.3[;_?>406D]RRUC>S>UTDVO;DT?K@WOAAC%@)9%9.
M;C=[3PUO7:C#%8.$\L(_:U&5"(=1U!P[<8U$G$G8VE5K'=T7R\?)PG69>&$*
MBWS4T,.G^5:%O!(5D";K6WQ-XTT-YP.7,Q&!`5/8K+4M6:EYU.ZRU48Z*ND#
M*QUO9([,1L7DCZ26G^UA6O6&S^,/UVF(Y?*GT)/N(O1,IM&QVF,+,U0H.7%V
M8Q_#'!M;EF,(B&]1.>-=],WB$L^+`@^<!+G2,8R-8YQP5238U?76%(5US0`E
MF04_<P0*2=WT$5CJD!N:.8!UN(.4<27\-V_N(_#DE;];^O!8A:Q&BIVNI?"F
M`XLN831LQCW)"\H'O1Y]_7I!3F=,@AWSYXBD,</(TZ\8/D)D^D\B5QMPLBH;
MB-*O"1O_DS$(M&A^'G'7]NO8ONHX?=+T#:MZR?'RP87#@)\'<^%<H"&`BV8E
MP\:`U=Y=":<I<P-FL>>1\UDV$ACH8!VXA[88AN"M([E,.=(=^;'%M:'W%@9W
MIRJ%^]32GN@T\;<V.@`.CJ78G]15#H-R9`0ZECX_+\A:TS-SW;B8R\T1,/X!
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M]\!WHF^CZ&?X94\/"/X1.+!9`;;^[IO\-7D3LI7%JQ.S?11WP#<479%]$]%=
M)BL?I;/C[4Z^[8)A[BAB]7XZ&1P:..=]0"7+F_6DCN4/7<&IYW^_?'M^WB3(
MJ-.7A:327<RXE5Q?Q$?Z_EUA#QB!-LP9_M5'_\_U9R\)8O"CU6/A&\6<$;H`
M,G_88&C;8,NVWPNMU1+^FMSR!CV/,E,K;O97-A<-:.SQZ58AD%%,0S9R!@&>
MKLS3%=`N39:?A6-A>PS7>J"O'QDT(6\'R'N>=)+5,GX0?%(?'=!N6A!1H?RP
MIX^%2:)@FQ=X(Z-?,+%AGD!\B-(F`^AGRZY#CZ9X<X7DZO4U.!4YM4V5V'#Z
M9%P]J$/R7-Y$&T)RCJ>SLC_GNK05]C/BOO<!=\SYG3N_7?H@6C6:>,#_^[8I
M;>3)6<)LYZ&]%>K!J$54;PR0KMC-O'"<+*P]%B_AGO/LR'DR*"ZJS%2I0SV<
M.OD>)P_".;LZYI175X&@18$\7/KA9G3(QA]/IG6H>`XHT4D&T#V;.`8;BTXW
MW;+R&O`D=K93`UAHLLC;@'(^J@WK*UQM>NR2EVA^?V[LDY%=/83/28KN4OC,
MAXF-Z,-QHEWOI[1RSO&EMF%';6:K-D."QP9G_'S+!A<DZJL%P0N8>7<^UTMA
M:R5Y`A_:N4U@FCA,T)8JTQ%5\)K<+WDKP`*.]H(AB0"?E-E$W3\2=^E+9HN]
M*220B%AS[W>/6:,#_^]PY.D0>)%X41;]D'L2)4TQ-Y'(A>^ALK"TT69E]]IO
M-.B^.VR<WZ=\TOR$U`#D(0<Z)X4;D<*GF:&ZMPR@6-=<R"-):Y$M=0C'L7"'
ME.G/;7.U\V>E'>:S,&J2HB-*!_A7`6>^LC6269ZN?C>1AT(%:Y5Y5C0Z5=O9
M>V\<YM)MA#FF9%%=RD#EHM\^3.R]!NOP-@604$><(135>1AVF.7^/":[PQ81
MS1,^BBOO8]N>=-P18*<7=<G(R$5N[Z$VO+LLTR_BX!$`<^_]VB>5-9_H/8?7
M0YRZ4`PGZ*]M%-K.XO"!/LO8L$J1RA%;UAI)=K,1OTV6G7F+IE5?78QH72<7
M?VMUR$#GZ(@?#_DG'L*])KN[Q\TU<;,KW,)/C'>I7MA=(-<'50K%'\]?_AL`
M,9%I:@IE;F1S=')E86T-96YD;V)J#3,T(#`@;V)J#3P\(`TO5'EP92`O4&%G
M92`-+U!A<F5N="`W."`P(%(@#2]297-O=7)C97,@,S4@,"!2(`TO0V]N=&5N
M=',@,S8@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O
M>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TS-2`P
M(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]4
M5#(@.#0@,"!2("]45#0@.#@@,"!2("]45#8@-C<@,"!2("]45#@@-C@@,"!2
M(#X^(`TO17AT1U-T871E(#P\("]'4S$@.3`@,"!2(#X^(`TO0V]L;W)3<&%C
M92`\/"`O0W,U(#@W(#`@4B`^/B`-/CX@#65N9&]B:@TS-B`P(&]B:@T\/"`O
M3&5N9W1H(#0P.#`@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*
M2(F,5\N.Z\81W<]7]"ZD(?&*#U'2TKD&@AA&-M'.R**';(WH2Y$*FYRQ\QGY
MXM2IJJ8HC6Y@#*`AF]7UZJI3I_]Z?/ER/&8F-<?32YD<2K.A/W[(RV13;$I3
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M67G81,>S(V4568MLG$<='.AZ8[V?V(6]++.O^ZARE#`[/B9^+^G((@1"*WE$
MOWD$77ZJ*N?]:6J1[89B?58"<SKV2,>*C<3(U=.3V4HP>8$G!`-W+A99EDQ6
M?-B4FVTT.>3.DA/73VYOQ>TMU<L:)^&-^UT_-%X/;!L%A_E\Z:SI/\FN3#](
M+CKW$40\%D-\[/OQ!RZA-.2_V&LCN'B;E%%WMO*_DO<+'"G"QSBE?"SZ`!GC
M+Y0V>:B-78C6\7J/0V@NUU;UJ::1Z]Y8,S:ZU'*@!64@PU9ST7?5UXG4$!?T
M<:5Z@XQ\D]]1/.;4BK2L<\?>^T#9$44GEJ-B4'V>Z@\B$T?AQ_ZRM$[E$%+)
MQY^6(9=X0BXIZ;8Z-R@\MI^1C7?'[N9<P%A`=>@"24MIHRCNA.@<$EJ@WM$^
M_7M,+P5Y3([3&IUUO#X@WMN)J_P00U!VA1)PW5F_SNJ#4P[YJ/4K=+#Z?OR3
MD8@=B6,7:3@B?QTMV5F%,&:`"_G;E#.PE9^`K926**0E<#2ODV\ZZN`5X9)G
MI04=U!JB+<(_&2K&P8Y-WPGHG9J@BI"#@VXLMV3=0(B>IK:F<@8T4HM?[.@&
MDA#\W`?[&F#][H9@U9%(MA2Q/#+*Z,2ZZ#BIS`,"HO$6`Q+3B@9O(8-7$&7'
M8W(&E!E;2/[HJG/7M_U;4Y'O7\^V>W-!1[G04>;SJ`V36*5TQ.<T'@-NI3I1
MTBS5B4+@:\[.MN.YL@B%)H7C''IWD2+81D@<U1+5.!".4T%C@3)OYR'@.CH`
M)##+!=/V2&QU5F$[J/(JQH!"NO\C"XX7Z#!4,FQEM0-J/N>:VT;7AF902$H,
MH=D_'.YLBO*D[;K.'V%;ZZXH0]U5Y[GJ`+4%=.)\[Q=--3$D#-1]>M"UU!_5
MY`G#$A,DH+!N1?<UW2A]B-)<(:^BS[WW[;N@.[TUE%X_#E))A(:\Z$>M1BL&
MN]H.M4_,\5,SZ2Q*\S"+EE;1'0$H-$-DK^H'&N1V;,(4TCG3:4M\<*;UFR0<
MWQO'_:7KW-?NHEL&.4\1U#4"`=@/1L`D<M(]QYON;@.0`K:ZBR.5)@VF[B,^
M2,39'D^(>'!=[3`,6?X0W<W8@YA(!5!V@9;IH#W<!FVZQ-17W[=NE%Z8.BU\
MUDW5>(A&^]JZ1#0)@>''R@;Z(N`1.,R!B_C`&0GT!>OI8VC;&1FWGY#QEBL=
MQXI?(#CR2""IAWSBGA'*HS3G\;`7)WG1U"M+E%+6CP-KTK0P*Q(6`C"^$C*`
MW(SJBG3GG1G`5]@Q=]NM3E`1<V$2PBPIB_#?]9(`SXW#O'512;!.K<.K5$E4
M0_%Z2PD?Q+$Z9G:5?(>;AJQG(>O@IKM\$_WCQJQ,?5?&RARU9%%9A&N4ZBN5
MHC<39<;X1J+4K\VIT6.RA!:4/1>RSAFNSEQK3ZSHR@70M(N8K`:2"&L-R+@<
MC=K_#FDMY[91])M:(F,T_!X'GWAO6_=P@_F1(LD6$UHG9P"JUGP`L&E,VF^8
MUZ@]137'<_C=T?5'^,J&^0I_NZ5BSZDHD`JV>YHHNH"2TE\$"FJN!LFTS<"M
ME$+]P]A-TL<.X@JA"Y.4W(9YV&O3-E+2F7RF>F99=IT=)P)X*_1;B4>HPDC.
M-$/TEL\N>@?YF0WH!>^B)BSK0Y]=6RL[58%8"ET)-Y8>7'#9K"@2P:Z1B,Q[
MP!]BB&CX/%(`C+XW(7;_%U0:*MNP!G1;Z2'T"NUWP3_M;^K??CS?%?"@D]Q9
MSR-P#+L#*H77!1J%^>6$[(("/)EA>I401H;F/WP>%#OMZQ1/"/QBZ5XQ<&$R
M>GF^F^FH0V,BJ%Q8P$%9P"Z213,/`3J4\48G^<HU,P2P`;IWR'D?.`LI;AZK
MQZO?3A*?TUB"YS/-Y0BWD;#=20GN'2QJ+)])[ZRY8JL@O=HU@?D*T!^":<RJ
MX*GE/<R$1::5)+3Z/6P!(1:!P6OV%Q]/<ATXJ8CPX4?0Y1,I%TA;<!&C]0/Q
M"N<3B#>.B7A+@!/K9XK_QN?B`CX'K*&3KE<R9@$LYMD-`R4O"9J&H+D;GUX#
MJ%KOU/,\563JU(:."I6C8F6VM@0V9RIYU7M)"/81KZE7M^&8A4XPD[B=[Y)%
M(,]/"TMH0F`'![`#/9ZI?3Q5[49H#!7([7=WF^1*#X:I=:YJ#\'E@2*PT46]
MSEQ;ZC6<1W!KSVY-CY>O54A-'Z8$V[6/$\C/Z3Z;)V=T47.=T/5Q1=3;=:;1
M:QN\T(N;>+$B]]419E@,N>"!H;C0]E6P.0QA_G\JFH]F/'\:=+>LI'/]7X<&
M2>W-/6O7G2<NF]#%EZO0LW`<27#JQ\?"Y@W+W`B4VZ:=AG`"9/:^93"0TO*Q
M\I6S@(US[P]S3SYM%!WDIU.@A'.5[IXW(;/R(@I:[Z'N<&.`2O6KN(`W,:@X
MY8/?9!KRH[GV7J"."B='9^@&N$_HA^=O*@J_BMDM?B3?<`]@)GF`:WOZYU7'
MQ$9%K?S*?B)D5WGG[H<"V0!>`=HYWR9X-6$U#V0%P=':\;>7+\=C88BZG!00
M=HJ8FQ2"T2\4W1O#?I#>+Z3+G*59,GS/]'N2;<WF$QO<;)=(7&SY.O,<+:GT
MJ?PF^]BK6EQ2Y+9B+NIP$+ZYL:N;=!^:KT4H#*$2C_7&4=O0$+6&V%%H1#)Z
M.J%:+77XR06O:FEIXM*)"3PH0[>,F%M@7KH?E<4PW8_Q;J:):\['`G$UP=2;
M9;A5Q@6?,."Z8$6T)^H[>7O%[$N%-::1AMN*//K9+?:`9O/K&+Z?]4&6/[C_
MY!E6:R`M_3>UK%TL<<U4G5GIMUD'WD0.Y1LM1)'K6V/^24OJ^`HH600/63-'
MNHI3!F.)![G-%KX\4O#B.0<WEX;9\WG$5)_`R(3U4HUU3C"0(90`^DR%0@='
MQF0/%PN/5N*KE1/V3/T7C<21;U0>VFAJ]E5#0Z<6;==^I`$/7B2U%[3=@4Z:
MZSUIMY]9(R+'F#P#$8@GQEMJ<H(<_#/RUL4LH;G&2JT"E%^YY<J5E_?@[L)/
M%?^.*&8"A9YO"R(BJ"2JV2K%E#)?%(*HA)$EO+_=!6!,G;E:L3TV8F9J=6'%
MDP]+9Y'4?.!9;'):1`38*1[<W&[$8=%V\_F>?FM#9?GFTU6,09;P`""+%T^$
MKQ4V>VZN<GLZZ!CEZ]TN^EWW-7X4Z@5P5]HM%+@A^H$+70R.H[B3H^!8EGJR
M?T6-,*^9=R;F)R?#BM)6SYJY\/['>+4LN8D$P?M^!4<4X9D8(2&A#]@];\3Z
M!QAHC3H6`0:DL?]^LRJK&QAYO#X!_2SJD9FU2HN]`>:Q,,",/MNKS[+4)+8F
M2R@[\=!>HYZE(N?9N=3^SB%."TH<4F6MLPX(5<ET*^4H+U?DK0;^8(NU^=&I
MQ);6<^[!E(F3+9'U7:A]KR!,VW@-;^\V,G2=\PF6`A9ZB?DA7=K)`$$D732A
MLO3R2<-5!/5:*?%>RKO#7U_+:=46#5*)96TJ4J2%2TS0GN<.PHKBD][IZ679
M/(U?0K\96Z?'-BDT>VS-*K]J@)JYL7O^>?R+$/]_;N8$]5_R?^G`P48L!KQV
M]"Y<H\.6#E9)>.&#83KS@[=-/"!F2NU'3MB)-[7&XK5YDJ";59X[6_M4-&22
MZ!;@(BU,2AXHC:QE[Y/Q1<S5GR>0K[6`MHL4ZQ;FS'^G00H`MR/`'6)R=K9\
MG5L&RWQ3?G90P1;.72IU2U$G$1Q];>.,OGVTK.NRTG^##-EI*N;H99-W3=6P
M4E5$GD*-O'ND)5H!:6P>;NN`L9*H.3/R:+^&(A<F"R8L"*U$-7)#I1?#D#%D
MFU`6KMWAL6@)#[-`,1=L3X&99'E.S;:@&@-CHO>*G5YM2CI*(XX;]VBJG%`.
M.FS+IDNYHJ??(@WY#6T"17")&$Z65AD&<A=.X$;1B;J6.P+=PHU,F._DGZ5Q
M`E%GTH_@OF_E3[;[:`NDP<*)4>5E11$:B3SMI.S4::*)GO)4T!;DJ/^MXL9R
M-K(Q4]5P-!,NEI+@[3HMQ^H&S0/U@]W$:^A#]6"F(1)$T"BE_DHQ1AR8+9"W
M7M?WO)QKNIY/KROU3CJ!?Q--C1;1&(IX'4#VOM+6!<YEL>7*Z"AQ9Y'>-YF]
M^89/$;NYB5T6=C&+%E6,ZJ9L+HFXZHQ+;SAPDFXTIP[.*2=?S"WXZK#B"HKF
ME^<2;3Y>*+NQTO9S;E0G=7JSV8@C@ID#+HW7Z!&<&`WG/S1>A^/<*VTC])B0
M^7NC%")=WU$"X4UKN*D<?B1?34Y4E[9KNK<?2;S@DUYMW?Y9P[9;=FMY$!_R
M)A9\Z-(,?R0'1K1)O0T*N(FL"9]M9-.KB&77EEHFU`VP^2@RHA]`#(0L\">+
M:W)-@S$T?S+=.RX>R.?'>#E/PAE0<]X6(:G;#6>U\=K-];@2#=M=$`V-KUP+
MT"TI`01K=T![?CF10N!Y]]UXO&K`_=`7M;N[INME6IE^O/5]8]RN&G!6Y[\X
M%O6A_2D$9,U>P4\?#H$#PM5@('L=-AI_G&#'PP)W[9NPU`2+T^N*C]R6QP2S
M\+8B0L:JZ5#0YHBC6BQP!?,02[78_*\][HY\Q.A]$C>)6+:(V#,%U"/?T*["
M0G-X*1:$<U+"@5T53!'=!%X%00JIC(J#&)6\`HA-FFR->Z,!L$PF9SG6#ZXJ
M;_R>RG\=#E*'%320BB@F>L:)[!0UA&+:ZR/2T_PLRM&`9;7[=D,_*/[<F[O<
M/<`!$N?JQY*3O?@+"C74@8`7=RW*+J.9A70Q&@0A#,>ZMP5OZX5)&)>$*0CT
M>JP*#IQ>X70W^:D326(TBD"BIETK&=EH`/<X[_281T%_GT(I65&LC3I:[GLW
M)NZ;#=W\O6P4(`8I'3=XO"BTZ]I?Z^_GY"]@J8"Z50.\-7QA[,MWU>$CNJWD
MW`TNZ&W:($+IUDZ#V%('\_A7?W[]X[\!`&L#'6`*96YD<W1R96%M#65N9&]B
M:@TS-R`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@-S@@,"!2(`TO
M4F5S;W5R8V5S(#,X(#`@4B`-+T-O;G1E;G1S(#,Y(#`@4B`-+TUE9&EA0F]X
M(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO
M4F]T871E(#`@#3X^(`UE;F1O8FH-,S@@,"!O8FH-/#P@#2]0<F]C4V5T(%L@
M+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#@T(#`@4B`O5%0T(#@X(#`@
M4B`O5%0X(#8X(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#DP(#`@4B`^
M/B`-+T-O;&]R4W!A8V4@/#P@+T-S-2`X-R`P(%(@/CX@#3X^(`UE;F1O8FH-
M,SD@,"!O8FH-/#P@+TQE;F=T:"`T-#(P("]&:6QT97(@+T9L871E1&5C;V1E
M(#X^(`US=')E86T-"DB)?%=;;^.Z$7[/K^#;D8I8J[OEQYX]P.D%!0JL]ZGH
M@R+1,;NRY*-+TOS[SC<SE.4D6P2(26HXG!N_^?CK\>'+\9B:Q!Q/#V5T*$U,
M?SS(RBC.X]+D6117YGAY^/)U*DPSL41LIN;AR^_?$O,\/:0D'Q>I.38/L3F^
M/@3&F/#X'YKLDNA0I;3[-WQIZ`O6DY0UT$\6[Z-]2H=D<53BC%T<Q3&.(]E=
MDN\@_LZL=!^5^6;+YXK5^'U>1.FJ6$R,XD,*,_\5],,<[O(H#<QU]$/;^#7]
M/8<[6C5?PUT1#!A?9/V*<=W3_S1X"ZO@E["BU0FJZ%.2!J-3C:JH'FGY0+))
M1>;NDI@E$GQZIOU\CHI.-(ZJU00^UM3AKMI\PQ[2>`AL[2UFI75O['_9`.]1
MF)!\[X7JR;0#-"<;[SHUD45?)S.<H/E="+[WZM&=XM9\H]!$A\"K].;8R=1]
MJT:-UH3_/OY-:B(I4!&2ZT)SPB,D93C-MC>4&F/[TT`>[J,B:&P+PU\0L#3:
M!\_#."Q3IS,*Z8&$(#&?A\D:U]/`RM'?$;8LH$3%).-FTO1MKF<[11N+RHU%
MI5J4802+2$]*51H<2>77X7)%TA.J/CDW#RB>Y"LL?M(/-LPH`)VS+Y8,J6?C
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MZF9.*FX>34<[76VX*_G\C+33MH%+JEE&7)#`LA<8F=,R+W39K@(P819HF>EG
MKD8I8#T,*:%)<Z;K,U%]48&:-:2C_6-Q(XJ8A=2*FU,HI@R>[?P0SK%#%($$
MMZ[B"YHF%#>8;74=\]DBDK1.=2XED@2F<PT/MH*33$S]+!OL1N+""3C<R7,T
M6+/\$(`F&SMJ`-0AZ&;=ZLT3"T;`V3Z0G7=N/(=)LI[^^;F4NK.16B5[KUXC
M5+T_38"1!29U4`7=_7DW?9(I'G.A'72_NT1&DD+=/)=N+G=^O_9>;<UK8][`
MP2V!DK\_/[F.2C`/W@S^#R$=_0\R#75-KM9T@S`QOU/+J]CH"B$^!*^H#ZK/
M$$"DYE1B#CQ)J#E_8LZ-@<11FJM,Q,V:P!?H6Q2Q%AU0K2@8LK,;9.\5STJ,
M/&07AP^0K:V"0GK6>4T7BN+O.\:UICO)[1,?"6Z=[=%[KKIB67QT@\Y;9&$?
MH&$:`#"P(=6"PX=7*HLBX)*@>W>N7[0I7;N:U#YR@[Q0.28E%X;8)ED>>JJ#
MA:[>$,KJ9^TSJ=3S/4;P_(I6'I!V4FXF-&RP"P`=J:7<\,J)S$H#9A]!4S,U
M("#@G[&6917G3H3UL\R9"&F^,0<9`A7"F(.<2&_"B6!$!-7`+X:S,AB6L4'C
MY;3\7SVIZ$FK&Z^A.Q&P<Q-AA=C,SC1A*@._G3]11^8\8H72W[)$SY&0>!A>
M85FF5-1.AA?JT'P$_[N'N=P#N.^9K79#^>F&J^\HW+[F1R3VUK%^\*KV#+G@
MI5QP=$^>F4DV="(U/?J>XM96I2KI"LK.^U8F:GS+5-'VOKGY+NAZ5>$[];5>
M.]PJ!;(12R(@JD3@KZRN7UN^]$G/#6YF:2!N(KXOK*:^J0EN,DLO7YXZSP:&
M3?R3@X^Z:^^4NY/:I@SD[+;-^9%\OW?[%I6[)JY"O?ECT1PXH0X:^I8`HG4O
MKO6?&3&F1:(EA$6SI='<<!@A#6Y679-AF"3=\]EY@^[,42+#'&?X$!>GZ3YM
MTWH1_]1ML>>=>3Z:`AS^+<0C!/94NP[,H1F6KF5\3-@4W`R"K=J@X65\()9F
M"V9.>.&(FM8MW1R^Y`00]B0/E1/Q5D]DN6Y6((9BQH@JB'!GT\#\A(NO+S;/
MFP#L98D:9-(KL(Y73=LZ4)='KC8.[Q;X<=XAPB,MIO@+GDB3`S#E`KUX<`U>
MX:6FP+.>9PM2I8(+XDQW&MR\D>]`?(I\S92;.T2)NTL%1`&":4SMQ&4<\NB/
MH.2S)0C0U`Q7;_?@=_I7@TQKUKP^(#Y_3BE*93E&W`\H,4/?VVY#EEM[M7W+
M9N2*KI2GR:&#E?)2HNH\.7:P)#R>14@;8PY`G<`3J>O!1N&:=K(J/S9GK[Q^
M=TY+3R*&REX`DC>,/RQ!XC-WPVDM/-1:9RF2=S"LK[.TJ-1!AL3<0Z+0]EP@
MD5;IE)5GY<'Z'.59&T+^XGHW,426NCZ[%]EM[G>=6,;)"ZO7;PW_.)EU^HR[
M$;5<=5[Y+!D_\1C5Y^0<[8BGC0UR%P=9NKT2Y$QFL[F@<DDUC1XW2<467+#W
M(=A"Z1U?BBO/E^SIQ,D[!`V\[_B1>6,D_C(<<!EN]$C7I!:HFE$+3\OD>CM-
M'D?J%3M2IJO@3\3[@1J2"D`'"GR/-@RV!`0YR<H-0818ON=R,.X7Y*,(;B<_
MOG-V13J/(52I2S<S9_O\=J$.3ZZO^P9F$A,3;(D^@-0G3';+OLN]I]AIL7)L
M#&'%;Y1:$,J2?+C*3]_J;\,_,C'?69#)389[^O>0O/=?WR2*_PP)FK&VR_CI
M@D\3U<4^P-WG:><)N7+M)*>N^I&0&W9D)U_?T>Q"(YG$Q0V-]_D'FEU(X122
M&[*$7Z7Z"8]33B?9>1I&*JU&9D!./,(ZXG>$4"HNJWTK#9<AJA"(*ABB`$Y2
MB*1O-LM5.X[GSX0H=GQQ_@P/63\LDVXIHN(G[#HNUW>%LH_9-N>>#O7%"\"R
MO1NXB,I`$:WB-Q(P3A\.);M!;4.@^%'O`]Y3(JY2'#9T`)V?0O0<\WH>+OIB
M*;E0F77*C7BRMK]#'?\"71.2;C6?O.K1:-`TJ+D$M5QQOQ+<WV*OSW]1%;ZY
M,+4!>!8"C%1PK<!6L5*5C(@C`(Z'9!;H01$(FF5"!0L!,]K3ZF>1!@<B$_M!
MJ2_1J'[V`TJBWW59GW.LT@A]\UJH=*9%C+P[4XB9!<2LZ\G6&.\(*D947<3)
M:S?<F6V]N3M`4L2O/O-K*([L@.%RE@#T,FE_F<_J['V<JS7.BE@>^TNQ/)5C
M*W[&5DH8B700T,)+H8%ET,FRMK-2NU.^;N9RF2XB1;2@7RY/HD_D11=NC,PO
M0@RN7L]P9XNU:L3K>:NDY^[$W)C(+$\NUZW56XM;^8"&-<BK8;6BL[6*\"M6
MX\`]_X/Z>G.R4V/5.DH0$R^O7=Y<Y-LF!7KI*WUP].T"?K`#5J0QT;=8"D)8
ME-P^2F_&7M#%(?NIH"XU*M7).TMWC+:KN<.<W=7P/?VA.]["+-:$V`L5%Y^D
MW_@GH<#2*^E:C[-KEJX>I46G8A/?8=HKMB@L,JF0O>\Z8J;UE6&TUI?`2"90
ML>='F<=BSQ;ILO3<D>'-AD#S/>!-E+EZYFBAVAE("GH"`BA'BWC0"TVW`'7V
M]#CA%H&'UU:;F,#NK`SV<75?Q7P4;AN<=X(1L!ZM&`#,!$409IT%=]=M9<KC
MT"Y$.#84=4M?014D>RL=*@-!^<C+_.054ZWQ_A_=Y=+<J!5$X7U^Q=T%5<DN
M@?7RVO&D,HG+KMBK9(7@RE`2H``:I_+K<_IU`<G>S,APZ?OJ/OV=[:AO)M(W
M"Y\>^R)+^<R00D+!OBJ).[`>H+ZF8.D[VI++BA2N%OF(I&.6^H_^0(>!3=WQ
M4K9R(&0^Y+SO^+03.6VN)NR1*[MB*1M_X[VK&KG;38AC[4Z'?M$OF2O_9D-C
MO"AZ^<ZH1DX)*=1U4"0S#9F,DU?GDGP`CU5;LG?=`98%;3RD0<AK^PHGDM:Z
M<\&(F%J&2SM2?09)X<XZ\RRYTBKZ29=4HHPG2"FE?6XU"F7$<&!AN/=B6E;3
MO(J3P'RQZCB[+VA5I'`R6W'%?#0D<DETF)'S81^0L)B!&$2I(L-_:0!;$=V$
M.TWR9=X9OJP,7RCOUHM%],>,'6@C';^SPB`Y#+"$5&1$/@2"(6#:!I(8Q&H*
M+PHF`CS!!ES`B]DP89@J54<`,W#!2X8Y7A>X)TM@CO7B_L(2?I9&);>"I5XX
M@ZNT5:Z)E\:U$X=@(&K5;U6`2PDF@04)^C/R"M_05S91H%Y:/I00%T"BY]NJ
M:?W<LI$(8(1K@9]EIY62VN1A[7U8!OD[>B9PK%,1O:5YKIJZH4:8L!_`.7=]
MDQU&R8H,T9TW)]DD0AZ\39OPM'K7X_7Y,;F+;X**_BASS_V[!6[J:BJ9G8^T
M1!W61"4XK@J]I>.#M=:19I-VT9VS8K24^W&5C=65W<M((\C%7!7$*OC>D8%9
M;[XV,'*N1=J9ZUU%ZAA7=J`>N\FAR?HZ1)#+L*.AG325#ZIF'F1\KY7>5"J6
MQUK,*(Z-4%,$>]%TI5R8,`TZ9*?U$:[HCKF38Y%>VJ:PI[*_*@@V.WHXM&VT
M'9]61Y1/SFL>NB"8GN/\-N,.K):,%S&=G_>8MLZ'NI$UY>X[%RADO_;N;C%W
MR6*1S.6*?R>M??7H\)0(98OIL9H7%":22T+JC)(M#T4)B8B3*Q%>ZI4G6]7`
MQW])0=<,A`EC>8(J)9U04(:>/I,$+R/YMY2>*2.9YK<,I4OU!X'C+:;LWY@]
M$<E>BV1CL#VD/W)YY3[DH78<B2[!3L<TDU\Y?V%FQ2+@XB&>LM#*[30.V&W'
M7H8UD<=]FVU8'&CD.,!!E\`S_T5'2&3.NWR7<?+-K4SGGNS/+S[;")0O+4CK
MQ/HT_#TT1*Q2+__ENKI/`35.#%!3Z,"NZZ%IU"9."GF"=6T_<%U?*/'9';2G
M!OD::*-1,GU/:Z*F@0U9@2B1FD"0K_[4^VJG`5L7(S_U'=+442I.2+86DO6&
MRB`OKA?]'E5CH65\*-[YQ>ZM'2VL$#^*\N@Q8<5^8J(O`+Q?2A4D*:M,JD,[
M3=.B3E]2P",$W^JM*>J.IGV"00V-(6L;]]0`-T.9U?W<J7"`I"J4(!5WVV`M
M4##Z_8*`2P4[S"\?\3%>@Q!^K;?*OU2M8!D!'2<5R1Z0JHRK,=%JU%I,="R=
M>,R#Z!WVO0I&MM%HU[P4CX")=%+98Q7ETJNI\]!=G83"*#'CZ$9B4RQ=7MDQ
MG,8<IE5&XS='GI$B=C/V`2\ADCXI\V&+M6S/V8*?RDRCR<KX$OB!?#L(;;S4
MJDTN"T93)KFSE'FZ8`:65O<KK>).$\5:\[C!4#_DF>@^B9^HRC14-LKYC7ZE
M&HS4T&0W^.!H"O.K(=5)Q-]:ZPG2&\^M?34H.=/3VE*S#DTUXT](`YYE*WMX
M7=_.Y82X3B3VQ?DH"2\V1L)63.\N:(22YJM7_*6DA@KWY,SBS4"7P0NA]O@G
M"A!4:A@LG\T#E.V;[-R1:@L1,8L:Y'8J^,T)2^C/-<[(@U(I]G>%5P'A_;X=
MPP(68>]OA>'=GV6?%5>,?M4);^PGJZHT"ZIMZ3!2/);?2]7LHSYK1/)#S]/'
M;V)<QTU+`\]H9;C>41?YM/N)'&B1:ZM:6]_5[CEII=*+2WEV_+Q=3V8MK6D.
M):]SA\*WM=^,?BLJ#)6__/QD3%'"IJW]U/UD^'&R*`A`O+QN?EN5__N%JB4)
MA&DSQ."-KGD3C7E5;QPKV>G?2)OH6/H?\'!]P58WO*!O:__A'AZ?AU1^H();
M1L_.QG'1WY-5(Z$'5^"S[*`OJ:H3SG2HUKG.YR&0#C!<WA(NEX3(GPO6(O2X
MVF<H!Y4:J;B!PE%+.^_2'3H/?@9'QF+0PF-4O,C\3.7C)MWPGW-IE9.3&Z&!
MG1^X^7:HD<%&L'EX?/OI_P$`2;$\!0IE;F1S=')E86T-96YD;V)J#30P(#`@
M;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`W."`P(%(@#2]297-O=7)C
M97,@-#$@,"!2(`TO0V]N=&5N=',@-#(@,"!2(`TO365D:6%";W@@6R`P(#`@
M-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@
M,"`-/CX@#65N9&]B:@TT,2`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]4
M97AT(%T@#2]&;VYT(#P\("]45#(@.#0@,"!2("]45#0@.#@@,"!2("]45#@@
M-C@@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@.3`@,"!2(#X^(`TO0V]L
M;W)3<&%C92`\/"`O0W,U(#@W(#`@4B`^/B`-/CX@#65N9&]B:@TT,B`P(&]B
M:@T\/"`O3&5N9W1H(#0V,#(@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T
M<F5A;0T*2(E\5\MRVT86W>LK>I&J`%,BC0<)DDN-Y?(D%3N9F*Y9)+-H`DT1
M-@C0#4"R?R-?/.<^FB1D34HEHA^W[[OO/?W/[<VK[38SJ=GN;XKYIC`)_GB0
M%_-DD11FD<^3M=D>;UZ][I>F[)DB,7UY\^KMA]0\]#<9Z)-E9K;E36*V3S>1
M,2;>?L)DELXWZPRG[VFGQ`ZMIQESP"=/5O-5!B%Y,B](QBR9)PF)`^TL7<Z(
M_)E:V6I>+*Z.7#&&*0LQY4J$FK%:+.@X'8"(;$&G9F'X=/-']%N<YO,L\G&!
MWZX:2QX,\7*^B,POM=W532VS;_%_MS^3L+4(6\US4C`8J3Y0A=2WR3Q;"HWL
MS&!%2OXI<EH4NUDIC(I$=3+Q+"LV2;0]./.Z.YYL&\_2A%5(-_,B,D?,,PQL
MG&.U;@=;M[W!_^AM6SHS=.;DN\'%LP)4)5,-QLKT(=[P49[4$(5/VP^F;&Q]
M[(WM^ZZL[>`J\U2KG.%@!N@R]LYT>U,//;&'KX;^UNS&P;!G..[I\FQ7)JDQ
M3S,:D5U#/%M`DP/)S"+GG2GCV1HK-DY)";-SINU(@]''LPUH=(/5R"*R;,+"
MZM34\M5I'\_R\UHKI,$U9:?,'O7K6(2WHLE#O)JO=<V0UZ.G;FR$4V5LY;Z,
M>DY44XER`'3I0L)$7.1\V3TZ;RB$&1V;[BEGJ[H>U1QXP/G`NE*!QCX$.H1+
M*9^Y5"*Q_8=F5J$1X!%%X"J;"LFF132/9S0S=Z9']B,KUG!TW^_')BB)O#`[
MWXV4.9`UR+H56EFD!!PX25X2@=0T[JNN$7.D44QW(>)DNB0N.4O8>F:_4O8N
MIDNJ^@@!PE*9@WUT1A4YVY[,\RP8?$0B^]HV"-VCRA=>OE=!QJDJ>U<.[&JL
M=>W$ENS*EA_)7<@Q)+XR[.L6)MT:[_JQ&<@VTYV",*_:#76'*VK;RNSK%K:2
M3IH?P5F5!*(FTKEY\^C:9^',M5`L:436C7!<&8*E][=DQX@NY'>R(X:<J[CD
M8LN*;,$TA3$:G3PZN;:JA]'S3=^/;47AB8G8H!#6#SRTI"(;<[2ME35RZS*2
MRK3468N4J(^.*(7%Q)[T7#;_B*!O-_J2(D%7DH+0SZ_J2G&I*^>L3D.0N5XN
MN%Y*32&'6P[SLYJRTJ*91>TY&^$A^S>I^U0WFA4-73(D1]L-Q+4?=Y^0,EIL
MJ1K"0]HOY,"W.&,69>!``;H5>0C<@5/[N^+)KEEIJ-=K#76)'K0D%1)\+$\H
MVM"N885\O.`@T$8(/=3A>=")CGZ+\Y0B@6U./SGQE:I?KD*4"5_2!=.&.\I3
MX=E>TX:+26.ZP?3UR(LT/>M$9HL0.3^()>1W8<'.%]9"!^^EG*-`$U$H$A/9
M8OU9K+^J`'"AI-<\6ZPWXD(J;T`#*)9P-:+"$PH-9I8GY-&.K$Q),5D;A,#(
M[,1G3Z3A)A+*[B3?6ND=?\X."[Q;.2-2E48:C!A!"UT[U.VHF\BKG0Z%PZ-P
M4%4;^>Z:"SGYDL?BRRNI[,N4HT[VT%B\H`?VK.C(2X.J?:WCQ17,9GJ--^$^
MINKHLN-&ED;Z<1Q"7]8RM3QM9$*7BKZX;FMB[1UI#**^:^VN"0QFLBD-/W!$
MA?@0SY9($BK%Y-R#*?6(K2<J]'1WD<JE=O,T"LW#'(-6633A[H.Z>H!:B"KB
M>[[0R&UC]WMQ,7</INM:H\.#J(7*0G/$5^8J\20SVWZ+B2D58["DQM*KZ%;/
M4W>9M@+%5C+2`GII/LY+(:525[S8>M!U*FTTEUOS/8Q57"W5:16J4[(\PV@:
M@O[-U_)@VP=G[EU3]TCBARD.GH+Y-`=F(72^7*)+7.#\E6P"4FF^VI#@/$WR
M"X2^8/Q5)AA_B8JVN7I':#XFFT3S<3MMY1NI[91/Y"8*G:L%'6RX]VR0')+V
M5%IKM`B>[7UWE'9*L_=W'RA(J^B>XK^*[OXMA7UL&P(X5#/[H2L_"_7)$YNC
M%:S.F"[AFVU^2*%SF&KD-GK%9ODS3)V$OI#2B(O:P7H7@%K7D^<W*)YH20+>
M-]3A]AT+6$7>R*,`A8%2H'?E.-2X!0.+16VOZE9)E4_O>K[U2[I"]*%DNGW>
M+E?BTCSZ"^[+(S9=-^CUD4:?S1/C$O3-2C<<;U"ZX*F!.W./,!QW8=.;_%;'
M5V4]702[,V0^<O=C6ZE!_A*:<O1JCPOJH4&.B,LM`Q8Y\.".KJ5.WJBC^"V$
M#'AT/?/Z7M&S=[EFLRP8I-@)0H"=8(M%TAPF9[U)UTFPIH+\M`A9F`>_FGK/
M!9QU>_FVIZMPVZ]<GPD?X)*07;WY87F+4_1/]8#3\-`UE?,`>E]&Q2>+<!!N
M?*=>67#8UZQV$8E_5(HL-36[IQ[$!4$D(TSRF2?^7O,[>V['Z@Q@0_:^K-K9
M-Z:!N!"?6X(,<."IZX=3UYZ#P;'2NL,KNEXY6S6X;+#O7]V3>YR&A',85Z?N
MS_B0GR`OH<%S>D\1QEH11K+6L(A/"-`4D?P.\EI0F(.W0ISJS@5^%0*_,@90
M!3?F-:,D>OFF_,1*4PZ*O/E")O(B-4RB)+>C2:^5HRK1H@JQ''D(B.`]TXW,
M6IK]A7<G4T8_4_U%1641P%K!+6K-29@1O[_X..X_RM*5.F2V(FEBURC7H_"@
M'-(!"N*UBZ66G\NZH+@]`KB)Y)>*'`-7JL0Z<3QI8ZJH0\/5B]$D5]A#K0OP
M7\)@4`IO/*..X(5IJ6":T2^`E8:*IDU]1!/EX7`MSH@^HT@=A9%N5>$HQTUZ
MRI6$/DX"P(3:%3TL>MGY,JHM`Q6CC8*R,R>Q8"X6L-NN^L7_[^;:55;GKA(2
M649<7W[_:4L9L8Y^HJ)81*_O?I&YN7O]^M>/[TF;(IK2O'\;(S7>R!H#L^<4
M[^YT/B4R=S&GQ?M[\_/'>V%-O-XIV?OME)Q-S?#,_%MK%7K,SH3YQ6"MIS0X
M/R"72?3KZ+DM=DU=66I+#)@H89!A]("CY,D96/&#$*459%0F@:]02TY,ZH$D
MG0PMP5E"8E00&7[;LNQ\)9MM0!9/]7#`CI`"HK;2:;B+`Z^=T+F$\,&URM#;
MIE%EOL6;[U^1$RB4YN'V0#R=1R*=R#XI"^BB-<T4T""OJ4+"LM[\&;V]N_M-
MUO^,44D)2YV\.UE@<4`!QIOP6G!4PD\<[J9VXAYM#+TV8,$7J<(M;C2*&+YK
M?H7:L*01V7"TG]%T<0..K"(!VT]C1?P6D0CC&@YDSMUT'952T*%UY\E.>R07
M,U9&W7<#8$%3VUW=U#&Y=J@)*'AT'KS%,-+^7D0G!\0D`B=]0!4LU,<H?'Q/
MD2"6/X/,*E/5?2D;'3\.E0SO&/,?9W9"W<LBN1441DGBA#4[3CCVA)L.*`94
MMJ5LK2.AX'=M%H[#`KQ=9<RDLBL+:#)1J<6:)5M=GA$0?K3/3W4CY,I;4];U
M`%KH\22/#6H?K*=J\80G%;-^$0\@/14/`(P1P*":N].[X1T]!;4-6WKN"D(:
M@;6N,5_MR_&(A&M+(5`Z15>WF@'G1]+3H<9K47"]8,5.X(47C+^S/9#!OO-(
MV,_/03'2;;(@67>5$V=X;G?=*-E7VO\Q7C7-C1I!])Y?P9&MLE-"$I9\W$,.
M.6>K<F8%LMD@4/$AN_+KT^^]'ABT+F<O0@PS/3T]W:_?`RG-#@N9N+=Z*YII
M9MM+<C+?EOS,F)^F,`\2F`S+2/BQQF)'-`X?&%-@+<7U&@(H\A-$P)A0U.`V
M^V2PC#M52,:OIW&R\O5PF3K-5\PGJD05&/>Q/"CK,X/Y!/X>Y-*`8N6I]FFH
M65T>IAL%,R_<3I1!7>\:E25):GY,[8,Y\Y0Z#@VUBKY%%(P]G.M3`6,G0*C7
MK'/V/6AC4Y_JV95U"7L-;PY'+V)E\+,R.&,&X]72DD]+4SYO/JS)/1J4VOZS
M.!__7(RP)B>?8;HVK44`GE,M:WP/RWH-U!H@/I^Y8@+;,Q$B.I-9Q'=<8H$$
M,0M[RKQ5`=]:JCE\?='R)(PG[KV^KKR8_-S.,#,'(OSIM>K:Z7W4:^DNNM-M
M;+/5,6O?(=%"K5-N6;,_W,/"SB_CB'^X#&N"S50:5V\-DP%VJ*.=TNZ@PN%U
M[])"V8.Z'9KNS4)_\S*3++#9UNJ0;7EZ,6RW+MJ]H1%[@\7"<S#6EOYGP$54
MPZGOWAY\**F-`=<].Q=76KVJ17.7KBLA!AZ^K(ZWI-IC^$N0"+=R[3RFX/TH
M=(_;<NM;)<HJL[@M:B%3_/%;^YW$:>9&'Y;E`MCH3C2]X\3;.K$>LYR((@_\
MR,J+4G/.;LAJ('.KL6UDLTS&NUQ"L<C'=\WP1!T&?1T-E.88WC&]^PK.0@6#
MU!UVF_3KD%Q#>3)MO=J"]Y(V<]5>-:N+7?6$'>8U//XU/MV5IXGWN:^];M*[
M%Y,'P<GFC#79$B]:O"LNTTES4?EL#)%JQ7@E$Y?XQ:]_2-Z0_H?T$^2"I@R*
M<KF^6`@]DY'L`B-Y#F!`,KBNYOU<S?NYFKN+]?CBW>5@94UI[T566%=&*=D^
MZ)H_IKX>ROJDLK:00AMX\WZKDNY:&0^MV`^L75_[CMW?^L^`V;>NN:';#($N
MNH$7F8&OA;4Z=Z.@&XTUG/ON$/31TW&K(YPH5PV4Q8#F7ZE=D-G9)@:8U4:#
MK(OS':W<NCC_6ROOF")A-:H33UE,I`TTU8@:$-,G#H-CM,T:YU#BRT40??3M
M5;Q;%>_1V_3B+N]^&WSGF70^WP8[)O'Y@-S+UF=]LF9?UC)[C@WJJXIAF\[^
MNCTY.%[FP'4R093F4;3]1\TZ>PZE?O:2S6;(^1A/#&*+".>\!"FWUK6J^O:^
M=^V&..5%/J(!S_S2,?<<EY)74+O"$:[ZJ1<B_7\52<>Y]C\#S>74C7>2D'B<
M]^"'135QY#6)\:N*@[X/H:[]*($ME,$EY*F=`#4U0YNZ^QK@[O'MN_>XT*-^
M@MUD6`%T%5OZ73>EWW`KZHI#P,=?[8L^_?\ZT8>`Z3K"F1JL3>'"'O.Y09:3
MMAV#:Z0JT?5Z2Y2JB3-^JXS?;H['0!ERHGO*0H<R_!=#@$EH0LOG#,)K9+]X
MT4L-\91#--[PU$*2`7.QQ2_/+-5F'S#2$HD)'%;0A=9`(GPKEOF`)T8H5WQR
M9D<Z=%RL-=P967[FJP9QWJV=EYN/0//9+YTFN)XT'>V#W'*#EBM+W_]_Z*/I
MF*H0Y^N_;"TCK7E`5`5ZA_Z3&Y5ONNO%N2$EA;6WN4M9P9[ZRO0(#O^W)FE=
M<IE`PM2P6HHV:SZXPJ;^Q_3LJW%!>S6-AMHH*Y,\9B@V[+Y)[8$V0F5DNSO5
MM<GV,\5Q_850"?.WA&R+Z*V*!\LE,_<^&S'?6\PU-O'-LE7SY14D5L%W9@S&
M4?:YW]@^O?BH)K6D!FI;VS1P!/QW6Z/>#-W??,YW/9M:SUO8_5461T3_"!XR
MGXI/-;(GY:,U:6OYT+R(L^P9Y=M0C_+[`YV=-Z5CO"P-`(>?6"(\:6TXLU:&
M2J=GC_I^XQ!84'!0:03]P)LTV`(3$18Q($GU[E_&BJ<'#RFP%0'@`,3]Q)BS
M[![1MPMZ/!#QMX`CHT\@/'<K-`4ZR>Q>L2+MZZY\6*?1HC^"U*V\YUY(E(^$
M7\$`XA8R4G-:?6ST4?A_E%2=#8TR\\[6#9IL-U@/-8$I5(IF#C[5]]+H)7ZQ
M2D]%"U("!,F6+P(I_%09K``ARP,@0!H\;3;I7[74FE=[?:Y/A=W3I6B])%\J
M"#QS9XMB_#&5FD_59^'O*Y#D2LI&M5Q68]5?ZA;01>V'HC=>BO.['0O#69<:
MT^``0P.A"0'Z``$"M.V.AP4!=JF0\<1?1X`=*SA3Q_?\8%F8C]0V!Z+"C@[J
M3ZEA&3OKH4_Q+CXK&67_W5_U%D!Z#'7PYY<,2UG0SRS8[SX3W"`/-M&S9C]F
M`,E8HKE$!LV&%M"Y[WI,\F&<%C^W]PYZ-!I9<#Q3Q]T)S\!%;&M,#H'ZX8&;
M.$O6:QT%HD18%=(ZOJ?<[VESS'5/Y%BY+0^RA2]]P<>H-QU<0TP!>*X0V<>P
MQ)S(Y80QJU)3U-'Q-8DVDN#,?8FLEYIWYI"OZ:,7D+(\R(F#._/NN^A-=[Q+
MYUZU<C,8>]P;MLH3S\C<K>D.C$=KJXC`,5G4V^'#^OQZW'P,$NO5HZ=8N'>G
M>&S26*/+^>/;;_\-`,8`V"0*96YD<W1R96%M#65N9&]B:@TT,R`P(&]B:@T\
M/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@-S@@,"!2(`TO4F5S;W5R8V5S(#0T
M(#`@4B`-+T-O;G1E;G1S(#0U(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W
M.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^
M(`UE;F1O8FH--#0@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=
M(`TO1F]N="`\/"`O5%0R(#@T(#`@4B`O5%0T(#@X(#`@4B`^/B`-+T5X=$=3
M=&%T92`\/"`O1U,Q(#DP(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-2`X
M-R`P(%(@/CX@#3X^(`UE;F1O8FH--#4@,"!O8FH-/#P@+TQE;F=T:"`S-3$R
M("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)E%?;<MLX$GWW
M5^!A4D-.60P)@!?M6R;)I+*5RU2L?8KW@9:@B"F)5$C*3O;K]S0`@K0,*I.D
MR@)QT(WNTQ<`?ZZNGJ]6G"5LM;W*HF7&8OS7`Y%%L8PS)D44%VQUN'K^LDO9
MNM,K8M:MKYZ_N4G8E^Z*8WV<<K9:7\5L]7`5,,;"U5=\+))H67!(OR)D#83F
M$ZXUX$?$>91S;"+B**,]%G$4Q[0=UBZ2;$'+S\SB>93)B8A?L34^EVG$]2KH
M35)M8I0D14IV?@[:4$9IH,(T$D%WVO<=VU1;/;>=(&85"Q=);.?-3!,F^'M@
M_<YJ".,H#Q2;?O75H=2?O9UEC57WH)A!-EK-UU/7FRW.U.GQ3W16-3.&G;2N
M_M0J=IP:7X4+DFPV'?8U&@^T&>9*_$K\_@@YR;+:X,K:MBAHLF\>6V#VO]M7
MW<YZP<+_KOYM0DX\O[*AS`WE9D24WY?[4]E73<W*_;YY*.MUN$!@0=O#KK+C
M'5LWI_V&M8J"0MZ5K"^_6X/9L6WNJXY4J&^G<D_&@3.V+ML62W+M2[*$3?`Z
MX=!7?PGID]'>5HEBS98UIY9MAHE01$FP561!$;2MVK#>BI>`>."V+[M.]5W$
MC,<H'VG*Q_B>NV2WM>`JP=!"7'#-RF(8$BV?$*9E\)K")(*;_^BO=ZL;]O&O
M,!$4@8]_F\%KL_+%ZNW'#WIT$Y)NR__JCYF]!>UM)L:"%R@6%ZG"1:HP)JW`
MZ;:A(%6:0!YH1@3Q@=`K1C0@[Q8Y"&O(<O#6[R#3ZG@@`1=YT%:4=%6]J=9E
MKS;7%FJ-V%K5R"4L^Z(#4FN."PI&T"/\]ZH^#5,=OH_VHPTYS%$=I!&G.SNK
MH\XM$PMQEHI)-CA((W)0E>L=0XX(R/;F1VG%!_,Q8&15E&GOZ7-G/A5[&2XD
M!HWYMD)'\U62$`U^A$4D@]]I5J)2!YFZ:_9&P&ZRL7*#(1N&P*:0L1,..`R6
M:@*M;1;LP@6'"%&I6\E;JFD9#+:LF\/4378;G`:HU#.GC8^.C5US&X:D;<A\
MVY1=K\U2Z?KQ)/\F33F'<3&ME$G$B[-^/Z8>,J]5BKUOZG[7L=?U!F1H39$X
M#^IY?PENU+%7ASO5XGRXUE*O5U<)J]B5P*9%G,!,'J6P/9(%6^B_K;K:_AP&
M$X6#DPR]DD\7I+&X)/\3>+H[2#`PI\/QJ;@/_W,UX5EFQ,>4YO.80)*#2AX)
M325."(UQ]".&/\E`G#.+RTA<<,H/C])8-AB-)O9$V@M[74J71:0]XH5NM=:K
MS[AR(-6S++;5#]LE.FD&[6@-CK'1MI^BA9R@"3]#EQ=D42.CK(AI(R\K?G&7
M:`8N)%UZINHI=G)^=\"7'`,\\2Q/S[2[F%QF+5Y&V9.`.<>\J#/,B[I]O:@_
M%4!-RL<FDKA.D)B4^*!Z]DD?(:K[%SO_I_OCD]E__@_R!6E($.#XF9M;BL=S
M9]F8+M/(%W/#W!QJ,L*@14J!\43<+SP$W*"S\9X1'HT6?#;>,_#4+@\\W=D#
M^T.>Q]3Q?J7\TT(WZEG;_;"SW0\[V_VPW_84-UOW%#'9NIBFZ\L&#P`<W&\:
MNC#=-+C_NEQ[G*IT81<TE>(`L#,BU1,97CO>O,OT63%+@Q]V-/AA1X,?]M.`
M9,[DKX4P%<3<;-',P;9J##Q?-GYQ5S<&GB^<&?'1="GG:??#4],\\'1K#^RG
M'6P7X_7L<_"F;;J._=TVVZK_QPU/Q`@/>!7#C,XZ25O[LTXL*=BS[OMAY[X?
M=N[[8;_["<(OQ[-"N+-"F.2[4?N]>>7DP;5YA+$WJM:OP31H\<@LZPU[81Z+
M(CA4==7U+=ZQ]XJ]_FYGCZKN\$QQ%8L;N@1A<"=V'`I.,\+6[1/">$IAFB7,
M#SO"_+`CS`_["8MQ=934FF:/UT]X?I4M7E#Z)"5Z7JE[S41"[S<0N6^.!\V@
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M/#S/",$]0EX@Q`\[0ORP(\0/>PD1Q3*:7#P+EV.%R;$/JC?4O`MY;%*MH%3#
M]4#DN77[F0O[@J?\;/+<\SBF",QVACG8=@8#SW<&O[CK#`:>[PPSXJ/IDV<D
MGE535!39F(9/9.=1LLNB`AL\-FQ*BV?K`9[1/K!FX8NL^1RS\)SMEE0+7R35
MHWV`9[3_!$8R/U^M),,%=CM):X&TEI36N8SRS+TG]>&*]K7ZBN$"5]J4K5[9
MB=4?=)#]1;VT0(+'@>T%_0ZUOVN5[JD\6+QOZG['CJJMFDW'7M<;M6$WZMBK
M0YB(X,XN:Q'$:\;CF.L7&:<KMJX`6,N-M>:I&X\6+,P,V27,+-/S2WWUPG\]
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M6Y+`Y<'7PGJ*W(4Q<L:G4J]4UIEY/Z:+I_Z?66[CN+0Q]$;/A@V+1@,-\ZE.
M,:J'B`UU-RE+?+DT?I+).)-3DX$FENEP2B7I>$K=A(L4B0@W$^3*7B&-']>=
MU-=SI^7I6<>0V'77Z+PJ@GVU*<G[KH0NME%K4*,?)URS1-D8=,`3NUZ:L_&9
MY4FQ;R>+E&VO)5I+E0[I([YTFE^;Q""),36@B$1M8J-JDK/$1EEK-Y(EC<B-
M;R?:T':Q1\'1VK-`EU\QMJKDFAW;ZE"VU1X'.*7@CQ"=`O?%C94XD6\09/OF
M@;*%LA4X%20GJLG2C:I[7;QP>,_6IZ['[:GM6-FS]]6:MC3TX<+*WEL%C=';
M-[2NU@X/:?,X1ND0HS5RKJI/%!?84JO.OB&QRT?J$EE`NO%S$[$7>N<6VS6T
MP[4EUYJ?Z0B:V!+%ZW8:UF%M(I[]O^YJ2783!H+[G(+-JYBJQ/4P_BZSR#I5
M22Z`07Y6PL>1P*Y<(R=.ST<R8+^-+80TFM%T]PSZD4I9Q2A?G"71E.!"A&QV
MW6%O%+0\R%EXPZHVB53U:17TJ>PF&$@XJ62*X"<*\(1WXH22C)1:S!2]O09F
M1SC7MC7)#7)4#2I7>M39OH&_I(B+6384:J]9@)IM2XN\EX:4JFL#OI+>HG$&
M`,K?MH4Q@I(_VTL#B/BD*2H`J1`0>JT6BCC#B-)W@A9$\H-]QA%3C%U<5PTE
M+)Y,72?9YB6QK5S6%+9S.NC;D83BHT8C>J1E6'URG0Z;24;(F1G;Z)L@!C.6
M134E"4)483LO9!8UIA*R[)E=`&BD$B5PBU6N\P;1JK$7F9YEZA#*'8T>\<1[
M2<@OSEQM-P@C=HM1+C*I!504Z?^P^.='(,1;M]2\P*+5R;:"K\Y.^%^I'09<
MA3:&%%(=F`CE01*UU`?QA4#<78WZ4*34&R#9TVAW$9<[B3;`&W@0O,\Z"()\
MKYT&:]".2MXC;G-,:YM!8,P7E;8NB,N94ML8-@J&52$PDOJF^`7%:'7]+8`5
MP!_:,G9#ZD]=,`]6K]I-F0*WFR1?CI*8C2YL^W'9O]?!PU[K8'\&-E(J@TG!
M?Z7^?E[S:?102[SRX-(U7PN-^^@4/54IG8OKDTTR"97VOA.C5NS$O0];;Q;]
MLFUM;]4&M2YT7#4^VZ>T\=/#04X&C4PCF6/3)]Y:/_%@*;!)OLOZJ_RA8(QO
M1=<FWYQY2_E^T>]0J6"S'1.8LOTW7=%+WZLOLLW/E'NE!3BCD:)/&LDU`W8K
M;<)!<9_Q5T)4$,-=@<X;7CX6=8XF-L+SJA#H&WF[7VH/ES-O][#Y$6(.&+'T
M<S%B9:)S@@-+E(KH`+O]#K]6@5^X$7.9%!'E@A!L"`44=WR,GPD9\ZGGJL1%
M/'),NW<!.;%$J0F(,4-;(G+G*I(3R'`S4A=5?&\:"ZNT%ZP[%4=G@T>]Q?YI
M/'GL_'*)Q_P9I#K!'DN87"'[#$Q1WN$FR1T9W8A4WYWHAMZC#C[Q))K+Q!Z9
M2]!":<4]U>A;9OUBKOWB%GE0,<39LW;ZWCA__?GA/W++)VD*96YD<W1R96%M
M#65N9&]B:@TT-B`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@-S@@
M,"!2(`TO4F5S;W5R8V5S(#0W(#`@4B`-+T-O;G1E;G1S(#0X(#`@4B`-+TUE
M9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y
M,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH--#<@,"!O8FH-/#P@#2]0<F]C
M4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#@T(#`@4B`O5%0T
M(#@X(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#DP(#`@4B`^/B`-+T-O
M;&]R4W!A8V4@/#P@+T-S-2`X-R`P(%(@/CX@#3X^(`UE;F1O8FH--#@@,"!O
M8FH-/#P@+TQE;F=T:"`T-C`U("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US
M=')E86T-"DB)C%=+D]NX$;[K5^!@)V!JQ`'`]QYW[7(Y51.G8MUF<N!(E,64
M1IR0U,[ZWZ<;#8"0!E#6KM*0_-`/=/?7:/RZ6=UO-HI)MMFORK0IF8#_^B$K
M4Y&+DN59*FJV>5G=_S85;#OI%8)-V]7]E^^2_9A6"M:+0K'-=B78YFW%&6/)
MYC_PLI9I4RN0_H3(%A#\+I76`'\R4:65`B.92$NTL1:I$&@.UJYEM<;E5VZI
M*BUS3R2LV#A?Y46J<)7UJ;'*]`.@E\O0?$8*C<"BLRA2J?S%Y&RA]VV>WE:/
M_!_=S*;VV$WL.5E+D1;\9R(;^,.F\_/4[_HV69=IQ<=D77D@KN7M:<=F>%*`
M&^#5*.F2+,TX&_:T<GN>YN&E&^GMK1L[HV%B^^%X'-XF]L3/I_:\ZZU"TK![
M2GYAR;\W?[^.!:QIRHM@>!G%4*RS*JWS+,>T*I'KM!)2ID4F)'Z715GB=]A@
M74H3R<LXREJD=8V&8']UO42R<9%L*)*;P]AU[&$XS8>)?3[MNAW[WE$\&@Z[
MRE+)NY=G"$(F[O265"J-&Z[F:`-*",5B_P"4Y&2>PC(KCEY)70V/_.LI6:N,
M;Y-UDRI,'82Z@U]\:^GC!*]96N-G?+V'5P@DIUB#KJQ</-,;ADAJW4_\4Z<5
MEWSL6E23@USWE)#HY\U*LIZMLB(M(*05%G[-1`H)6",9V-BM]BM9EF`A"F<%
MQ%I$X3R3M^!?-P%NE0W(N.Q1H.P3-8%/W6ENC^]I5Y54:4[#=:5YQ5+6J;Q8
MRS^\5RBK_'K5E1XEZK04_HI'+N^@_]Q!N0$?&P%Z,=IUJ@H0L3DB>N/:(I.T
M-LMKY.,3E\7'I\2FR&9'Z'9)`=2_%'Z,F4,E1#E3/NZR%Q9'N%[DZS2_0"NH
MLSPN#'"E%N$"?SU<E8)R'Q97);"]7GS'+G&!0^QO6$?XEG57F+'`"=]Z)=/B
M(G"N<"/B-BL*2IE`Y.AUT$/H$I80NK@=0A>O0FB8356%6W-T4HY.RM+IH=OU
MVQ"?:LA`?:'CFE`UY$`UX`DTWVKIVQX_9&7XX73P0BA=\>_LJ;*B#EY6#19R
M@&^9+*_U$9]<FQ`9-?D\*XE7N<R!%L@JQJY85=9U&B45@7%.A84MI0B-,"HB
M:@AE1&-\"@M;.AFO8VR*"!LR12S;HHR%2WB6HTR*""^)@"C'F!2!_8@$8-_M
M`.P[%H##;"HS"",(77#A44^!>'1_3>`P/^U@AAI[/1WA*8Z']S$P&<&)(<25
M4DLK&(/4GZ*5+ROS^O\1J\3)]#:Q/(T71Q4HN3JH\L!!54(I%2K**4)OD"HL
M[EA%<(Q6$6'+*R,<)598W#'+^!ZE5D3<<BMBW55I+'#"MQZG5T1\R0KD/<JO
M,.P')@#[G@=@W[,`'.977F-T7>E5KJM7CFC_ZE[;?F1_22H8TXEVW^9#-P88
M)O&F4U[HO3[!"N+8GZ&:T\'AOF:)!I5/*V"C.5XA6=9@`I8)-T;%0J15>9N*
MGL6\\BS2BJA%3U5308+?!U9J3N.L62.%C5:]V&E5^A:U*+:EA`691PE.Z`V"
MA\4=P0F.$3PB;`ENA*,$#XL[@AO?HP2/B%N"1ZP[FL0")WSK<8)'Q$U6P$@5
M'T4CL`M,&':>AV'G61@.$SS+X2+HGRY7@QM_Z+?CP!Z&>1@G%KB2B=*<FIZF
M6_>\QG#)6_X(=S*XA1:"PR!::6+19"@A^'1)`R2K)2&@L,*]+;>WA3Z91Q^3
MB;S0#D?X0>@-?H3%'3\(CO$C(FSY882C_`B+.WX8WZ/\B(A;?D2LNRJ+!4[X
MUN/\B(@O6<GKI48;]3[L(=P/30CWG0_AOG<A/$P2A5MVA4TU[548Z"SB%4;H
MC0H+B[L*(SA681%A6V%&.%IA87%78<;W:(5%Q&V%1:R[),4")WSK\0J+B"]9
M$76\`X=A/S`!V/<\`/N>!>!P<4$#S>NE_^:N_^8T8GT;NV0-\P7_D4#OY,.)
M44O^#CT3TL!_)A*_3W/W,C$W_9OB$S!/X=PE\:RZ,0;)`F-^X4Z\B2\CF%O,
MRURX[ERGTFO.HG$[:FA'5=WHM3`L9A!P[-L-]&UV?74!,^I&!L.PRV`8=AD,
MPRZ#83B8P:*!>^62P'*)VV:8V^/[,Q/8I8=`)^BUE<!1Z98I.`U1[0>F[BI9
M>?'&060)N)[2%=HP4_H'EMW)RB1(P7><TQNA(Y^'(B^RI3L&.E8$MCV)X!IU
M!9M.6-PUE8BXRUQ8W'4-@N-=(R+N=AXH&0T5=9-&+W01D%A(X(T3(&#48F'%
M]G`@M,9Q[R(1.5P5HK*0ID4SA#G/(UF*<BNLV)X:=KM7NU55=L,KS/X-K[SD
M1RD=RX'PO+I5%M%F$%9\&PUWBJK"22/07`7837&,M1?>S=_@8?F'G^XW&[@-
ML0T$"[5XA#<SNZQI9G_D7Y(J+?B89/`[3!/[YSCLDS5<)WD_3YKLH$R1LB*M
MY;ON`<HJVSU2;-12\,VA8[\-+Z_M"4X>D59T\F3\KPD(%GQBV^$T#<<>%H.#
M?(>?*][.W8[D\?S*P"GH3-JIUW'`[[!FK[_U,]L/(YL/YFO'_GMNQUF??HV1
M8]UI9V'8G>0[]KU[A://&'WN1I:).Z:$4-35UL".;(DN[;$P>\Q%07O<=5LZ
M9L%AT)OQJ2,[!6>R^LB&W\U;-V(<X>M\,.O9U+Z@JV:!];CB(^M/=C<@"/LE
M40/_3F'KA_-$\='A='!K#>W.UM`\,*<"?=R=MS090(2G]MA-H$9BD-J9/0_.
M,AM>K=>TM[D_82Y0=_][/_60MI2"!55W>6:7]LS^,IJ4[2%-VMW6N-VRUPZU
M2SYNN].<(($D6,)T_.@8Y;C1.9;<\Q,VM#.".O:5DX+8PUZ-',O51Z@+\S92
MW'$M58<Q!VG7SMCR:"!$N@A->3Q3!$"=K0ZK?DO:!LQ&PZ&ZQPOKEV$QW!"%
MY4:>?S1%&ZM6\\%SQ+H@V;8E\(P[?C9U;5C%($X3:Y^G87R=(46TOV'/7MK3
M>=]NY_/8GXP(,0N*5!NK^7@P5EO#D?:T8_O^#X\Y"OBIA2XW6!MBE/B$&]P.
MTSRAYI&U;'IICT=XTK&L40\G7M#SZ=RQYW;J[LC7??>6`/M*C8WL@(TAT[XJ
M?L!PUQPV,]('H`H4U^YLU&UG=FS/I^W!4S]A7=/L^S#,PPCE"`'O(885/QZU
M\I^)0F6FZ&J^WT_=C)%5^/936W([Q@U+W0G6]A%W?.A_)%">!?@H-=4*W;5R
MY,N+B6!+'\W"_C01U6DMH\60`K@&\1=:VY^0='HY^_;P'7B@/Q])9,(>:]VZ
M.AI<;J2;HR5YZIT//CTGLV%)I01%/)V?IW[74TM9/K\1);`<H%L11B\,R+T?
MCL?!+)F('>R)GT_M>==#3W]*?B&7+V?;+,=+&9QU>0&*@F?=&@:ALLHK;,I*
MX/W!'GHP\@@X+KWO95IDF:3Q^'H^;B0<@VA)V5,U<M_8',:N@YHYS8>)?09*
M:C(:AD,'T0W$,3.TJ29+RUR;:B*;6OS*E1GO+_V2^I!^Y%_Q],PXM!TLQI&Z
M%OSB6TL?)]W4L.CA5?)[>"U<X2Y3>I[=&$@C(`VD!$I5_(_S:FERVX;!]_X*
M'I(IW=FHHD31TCG),4VGV5OVHMATHZDMN9)VDY]?/$CJ8=&39@]K2B`(",#W
M`5P-0\JH.\K*9#/M,M'+J1+6.JH*TBKST@P^QRS'N]+<\[K<+]R&T7<AKBH:
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MOGG:W5`=-$X5IS.6WN&S;?5`:"R.,5I$V5.:,Y[F27ISHZ6T;^NC6)<QXUF9
M,:=%E,N<26TRGFWR:21NGE!]X&*,NJT>*-6Y'N74B'6?TQ2[0!1,V^(IJIOB
MZ<,WQ9-GF^)M,)6XF.I:A[K67-<?^>9H:+0U$D9UQM<G:/0:^C:-6T8.,/T/
M4V%SZ>:E1GI7$*F,8F@B_*Z*-,G*A3L_@LF5[RLB@/M+81:8+-(J8-(0)HM\
M&Y)YA3P>35]$[-,7$?OT1<0^?1'Q=OKV<-4T4PC,%+7';JS/M_1GW/PV:7)S
M7,^?1G/+75L@X@.G"D]\KX1Z@/Q18'<YO(>C\J),29!7*P&T31#`52''\&<Z
MC<0?*"#5&YRF[HH=J3DQ$D=AME@KHN]Y::9ORBWFB>A[9G'BDH:5#>J(J?MO
MS]#MF^IQ4E-B/F*Z$:G#(TOCK21B.HBW3_>=QHGIWRHK:1G7!O'L<`SZDG"G
MI&TZ%\3;Q_M.%'$.4UYD<6W,5+IP;EE14T5L)\V+(WEQK<H?OVYT4$]WG,-.
M-7,.BVN[VC9="^+(X??%-Q0>&*F`RT1YG\'#7EV@:AB24_`O406/QV)C=M,%
MWU3S/$L4DU?B>!\5Z`^U?G]\!/B*Q]/,J#$\YD^Z;X(R+`K7,SY"KX"V=L6F
M!Y?4OAX;?M/RF[]W;W(IWL.#_(Y+OW&7PO]VL`,Q&3B0L0-E8G)P`#Z)^;/R
M]G"%!A,A/EZAQ^X3)?L=^";!)!B#)EY1TU52V._N^6K)Q!OHJ'LICO;0HV(E
MX1I@CVZ/&#OQ"CDY0V[U+T]=+\:OSH[X][GNQX5185M_@-WE\B@^.?$5.OL7
MVXL\?6"61N,0P)"JSW2Q$J>^NZ!=N&HL[;H5F0?#[G%F?V$Z@_]H_#KNL%B5
M=+LN$&SX\9[@]>O!VZC=5QW=WD/O%C4=Y^/%AXONQ#$3JDR*UXG`4^0C^+9T
MXC"/#E^SZ!#1#.)2-^T9!B#TB`8@,$ZQ>?QMT8B35.$*TWQ\MIB80S>,8JA?
MFA93JZ6XP-$<$T.VX"HWB.9R/=N+;4=[%/5(@3MT_;6#:K2B;H_BV+PT0].U
M]5F<[8L]BZ8%7`[7#LH#S:#&N2,+WR!B0WV&4VL79K-R%AC&#4ZX0F=[>WP^
M@&T*#5O&^R:6)HQ.20Y1@)B7L#CL,"CN;<,_+Q`9V.N>G`S"A$%/X$@JM^#"
MFB;@513\Q!J9R?\_^`'!Z4*7OEQY--(*O_PO.]BZ/WQ%S`/"ZI871_?\#H/=
M7?GILD,D2.OVC!RNMY#A-0DHF)07+%"$4;4(+("FD4SV@`VLO4(>OG*R[0OE
MK4!D0BC!`:P-SPJ%8P6H`2A\5ZB0HJ,8S@U662&_CEBM&1Q-U5H@1SA=\0I&
M,Y[1&-PPZ\_`S6$*46)G'9<PBQ!,,V!*!V-%^"D9Q/0\(G1AQV4&7L\7.>W8
M\UP^.Q<#D$G@"#R6]APMT\+B&/7`0:];_GI6J\D!0,(2D_L0]#U_1W<2*C%`
M`8A^T,?H5X3"/""^6"!>(3-0#*$).$BCQR@>+>NW=7NPP#+L6>^R6KFL[C&K
MW[K^'T00=HX1T0)LQ->J#]W8]015\?'#)SQ^>+X"_,;P+9]E:[^):]\!1$?'
M67NJ#"6I."^V=2_'Y.=@5F0`%57IG^FQRBQTF6`\&^K,L>$?=A3$#R7W52TA
MTW;`FK[RLT5^"=(!2PA>)F*%K`KMS(!5>DNX0DN"3+7A>`I-R9`1W^H!6A;=
M`9%!,9.GIN?$&P`TM\D^)//4#`>@7*K?HSL)R!M_0BF<GL]8*+F<NJ793X`*
M>'HS`Q06/,:BWVFL!X5H"2_$\\`/KM1I#?7!"Z"&RKUKSOS[I3DW(WU#!K6:
M*6IY<`ZV_^F<0S#`;X\[H.Q1G)N6GY/=#[#T9CW`N,DIH8SH\+&XQ*_]<T>N
M]4B;I>RXDXD39MK(#@8I#3/!8_U]I]*$O<OD[5B5;XY5Z316(:C?=I<K<GB6
M>MPJ^2LF;"\'8=T@<+('/VPT+Y#'VD];@OIM1]S27:QXDF>WKQL&N+02A757
MZX8PGC9&^)@!*4.GKP.CN5*`0LE7W'K;"ES1#6$L\KP_\1^WB8E,'X@PD`\]
MXJ=L\%"]IWRLDOC^\9?_!@!+4)#^"F5N9'-T<F5A;0UE;F1O8FH--#D@,"!O
M8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#<X(#`@4B`-+U)E<V]U<F-E
M<R`U,"`P(%(@#2]#;VYT96YT<R`U,2`P(%(@#2]-961I84)O>"!;(#`@,"`V
M,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T92`P
M(`T^/B`-96YD;V)J#34P(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E
M>'0@72`-+T9O;G0@/#P@+U14,B`X-"`P(%(@+U14-"`X."`P(%(@+U14."`V
M."`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Y,"`P(%(@/CX@#2]#;VQO
M<E-P86-E(#P\("]#<S4@.#<@,"!2(#X^(`T^/B`-96YD;V)J#34Q(#`@;V)J
M#3P\("],96YG=&@@-#8T-R`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R
M96%M#0I(B:Q737/CN!&]^U?@X*J0*8M#`OS,<9U-JJ8VFTI&57M8YT!+M,V,
M),HD9>_\^[Q&@R`E`YJDLCNU%HC7#?37`QH_K&\^K==2)&+]=)-'52YB_-,#
ME4=Q&N<B55%<BO7^YM/]D(G-H"5B,6QN/OWU2R*>AQL)^3B38KVYB<7Z_280
M0H3K?^-CE415*:']9T(V0&@^D7H%_*BXB`J)350<Y;3'*H[BF+:#["HI5R1^
M898LHCQ=J"P6ABLIN[+8PKA1I"FI3WLDA3;7C-YO?@U^"E=I5`1MN%)1%;R&
MJRS*@A/_M&$>)<%V^M`2XS=1'\R4N*^/YV"]XX$(DSCX9S-T9J5^TPR(SK_6
MGSD\26:#8V)G'#$Y82&EA<A8:<PNRY+-7K\T(0QX"M-(!EV8X.]NU[VWA^<P
MH0\QUL`?=UH*1I91&?1:F&:&<%5%N1X>M.XXB(&^M/P&_X_A*M'X5N-FHY9F
M#[56TTN2:$O?.S'H'<=V&%N:'806VXKVL#22;=C3.BS>'<1'7(SL'BW$\_LC
MB?<4S=)HOFF1UY,&QD;#6GE',\,HL$D<?`MEHKU&FJM@L<B';'`1YE.!T(@B
MC6R3.5@52V(WVFJ5ZW#**`W$0W`ZU"?:"Q%%8=!/.S;;A_!/O`6R6G)6JZFD
M]2!/>9>\S"(E;4T[ZT&JJ,@J:)J"2+697-+&SG^$5'BG4-L!*T.L"K<EBKL7
M/QYX?MMLQ1=4=6:0XR2&>DB1%NR3!H]-#YK=A8F"!J*HXBK']'^W0:NGJ0QC
MK4T1^'%]DXA6W,@"-1,G(J_2J!1QE)9BI?_VS<W3=]$JDN6$)GD2X>A9X&D:
M7]%.TV2AC8#'9W"&LTSE/N7KZ-)LI)'A1)OWP3`7OES=A?^P]M5-H2)]0E,5
M9(4M"&E.-F1.I@J^YH'$+#ZS,LN02'PE^$IEB9`&GT]T8A1T$-!/@RR#',B_
M@!S/29M&ZVPI;2@6MJJLN@;;4+AA&PDWC$"H*1#J+!!Y$6F?'!2"3)9D"3-'
MQI!+,Q)!>"@@Q7P2P+NLY/T+*I:/9?`]M$S]:(7<6E0FE:^(W.JV^!DNXXOB
MMW%WJZL\OJIN\^)6M^0QZE[V?"=NL<TJDI)?.NY"9[]<Z&RV"YVM<J%^5F4H
MIM04$Q%K/FFE.6GOPTI?)3B3@^&%*(*#KC[P8"LVM9UL7D\\:NG.*8(W_F+5
M'<YA??26X*31'O7<$!(QJ4"35*D"\&U25#B04XC`2B(OG\FWX/#Y?)9*Z-Y*
ME2_G+PH\S^'C1X;99'APFPX/;A/BP6U*/+B?X1DND]3%;YR!JE*5A]])@LM?
M?21XAI9/>BG,*)$4)KA(ZE:W)&783U*WNB6I1]T&UZUN26K4O23U^CZA-C.H
M'H?G#GCIF0->6NZ`EY8Y8#]3L6R6STQ-J[DGJIBI/YN.5P74K8"0X&98HOMY
MH?8$;?JQ[]YXV&H!]&]H!P-T28\8*2BC?U2ZR6,Q5J<5M^A;$PF=/M0U''2Z
M?2J"AU!TQZ:O>4M>M^-U#\M%J$!SOH,?0/"*,7E'MRZ-8BR$Y@LG`"T:W"HS
MGUY*E"B\C"0JR?/5N<1%\:<5G8*6?.E%BMVP3;$;MBEVPS;%;MC/>Y6:5^CO
MPWM51DGNY3VC5WCO5K>\9]C/>[>ZY;U'W8;6K6YY;]2]O/?ZSFA!A//RW@W/
MGCGAV7(G/%OFA/V\EZF]G-/IM5:9IO>7KO]*5VD*XN7,./IXYA]!5W>A[]\L
M.++$J/_RU$Z/J8"*O,`Y&=R";!GK)G<Q#_0]J^A>5H27DJ?5.5Z4"DO=JKNJ
MXNEJB5_6I;IR&;O`.?(.<(Z[`YRC[@#]1$S0A?Q^/,1LZF^A&;W"0[>ZY2'#
M?AZZU2T//>HVJFYURT.C[N6AUW>#^EMD![;PR=\>.["%-?]#:QRC"&;NJ;DQ
M5G-C3/<A7:`@%U$K$#^%"5U@Z(!S9J/2;TR0L3OQYT@0W8F5UJ@U:D1Q(<>S
MMAX_,R(>Z]TLO6ETO<E8Y=3^@K^Z_56F+<Y+O!&SX';9(N-$7,I<E&B2DZ]^
M5GIPFQ`/;I/BP6UB/+B?H3$6=E(T0P.2Y\62HO.;AMHG$A1:=.%_G$:5OT5F
M]`I%W>J6H@S[*>I6MQ3UJ-O@NM4M18VZEZ)>WR<TO=(BN^&E9PYX:;D#7EKF
M@+V,S2H0)J>B***RE)FMC%_U)9="2*?^O/:SJB(M7X?H@2<//?#DH0>>//3`
MWK+/2G3X<X?X?U1\5M*OK^(-ZJ]XC_I4\0;V5KQ'?:IXG[J-JEM]JOA)W5?Q
M?M\9I>KQ5KP'GCUSPK/E3GBVS`G[*QYMFYRN*#5?4;&YHGX^X94FT9GA?2=Q
MF32]Z/".0].WK<$(NE^^X193N(]R>B`:D+\FB5TSH2<MBPNL-`IZ6(>)OL$J
MOL!HG_;PK#]%R].BWFSH49A&9<"+'"Z78EK&@EZ.69Y3+6NG%B3NFTW3OH65
MWA$^[1I1CZ+!4GB>DNEDK7@]D40_PE>])#:-4QTZ'B5%AAJGX.5XSU)2SNET
M'FE9TAET&6K-KR2J$FD:<=`KH3AG)77#]/K(`K`0+J-=)*LF//]P_*!SGDY?
MJ<C`LV($(_SO&#^J2<SH-1([M[:P>W7+<8:O<-RYNH7=J]LCP+/Z3"3GZA9V
MKVY/"+.Z_X1P)V6"/7&_#H/%B>1"E`*-6ZS+*BV)\1>-C/F/RE$Q(X@/3&W)
MC\!$CZCVUB^-N._VQ_J@"2M!::2\#/X0QL$@WCLSVW]M)X%GL:F/[5COB#]?
MFN/8[!]!%Q4;_$Y(6KT];/JF'NAAHYO8'#0;.W&;1HG8M[M=VQW$4]_M:2:F
MF1!/VV#7ZA]@6%P7^^J##[EYR)8T(A\^A_KZ"TZ'!F;P_C@AT#;7"-[VM!EI
ML^Y)W"*_9BL9S!:,^ON%6N8\:,10[QMQ;/JVVXI=/8Q$Q)CCDL*558[PU'VD
MW473+N[KX47\)<S`VAV=8&70O8N'X#0T6[W^0RC^CN5JLF)@I]9_9%\2=D5F
M"7OR7@_0O$TJ>0=''T(ZX1!),2)+VHK7DSF<Z*,Y;)NM#K#-0[@B5WH;!A;<
M4(+[2199P!XJ3GD/\=3I^9YV(7V(O.J9$_X&[OW.O##G+-6DN3J697''RK`F
MB<0O%+Z,8ZV"%H<PN;;KAD$\T=X*3R*Z`Y"537<8V\.II:<*5/2E@+.P.^K`
MXV74LX*)*X5N:)'<FK?HQ6,SOB.`\*=I#NP<`4BMD4""ASMMP.;%+&IHH`+>
MC0HWTQ<1SUJ_=?(RD[VXS$SZNC[$XS#XBBLFT_<8/4<"DP14"#;0?X\L,/+7
M3C#6Z=G]L3N0V1EVS_1E1[/C()8+G/3DP!);WJ!>B(MV?V1;NK=F;Q8:J926
MJPPA77HO"'W*Q4N?*-XGH[I'M%F7)UAK;(U]DWOUQLR_M6/+\D,DQ-^,0;61
M8\0:8QJ$BU(J32E)&E%,'YM=V[PU`_*$(V$\/ZY*W8%(G%::N_;`*O6!]:PQ
M$WUS9AVHQ(-FJP\FHB_BHRM?3"LBY\%O9@PCD?3QO=F]-6*/@GQ!&NH#2LN$
M?-N`D6-#O%=\1$CJ@'CMT_'8@3U;00T4&\L";O;D$WLVI[YO_D-YU?2V;07!
M>W_%.R0`!<B&2%&2=6R3%LC!:($&Z*47BJ(J(A2I\L-V^S/ZBSN[LTM*LM.@
M%ULDWULN]\W.S.*T+J!.D-_SK<(U6Z!%>ZBJFN?2FV,">9>AMQK;?]">FECD
M!Y@F^"PA*YQRWS;@\GH?/ARSJBIN.X#Q``3O-^T)S6<>3AF.%P!#MD>2O=!'
MKSV81E_0=UU?G'%XS6T'D?]<C[9QXC8-?%TX;;4HH&`M09<7<E220AJU1_N1
MX<-$6"1[\$775.5>5YXUE41)@MN5)`Y-&_YHKS8+N]F-PZ',2_LM5<"^G-^,
M@X/21@#UYZ-'[@KN0WD1%OUYS)[\F49V!B-GOC[W=-2QE-_>']MFD+*OT9-R
M6#S_5#EQ+6]$F?ORI&>"^#M[K+#"-3KE5-99;W251HP5<*I!:WD53NITM%#9
M/F\&!)<Z$MA=U^1\IC#1Y?M0O%B(<U%WZ$FONWT@RT\TXKUEWUT1YF([S1A;
M?K+P2PJ8M0"56'/Y;7Q>]L?`AWCI%K`J.PV-]\/P/Y;YQ<8F/#9]P]]":L`@
M8R&_GQ]_Y3<=+M[!S66EA"4_NVE#U_,GU_/O_4S?.GW.A=]ZTVBM1J.UFHQ6
M-^RZ<E]F;8G:P8^,#7E!:2L>I[3<KL_*&E7/PKOEW!XBM,@V?,U34SVQU%A;
M8:&U^TK;'??@O_9E3XNCNKL!<V`P7&K_KZ(/6"ZM_&FF`BOB\)AQW5^,^M\&
M+$[<@*G3@*TX#"A??S1G5)2M\_$:?&P_F')Z0\L$'78WJ(D2S=I6<+79KAI,
M6!E3XP6@<:-$]*4M$7!C/6\_&R?A=>_BS5HKUPP]3KC>EQ[&\O%,:VH)C<E4
MUK66-;UM8COGQ<;/V:J>Z0%/MDRJ"C?DITAW-@_[YKF&`UZKW^-1T<TNK]RL
M$,],^5.=$[0T'+)<X(OF3/3`$CVQH[U`2'HIH(9X-4'DQV%EN=A!MX0*2/"D
MS5S>&-3%9K1V-JSN,O&U3>WRC49LF_%"NE!:"<&WWGQVE2O%=$%/E]8JCG(^
MXT7YE.TJLHH'[`K;/-"^ZDW*Z89?)/I\]`3DM+4ZK:$A+S2H>DB\YBJVT&)C
M:/5\VI'^"J3J80],^4:[C+_C-#;^?@15RJ"#@D@E>"$QA'-)EJC'[&X%JKSG
M;1&4(NR:MH6*<P/ZXT&]#/#SJ(DGT?\('&#T`T,,AOU,11#_:]M:F">)*1ZR
M-OS"[>U,G$MS]U$X5Y1,6_'%(LTMZT^S)&:KR&5^[[*HC7>%G_7HYXPKRAI@
M*S!5M2K4G&U&,,>)VR1G""#2(1?.+<2/&W^/F!F(>O7^=A)ETV"T.5>#]$",
M3-X+0<7WVNNRY909S;#]07Z35,6OT'[!&K(>H-LY./3HO!WXL%.C4#C2I:LR
MS)UU>1I.82Q`?LQL!7<1@?QJ&5;C9+X"*<!X!9A,]L$TC%GE2#>&[^OQQ/"9
MK!^L]&+S4S7QB4XC261%IS=5.-P+5-:1Y9\J]:Y&%\V]K4!E[0_RPF[*8H_&
MA:60%5@[\,U^R8=U[FLN=L"(\N$^U!R#UM&=;AY#Q&_$\,V\E#DJC9ZXF]GY
M^KY3?9('O-,S)W7.^CDJQ5R,=\E"JTPX#3BT$Y<5O<!I9WM*R_0KV-\Z]G/$
MKLJLAL%5>R,'*-0[F@&7[)MV2+8\&96A$+[7]="#Z`;TBF35%>5=%/%1B4`M
MW(/3AS#T,R`8'/,+%?A4!'XRY:,_U\1G*ZUJ$ND'X$HJ+[6-^"5RJ]+ZR\!9
MZXI>Q'F*KP;B6[XI]EDHYHO%F^A!1-[@PC-JL"'U)J*7<XW2(AAOK^0=BVA'
MX6-)SP_84Y_.YY:/Q;%C&IP+@\@LPU7H1WN%3#;=/V%?JE=*H@XG)/Z4+VV+
M\R#<&N4^_&!\E+,9SM_R3@O'!&"T,D_7@1"*[M9OY'Y]P@`*<]KD7T@O2/C%
M39402]^(DWK*JJ$P/%$#@Q&=\$L2(>,QVY3<5#>*YL*CY;81S/?.<AO!!]0M
M;GC&97#K1K<4D1?B2!%$*I2JWWX0\T(#_J`N/;$EDH-VD_"$MC@[5I[5W,F%
M^UDLQ`N\*>CXR.-!K_`&2)_B0_?*Z_A3<N#"?IS1-*(.45OM<1UR<1<L:TMU
M$+$\Q-A*%)G0\`9M7F8_]&A6B_KWM!-G@.6Z+-9U;QNKA4O-;V3XGT`I*W7H
M2W/H&SKTI3AZ4Y0KDDB$^LT+W0N=;82^I1Y;VD61H(L)8S).[GTR59Y.\>RJ
MEM\\!!B2^=)0:FET0B%C]T&D)GDJ+J12.M<=V)5"&S]HDZQ?#T^+U>7P].:,
MM+/K0OUN519/2(HOV[A71FO+))IGW9$#J_PH_AQLJY+C)D+?2*^+UA]EE5L*
M^N03%UTF#PIH.'WQY;U[;R^!8/0K<]25/L>NSU0OBH_TQQHHH^Q55*GF66$.
M5/$V-9=R=P)Z+Q6OO1![$SD73Z!Z'DJ&"&]JW5Q#^F>`V%WINN%@0FS*:_*J
M!.+:>"6L4GK&:9C2%V8IZ.!DEC,%&02O/8`FL3=IO2S.69],ZXDXO7CA\K/E
MA489KFW,51-NQR8T\FJ!"XB%TGXXD'G!!PKR75:I/L21"#@8]E!V.6^`=P&)
MY6L\W^K=CY^_^W<`>/W/=0IE;F1S=')E86T-96YD;V)J#34R(#`@;V)J#3P\
M(`TO5'EP92`O4&%G92`-+U!A<F5N="`W."`P(%(@#2]297-O=7)C97,@-3,@
M,"!2(`TO0V]N=&5N=',@-30@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y
M,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@
M#65N9&]B:@TU,R`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@
M#2]&;VYT(#P\("]45#(@.#0@,"!2("]45#0@.#@@,"!2(#X^(`TO17AT1U-T
M871E(#P\("]'4S$@.3`@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,U(#@W
M(#`@4B`^/B`-/CX@#65N9&]B:@TU-"`P(&]B:@T\/"`O3&5N9W1H(#$T-3@@
M+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(F45TN3VT00OOM7
M=.4D4;:BD>2'CF$3*#@0BOC&<M!*XUA$UI@9:9WDU],O^05+BMJJU3SZW5]W
MC[_?SEYOMQD8V.YFJZ1<08I_O,A725JD*RCR)-W`]C![_1"64`>F2"'4L]<_
M?C#P,<PRI$^7&6SK60K;TRP"@'C[)VX6)BDW&7*_I9L:;^C<9"P!/WFZ3M89
M*LG39$4Z%FF2IJ0.:1>F7!#YG5G9.ED55RQ7@M&50ERY4J%NK(N"V)'A]^BG
MP<:+59)%A]CD$>0)/+A^\*X+4/4-Q`N31K_&)DTVD1="5]MF]#9`_,?V9W',
M+,FMLV*-8<Y7.5VQ+QG[@BL.PPF5OQ\]/,2+)0K?QXL,/RWN(AN;:!<O2MS#
MN\]H`MW8>ASHDBF>A=K">Z73#U_6UHO=Y,`WQ/_`)[WJJ/"FK_F(EATM1-3[
MW4YE(V/DX3%RHS+Y.,6HP/%F.XFE$Q%XK*[$V?_VRNGMG=*S4T=_8W9-UY,2
M2<LBO^3E"DBX6J8:_%W;5^@L<CC6@^G'R,U%"^;WB%K7*#N/AO;9=DSP)38E
M>O<8QQGYO"=:CEL>/5OAK%U?=V-CFSD\520AV`9<#\/>MA[L<]6-U=#B045P
M*J.`7,DJ0B/@%_=L#T^8/3.'#/&"448!*/]5O$Z*Z-W$JUI[_8K'V^_4T;4Z
MFM&*''U;"<9+EK,4Z_-HCB95`X>PC,@\:&QH=?\Q+I$$-:3)6G.F]F+XW=%Z
M\4%,62.<2"*XT9/!R"&:&N%OR4>#^UI$=)3G,G(!RPCJJ=RNLCN)Q>`G)E+C
MN>A>84RJ21P:C$E46LNT#;0]_#9VZH8<!C!YM3"%4F)4R=KZ,;Z-G#$2.5/2
MBB)'UIAE@ZR/3#[V#:M&FSQ%C)Q%MS\@BGT[M-@3N%R)H-Y7_<=XPS9D%)$W
M\8)V->\&2K<I\V(.%3::@^T1,,J)'E+T3'0C2Y<7D9M[D<*$R<5#_AK*:^5E
M;\'N=FIP38"&P=T!IU#@K&E%[MN>,T0PP;#NG#](UCG)!0>WB/X:6X\(1VE/
MB*`VU)TCQ#]QL`NIF)5"B$#VX`Y'<B>[OFVY/L!SJE?1T?DAP*[MJ'0\A/'I
MT`X#;K`11_>2QT!YL6K4MXJ!U'!@&5\26%H*X`4O8NR;&KV>8*G(K4<E/XP=
M5A76N%=TULY3S>OU2Q@.@7C">#A4OOTJ9Q-P*P87<VL5*1-%0R+L)O4>#F?+
MN2XW-PX<E+,?YAA::D=M+_?G\##@<P7\9J/1H0(NB.PH7V2.ERBPI4)&2RK>
M==K$>?.9\+76C5"/"#WIFKP5:K=CB?)?Y0FY4'D:5.B[J.A91".RX6*6'+Q@
M7`<WTGL5I523[4YD_)LYDR5T-F<+IM9'YP$G&S:=ZJC!<5.0Y'I0;ZFN+DQ=
MYTXPM`<>(*3D2YRQX.:?<5,S`M98>`''Z83C"7>2UHK3[IOV%LYPVD_=$7'O
MS^W:2[ONW3!5+-4Y@MU;*>?D@I.KIQP];^[GJBFGKD$KLFR+FG06GJR7%F6E
M&?4.>,(4VLD,S["$AS>=[6(C82@X)MRXM/65T2#'<.Z&I<H0X8%;/H)%V57R
MW5:%"(OOZ4U2G"&*H^A6%\XE602:6`1$?R_>*>E^<A5V6)#X)M%SYP,,ZO)>
M>*JS)VY4^<W_BDN&05$9-$KIB\UP<_:CVHDI.SM9\=*CJ)P:0*K):_O!4E@N
M8QF;;T!4V'X@9'/[O+QAJ!_3\V*.J?5PXOF"8:.9(0T94P_:J4KIV).1H26,
M&GECL*<F9U<S<K5&#WF\ZW'=6GRKJ7Q^,DDV<")9WU:=DMVTM\FGDZT^]3;(
MJP%+(="XP98"XJP:=^5S`F]P*,/D0$POB3!V`WF)1-ZK'3)'*]TPV<"UB[A7
MDG-%D;&CJJ)I-52?=&=[K;;+3Q;Y4;$^_U:ZJK^[GQ>K_/++XSJ]<O)N._M[
M`$;,99`*96YD<W1R96%M#65N9&]B:@TU-2`P(&]B:@T\/"`-+U1Y<&4@+U!A
M9V4@#2]087)E;G0@-S@@,"!2(`TO4F5S;W5R8V5S(#4V(#`@4B`-+T-O;G1E
M;G1S(#4W(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!"
M;W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH--38@
M,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O
M5%0R(#@T(#`@4B`O5%0T(#@X(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q
M(#DP(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-2`X-R`P(%(@/CX@#3X^
M(`UE;F1O8FH--3<@,"!O8FH-/#P@+TQE;F=T:"`Q.3,V("]&:6QT97(@+T9L
M871E1&5C;V1E(#X^(`US=')E86T-"DB)O%?;<MO($7WG5\PCD!(@8#"X<-^\
MLKV6LVNI)&[RX$JE(!`4D5"``H#V.I^1+\[I[L&%%+FKJK@B51%SZ9XY?>_Y
M<;6X7*VT"M5JLTC\9:("_/,@2OS`!(DRD1]D:O6TN+SJ8E5T3!&HKEA<_G0?
MJL=NH4$?Q%JMBD6@5E\7CE+*7?T#$R_TEYD&]UO:*;!#ZZ'F$_")@M1/-2Z)
M`C^A.[S`#P*Z#K2>#CPB/X*E4S\Q,Y;9P1#%B"C3%3J+?).!/C6&^(F#[HB)
MS1N&7Q>?G5LW#/W(>>-Z*3YW*W5]#3G^MOJX\"(_S4B8,"919B"'$?'?K%P0
M9LZ'=_*]4]>?WKMAX-Q@[MS]\L;N7[L>+DID^9/<,!D!6S&).ZC,:I3$\V)_
MR2@BVK5K6OLQ+Z;3XDP/V`PFS'K$K`7S=5^Z7N(;Y\D--;"!RU,_EX_Y3@%E
MX-RV36$I2C<"Z'55/W;J&+076A#1*=S1L>IB@:%'U:^VI;IJGI[SFF[U8^>;
M&R[Q456G<O6<MSW6M9^.ZWVCOEC2'+@BIZV:?:=VC/QY`)TRZ(A!N\37J:HN
MJG59]R##&57?*;+0P[ZKZK+K+E3=U*5J-NKKMBJV*F_YG,09_&"2A`0)]>A$
MH55HX<9.4W>X`X/6-;YV:+1V0XS4`S!G4/,W5_.\W]+F*/K!5J,>>/,IQR_)
M'SK3F17F#FWL:*`&$CH1*NNK)R+U!37"4/M)>LHR)QR%#11.P1$>.$I(CA+A
MH[0O'L*_0>!<;?/ZL20%J_NRV+=57V&6UVOU:T<:)>ZEHQ!D`;XM[+)TK)E"
M-M/267?^L6/IZ&4HB-]#CS.7$QMP)O@$"_I"DQQ)_@?18<;H,`=")Q(=\(+H
M2.BWY8:RA8$I<(1Q]CLXU*_/#>F@=F.8$X8BSJ95]SP?5?-"5!(H/2NM\8/T
MNXG+W.GDN^D@+GP+,0-IZ:O,D;3W^P>[575=!2]7#:7,U($28H29^@4B4D#2
MFIQE3^3UEG\[UUN2_\A.P[2(\;^(0\Q8A8EB\5Z&!?_N2:&A/:PBM<>6P4Y*
M>PVYF>#_T.S6AQ!H[Z6O9;[6YPR@40+T=_:W>/2W^,#?4O$W"!\?6>`&":-5
MUS5['1*-2-Q:\KR'45[Z%>KW6;'@<]]/*A8EF5)',I,JEBBB$H(Z?BC5N]^V
MU0.EXIR20^(@9]R5STV+%432>_(Q`UEIJST\*2-G,HXG%>K/;H9?GPE?:&'I
M9R?*JO0C(3H=Z1=X-'4^L:\-=0PB<@)EA1*%QE8ZB*DY;7P6*0A7Y$`6OO[=
M:A&J2BW"(,.)H3)([8;/)U]"PLA46RXVBQ]7+S"$Z%;2A$"@P"=F:%N,M$8_
MB&6PDEC[Q7#=P0139`<VLJ'62+O<=4#I:4I1]M>\=5-2*2H/[Z"`&(K,_%'F
M;4F9(*50K'OUM7(3Y*]^J^X:V7\H499I37UHOLA26:IU+HNP.6`Y:W53H/2"
ML4$YHT&K+)(+&`JQKZD9&0K5I%H!'1%I/(&^0M;9[UR*D9Z*NNSF=C`@3B;$
M*2&6FG/76,3IB#B>$*>"6`^(TP%Q2H@O"*9P6+"K/UF(Y@BBZ#4>]!J+7O4?
MHQ2]QDZ=[];J)Q]=@<R[#A`%4;FVE]T40&<E$-ARJ8HN7BAT<(VCVA\<.W+(
MH8NSTJ'H+Y&I;2:ZV6PJEWRA*%N$&5#]!VK58I22%`P]]4Q1;9B@*F0UMZL(
M908UZ_YMG$4&E=&,O?S+-X1T7`(;>A\'WI1QY@GG=M]V^QRZ10^%A(D8^]>^
M:J%TCWM<:C:T4U-VV?#^K%]Y]QMWE8E3<#NCWA0]47&Z"I>1N6"&6:N:2$MJ
M'+6U<^E'8;/]SEXX4/`I1;[ORK6,N5EK.=6-3B4R1:-,D<C$[:#JJD=VA)H2
M?^3@'&B5,N=#*=='?#W:PHV\8KCCI&7&D'+'J?;UVJZ6;5<QR-@Y/I@JC9S!
M-0F%MP:&0:AX/##?]]NFK?YM'PEK?Y3DV.'."_<V[\L?%/]]:KZ43P_VRM:E
MGE^%Y-06,?FVLN^/Y?`PY$&8V;>D3B+*H$?N=/CPU`FZMN"0>(3FS;%==I?J
M-N_;JOBG&.UG:M!#+C/0[T?["FFV=3=X^"&N*#5(^J_$-82$-DN4'HK#IS$4
M#H]%S)R@/"?EG.COO_]W\J[DQ#GGH*-J&O,*X#.Z<[!'DG.1?F08O"EA&(\;
M`+(,-PYLF0MUM:W*S13@B/F^^E)R8I-G")4F>J_<LM^#HN.7XBF;QJ2'[`#A
M*VP*OY%*_IESP3*(`D>-WOQ_"X\@1;85&[XF0&;DWO1PF+\;+EV/FO>..O-X
MF%'1=3[:9%&ZU+-O-BT5JQ2[R![9$#Y$X%,1@RQW5"NYE:<S>OD4S+TMR2P3
MZZE02S)_^7H9!\.$2T.#5P3;(>49C1T0_0_!]GN7C="SX)5YXI#R'/09$1M;
MCV\4;=\H9+&(JT*(7VO2##;[1CU-+"8E`E_<@4QJGVKR(.1/P=QDTAGKA>6X
M$HZM3"VCO4]"_;U=K/.ZL,.<]W<R43<V'JAKL1?R37)*>\IY3(I&^U@)Q\[C
MF<C/(O1,U'-Q-S[T)>CU_SL`/BS'30IE;F1S=')E86T-96YD;V)J#34X(#`@
M;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`W.2`P(%(@#2]297-O=7)C
M97,@-3D@,"!2(`TO0V]N=&5N=',@-C`@,"!2(`TO365D:6%";W@@6R`P(#`@
M-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@
M,"`-/CX@#65N9&]B:@TU.2`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]4
M97AT(%T@#2]&;VYT(#P\("]45#(@.#0@,"!2(#X^(`TO17AT1U-T871E(#P\
M("]'4S$@.3`@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,U(#@W(#`@4B`^
M/B`-/CX@#65N9&]B:@TV,"`P(&]B:@T\/"`O3&5N9W1H(#0T,C8@+T9I;'1E
M<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(F<5TN3V\81ON^OF,K%0(JD
M,'@2UBF*E)1<.3@Q;U8.6'"6BXA+K`;@ROKW[NZO!P0H6B6GMHJ+F>EW]W1_
M\V9W]VJW2XTUNX>[<E.7)J$_^<C*39(GI<FS3;(UNZ>[5W\?"M,.0I&8H;U[
M]<]?K#D,=RG1)T5J=NU=8G:?[R)C3+S['RW6=E-O4^)^RR<MG?"^344"_<N2
M:E.EI"1+-B7K6">;)&%U1+M.[9K)K\Q*JTV9SUAF@NM`6<\=J/)*Z$BRK<5(
M_K)LZ:_1^Y7Y.5YO-VG4Q$DT^J[]&%>;.C+_BFVRR:)-3#[8R/P4K\M-$?7Q
M.J?EH]"<Y'>(B\L!ME:F=7[LXG6]R:.'+W&:1&;$"IS-^*.)_[O["2&R15E*
MB,BN;!Y%]FGW5]G/2SZ0\-@2IMN-B==IF:0D]KUY9'M+\B+=5-$+%DX6QCM=
M=V1J1KMBR>?8%F2*V[-I)=$]SHF&F&-B/I'[&;EW5NE^5!$LV!_!2`Z*'J)-
M*0;>/?=*9V*;1OT)S.8?L8;0DGI/_^QF&SW%:49+8Y,U$1//O^.,S/I%:-^8
M_@&[YF??*\%;(8`)OT'T*K:LX+UJ:C>O5?TEQGE>3F6H\9UJ=)Z`M$")V"Q#
MF%,)<UY2345OXG6!4B$M`YEHR0[^WAOR<DL6FZ>X)@K..5ND(?DH9Z!@_PLZ
MH_AGY/^1O$DI"[I[$!H(79GQ498=5^A6%9I/9]FD7#C.`)\$=0B]1'W?.Z6?
MU'(B1]-R%,NPQN$H1C2=^M"<ON#CK,=>RJ".SC/K#,0KZ^@DGT4$_YTRA@!P
M&A,NJ(8"E%K*#6)(+G3-,5`I4=..IO>F5\IN-&-_K8T$27*S36GSXJLDIGK/
MRW#/G\B>6I1F0>E#S"DE97P?K-2JW&`N?-<ZK4^^WN$7[!R,7'(L5P1L9&%0
M`;Z/D",<@0:*'G%B('.D.JZG^&W54'<:<<SUI'KW;J6".@@ZS0TXZN8!XD?=
M1K75$9R];0@VV\ZW:L,91BP,U"/H;)U:=\9Z[[R1>BY4:!=$8:F^GL%\Z^@/
MPK#02B&A?D,LJ@K!]<[,DRM1XLK0QIE,+3_54CA1)=4<F()#$6KO*;8U-12*
M(M5@'@U'U^Q!0K="_A^$+]!_YJB1H])Y1N5Z!(EWPS-X7,O%2Z<5VSWBW)EP
M2@>1[]0456=:7;^`6&A<..2K?8_O+V2QS)69ZFZ0ELW:SJ!"FP`MM0=LJ@;/
M/2"/QM<&(5O?N$U7_3)$M0I=,M\BJAF+E'DI[7K>,BNI'C)I@!MTW.,_IZ+B
M&J_(#+*1>]FE9_(9*!!!F5DI=4R>'](Q>>\@%`X:5H@QUAEK>J#:R"5-N0IK
M]`BK%HS<$(81]<>',,DM2,=A1:U1/J_\&$7\(Q9JBO\SJE%C6006E>KE[E8H
M36KX8Q?BH''K5,Y1:J!$RK-@G-H13%7B$"!4"I^<89J.$Q$44J$%D\TLRKC<
M5^J;YK7[BO&Z-X?I.QNPB4T5R#Q['573U-"!%\;14<><E$8T#1`,'.WF0<8S
MYAI=O(%MKJ,P1!VX=<8L-`116+4RF5AFJT-]#YG="*9.MU<QX;%"KCM483P>
MQ\6XGD9?_^P\Y_"D!XT*-VW0CX-':%N8"Y1P!1V"@Y,&51S\]>[0S<>F7_J)
M3=-<BZ$B7]#M%Y8H;O"2X9S4%45.B%N3:\/@M5F-Y,J-K&04\KT.M;$.K%>3
MVT[=6FN#C&/6A"Q$IY2")M]SQB!R+%5)]3Y0_=`ME28C]8YJKRY=T5**%J6>
M21?E;*#4I="#P/^C+^;`[YN4Z.!`+O`QV_(C82=QS8&T,V0(GP2ZR25^&A!P
MID2=1FZ;/S!$W^J!Z64O\,8,^[T\-&)!B)6\-%+I.&MNG$)WH+0RA!8-1*RR
M&D8`$]'>O#>-=U+(?/S,-<H?S'3/=[RB"BQ4J1%Y/;:]<1!UL;X1JONCF,5N
MZ9-)'9W9!A%\$=0,W.^&V73O(G#.N?1P?XE>*Z2L6NT;SJ`B[]I^)M/WQXMM
M%PND/]_H7[,*S=/+2RP4J>];MS_C@G@N5NIE;!!)^A`U^K5W%#@K4<WE]2CD
M'%-V?;%IWOV&CY:#NT7P"/>>#G.F,"G_QF52B._L7#Y#*?^1&WP.320'H*BU
MJ,@HFS5K6&5S#0.-#&.+_;3](39JN,1T2SF'$K5J*N-4/8-HT/@@4^UJH'U2
M-*$I`#IQ*W@KJY>YQS^J<]]Y*6\/H(!=TJ121-B0BWQ)JPS-?C8]A^XPARH3
M@!G.TPCG5H&9:O04(W]HCSHVJ<PJ.@:+5.)<)L"#U[WC<(TQGA>S5\G:8(D*
MQ:$;!&T*FX.404$!J=7)WRPQ;Q&FN`[23D?Y=R.2&9!3N=X=Z4@%'!1V!+L"
M0).J$22":"%&&HQF'IJ5/+CR;][*)-?!4>4Z>`3OY`$<U1*H'$$M%=.78AP)
M[L9!DZ)^ESQ@(MTY=LK58+;PX!D@[E[&2B74@:IK?.<(*M+4F>+,HT?"7`0+
M'%;FH\B!K;U*^\S7K0J6:.CHXWPQS03-@K@*1:*E1,Q*.>9!A1]F;Q:K`;?Z
M9JF5MM,5#$&2I@"P0F<`ADLE&;LQ\+"SSQHA53EV+0)T%%V-#UD(YFH40.27
MVC4I2P.#]L7C[GO1@H*!*0QI+E.XPCLUDT_5AX6BXUMP85[F7T,&SOK]S`I1
M?&"F!52118-G7?3ZSZ(,!1E)5JK?]Q]B;I,5WEUUQDEYB>NH.9[YEV$'XR).
M*S\_W<,#R`DE"Q#F-HNGIJ4<<$8Y/;D`TC(@0W4\4B%\?>M(V4'(B+*2R\M(
M0`Y^4!'[#A^MU,.Q5P5LGH[FB85&LS*)H+T)X[66_B-(3\^O[6O,OF%LS-["
M6,HURCN3=B(*'B]VLP)3)\3V):Z#N\]4.CSC!'SU<?W-QG-=@@(XG7GHCIV6
MS%0!DNP&=4'V2=UP>[U9>W^$5JO;4-4P)ON@VJ'"_$7JM(C>45&07R]Q%;0?
M13"ZM]AGWE)O"_143"+T-2>@TAOT58F&B7I5HLE7>"F\]ZIDBQ"U/&XK13!I
M6F1X`6[Q`K2)O$T*'?JE8"->Z1''J@R82)!O*7"&V<VG,W8;/Y?`X6.B+RJ!
M`M@K@>F5PP=\""!5,HBD<ST=8$*@4&W-?>!6FPR$JFE:@@S[THT\H-+))`%V
MP4\(?U$NG)P6*RA4M?W#M9[](@IS^WLTY"%XZ2YN0H8`808ZZI(>7FX=^&(!
M8<.W;D)63<"8(9;T)<&^#*88-^X-7W,N=PI;C<?#BWPT#$VE&_!"B$?9Z>2W
M5P"@W"I4KKW525&1QX]R[,R[2:AL?Z?4MW&V((+-K^,+\OB.!GV+A$,3ND2:
M(S"%O`J+BGO03JX=S+>AL=(7]ZRM]*1*.NL6G16C>TOIH.=A+M-9`%:ONRHF
M9DB']V%'#\.+P!.D:]/<1@^=/`M+?8GQ&;\'(:81,2\SD=K)*^GDJ71R@7,Z
MK/<K<]^$+0N(;^7B0.E9_GOS%*?ZHD@W]<))\K]UZJ<)8F&!C#-%4M)$.Y6[
MBOG)14!))MS-*`KXO!W&X/Q9LER07;:H3#)U^&Q*\J_<#'.&4(S)^,,+;K6A
M0G)**#\+KYX<^>7)J"\.OF84&RZU2NXQF=R<9;.3/9P(*K7\1GUZPHR;G^+7
M.;T),AHX--$!5'Q/2J7"0RR2JT)C6=Y;.#?W?>/W%QEJ`*4!G+U7N@\1*#AI
ME$+.Z[/30VDJ02#MJK#>2W'G!('3E$+?0?WOI%?;CMPV#'W?K_!;/$"PL>3+
MV.E3FP9HTV`W:/>Q0.'U>"[8N22>2[O]^I`\I'R9;="B29"1)8HZI"CR4(2Y
M9]2WFYH+6DG@)L89$9<MO>M<<J>+U9!LT''H<6=&)LN-2$((]I@C!T!_G[U5
M+?^]H1R\;E_HZW8^'S64),-]['8;<8AYB45JB/:4:@LPD'DLKY!:QJ;>GZ)%
M:Y\BV6R$DDF.XBWT#47,9TMI#:!D+5]4!]H7#HJ(S!P^MUQ].`SDT90];4J#
M-N(9&%`7V*C0230I)?.QD2J7"C$7.QK%B$_:>9;!5G8NHGIQ`3H5ZZ"IW0+Z
M\\R#NBT5#87=U"Q^RW!9JES3&[!ZY"#=)XG1X=&7WV9O7J^N+.QE/O+#IDC=
M;D#*'-.&"F1%8@U/'XE*A]T"O]('R00S*!?K<M,>J46B&BQ?._Y!4TC<O-O\
M32]?5)=,Q3AE!OVJ[3!2>HJ8-%;:LCG=-%;1,,^CR*>;5-2JM,;"J19N-SA,
MQ=:FC*4N\M&JYFBCLI2=Y9<*RZ:=[`<T`QR9"Z&V17YB92N9X$Z4LO^I&Z.W
M7:\0LY)BO23H`>*-W4,7UA77LT$:=(J)#SQ=6>B.P@B]$?NC[0:^^I.SB7`O
M)\R!.\\R?I*XVR-Z=>YX#"-^17B;$I).)4DS??<[3=MV)AR=(R@7PQ'4TKGJ
MW/8H#+R`S7TH_XM$E0PKD!2>PBA(EJ=*SM1:[AWYX8;6D2`R(*P^<YK'LU]V
M<B\9!,X<(Q)7(O>:B:H+"0+T%$LMBY_0\*WEPQ1Q#R0B86)O,RH/?3L$0JV*
MJ#?*XI&B#:1%8(NQ`;*#`;<>8(ETEYEZL;.W>L0%>^2D(S.5W/#`1?2_9X%5
MJX.=#?9VQ)6!$_LF_@B*8/#G'E`.QNHS<JS<B6R\AC9VO9T6K0WK1;9$8D!T
MW*BEJ[V-ENJ4A@7JJ3D&]#`&!IV].Q-UO&A<!R^*KF^E8U_9*S6BA-1?2>H'
MU<TE]1>6^IVD_@JI/T/JSU0PVF!2)5#>\.:=@$]1L$R#J$6IR^/OHO$!B__;
M!#`Y8.-<4E8PKKC%H\ND!TCEWDIIZ&!V+F9[L<8)/B\\KD3'65)&>(4U8O^Z
ME3)(8;P?(DLIL4HXRAC;H5ZB,:<UJ;V^[P70"9;2"'(OP".X(X\O@X.BD=(%
ML1C%U2[`*N@,1::2JOW+&3H[NI4M5A0FE[U#=QKD8DZ7:ZY]=.K$3*(V..6`
M]9.=UE*G.]:@6]H("!0._+#';JIG38TF(+W-TE2;`.3/01.P1VBG@?57MZ6K
MTG_DA7,_Q\8&C*;>KY02)2AODMLW>_HWYF!R.WG\,A6SU0YE*G!"A()I[P84
MF>E5W9P.2L'&-*L^]0>.&9QQ2A$&\A<I+#CKE)'Q9.!Z`M`DE@`^X'VJ<$I'
M51YX^+V>>B_@!X`?%;XRS"_G$?$<`I)6<<*=ZU/;4^*#-H/T*JA>6B_HBJQ_
MZQT>NXI,[SX+F:PPOD$=KX_A8KYU8''6\'*B0L/+U?@BW[4XKA+SN+HE'.+@
M[U+@^B=8Q9AL1CL6'-=T3UA;R?_J_@)!7^#9Y>S6CEL^U8;SB9DV?!Z#'3VG
MN=RV0Q9")\#5H5T-@%)/25[FK9!=`84>((YVX[['J:3U/0$C&A_-21FG8F!1
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M5VN6!1//ML3^R-.A&RY7NX+F>Q9&+5#GA=.OO1BV!T]'%CA?!P!I^`YH"F5N
M9'-T<F5A;0UE;F1O8FH--C$@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R
M96YT(#<Y(#`@4B`-+U)E<V]U<F-E<R`V,B`P(%(@#2]#;VYT96YT<R`V,R`P
M(%(@#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P
M(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#38R(#`@;V)J#3P\
M(`TO4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`X-"`P
M(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Y,"`P(%(@/CX@#2]#;VQO<E-P
M86-E(#P\("]#<S4@.#<@,"!2(#X^(`T^/B`-96YD;V)J#38S(#`@;V)J#3P\
M("],96YG=&@@-#0P-B`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M
M#0I(B9Q72Y/;QA&^[Z^8RL5`BH0P>!+6R8J4E'Q*;-ZL'+#@D$3$)58`N++^
M?;K[ZP$!BE;)+I6XF.F>?D_W-V^V#Z^VV\18L]T_%%%5F)C^R4=:1'$6%R9+
MHWACMD\/K_XQY*89A",V0_/PZE^_6G,8'A+BC_/$;)N'V&P_/P3&F'#[/UJL
M;51M$CK]EBD-47C?)B*!_J1Q&94)*4GCJ&`=ZSB*8U9'O.LD63/[C5E)&179
M[,A,<.4YJ[D#958*'TFVJ1C)7R5;^EOP?F5^#M=E9`,7DO(BV(>5_._#=<I[
M-HG*X$MHJR@+/&M$V[1K?FG'YAB6T9R15RNE-ZX?VSWVS$B;<7`,UQF1ZO%'
MBM%_MS\C2#8OBBE(&D-V:/MW,38K>%]B8PO8;2,3KI,B3LBL]^886K:]#MF&
M%RR<+$SO=-V&.0QE3SZ'-H^JP.W8K(+XCG.F(=Q$26`^D<5IE`<7E=Z/*H(%
M]R<<_!(FHD<"8(/>/7?*9T*;!-T9A\T_PX)$=1R9C(-K;;0)GL(DY;C:>$W,
M=.8_84IF_2J\;TRWQZ[Y=]\IPUMA@`F_0_0JM*S@O6IJHM>J_AK>++L;WF7L
M*;I)COJP:8HP)Q+FK*"""MZ$ZYS"4H>L92`3N6;X>V?(RPU9;)["BC@H).*R
MAN2CT,#!_N=$H_BGY/^)O$DH"[I[$!X(79GQ*,LV7&^(%0K-IXML4BX<9X`I
M7AU"+U'?=4[Y)[6<R-$T',7"KT$<Q8BZ51_J\Q=\7)3<2QE4P65FG8%X/3HZ
MR6<>P'^G!WT`.(TQ%U1-`4HLY08Q)!?:^N2YE*EN1M/UIE/.=C1C=ZN-!$ER
MTZBP6?Y5$A.]Y(6UR.(3V5.)TM0KI2O.6\W(]\%*K=*?LQ2^:YS6YT"5Y']Q
MG(.128[EBN`86>A5X-Q'R)$3G@>*CJ`8R!RICJLI?ALUU)U'D+F>5._.K510
M"T'GN0$GW3Q`_*C;J#;I9_1[WQ!L-FW?J`T7&+$P4$G0V3BU[H+USO5&ZCE7
MH:T7A:7Z>L'A>Z0_",-"*X6$^@T=454(;N_,/+D2):X,;9QQY?M]HJ5PIDJJ
M.#`YA\+7WA/W]Y)#2S68!</)U3NPT*V0OP<YY_D_<]3(4>D\HYXZ@J5WPS/.
MN(:+EZ@EVSV"[HRG$B'H6S5%U9E&UR]@%A[GB7RU'_'-$TEGRJ2Z':1EL[8+
MN-`FP$OM`9NJ@0<<'1U?ZR!:W[E-]\=17/HNF6T0U91%ICP7I5W/6V8IU4,F
M#7"#R!W^<BI*KO&2S"`;N9==>R;3P($(RLQ*J&/R_)".R7L'X7#0L$*,L4Y9
MTYYJ(Y,T92JL5A)6#0YR0QA&U!\389);L([#BEJC?-[X,8KX(Q9J2O]G5*/&
MT@!'5&HO=[=$:5+#'UL?!XU;JW).4@,%4IYZX]0.;ZHR^P"A4IAR@6DZ3D20
M3X463#JS*.5R7ZEOFM?VJX.WO=E/W]F`C6VB0.:YUU$U30T=>'X<G73,26D$
MTP#!P-%N[F4\8Z[1Q1O8YBKP0]3AM,Z8A08O"JM&)A/+;'2H[R"S'7&HU>T5
MP\5<KCM483R>QL6XGD9?]^QZSN%9";4*-XW7#\(1VA;F`B7<0`?OX*1!%7M_
M>W=HYV.S7_J)35/?BJ$B7_#M%I8H;N@EPQFIR_.,X+8FU_K!:U/M"W(C2QF%
M?*]];:S]T9O);:=NK;5!Q@&75]HII:#)]XPQB)"E*JG>!ZH?NJ729*3>4>WE
MM2M:2M&BU%/@>NM+70K="_P+?3'3UT5"?'`@$_B8;G(*VE;BF@%II\@0/@ET
MDTLE.4G`F1)U'KEM_L`0?:,$T\F>/QLR[._E?1$*0BR#O0#Q#(LS^`Z45H;0
MHH&855;-"&!BVIGWINZ=%#*3G[E&^8,//>(E<PIS56I$7H?MWCB(NEI?"]?C
M2<QBM^BY8[W="]OTC51/9N!^UWQ,]ZX"YR>7'NZNT6N$E56K?<,%7.1=T\UD
M]MWI:MO5`NG/=_K7K$*SY/H2\T7:=XW;77!!>BY6ZF5L$$GZ$-3ZM7,4."M1
MS>CW#':.*;N^V#3O?L='P\'=('B$>\^'^2$_*7_B,LG%=W8NFZ&47^0&7WP3
MR0`H*BTJ,LJF]1I6V4S#0"/#V'PW;7\(C1HN,=U0SJ%$K9K*.%'/(!H\O9>I
M=M70/BF:T!0`G;CEO975R]SC']6Y[[R4]P>0QRY)7"HBK,E%OJ1EBF8_FYY#
M>YA#E0G`#)=IA'.KP$PU2L7('YJ3CDTJLY+(."*5.)<)\-#KWFFXQ1C/B]FK
M;(VW1(6"Z`9!FW+,0<J@H(#4ZN2OEY@W]U-<!VFKH_R[$<D,R*G<WIV(I`(.
M"CN\71Z@2=4($D&T$",-1CT/S4H>7-DW;V6<Z>`HLPI)%;R3>7!42:`R!+50
M3%^(<22X'0=-BOI=\(`)=.?4ZJD:LX4'SP!QCS)62N'V7&W=MXZ@(DV=*<X\
M>B3,N;?`864^BAS8VJFTSWS=2F^)AHX^+E?3C-<LB"M7)%I(Q*R48^95],/L
MS6(UX%;?+)7RMKJ"(4C2%`!6Z`S`<*$L8SOZ,^SLLT9(58YM@P"=1%?=^RQX
M<S4*8.J7VC4I2P.]]L7C[GO1@H*!*0Q))E.XQ#LUE4_5AX6BXWMP85[F7T,&
MSOKCS`I1?.!#"Z@BBQK/NN#UGT49"C+BM%"_'S^$W"9+O+NJE)/R$E9!?;KP
M+\,.QD6<5GY^NOT>[(22!0ASF\53TU(..*.<GDP`:>&1H3H>J!"^OE6@Q\'(
MB+*4R\M(0`@_J(A=BX]&ZN'4J0(V3T?S=(1&LQX203OCQVLE_4>0GM)O[:O-
MKF9LS-["6,HURCN5=B(*CE>[68&I8CKV):R\N\]4.CSC!'QU8?7-QG-;@@(X
MG=FWIU9+9JH`27:-NB#[I&ZXO=ZMO3]"J^5]J&H8DWU0[5!A_B9UF@?OJ"C(
MKY>P]-I/(AC=6^PS;ZFW>7XJ)A'ZFA-0Z@WZJD3]1+TIT?@KO.3?>V6L3X*&
MQVVI""9)\A0OP`U>@#:6MTFN0[\0;,0K)7&L"H^)!/D6`F?XN/ETP6[=SR5P
M^)CIBTJ@`';*8#H]T7M\""!5,(@DNE('F.`Y5%O]Z$^K309"U30M089]220/
MJ&0R28"=]Q/"7_04*.?%"@I5;;>_U;-;1&%N?X>&/'@OW=5-R!`@S$!'75+B
M]=;A7"@@;/C634C+"1@SQ)*^)-B7P13CQIWA:\[E3F&K\'AXD8^:H:ET`UX(
M\R@[K?QV"@#TM`J5:V]U4I3D\5'(SKR;A,KV=TI]&Z8+)MC\.KPBC^]HT/=8
M.#2^2R09`I/+JS`ON0=MY=K!?.L;*WUQS]I(3RJELV[063&Z-Y0.>AYF,IT%
M8'6ZJV)"AG1X'[;T,+P*/$.Z-LU-L&_E65CH2XQI_!Z$F%K$O,Q$:B<OI9,G
MTLD%SNFPWJW,8^VW+""^E8L#I1?YVYNG,-$711)5"R?)_\:IG\:+A04RSA1)
M21-M5>XJY"<7`269<'>C*.#S?AB]\Q?)<DYVV;PT\=3ATRG)OW$SS!A",2;C
MCUYPJ_45DE%"^5EX\^3(KD]&?7'P-:/8<*F5<H_)Y/HBFZWL@2*HU/(;]>D)
M,VY.Q:]S>A-D-'!H@@.X^)X4RH6'6"!7A<:RO+=`-X]=W>^N,M0`2@-.=KWR
M?0C`P4FC%')>GYT2I:EX@;2KPKI>BCLC")PD%/H6ZH69WXQZ=U,?@O^37C6]
M;1M!].Y?P5MH(%7X+2J]-770YM`"02X!"A@T14M$9"FA9!7NK^_,>S,KDG:#
M%DT+:TG.SKZ9G8\W'0JXBVE%Y&5C=EVB=J:Q&5*,)@X[[E&1X7,+20K1'G?D
M".@?UV]-RW\?*$?9G566W6E63@9*D=$Y=K>+-,0RQ*(,1'LIM149R#)&%LK(
MV#;[4[3N_!&2;0]*AAJE6^29BI3/UA@-J&2+)^D#W0L'14)F#E\[[3X:!DB:
M^D*;\J!->`87,@6V)G2")J-D6>RD*LU!S&%':QCY*#L?L=AAYSIJUF>B,[&!
MFKH=H3]=9Z1N]X9&PFYNEN8R798;U\P<6#-QD.U#84R9]/7WV5MF5U=7GIEW
MFM@2J;N>I"Q5VK`B64&L,?59J&PYK/F+.0@OE$&EL7UNNZ.,2-*#\?2@/QP*
MA9L/_5^2^5!=*Q73DAGTF[;#1.DI4M*XLI$MM4U3%:WR/(E\N4E#;4H;?C@U
MX':CPTQLZ\I4ZHR'SC1'O<E*=<:O-):^F^TG-`<<N0NIMF-]4F4;O-!)5*K_
M:9BB]UVO&+,HL1D*]`AQ[_<PA.^&Z\DAC2;%)`L\W5CH@X019R/U1S>,?/6G
M5A-PKQ3,02?/.OZ"N-LS>NW=\1A6FD7,381D:I*B69XO.UW;[AH<72.HA.$,
M:DRN]FYW!`.O:/,EE/]%H4K&'0B-IW(*4I2YD3.S5F='3=PP.@I$!<2O3UKF
MF?;W`^ZEH,"CQ@CB"G*OE:BFH4"0GO)3I^(G#GQ;/+@BG8$@$E[L_8W)4]\#
M`Z$Q13(;%?%$44]I".RX=D!^,.$V(RR1[7)3SW[VSHXX<P]..BI3*1T/721_
M,Q78=+9X\,7>CWAFX,R^F3^"(AK\]0*H)&/-"G$L[@0;GT.;NMY/B[:.]8PM
M$0R(CKU9NMG[ZMZ<TJI`,S?'@1ZFP*CSXL[$'`^-V^!%Z/I>.<Y6GJ5.E%CZ
M5RC]I+HE2G_EI3]%Z5^Q]!<L_84)1CU?F@3;&W,^!?B<#<LU0"U;71G_&$T/
M6/_?(4#)@1J7)O6*QE4+)EV!&2#'O=48Z&AV";,S6),"7P8>5W/BK*4BO.(W
M8?^V52I(Y;R?(O=HL48XZIC;J1[16,HW]-[L,@MP$JPQ".HLH"NZHXS/HX.B
MB=*UL!C#U:W)*N0,0V:2IOW;(W4.<BL[?C&8VO8.PVE4B[5<;K7WR:DS,X7:
M\)0#OY_\M$XFW:D&V])%1&!PZ(<]=TL_:QL.`?FBR',;`E@_1T/`GJ&=!]:_
M6M3I*O]'7KC,EMS8DM$T^XU1HH3M#;6]W\O_4PZ&VRGCEZF8?QW8I@(G9"BX
M]L%J-\E5TYX.1L"F)*LY78Z;\C=GE!`F[A<)+!GKG(_IR\#T`,\E[@E[Q/I,
MX9R,FCSQ:+:>+C[@#P'?&7SCE]\>)[1S#`B#XHPY-Z?N0H@/-@I*3DBW]$DP
MK8I+I@],=1.9WWP1ZECE;$/FW2RFB_7.B27U<5?+%,==[<5G/#=PW`KF:6]+
M-,#)WM'>+@FXBOFRG>Q8:U3+/?';!G_-_15#OF+2E>K600<^T\;SA9>V>IZ"
MG233$K>=L@9Q#M#>T&U&0&6B%"_K5LINB,(.@*/3Z=23FJ1//0$CQQZK2(46
M8F(QG[I%SSB<`NV:+]S5`97D&KI(#(T+R+XT_QES>I%625W(_:(37'3\LT3/
M6TC(0)'(?_)3B4657'^VJA;+2OO9`RM)4DV#(_[M<.X>[KHA2O/742;1HXI6
MBU4%55BDI92(9*;M6=\18R3T4H"LRU)!2KA7!1I/'-F_*<Q<&$52J.8ZDY-,
M<X#YPSB(WQS?1')3"(:R2N(/8`-9?'.M&?9>\JZVOQ^5DA3QS>?(91;L%Q]_
MO<[T3C^]^^5&0Z&*/\/Y-Y^NTJB/K@@G%31RI878G:CY&NH27U?W5S]]FGFF
M6)9$.,=?+@-^+[_1K?Y3<K^,;V^]>!=:H)'"65+44Z=9P7?7?;C.\[("F<GS
M*D/CE'#(M'7Z8M!/"68$$=:@>Y)%G8%BRR=MH4'/PM^$3Q]UH9VIUT7)29>+
MUA5N]:P$;?#Y$6I4,BY(%_CO7'=0$`X)FH(=`=%[753(79'),<G8]L9WA3>M
M.R9H;OS-SM\$S;_K=C8!\UDXO1\;C>W!Y<'!EP&/\:V!+7'T]P"'/PZ*"F5N
M9'-T<F5A;0UE;F1O8FH--C<@,"!O8FH-/#P@#2]4>7!E("]&;VYT(`TO4W5B
M='EP92`O5')U951Y<&4@#2]&:7)S=$-H87(@,S(@#2],87-T0VAA<B`S,B`-
M+U=I9'1H<R!;(#(U,"!=(`TO16YC;V1I;F<@+U=I;D%N<VE%;F-O9&EN9R`-
M+T)A<V5&;VYT("]4:6UE<TYE=U)O;6%N4%,M0F]L9$ET86QI8TU4(`TO1F]N
M=$1E<V-R:7!T;W(@-CD@,"!2(`T^/B`-96YD;V)J#38X(#`@;V)J#3P\(`TO
M5'EP92`O1F]N="`-+U-U8G1Y<&4@+U1R=654>7!E(`TO1FER<W1#:&%R(#,R
M(`TO3&%S=$-H87(@,3$W(`TO5VED=&AS(%L@,C4P(#`@,"`P(#`@,"`P(#`@
M,S,S(#,S,R`P(#`@,C4P(#`@,C4P(#`@-3`P(#4P,"`U,#`@-3`P(#`@,"`P
M(#`@#3`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@-C$Q(#`@,"`P(#,S,R`T
M-#0@,"`P(#@S,R`P(#`@,"`P(#`@-3`P(`TU-38@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@-3`P(#4P,"`T-#0@-3`P(#0T-"`R-S@@,"`U,#`@,C<X(#`@
M#3`@,C<X(#<R,B`U,#`@-3`P(#4P,"`P(#,X.2`S.#D@,C<X(#4P,"!=(`TO
M16YC;V1I;F<@+U=I;D%N<VE%;F-O9&EN9R`-+T)A<V5&;VYT("]4:6UE<TYE
M=U)O;6%N4%,M271A;&EC350@#2]&;VYT1&5S8W)I<'1O<B`W,"`P(%(@#3X^
M(`UE;F1O8FH--CD@,"!O8FH-/#P@#2]4>7!E("]&;VYT1&5S8W)I<'1O<B`-
M+T%S8V5N="`X.3$@#2]#87!(96EG:'0@,"`-+T1E<V-E;G0@+3(Q-B`-+T9L
M86=S(#DX(`TO1F]N=$)";W@@6R`M-30W("TS,#<@,3(P-B`Q,#,R(%T@#2]&
M;VYT3F%M92`O5&EM97-.97=2;VUA;E!3+4)O;&1)=&%L:6--5"`-+TET86QI
M8T%N9VQE("TQ-2`-+U-T96U6(#$S,R`-/CX@#65N9&]B:@TW,"`P(&]B:@T\
M/"`-+U1Y<&4@+T9O;G1$97-C<FEP=&]R(`TO07-C96YT(#@Y,2`-+T-A<$AE
M:6=H="`P(`TO1&5S8V5N="`M,C$V(`TO1FQA9W,@.3@@#2]&;VYT0D)O>"!;
M("TT.3@@+3,P-R`Q,3(P(#$P,C,@72`-+T9O;G1.86UE("]4:6UE<TYE=U)O
M;6%N4%,M271A;&EC350@#2])=&%L:6-!;F=L92`M,34@#2]3=&5M5B`P(`T^
M/B`-96YD;V)J#3<Q(#`@;V)J#3P\(`TO0V]U;G0@,R`-+T9I<G-T(#<R(#`@
M4B`-+TQA<W0@-S(@,"!2(`T^/B`-96YD;V)J#3<R(#`@;V)J#3P\(`TO5&ET
M;&4@*%5.251%1"!35$%415,I#2]$97-T(%L@.#(@,"!2("]&:71"(%T@#2]0
M87)E;G0@-S$@,"!2(`TO1FER<W0@-S,@,"!2(`TO3&%S="`W,R`P(%(@#2]#
M;W5N="`R(`T^/B`-96YD;V)J#3<S(#`@;V)J#3P\(`TO5&ET;&4@*%=A<VAI
M;F=T;VXL($0N0RX@,C`U-#DI#2]$97-T(%L@.#(@,"!2("]&:71"(%T@#2]0
M87)E;G0@-S(@,"!2(`TO1FER<W0@-S0@,"!2(`TO3&%S="`W-"`P(%(@#2]#
M;W5N="`Q(`T^/B`-96YD;V)J#3<T(#`@;V)J#3P\(`TO5&ET;&4@*$9/4DT@
M,3`M45-"*0TO1&5S="!;(#@R(#`@4B`O1FET0B!=(`TO4&%R96YT(#<S(#`@
M4B`-/CX@#65N9&]B:@TW-2`P(&]B:@T\/"`-+U!R;V1U8V5R("A!8W)O8F%T
M($1I<W1I;&QE<B`T+C`@9F]R(%=I;F1O=W,I#2]#<F5A=&]R("A-:6-R;W-O
M9G0@5V]R9"`Q,"XP*0TO36]D1&%T92`H1#HR,#`R,3$Q,S(P,3DR.2TP-B<P
M,"<I#2]!=71H;W(@*$5D9V%R($]N;&EN92!(5$U,('1O(%)41B!C;VYV97)T
M97(N(%9E<G-I;VX@,BXP*0TO4W5B:F5C="`H141'05)P<F\I#2]4:71L92`H
M4%)/($1%6"!)3D-<*$9O<FTZ(#$P45-"+"!296-E:79E9#H@,3$O,30O,C`P
M,2`P.3HT,#HR.5PI*0TO0W)E871I;VY$871E("A$.C(P,#(Q,3$S,C`Q-S0U
M*0T^/B`-96YD;V)J#3<V(#`@;V)J#3P\(`TO5'EP92`O4&%G97,@#2]+:61S
M(%L@.#(@,"!2(#$@,"!2(#0@,"!2(#<@,"!2(#$P(#`@4B`Q,R`P(%(@,38@
M,"!2(#$Y(#`@4B`R,B`P(%(@,C4@,"!2(`U=(`TO0V]U;G0@,3`@#2]087)E
M;G0@-S<@,"!2(`T^/B`-96YD;V)J#3<W(#`@;V)J#3P\(`TO5'EP92`O4&%G
M97,@#2]+:61S(%L@-S8@,"!2(#<X(#`@4B`W.2`P(%(@72`-+T-O=6YT(#(R
M(`T^/B`-96YD;V)J#3<X(#`@;V)J#3P\(`TO5'EP92`O4&%G97,@#2]+:61S
M(%L@,C@@,"!2(#,Q(#`@4B`S-"`P(%(@,S<@,"!2(#0P(#`@4B`T,R`P(%(@
M-#8@,"!2(#0Y(#`@4B`U,B`P(%(@-34@,"!2(`U=(`TO0V]U;G0@,3`@#2]0
M87)E;G0@-S<@,"!2(`T^/B`-96YD;V)J#3<Y(#`@;V)J#3P\(`TO5'EP92`O
M4&%G97,@#2]+:61S(%L@-3@@,"!2(#8Q(#`@4B!=(`TO0V]U;G0@,B`-+U!A
M<F5N="`W-R`P(%(@#3X^(`UE;F1O8FH-.#$@,"!O8FH-/#P@#2]4>7!E("]#
M871A;&]G(`TO4&%G97,@-S<@,"!2(`TO3W5T;&EN97,@-S$@,"!2(`TO3W!E
M;D%C=&EO;B!;(#@R(#`@4B`O6%E:(&YU;&P@;G5L;"!N=6QL(%T@#2]086=E
M36]D92`O57-E3F]N92`-/CX@#65N9&]B:@TX,B`P(&]B:@T\/"`-+U1Y<&4@
M+U!A9V4@#2]087)E;G0@-S8@,"!2(`TO4F5S;W5R8V5S(#@S(#`@4B`-+T-O
M;G1E;G1S(#@Y(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R
M;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-
M.#,@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\
M/"`O5%0R(#@T(#`@4B`O5%0T(#@X(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O
M1U,Q(#DP(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-2`X-R`P(%(@/CX@
M#3X^(`UE;F1O8FH-.#0@,"!O8FH-/#P@#2]4>7!E("]&;VYT(`TO4W5B='EP
M92`O5')U951Y<&4@#2]&:7)S=$-H87(@,S(@#2],87-T0VAA<B`Q-3,@#2]7
M:61T:',@6R`R-3`@,"`T,#@@,"`U,#`@.#,S(#<W."`Q.#`@,S,S(#,S,R`P
M(#`@,C4P(#,S,R`R-3`@,C<X(#4P,"`U,#`@-3`P(`TU,#`@-3`P(#4P,"`U
M,#`@-3`P(#4P,"`U,#`@,C<X(#(W."`P(#4V-"`P(#`@,"`W,C(@-C8W(#8V
M-R`W,C(@#38Q,2`U-38@-S(R(#<R,B`S,S,@,S@Y(#<R,B`V,3$@.#@Y(#<R
M,B`W,C(@-34V(#<R,B`V-C<@-34V(#8Q,2`--S(R(#<R,B`Y-#0@-S(R(#<R
M,B`V,3$@,S,S(#`@,S,S(#`@-3`P(#`@-#0T(#4P,"`T-#0@-3`P(#0T-"`S
M,S,@#34P,"`U,#`@,C<X(#(W."`U,#`@,C<X(#<W."`U,#`@-3`P(#4P,"`U
M,#`@,S,S(#,X.2`R-S@@-3`P(#4P,"`--S(R(#4P,"`U,#`@-#0T(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`S,S,@
M#30T-"`T-#0@,"`U,#`@,"`P(#DX,"!=(`TO16YC;V1I;F<@+U=I;D%N<VE%
M;F-O9&EN9R`-+T)A<V5&;VYT("]4:6UE<TYE=U)O;6%N4%--5"`-+T9O;G1$
M97-C<FEP=&]R(#@U(#`@4B`-/CX@#65N9&]B:@TX-2`P(&]B:@T\/"`-+U1Y
M<&4@+T9O;G1$97-C<FEP=&]R(`TO07-C96YT(#@Y,2`-+T-A<$AE:6=H="`P
M(`TO1&5S8V5N="`M,C$V(`TO1FQA9W,@,S0@#2]&;VYT0D)O>"!;("TU-C@@
M+3,P-R`R,#(X(#$P,#<@72`-+T9O;G1.86UE("]4:6UE<TYE=U)O;6%N4%--
M5"`-+TET86QI8T%N9VQE(#`@#2]3=&5M5B`P(`T^/B`-96YD;V)J#3@V(#`@
M;V)J#3P\(`TO5'EP92`O1F]N=$1E<V-R:7!T;W(@#2]!<V-E;G0@.#DQ(`TO
M0V%P2&5I9VAT(#`@#2]$97-C96YT("TR,38@#2]&;&%G<R`S-"`-+T9O;G1"
M0F]X(%L@+34U."`M,S`W(#(P,S0@,3`R-B!=(`TO1F]N=$YA;64@+U1I;65S
M3F5W4F]M86Y04RU";VQD350@#2])=&%L:6-!;F=L92`P(`TO4W1E;58@,3,S
M(`T^/B`-96YD;V)J#3@W(#`@;V)J#5L@#2]#86Q21T(@/#P@+U=H:71E4&]I
M;G0@6R`P+CDU,#4@,2`Q+C`X.2!=("]'86UM82!;(#(N,C(R,C$@,BXR,C(R
M,2`R+C(R,C(Q(%T@#2]-871R:7@@6R`P+C0Q,C0@,"XR,3(V(#`N,#$Y,R`P
M+C,U-S8@,"XW,34Q.2`P+C$Q.3(@,"XQ.#`U(#`N,#<R,B`P+CDU,#4@72`^
M/B`-#5T-96YD;V)J#3@X(#`@;V)J#3P\(`TO5'EP92`O1F]N="`-+U-U8G1Y
M<&4@+U1R=654>7!E(`TO1FER<W1#:&%R(#,R(`TO3&%S=$-H87(@,3(R(`TO
M5VED=&AS(%L@,C4P(#`@,"`P(#`@,"`P(#(W."`S,S,@,S,S(#`@,"`R-3`@
M,S,S(#(U,"`P(#4P,"`U,#`@-3`P(#4P,"`U,#`@#34P,"`U,#`@-3`P(#4P
M,"`U,#`@,S,S(#`@,"`P(#`@,"`P(#<R,B`V-C<@-S(R(#<R,B`V-C<@-C$Q
M(#<W."`--S<X(#,X.2`U,#`@-S<X(#8V-R`Y-#0@-S(R(#<W."`V,3$@-S<X
M(#<R,B`U-38@-C8W(#<R,B`W,C(@,3`P,"`--S(R(#<R,B`P(#,S,R`P(#,S
M,R`P(#`@,"`U,#`@-34V(#0T-"`U-38@-#0T(#,S,R`U,#`@-34V(#(W."`P
M(`TP(#(W."`X,S,@-34V(#4P,"`U-38@-34V(#0T-"`S.#D@,S,S(#4U-B`U
M,#`@-S(R(#4P,"`U,#`@-#0T(%T@#2]%;F-O9&EN9R`O5VEN06YS:45N8V]D
M:6YG(`TO0F%S949O;G0@+U1I;65S3F5W4F]M86Y04RU";VQD350@#2]&;VYT
M1&5S8W)I<'1O<B`X-B`P(%(@#3X^(`UE;F1O8FH-.#D@,"!O8FH-/#P@+TQE
M;F=T:"`R-C(T("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)
MY%?;<MLX$GW75_3;@EL60X#@+6^.K4PTM9$S$E.;J3@/-$7;G,B2AZ1RV<_8
M+]Z^@-3%EF?>UZF(!-CH;G2?/FB\R4>O\MR`AOQV%/M9#`'^XY<P]@,;Q&!#
M/T@A?QB]NF@C*%N6"*`M1Z]^66BX:T<&Y8/(0%Z.`LB_CQ0`>/D?.!AK/TL-
MKKZD+R5^H7EM6`,^0AWXB4$C8>#'9&,<^$&@(Y8=ZS%)'WEEK!_;O14G](:^
M(:G$1KXA,9$8TR)TBBQ<NCG<OY7]:XL[%A7\9J+`U^1=HB/?VIU_EFSR:Y#P
MAC_.IOGD$A;Y>3Y9R.;'L9]$1K,U&X5DCU<87LQK0UK[62TF%Q_G4P\76)6[
M)VHYGUW"Y-/%N_/9+Q.XN'K_WGU:+*97,_"^Y+^.(C^*+9HP'&!2G@R>V52T
M_[OP$M7>UVM/:S]5=YV',<_49GWF61S#I8=Q53X/+O;>P001KK3X/_-P$[$2
MFSNX[(7;026.K!_NLN+`<!ADE\O=&LQ0:G<ILA&'+-XER$A.\&$0:6%,BP+*
M+QMR@>SSP3%5;Z_F[T$'X]\6;QA"O<TT$KCMK3]R]!@#O9M1N@>CO9T'_?<X
M0=5[2#/&CW90$^?2(?4N.9\_?8&]O]\^GL]S;QQB^"?RF'L:4_XO3`"-?N<1
MS-W'#YA*=87OJE\%*!C(_,?YPAMCK:B/WCC%QSFOG<F@%W=/U@%.WBF_(+S8
M7I(@IT.XFLLLZ.A:75Y[<$6>J;=DL%?VCI0Y)<<Z$>>]0L&4^\!BB4.8?1HX
M/01.2^!<87@8=#6!\XN</3&^^,*J*!(Z"ZTO6L<':I^D76,I'5L-CRN5=4=J
MX^'W4#5BH[NOX,]MT705U6>D&B_$W]5/>*R:>K.$:KVLEK"H'KOJP4,7$W53
M-0B<,UENL&K%PP&E`Z:"4^6T`Z#)$D?3&99WVI>$8396F*]]^".-'<L^RYX]
M\R>IHWZ1R/]Y$L<`!T#NL3`_GSD$3/>`]/^$WQU\Q\_C-SO`KQ:,90?X!7"3
M*$,B<\C?32"GX$YSVMD'^3RASYF:3Z\NX>W<&U-Q7+T_R(MX.,E'&FH8V<3Z
M%EVR-B/&#;D"##35Z';T)M]#1(3Z;4"0P"/1IJ>)-[\ZL.83;-!:%&*4_HZA
M7=,1^W'Z'/01A`-3IT]*-AJ0&4F@+S842"S(!RZ^2-5M6V_6$M%0U:L*9EL4
MP4I33N+&#;%*\2_`069=B69]+\(O&!$_YJ@$F2N4TX4Z5'6884NR5U5[QQMB
MDX^W,`FD:Y%-Q?VFZ%2D37V87XTO)Y_.8#J[\'=IW1G38>;ZJBC<K_1`UE^K
MR8^B[&!=,,IPW[A;CP&_N47<*&@Y:JE\*E8KN-FV];IJ6\#X>9EOU%:0CT$J
M6F@?J[+FE35"&F>74*^A[EHH[XD9&RRUP<VC(":1M&H[5T_Q46B#@8^DR3I2
M%3V5.Y6$`U7/*0N-_BMMVCKN#;$OD93N)8RPM]HTQ9*XP<JAT3=15("\6'-#
M2[ZGAR5QZ(S.TF-+SS*W10"S_6./N%!5:I%C8HWA!E>8LF#P(DKH]P5';((,
M$_^U(VF*31V)H7Z[Y\>3@_Q:+;JBJV#3P!6>I'2$TLGZZ[:IVV5==E2KC$GD
M/<G4.$F3`-=-YPN8<,EFZG&U^8E(G"ZK=5<[Z9K8,%1EP3IF&Q\Q^`S^HA!W
MFQZX>KJ(TTBV93`?,1$:H6*Z+C?-(V9:G,6--'?%NOX/CP7X3^%EHDSN%@>J
M3L'U4.A9N/9G^XOZ>G4I<N>+ZOI2.I0\Y=V1NA?+Z26-FH)"Z#*)[@F5L&)V
MQXP1V.A(P\0'K+`M413RT0WQ4:R0I.#\6[7>5F>P*-9=`>?KX@PNBA7A(D9N
MVC1KCT!&^%`%9";!2]S>P<@^:#`Q4BB%,Z3'B>/*1H@^<^CP$7B.XQH=+W@2
M!.SH0A;!:MRK89T-QT#6U\XYD@M>:91[-$305"TI=1`?/'HTV#=EM%F+-;$6
MN=(-'V5(IP#*K&02)O3,U`^9K<JM2'5NT;>*>A5Z<X;<PWTNJ_8%LM>)']N#
MO1W':QRF?JC#D$/.MUAIHD+A5*$`$P=93'W<LX??$$`L;20KO6.I:=MNJ^8?
M+735JGJ\WR!8UML'[,=?0Z+Q`+;4HFCM$(QH"/$@C7'6A$C>%I+H)!*P99"=
M[1E]%@%#")X(OLIS]![RVX,@Z!3QB4$0F8"GK(V/IZ(X[D-E^O[<6'=QF:X1
M"ZE"0B6NI08GP@KXZ1EN-<M[_EJ5.(^[4U]Y"*XA??`,=;J%%S":Z"8:'XE\
M]S2EWJGI"`^1ND="[MP4S#VBY(IUW-6M1\GK^*+4%,ZJN"B3<*TTHDA6BV59
M`[=R!<.^;=E;I_:DJ9"`.R?35']N>67=D)1&<NBWNJA*YQYQ-=X(-BQ(VR*S
MFD<148G!\EI>>V*.BDI>AATMJ#!X;=UK9-<KYX1S;O*#A<I^*P35B*@P)>BX
MA%F7KS!R]+:^HQL),IG'B2H]4M5YNSO&N-=QE/JP)XDHLZ**/*?\`=TE8+G%
MY@W36*,%>H&.#DN+J:-1!8]-55;+X2MM0CF1[YY)J"M>R?";K.`^43M)A`K=
M;S?<0%-&2>3`0DLDP?G%<])YMI%;30.M.%<ZG;("VOL-=9#P6#7U9DD)H.FB
MZ]\&%YI*O*[%8(N0BSAH,8)L[=P01[]37)']/:-:@0LO)+AT&Q%QSM$%@<>]
M<_<#UDC]M7<&?4Y-DNB]G(9#)B01Q5JN'$O<O.E[D7&_[CB/3X^\>VZ["Z3S
MD(L!R^^FJM8\VZ--YK<\=_,'P1*+#AM]W-3^I_+^8-6M7!_K52TKUG=]3`S%
M9+@*&*.<O4X$G1MN/><1ZP'<5S&"F"I$CDH;\RD:>E,BXTRXA3^)<4(%R\+-
MNPE1PQ>>WRMG^_.G+]C;P6?XXLX!O!\^<V5D6GQR.61:C'I:Y-+&`N[#(A_Y
MGH/71XFI#!"-0@B&;TIXI"M96S3LEQY"N]GR?">SG7!=Y%0O11M56[HC&=19
M%:43O#_ZPA%*5>_IG(-0.6$A5LV!-H1YL2U+_BL:G'OEJG=%)N2W.IC;6;U@
M,QL^-F+U\"#IZ,=B!A948+$SOBF_.L__3@#$0YESL2AZ'YR1(0#]UH<-=(=>
MBWTD,HQA7YAQM%>803K`XS,V-65Q0QDTB@I]*$E:L7?0<D'KH22UN[PL"Z(7
M2H!!!:_Y'2`]2SQF))N<&7D+`B"^2#!Q/&:<T!B$GE.*<2JW1&JZ'IA),V%2
MM99%&.%8B<$-XH/8Z*M\.4-2T%19/'(ZL.X:^.;LL8,K7KN5*>R/"^=#C]7>
ME1F&<'#%::C$H//KQO6&#>@S,%A:OJN^PU[D^3JD=D;JT+CV)*<DTR%,K45!
M[7FBVAJO3Y294,D$=ZFX"0):AOX]>,3G=/B_0>2IK<BVM4A7W*C@N(5+M[\:
MHX3'0KER:EL"+"V,N76&MVZ^8<@E:$!G5-/=:W!_R#K(-$@UU%/,G/C_!BZ"
M<!4]P"8D`%T6\[<*96YD<W1R96%M#65N9&]B:@TY,"`P(&]B:@T\/"`-+U1Y
M<&4@+T5X=$=3=&%T92`-+U-!(&9A;'-E(`TO4TT@,"XP,B`-+U12("])9&5N
M=&ET>2`-/CX@#65N9&]B:@UX<F5F#3`@.3,@#3`P,#`P,#`P-C0@-C4U,S4@
M9@T*,#`P,#`P,#`Q-B`P,#`P,"!N#0HP,#`P,#`P,38W(#`P,#`P(&X-"C`P
M,#`P,#`S,S<@,#`P,#`@;@T*,#`P,#`P-C`V."`P,#`P,"!N#0HP,#`P,#`V
M,C$Y(#`P,#`P(&X-"C`P,#`P,#8S-S<@,#`P,#`@;@T*,#`P,#`P.3@T.2`P
M,#`P,"!N#0HP,#`P,#$P,#`P(#`P,#`P(&X-"C`P,#`P,3`Q-3@@,#`P,#`@
M;@T*,#`P,#`Q-3`Q-R`P,#`P,"!N#0HP,#`P,#$U,3<Q(#`P,#`P(&X-"C`P
M,#`P,34S,3@@,#`P,#`@;@T*,#`P,#`Q.3,V-2`P,#`P,"!N#0HP,#`P,#$Y
M-3$Y(#`P,#`P(&X-"C`P,#`P,3DV-S@@,#`P,#`@;@T*,#`P,#`R,C4V."`P
M,#`P,"!N#0HP,#`P,#(R-S(R(#`P,#`P(&X-"C`P,#`P,C(X.#$@,#`P,#`@
M;@T*,#`P,#`R-C,P-B`P,#`P,"!N#0HP,#`P,#(V-#8P(#`P,#`P(&X-"C`P
M,#`P,C8V,#<@,#`P,#`@;@T*,#`P,#`S,#,T,R`P,#`P,"!N#0HP,#`P,#,P
M-#DW(#`P,#`P(&X-"C`P,#`P,S`V-#0@,#`P,#`@;@T*,#`P,#`S,S8S-B`P
M,#`P,"!N#0HP,#`P,#,S-SDP(#`P,#`P(&X-"C`P,#`P,S,Y,S<@,#`P,#`@
M;@T*,#`P,#`S.3$U-2`P,#`P,"!N#0HP,#`P,#,Y,S`Y(#`P,#`P(&X-"C`P
M,#`P,SDT-38@,#`P,#`@;@T*,#`P,#`T,S0S-2`P,#`P,"!N#0HP,#`P,#0S
M-3@Y(#`P,#`P(&X-"C`P,#`P-#,W-C`@,#`P,#`@;@T*,#`P,#`T.#,U,B`P
M,#`P,"!N#0HP,#`P,#0X-3`V(#`P,#`P(&X-"C`P,#`P-#@V-S<@,#`P,#`@
M;@T*,#`P,#`U,C@S,B`P,#`P,"!N#0HP,#`P,#4R.3@V(#`P,#`P(&X-"C`P
M,#`P-3,Q-#4@,#`P,#`@;@T*,#`P,#`U-S8T,"`P,#`P,"!N#0HP,#`P,#4W
M-SDT(#`P,#`P(&X-"C`P,#`P-3<Y-3,@,#`P,#`@;@T*,#`P,#`V,C8S,"`P
M,#`P,"!N#0HP,#`P,#8R-S@T(#`P,#`P(&X-"C`P,#`P-C(Y,S$@,#`P,#`@
M;@T*,#`P,#`V-C4Q."`P,#`P,"!N#0HP,#`P,#8V-C<R(#`P,#`P(&X-"C`P
M,#`P-C8X,3D@,#`P,#`@;@T*,#`P,#`W,30Y.2`P,#`P,"!N#0HP,#`P,#<Q
M-C4S(#`P,#`P(&X-"C`P,#`P-S$X,3(@,#`P,#`@;@T*,#`P,#`W-C4S-"`P
M,#`P,"!N#0HP,#`P,#<V-C@X(#`P,#`P(&X-"C`P,#`P-S8X,S4@,#`P,#`@
M;@T*,#`P,#`W.#,V."`P,#`P,"!N#0HP,#`P,#<X-3(R(#`P,#`P(&X-"C`P
M,#`P-S@V-CD@,#`P,#`@;@T*,#`P,#`X,#8X,"`P,#`P,"!N#0HP,#`P,#@P
M.#,T(#`P,#`P(&X-"C`P,#`P.#`Y-CD@,#`P,#`@;@T*,#`P,#`X-30W,"`P
M,#`P,"!N#0HP,#`P,#@U-C(T(#`P,#`P(&X-"C`P,#`P.#4W-3D@,#`P,#`@
M;@T*,#`P,#`P,#`V-2`P,#`P,2!F#0HP,#`P,#`P,#8V(#`P,#`Q(&8-"C`P
M,#`P,#`P.#`@,#`P,#$@9@T*,#`P,#`Y,#(T,"`P,#`P,"!N#0HP,#`P,#DP
M-#,V(#`P,#`P(&X-"C`P,#`P.3`X-C0@,#`P,#`@;@T*,#`P,#`Y,3`W,"`P
M,#`P,"!N#0HP,#`P,#DQ,C<P(#`P,#`P(&X-"C`P,#`P.3$S,S,@,#`P,#`@
M;@T*,#`P,#`Y,30U.2`P,#`P,"!N#0HP,#`P,#DQ-3DT(#`P,#`P(&X-"C`P
M,#`P.3$V-SD@,#`P,#`@;@T*,#`P,#`Y,3DY,R`P,#`P,"!N#0HP,#`P,#DR
M,3,W(#`P,#`P(&X-"C`P,#`P.3(R,3@@,#`P,#`@;@T*,#`P,#`Y,C,V-2`P
M,#`P,"!N#0HP,#`P,#`P,#DQ(#`P,#`Q(&8-"C`P,#`P.3(T-30@,#`P,#`@
M;@T*,#`P,#`Y,C4Y,2`P,#`P,"!N#0HP,#`P,#DR-S0U(#`P,#`P(&X-"C`P
M,#`P.3(X.3(@,#`P,#`@;@T*,#`P,#`Y,S0Y-"`P,#`P,"!N#0HP,#`P,#DS
M-C@U(#`P,#`P(&X-"C`P,#`P.3,X.#,@,#`P,#`@;@T*,#`P,#`Y-#`V,R`P
M,#`P,"!N#0HP,#`P,#DT-3<U(#`P,#`P(&X-"C`P,#`P.3<R-S0@,#`P,#`@
M;@T*,#`P,#`P,#`Y,B`P,#`P,2!F#0HP,#`P,#`P,#`P(#`P,#`Q(&8-"G1R
M86EL97(-/#P-+U-I>F4@.3,-+TEN9F\@-S4@,"!2(`TO4F]O="`X,2`P(%(@
M#2])1%L\83$W960R-F1E868U964Q-#$P835D83,Q9#9C83=F9#@^/#@W9&(P
M,#DY.3ED,SAC.3$Y96%C.#4R,CED83`X8F4P/ET-/CX-<W1A<G1X<F5F#3DW
*,S4R#24E14]&#3\_
`
end

</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.32
<SEQUENCE>4
<FILENAME>ex1032.htm
<TEXT>
<html>

<head>

<title>Exhibit 10.32</title>

</head>

<body>

<p align=center><b>Exhibit 10.32&nbsp; Warrant agreement with Robert Hovee dated October
2, 2002</b></p>



<p align="justify">THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS.&nbsp; NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED
THERETO OR COMPLIANCE WITH AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS.</p>

<p align="center"><b>PRO-DEX, INC.</b></p>

<p>W-2002.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; October
2, 2002</p>

<p align="center"><b>WARRANT TO PURCHASE<br>
SHARES OF COMMON STOCK</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; THIS CERTIFIES THAT, for value received, and subject to the
provisions and upon the terms and conditions hereinafter set forth, <b>Robert Hovee</b> is entitled to subscribe
for and purchase, at an exercise price per share equal to<b> $0.54</b> (as adjusted herein, the &quot;Warrant Price&quot;), up to <b>sixty five thousand (65,000)</b> shares of
the fully paid and nonassessable Common Stock (as adjusted herein) of PRO-DEX,
INC., a Colorado corporation (the &quot;Company&quot;).&nbsp;
As used herein, (i) &quot;Date of Grant&quot; shall mean the date as set forth on
the signature page hereof, and (ii) &quot;Shares&quot; shall mean the Common Stock issued
or issuable upon the exercise of this Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Term</u></b>.&nbsp; The purchase right represented by this
Warrant is exercisable, in whole or in part, at any time and the date hereof
through the date which is <b>three (3)
years </b>from the Date of Grant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Method of Exercise;
Payment; Issuance of New Warrant</u></b>.&nbsp;
Subject to Section 1 hereof, the purchase right represented by this
Warrant may be exercised by the holder, in whole or in part and from time to
time, by the surrender of this Warrant (with the notice of exercise form
attached hereto as <u>Exhibit A</u> duly executed) at the principal office of
the Company and by the payment to the Company, by check, of an amount equal to
the then applicable Warrant Price multiplied by the number of Shares then being
purchased.&nbsp; The person or persons in
whose name(s) any certificate(s) representing Shares shall be issuable upon
exercise of this Warrant shall be deemed to have become the holder(s) of record
of, and shall be treated for all purposes as the record holder(s) of, the
shares represented thereby (and such shares shall be deemed to have been
issued) immediately prior to the close of business on the date or dates upon
which this Warrant is exercised.&nbsp; This
Warrant may not be subsequently assigned by holder.&nbsp; In the event of any exercise of the rights
represented by this Warrant, certificates for the shares of stock so purchased
shall be delivered to the holder hereof as soon as possible and in any event
within thirty days after such exercise and, unless this Warrant has been fully exercised
or expired, a new Warrant representing the portion of the Shares, if any, with
respect to which this Warrant shall not then have been exercised shall also be
issued to the holder hereof as soon as possible and in any event within such
thirty day period.</p>

<p align="justify">&nbsp;</p>

<p align="center">&nbsp;</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Adjustment of
Warrant Price and Number of Shares</u></b>.&nbsp;
The number and kind of securities purchasable upon the exercise of this
Warrant and the Warrant Price shall be subject to adjustment from time to time
upon the occurrence of certain events, as follows:</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Reclassification
or Merger</u></b>.&nbsp; In case of any
reclassification, change or conversion of securities of the class issuable upon
exercise of this Warrant (other than a change in par value, or from par value
to no par value, or from no par value to par value, or as a result of a
subdivision or combination), or in case of any merger of the Company with or
into another corporation (other than a merger with another corporation in which
the Company is the acquiring and the surviving corporation and which does not
result in any reclassification or change of outstanding securities issuable
upon exercise of this Warrant), or in case of any sale of all or substantially
all of the assets of the Company, the Company, or such successor or purchasing
corporation, as the case may be, or its parent corporation, shall duly execute
and deliver to the holder of this Warrant a new Warrant (in form and substance
reasonably satisfactory to the holder of this Warrant), so that the holder of
this Warrant shall have the right to receive, at a total purchase price not to
exceed that payable upon the exercise of the unexercised portion of this
Warrant, and in lieu of the Shares theretofore issuable upon exercise of this
Warrant, the kind and amount of shares of stock, other securities, money and
property receivable upon such reclassification, change or merger by a holder of
the number of Shares then purchasable under this Warrant.&nbsp; Such new Warrant shall provide for
adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 3.&nbsp;
The provisions of this subparagraph (a) shall similarly apply to
successive reclassifications, changes, mergers, consolidations, transfers,
amendments and waivers.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Subdivision
or Combination of Shares</u></b>.&nbsp; If the
Company at any time while this Warrant remains outstanding and unexpired shall
subdivide or combine its outstanding Shares, the Warrant Price shall be
proportionately decreased in the case of a subdivision or increased in the case
of a combination, effective at the close of business on the date the
subdivision or combination becomes effective.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Stock
Dividends and Other Distributions</u></b>.&nbsp;
In case the Company shall make or issue, or shall fix a record date for
the determination of eligible holders entitled to receive, a dividend or other
distribution with respect to the Shares (or any shares of stock or other
securities at the time issuable upon exercise of the Warrant) payable in (a)
securities of the Company or (b) assets (excluding cash dividends paid or payable
solely out of retained earnings), then, in each such case, the holder of this
Warrant on exercise hereof at any time after the consummation, effective date
or record date of such dividend or other distribution, shall receive, in
addition to the Shares (or such other stock or securities) issuable on such
exercise prior to such date, and without the payment of additional
consideration therefor, the securities or such other assets of the Company to
which such Holder would have been entitled upon such date if such holder had
exercised this Warrant on the date hereof and had thereafter, during the period
from the date hereof to and including the date of such exercise, retained such
shares and/or all other additional stock available by it as aforesaid during
such period giving effect to all adjustments called for by this Section 3.</p>

<p align="justify">&nbsp;</p>

<p align="center">2</p>

</blockquote>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Adjustment of
Number of Shares</u></b>.&nbsp; Upon each
adjustment in the Warrant Price, the number of Shares purchasable hereunder
shall be adjusted, to the nearest whole share, to the product obtained by
multiplying the number of Shares purchasable immediately prior to such
adjustment in the Warrant Price by a fraction, the numerator of which shall be
the Warrant Price immediately prior to such adjustment and the denominator of
which shall be the Warrant Price immediately thereafter.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Conversion of
Shares</u></b>.&nbsp; In the event that all of
the authorized and outstanding Shares are redeemed or converted or reclassified
into other securities or property pursuant to the Company's Certificate of
Incorporation or otherwise, or the Shares otherwise ceases to exist, then, in
such case, the Holder of this Warrant, upon exercise hereof at any time after
the date on which the Shares are so redeemed or converted, reclassified or
ceases to exist (the &quot;Termination Date&quot;), shall receive, in lieu of the number
of Shares that would have been issuable upon such exercise immediately prior to
the Termination Date, the securities or property that would have been received
if this Warrant had been exercised in full and the Shares received thereupon
had been simultaneously converted immediately prior to the Termination Date,
all subject to further adjustment as provided in this Warrant.&nbsp; Additionally, the Warrant Price shall be
immediately adjusted to equal the quotient obtained by dividing (x) the
aggregate Warrant Price of the maximum number of Shares for which this Warrant
was exercisable immediately prior to the Termination Date by (y) the number of
Shares for which this Warrant is exercisable immediately after the Termination
Date, all subject to further adjustment as provided herein.</p>

</blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Notice of
Adjustments</u></b>.&nbsp; Whenever the
Warrant Price or the number of Shares purchasable hereunder shall be adjusted
pursuant to Section 3 hereof, the Company shall make a certificate signed by its
chief executive officer setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which
such adjustment was calculated, and the Warrant Price and the number of Shares
purchasable hereunder after giving effect to such adjustment, which shall be
sent pursuant to Section 12 hereof to the holder of this Warrant. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Fractional
Shares</u></b>.&nbsp; No fractional Shares
will be issued in connection with any exercise hereunder, but in lieu of such
fractional Shares the Company shall make a cash payment therefor based on the
fair market value of the Shares on the date of exercise as reasonably
determined in good faith by the Company's Board of Directors.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Compliance
with Securities Act: Disposition of Warrant or Shares of Common Stock</u></b>.&nbsp; This Warrant may not be assigned or
transferred in whole or in part by the holder hereof.&nbsp; The holder of this Warrant, by acceptance
hereof, agrees that this Warrant, and the Shares to be issued upon exercise
hereof are being acquired for investment and that such holder will not offer,
sell or otherwise dispose of this Warrant, or any Shares to be issued upon
exercise hereof except under circumstances which will not result in a violation
of the Securities Act of 1933, as amended (the &quot;Act&quot;).&nbsp; This Warrant and all Shares issued upon
exercise of this Warrant (unless registered under the Act) shall be stamped or
imprinted with a legend in substantially the following form:</p>

<p align="justify">&nbsp;</p>

<p align="center">3</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<blockquote>
  <blockquote>

<p align="justify">&quot;THE SECURITIES EVIDENCED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS.&nbsp; NO SALE OR DISPOSITION
MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION
STATEMENT RELATED THERETO OR COMPLIANCE WITH AN EXEMPTION FROM SUCH
REGISTRATION REQUIREMENTS&quot;. </p>

  </blockquote>
</blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Rights as
Stockholders; Information</u></b>.&nbsp; No
holder of this Warrant, as such, shall be entitled to vote or receive dividends
or be deemed the holder of Shares or any other securities of the Company which
may at any time be issuable on the exercise hereof for any purpose, nor shall
anything contained herein be construed to confer upon the holder of this
Warrant, as such, any of the rights of a stockholder of the Company or any
right to vote for the election of directors or upon any matter submitted to
stockholders at any meeting thereof, or to receive notice of meetings, or to
receive dividends or subscription rights or otherwise until this Warrant shall
have been exercised and the Shares purchasable upon the exercise hereof shall
have become deliverable, as provided herein.&nbsp;
Notwithstanding the foregoing, the Company will transmit to the holder
of this Warrant such information, documents and reports as are generally
distributed to the holders of any class or series of the securities of the
Company concurrently with the distribution thereof to the stockholders.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Right to
Convert Warrant into Shares; Net Issuance</u></b>.</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Right to
Convert</u></b>.&nbsp; In addition to and
without limiting the rights of the holder under the terms of this Warrant, the
holder shall have the right to convert this Warrant or any portion thereof (the
&quot;Conversion Right&quot;) into Shares as provided in this Section 8 at any time or
from time to time during the term of this Warrant.&nbsp; Upon exercise of the Conversion Right with
respect to a particular number of shares subject to this Warrant (the
&quot;Converted Warrant Shares&quot;), the Company shall deliver to the holder (without
payment by the holder of any exercise price or any cash or other consideration)
(X) that number of shares of fully paid and nonassessable Shares equal to the
quotient obtained by dividing the value of this Warrant (or the specified
portion hereof) on the Conversion Date (as hereinafter defined), which value
shall be determined by subtracting (A) the aggregate Warrant Price of the
Converted Warrant Shares immediately prior to the exercise of the Conversion
Right from (B) the aggregate fair market value of the Converted Warrant Shares
issuable upon exercise of this Warrant (or the specified portion hereof) on the
Conversion Date (as herein defined) by (Y) the fair market value of one Share
on the Conversion Date (as herein defined).</p>

<p align="justify">&nbsp;</p>

<p align="center">4</p>

</blockquote>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">Expressed as a formula, such conversion shall be computed as
follows:</p>

<p>X&nbsp; =&nbsp;&nbsp;
<u>B-A<br>
</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y</p>

<p>Where:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
number of Shares that may be issued to holder.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
fair market value (FMV) of one Share.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
aggregate Warrant Price (i.e., Converted Warrant Shares x Warrant Price).</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
aggregate FMV (i.e., FMV x Converted Warrant Shares).</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No fractional shares shall be issuable upon exercise of the
Conversion Right, and, if the number of shares to be issued determined in
accordance with the foregoing formula is other than a whole number, the Company
shall pay to the holder an amount in cash equal to the fair market value of the
resulting fractional share on the Conversion Date (as hereinafter defined).&nbsp; All references herein to an &quot;exercise&quot; of the
Warrant shall include an exchange pursuant to this Section 8.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Method of
Exercise</u></b>.&nbsp; The Conversion Right
may be exercised by the holder by the surrender of this Warrant at the
principal office of the Company together with a notice of exercise
substantially in the form attached hereto as Exhibit A-1, specifying that the
holder thereby intends to exercise the Conversion Right and indicating the
number of shares subject to this Warrant that are being surrendered (referred
to in subsection (a) hereof as the Converted Warrant Shares) in exercise of the
Conversion Right.&nbsp; Such conversion shall
be effective upon receipt by the Company of this Warrant together with the
aforesaid notice of exercise, or on such later date as is specified therein
(the &quot;Conversion Date&quot;), and, at the election of the holder hereof, may be made
contingent upon the closing of the sale of the Company's Common Stock to the
public in a public offering pursuant to a Registration Statement under the Act
(a &quot;Public Offering&quot;).&nbsp; Certificates for
the shares issuable upon exercise of the Conversion Right and, if applicable, a
new Warrant evidencing the balance of the shares remaining subject to this
Warrant, shall be issued as of the Conversion Date and shall be delivered to
the holder within thirty days following the Conversion Date.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Determination
of Fair Market Value</u></b>.&nbsp; For
purposes of this Section 8, &quot;fair market value&quot; of a Share as of a particular
date (the &quot;Determination Date&quot;) shall mean:</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If the Conversion Right is exercised in connection with
and contingent upon a Public Offering, and if the Company's Registration
Statement relating to such Public Offering (&quot;Registration Statement&quot;) has been
declared effective by the Securities and Exchange Commission, then the initial
&quot;Price to Public&quot; specified in the final prospectus with respect to such
offering.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If the Conversion Right is not exercised in connection
with and contingent upon a Public Offering, then as follows:</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If traded on a securities exchange or The Nasdaq Stock
Market, the fair market value of the Common Stock shall be deemed to be the
average of the closing or last reported sale prices of the Common Stock on such
exchange or market over the thirty day period ending five business days prior
to the Determination Date, and the fair market value of the Shares shall be
deemed to be such fair market value of the Common Stock;</p>

<p align="justify">&nbsp;</p>

<p align="center">5</p>

</blockquote>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If otherwise traded in an over-the-counter market, the
fair market value of the Common Stock shall be deemed to be the average of the
closing ask prices of the Common Stock over the thirty day period ending five
business days prior to the Determination Date, and the fair market value of the
Shares shall be deemed to be such fair market value of the Common Stock; and</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If there is no public market for the Common Stock, then
fair market value shall be the price reasonably determined in good faith by the
Board of Directors of the Company.</p>

</blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Reservation
of Common Stock</u></b>.&nbsp; The Company
hereby covenants that at all times following the date hereof there shall be
reserved for issuance and delivery upon exercise of this Warrant such number of
Shares as are from time to time issuable upon exercise of this Warrant.&nbsp; The Company hereby further covenants that
from time to time following the date hereof, the Company will take all steps
necessary to amend its Certificate of Incorporation to provide sufficient
reserves of Shares issuable upon exercise of this Warrant.&nbsp; All such shares shall be duly authorized, and
when issued upon such exercise, shall be validly issued, fully paid and
non-assessable, free and clear of all liens, security interests, charges and
other encumbrances or restrictions on sale and free and clear of all preemptive
rights, except encumbrances or restrictions arising under federal or state
securities laws.&nbsp; </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Modification
and Waiver</u></b>.&nbsp; This Warrant and any
provision hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement of the same
is sought.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Registration</u></b>.&nbsp; The Company has certain registration
obligations with respect to the shares of common stock underlying this Warrant
as set forth in that certain Consulting Agreement dated as of October 2, 2002
by and between the Company and Robert Hovee.&nbsp;
</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Notices</u></b>.&nbsp; Any notice, request, communication or other
document required or permitted to be given or delivered to the holder hereof or
the Company shall be delivered, or shall be sent by certified or registered
mail, postage prepaid, to each such holder at its address as shown on the books
of the Company or to the Company at the address indicated therefor on the
signature page of this Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Binding
Effect on Successors</u></b>.&nbsp; Until the
issuance of any new Warrant required to be issued under Section 3(a), this
Warrant shall be binding upon any corporation that issues securities in
exchange for securities of the class issuable upon exercise of this Warrant in
connection with any merger, consolidation or acquisition of all or
substantially all of the Company's assets, and all of the obligations of the
Company relating to the Shares issuable upon the exercise or conversion of this
Warrant shall survive the exercise, conversion and termination of this Warrant
and all of the covenants and agreements of the Company shall inure to the
benefit of the holder hereof. The Company will, at the time of the exercise or
conversion of this Warrant, in whole or in part, upon request of the holder
hereof but at the Company's expense, acknowledge in writing its continuing
obligation to the holder hereof in respect of any rights (including, without
limitation, any right to registration of the shares) to which the holder hereof
shall continue to be entitled after such exercise or conversion in accordance
with this Warrant; provided, that the failure of the holder hereof to make any
such request shall not affect the continuing obligation of the Company to the
holder hereof in respect of such rights.</p>

<p align="justify">&nbsp;</p>

<p align="center">6</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Lost Warrants
or Stock Certificates</u></b>.&nbsp; The
Company covenants to the holder hereof that, upon receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Warrant or any stock certificate and, in the case of any
such loss, theft or destruction, upon receipt of an indemnity reasonably
satisfactory to the Company, or in the case of any such mutilation upon
surrender and cancellation of such Warrant or stock certificate, the Company
will make and deliver a new Warrant or stock certificate, of like tenor, in
lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Descriptive
Headings</u></b>.&nbsp; The descriptive
headings of the several paragraphs of this Warrant are inserted for convenience
only and do not constitute a part of this Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Governing Law</u></b>.&nbsp; This Warrant shall be construed and enforced
in accordance with, and the rights of the parties shall be governed by, the
internal laws of the State of California without regard to its conflicts of
laws principles.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Survival</u></b>.&nbsp; All agreements of the Company and the holder
hereof contained herein shall survive indefinitely until, by their respective
terms, they are no longer operative.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Remedies</u></b>.&nbsp; In case any one or more of the covenants and
agreements contained in this Warrant shall have been breached, the holders
hereof (in the case of a breach by the Company), or the Company (in the case of
a breach by a holder), may proceed to protect and enforce their or its rights
either by suit in equity and/or by action at law, including, but not limited
to, an action for damages as a result of any such breach and/or an action for
specific performance of any such covenant or agreement contained in this
Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Acceptance</u></b>.&nbsp; Receipt of this Warrant by the holder hereof
shall constitute acceptance of and agreement to the foregoing terms and
conditions.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>No Impairment
of Rights</u></b>.&nbsp; The Company will not,
by amendment of its Certificate of Incorporation or through any other means,
avoid or seek to avoid the observance or performance of any of the terms of
this Warrant, but will at all times in good faith assist in the carrying out of
all such terms and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the holder of this Warrant
against impairment.&nbsp; Without limiting the
generality of the foregoing, the Company (a) will not increase the par value of
any shares of stock issuable upon the exercise of this Warrant above the amount
payable therefor upon such exercise, and (b) will take all such action as may
be necessary or appropriate in order that the Company may validly and legally
issue fully paid and non-assessable Shares upon exercise of this Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Severability</u></b>.&nbsp; If any term, provision, covenant, or
restriction of this Warrant is held by a court of competent jurisdiction to be
invalid, void or unenforceable, the remainder of the terms, provisions,
covenants and restrictions of this Warrant shall remain in full force and
effect and shall in no way be affected, impaired or invalidated.</p>

<p align="justify">&nbsp;</p>

<p align="center">7</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Notices of
Record Date</u></b>.&nbsp; In case:</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Company shall take a record of the holders of its Common
Stock for the purpose of entitling them to receive any dividend or other
distribution, or any right to subscribe for or purchase any shares of stock of
any class or any other securities or to receive any other right; or of any
consolidation or merger of the Company with or into another corporation, any
capital reorganization of the Company, any reclassification of the capital
stock of the Company, or any conveyance of all or substantially all of the
assets of the Company to another corporation in which holders of the Company's
stock are to receive stock, securities or property of another corporation; or</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of any voluntary dissolution, liquidation or winding-up
of the Company; or</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of any redemption or conversion of all outstanding
Common Stock.</p>

</blockquote>

<p align="justify">then, and in each such case, the Company will mail or cause
to be mailed to the holder of this Warrant a notice specifying, as the case may
be, (i) the date on which a record is to be taken for the purpose of such
dividend, distribution or right, or (ii) the date on which such reorganization,
reclassification, consolidation, merger, conveyance, dissolution, liquidation,
winding-up, redemption or conversion is to take place, and the time, if any is
to be fixed, as of which the holders of record of Common Stock shall be
entitled to exchange their shares of Common Stock, for securities or other
property deliverable upon such reorganization, reclassification, consolidation,
merger, conveyance, dissolution, liquidation or winding-up.&nbsp; Such notice shall be delivered at least seven
(7) days prior to the date therein specified.</p>

<p align=left>Date
of Grant:&nbsp; October 2, 2002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX, INC.<br>
<br>
ACKNOWLEDGED AND AGREED:<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>
<br>
</u>______________________________&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Name:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>
</u>Signature<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Title:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>
</u>Robert Hovee<br>
<br>
<u><br><br></u></p>

<p align=left>&nbsp;</p>

<p align=center>8</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<b><br clear=all>
</b>

<p align="center"><b>EXHIBIT A</b></p>

<p align="center"><u><b>NOTICE OF EXERCISE</b></u></p>

<p>To:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX, INC.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned
hereby elects to purchase __________ shares of Common Stock of PRO-DEX, INC.
pursuant to the terms of the attached Warrant, and tenders herewith payment of
the purchase price of such shares in full.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please issue a
certificate or certificates representing said shares in the name of the
undersigned or in such other name or names as are specified below:</p>

<p align="center"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>
(Name)<br>
<br>
<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>
</u>(Address)</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned
represents that the aforesaid shares are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection
with, the distribution thereof and that the undersigned has no present
intention of distributing or reselling such shares.&nbsp; In support thereof, the undersigned has
executed an Investment Representation Statement attached hereto as Schedule 1.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature<br>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date</p>

<br clear=all>


<p>&nbsp;</p>
<p align="center">9</p>
<hr color="#000080"><p style="page-break-after: always"></p>


<p align="center"><b>EXHIBIT A-1</b></p>

<p align="center"><b><u>NOTICE OF EXERCISE OF NET ISSUANCE CONVERSION RIGHTS</u></b></p>

<p>To:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX, INC.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned,
the registered holder of the Warrant delivered herewith (the &quot;Warrant&quot;), hereby
elects to exercise the Conversion Right (as defined in Section 8 of the
Warrant) as provided herein.&nbsp; __________
shares subject to the Warrant are being surrendered hereby in exercise of the
Conversion Right.&nbsp; The number of shares
to be issued pursuant to this exercise shall be determined by reference to the
formula in Section 8(a) of the Warrant, which requires the use of the &quot;fair
market value&quot; of the Company's stock.&nbsp; As
of the Determination Date (as defined in the Warrant), the &quot;fair market value&quot;
of one of the Shares shall be determined in the manner provided in Section 8(c)
of the Warrant, which amount has been determined by the undersigned (or agreed
to by the holder of the Warrant and PRO-DEX, INC.) to be $_____ per share.&nbsp; Therefore, ___________ shares are to be
issued to the undersigned pursuant to this exercise.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please issue a
certificate or certificates representing said shares in the name of the
undersigned or in such other name or names as are specified below:</p>

<p align="center">_______________________________<br>
(Name)<br>
<br>
_______________________________<br>
(Address)</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned
represents that the aforesaid shares are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection
with, the distribution thereof and that the undersigned has no present
intention of distributing or reselling such shares.&nbsp; In support thereof, the undersigned has
executed an Investment Representation Statement attached hereto as Schedule l.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature<br>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date</p>

<br clear=all>


<p>&nbsp;</p>
<p align="center">10</p>
<hr color="#000080"><p style="page-break-after: always"></p>


<p align="center"><b>Schedule 1</b></p>

<p align="center"><u><b>INVESTMENT REPRESENTATION STATEMENT</b></u></p>

<p>Purchaser:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p>Company:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX,
INC.</p>

<p>Security:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p>Amount:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p>Date:&nbsp;&nbsp;&nbsp; </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In connection with the purchase of the above-listed securities
(the &quot;Securities&quot;), the undersigned (the &quot;Purchaser&quot;) represents to the Company
as follows:</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser is
aware of the Company's business affairs and financial condition, and has
acquired sufficient information about the Company to reach an informed and
knowledgeable decision to acquire the Securities.&nbsp; The Purchaser is purchasing the Securities
for its own account for investment purposes only and not with a view to, or for
the resale in connection with, any &quot;distribution&quot; thereof for purposes of the
Securities Act of 1933, as amended (the &quot;Act&quot;).</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
understands that the Securities have not been registered under the Securities
Act in reliance upon a specific exemption therefrom.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
further understands that the Securities must be held indefinitely unless
subsequently registered under the Act or unless an exemption from registration
is otherwise available.&nbsp; <u>However, the
Company acknowledges that it is under an obligation to register the Securities
as set forth in that certain Consulting Agreement dated as of October 2, 2002 between
the Company and the Purchaser</u>.&nbsp; In
addition, the Purchaser understands that the certificate evidencing the
Securities will be imprinted with the legend referred to in the Warrant under
which the Securities are being purchased.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser is aware
of the provisions of Rule 144 and 144A, promulgated under the Act, which, in
substance, permit limited public resale of &quot;restricted securities&quot; acquired,
directly or indirectly, from the issuer thereof (or from an affiliate of such
issuer), in a non-public offering subject to the satisfaction of certain
conditions, if applicable, including, among other things: The availability of
certain public information about the Company, the resale occurring not less
than one year after the party has purchased and paid for the securities to be
sold; the sale being made through a broker in an unsolicited &quot;broker's
transaction&quot; or in transactions directly with a market maker (as said term is
defined under the Securities Exchange Act of 1934, as amended) and the amount
of securities being sold during any three-month period not exceeding the
specified limitations stated therein.</p>

<p align="justify">&nbsp;</p>

<p align="center">11</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
further understands that at the time it wishes to sell the Securities there may
be no public market upon which to make such a sale, and that, even if such a
public market then exists, the Company may not be satisfying the current public
information requirements of Rule 144 and 144A, and that, in such event, the
Purchaser may be precluded from selling the Securities under Rule 144 and 144A
even if the one-year minimum holding period had been satisfied.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
further understands that in the event all of the requirements of Rule 144 and
144A are not satisfied, registration under the Act, compliance with Regulation
A, or some other registration exemption will be required; and that,
notwithstanding the fact that Rule 144 is not exclusive, the Staff of the SEC
has expressed its opinion that persons proposing to sell private placement
securities other than in a registered offering and otherwise than pursuant to
Rule 144 will have a substantial burden of proof in establishing that an
exemption from registration is available for such offers or sales, and that
such persons and their respective brokers who participate in such transactions
do so at their own risk.</p>



<p>Purchaser: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></p>

<p>Date:&nbsp;&nbsp;&nbsp; _______________,
____</p>





<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p align="center">12</p>





</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.33
<SEQUENCE>5
<FILENAME>ex1033.htm
<TEXT>
<html>

<head>

<title>Exhibit 10.33</title>

</head>

<body>

<p align=center><b>Exhibit 10.33&nbsp; Consulting
agreement with Robert Hovee dated October 2, 2002</b></p>

<p align="center"><b>CONSULTING AGREEMENT</b></p>



<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; THIS CONSULTING AGREEMENT (the &quot;<u>Agreement</u>&quot;) is made and
entered into as of the 2<sup>nd</sup>
day of October 2002, by and between Pro-Dex, Inc., a Colorado corporation (the
&quot;<u>Company</u>&quot;) and Robert Hovee, an individual (the &quot;<u>Consultant</u>&quot;).</p>

<p align="center"><b>AGREEMENT</b></p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NOW, THEREFORE, in consideration of the mutual covenants and
agreements hereinafter set forth, the parties hereto agree as follows:</p>

<p align="justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Term of Agreement</u></b>.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
This Agreement
shall commence on the date and year first written above and, unless modified by
mutual agreement of the parties or terminated earlier pursuant to the terms of this Agreement, shall continue for three (3) years,&nbsp; (the &quot;<u>Consultation Period</u>&quot;).</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The provisions of
<u>Section 1.1</u> above notwithstanding, in the event of a material breach of
this Agreement, this Agreement may be terminated by the nonbreaching
party upon three (3) days prior written notice to the other party.&nbsp; Such notice shall be made in accordance with
the provisions of <u>Section 7.9</u> herein.</p>

<p align="justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Scope of Services</u></b>.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Consultant
shall provide consulting services and recommendations to the Company with
respect to the nature and magnitude of compensation of Company executives, with
such services to be provided on an as-needed basis.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Consultant
shall devote such time as may be reasonably necessary or appropriate to perform
the consulting services hereunder; provided, however, that the Company shall,
in making use of the Consultant's services hereunder, make reasonable efforts
to accommodate such other business and personal commitments as the Consultant
may have.</p>

<p align="justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Independent Contractor</u></b>.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Consultant
shall act in the capacity of an independent contractor with respect to the
Company.&nbsp; The Consultant shall not be,
nor represent himself as being, an agent of the Company, and shall not be, nor
represent himself as being, authorized to bind the Company.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
As an independent
contractor, the Consultant shall accept any reasonable directions issued by the
Company, through a designated executive officer(s), pertaining to the goals to
be attained and the results to be achieved by the Consultant, but shall be
solely responsible for the manner, working hours and place at which he will
perform his services under this Agreement.</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
As an independent
contractor, the Consultant shall not have the status of an employee of the
Company.&nbsp; The Consultant shall not be
eligible to participate in any employee benefit, group insurance or executive
compensation plans or programs maintained by the Company.&nbsp; The Company shall not provide Social
Security, unemployment compensation, disability insurance, workers'
compensation or similar coverage, nor any other statutory benefits to
the Consultant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
As an independent
contractor, the Consultant represents, warrants and
agrees that the Consultant shall be solely responsible for any taxes and
withholdings applicable to the payment of compensation, whether current or
deferred, to the Consultant pursuant to this Agreement, including, without
limitation, any income taxes, Social Security (FICA) payments, unemployment
insurance taxes, and disability insurance taxes.&nbsp; By reason of the Consultant's status as an
independent contractor and the representations contained herein, the Company
shall not make any withholdings or payments of such taxes with respect to
compensation paid to the Consultant hereunder.&nbsp;
The Consultant expressly agrees to treat any compensation paid to the
Consultant pursuant to this Agreement as self-employment income for the
purposes of determining liabilities for income taxes, Social Security (FICA)
payments, unemployment insurance taxes and disability insurance taxes as and
when the same may become due and payable.&nbsp;
The Consultant shall indemnify and hold the Company harmless for any
such taxes or withholdings for which the Company may be determined to be
liable.</p>

<p align="justify">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Compensation; Registration Rights</u></b>.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As full
compensation for the Consultant's services, commitments and covenants under
this Agreement, the Company shall issue to the Consultant a warrant in the form
attached hereto as <u>Exhibit A</u>.&nbsp;
Such warrant shall be deemed fully paid for upon execution of this
Agreement in connection with Consultant's making himself available for the
services to be performed under this Agreement.&nbsp;
Upon their issuance in accordance with the terms of such warrant, the
shares of common stock underlying such warrant shall be validly issued, fully
paid and non-assessable regardless of whether this Agreement has subsequently
been terminated or Consultant has ceased rendering services hereunder.&nbsp; The Company shall undertake to use its best
efforts to register for resale with the Securities and Exchange Commission the
shares of common stock underlying the warrant issued to the Consultant under
this Agreement upon receipt in writing of Consultant's request that the Company
effect such registration. </p>

<p align="justify">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Confidential Information</u></b>.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Consultant hereby acknowledges that he is being entrusted
with certain proprietary information respecting the Company, including, without
limitation, information related to the Company's inventions, discoveries,
products, product developments, processes, data, programs, customers,
suppliers, distributors, trade secrets, marketing techniques, marketing
opportunities, sales and business plans, licenses, patents, trademarks,
copyrights and service marks.&nbsp; Consultant
hereby covenants and agrees that all such proprietary information previously or
hereafter received or obtained by him shall remain confidential, and that the
Consultant shall not, without the prior written consent of the Company, at any
time either during the term of this Agreement or thereafter, directly or
indirectly (i) use such proprietary information for
himself or any third party, or (ii) disseminate or disclose any such
proprietary knowledge or information to any person not employed by the Company.</p>

<p align="justify">&nbsp;</p>

<p align="center">2</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Consultant hereby acknowledges that, during the course of his
engagement as a consultant for the Company, the Consultant may acquire
possession of materials which incorporate proprietary information of the Company.&nbsp; The Consultant agrees to promptly return all
such materials, and any copies thereof, to the Company upon the termination of
this Agreement for any reason.&nbsp; The
Consultant agrees that in executing this Agreement, he thereby certifies that
all such materials previously in his possession have been returned to the Company, and that to the best of his knowledge no other
third parties, whether or not employees of the Consultant, have any such
materials in their possession.</p>

<p align="justify">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Ownership of Work Product</u></b>.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All inventions, discoveries, new products, trade secrets,
proprietary information, patents, trademarks, copyrights, service marks and
other intellectual property rights associated with any ideas, concepts, or
works and authorship developed or created by the Consultant, and which relate
to any activity conducted by the Company during the course of the services
performed by Consultant for the Company (collectively, the &quot;<u>Work Product</u>&quot;)
shall belong exclusively to the Company.&nbsp;
The Consultant hereby assigns and transfers all of his right, title, and
interest in and to such Work Product to the Company, without further
consideration.&nbsp; The Consultant shall mark
all Work Product with such copyright or other proprietary notice as requested
by the Company and shall take all actions deemed necessary by the Company to
perfect the Company's rights therein.&nbsp;
The Consultant agrees to execute any documents of assignment or
registration of copyrights or patents requested by the Company respecting the
Work Product.</p>

<p align="justify">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Other Provisions</u></b>.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Counterparts</u></b>.&nbsp; This Agreement may be executed simultaneously
in two or more counterparts, each of which shall be deemed an original but all
of which together shall constitute one and the same instrument.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Assignment</u></b>.&nbsp; This Agreement contemplates the rendition of
unique personal services by the Consultant and is not assignable by the
Company.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Effect of Waiver</u></b>.&nbsp; The failure of either
party to insist on strict compliance with any of the terms, covenants, or
conditions of this Agreement by the other party shall not be deemed a waiver of
that term, covenant or condition, nor shall any waiver or relinquishment of any
right or power at any one time or times be deemed a waiver or relinquishment of
that right or power for all or any other times.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Entire Contract</u></b>.&nbsp; This Agreement contains the entire contract
between the parties with respect to the subject matter hereof, and supersedes
any previous agreements, commitments, representations or understandings between
the Consultant and the Company, whether oral or written.&nbsp; Any amendment to or modification of this
Agreement may be made only by a written document signed by both parties.</p>

<p align="center">3</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Attorneys' Fees</u></b>.&nbsp; If any party hereto incurs any legal fees,
whether or not an action is instituted, to enforce the terms of this Agreement
or to recover damages or injunctive relief for breach of this Agreement, it is
agreed that the successful or prevailing party shall be entitled to reasonable
attorneys' fees, expert witness fees and other costs in addition to any other
relief to which he or it may be entitled.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Governing Law</u></b>.&nbsp; This Agreement shall be governed by and
construed under the laws of the State of California.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Gender</u></b>.&nbsp; As used herein, the masculine gender shall
include the feminine and neuter, wherever the context requires.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Headings</u></b>.&nbsp; The various headings used in this Agreement
are inserted for convenience only and shall not affect the meaning or
interpretation of this Agreement or any provision hereof.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Notices</u></b>.&nbsp; Except as otherwise expressly provided
herein, any notice or payment required or permitted to be given or paid shall
be deemed duly given or paid only if personally delivered or sent by United
States mail and shall be deemed to have been given when personally delivered or
two (2) days after having been deposited in the United States mail, certified
mail, return receipt requested, properly addressed with postage prepaid.&nbsp; All notices or demands shall be effective
only if given in writing.&nbsp; For the purposes
hereof, the addresses of the parties hereto (until notice of a change thereof
is given as provided in this section) shall be as follows:</p>

<p>Company:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pro-Dex,
Inc.<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
151 E. Columbine Ave.<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Santa Ana, CA 92707<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Attention:&nbsp; President<u><br>
</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Telephone: (714) 241-4411<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Facsimile: (714) 513-7755</p>

<p>Consultant:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Robert Hovee<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Telephone:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Facsimile:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Severability</u></b>.&nbsp; The provisions of this Agreement are
severable.&nbsp; If any provision of this
Agreement shall be held to be invalid or otherwise unenforceable, in whole or
in part, the remainder of the provisions or unenforceable parts thereof shall not
be affected thereby and shall be enforced to the fullest extent permitted by
law.</p>

<p align=center>(Signature page follows.)</p><br clear=all>


<p align="center">4</p>
<hr color="#000080"><p style="page-break-after: always"></p>


<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; IN WITNESS WHEREOF, each of the parties hereto have executed this
Agreement, in the case of the Company by its duly authorized officer, as of the
day and year first above written.</p>

<p align=left>COMPANY:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX,
INC.,<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a
California corporation<br>
<br>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Its:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></p>

<p align=left>&nbsp;</p>

<p>CONSULTANT:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Robert
Hovee, an individual</p>

<b><br clear=all>
</b>

<p>&nbsp;</p>
<p>&nbsp;</p>
<p align="center">5</p>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align="center"><b>EXHIBIT A</b></p>

<p align="center"><u><b>Pro-Dex, Inc.-Warrant No. W-2002.1 dated October 2, 2002</b></u></p>



<p>Attached hereto.</p>



</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.34
<SEQUENCE>6
<FILENAME>ex1034.htm
<TEXT>
<html>

<head>

<title>Exhibit 10.34</title>

</head>

<body>

<p align=center><b>Exhibit 10.34&nbsp; Warrant agreement with Ron Coss dated October
3, 2002</b></p>



<p align="justify">THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS.&nbsp; NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED
THERETO OR COMPLIANCE WITH AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS.</p>

<p align="center"><b>PRO-DEX, INC.</b></p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; October
3, 2002</p>

<p align="center"><b>WARRANT TO PURCHASE<br>
SHARES OF COMMON STOCK</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; THIS CERTIFIES THAT, for value received, and subject to the
provisions and upon the terms and conditions hereinafter set forth, Ron Coss is
entitled to subscribe for and purchase, at an exercise price per share equal to$1.25 (as adjusted herein, the
&quot;Warrant Price&quot;), up to onehundred
thousand (100,000) shares of the fully paid and nonassessable Common Stock (as
adjusted herein) of PRO-DEX, INC., a Colorado corporation (the &quot;Company&quot;).&nbsp; As used herein, (i) &quot;Date of Grant&quot; shall
mean the date as set forth on the signature page hereof, and (ii) &quot;Shares&quot;
shall mean the Common Stock issued or issuable upon the exercise of this
Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Term</u></b>.&nbsp; The purchase right represented by this
Warrant is exercisable, in whole or in part, at any time and the date hereof
prior to the expiration date of June 30, 2009.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Method of
Exercise; Payment; Issuance of New Warrant</u></b>.&nbsp; Subject to Section 1 hereof, the purchase
right represented by this Warrant may be exercised by the holder, in whole or
in part and from time to time, by the surrender of this Warrant (with the
notice of exercise form attached hereto as <u>Exhibit A</u> duly executed) at
the principal office of the Company and by the payment to the Company, by
check, of an amount equal to the then applicable Warrant Price multiplied by
the number of Shares then being purchased.&nbsp;
The person or persons in whose name(s) any certificate(s) representing
Shares shall be issuable upon exercise of this Warrant shall be deemed to have
become the holder(s) of record of, and shall be treated for all purposes as the
record holder(s) of, the shares represented thereby (and such shares shall be
deemed to have been issued) immediately prior to the close of business on the
date or dates upon which this Warrant is exercised.&nbsp; This Warrant may not be subsequently assigned
by holder.&nbsp; In the event of any exercise
of the rights represented by this Warrant, certificates for the shares of stock
so purchased shall be delivered to the holder hereof as soon as possible and in
any event within thirty days after such exercise and, unless this Warrant has
been fully exercised or expired, a new Warrant representing the portion of the
Shares, if any, with respect to which this Warrant shall not then have been
exercised shall also be issued to the holder hereof as soon as possible and in
any event within such thirty day period.</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Adjustment of
Warrant Price and Number of Shares</u></b>.&nbsp;
The number and kind of securities purchasable upon the exercise of this
Warrant and the Warrant Price shall be subject to adjustment from time to time
upon the occurrence of certain events, as follows:</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Reclassification
or Merger</u></b>. &nbsp;In case of any
reclassification, change or conversion of securities of the class issuable upon
exercise of this Warrant (other than a change in par value, or from par value
to no par value, or from no par value to par value, or as a result of a
subdivision or combination), or in case of any merger of the Company with or
into another corporation (other than a merger with another corporation in which
the Company is the acquiring and the surviving corporation and which does not
result in any reclassification or change of outstanding securities issuable
upon exercise of this Warrant), or in case of any sale of all or substantially
all of the assets of the Company, the Company, or such successor or purchasing
corporation, as the case may be, or its parent corporation, shall duly execute
and deliver to the holder of this Warrant a new Warrant (in form and substance
reasonably satisfactory to the holder of this Warrant), so that the holder of
this Warrant shall have the right to receive, at a total purchase price not to
exceed that payable upon the exercise of the unexercised portion of this
Warrant, and in lieu of the Shares theretofore issuable upon exercise of this
Warrant, the kind and amount of shares of stock, other securities, money and
property receivable upon such reclassification, change or merger by a holder of
the number of Shares then purchasable under this Warrant.&nbsp; Such new Warrant shall provide for
adjustments that shall be as nearly equivalent as may be practicable to the
adjustments provided for in this Section 3.&nbsp;
The provisions of this subparagraph (a) shall similarly apply to
successive reclassifications, changes, mergers, consolidations, transfers,
amendments and waivers.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Subdivision
or Combination of Shares</u></b>.&nbsp; If the
Company at any time while this Warrant remains outstanding and unexpired shall
subdivide or combine its outstanding Shares, the Warrant Price shall be
proportionately decreased in the case of a subdivision or increased in the case
of a combination, effective at the close of business on the date the
subdivision or combination becomes effective.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Stock
Dividends and Other Distributions</u></b>.&nbsp;
In case the Company shall make or issue, or shall fix a record date for
the determination of eligible holders entitled to receive, a dividend or other
distribution with respect to the Shares (or any shares of stock or other
securities at the time issuable upon exercise of the Warrant) payable in (a)
securities of the Company or (b) assets (excluding cash dividends paid or
payable solely out of retained earnings), then, in each such case, the holder
of this Warrant on exercise hereof at any time after the consummation,
effective date or record date of such dividend or other distribution, shall
receive, in addition to the Shares (or such other stock or securities) issuable
on such exercise prior to such date, and without the payment of additional
consideration therefor, the securities or such other assets of the Company to
which such Holder would have been entitled upon such date if such holder had
exercised this Warrant on the date hereof and had thereafter, during the period
from the date hereof to and including the date of such exercise, retained such
shares and/or all other additional stock available by it as aforesaid during
such period giving effect to all adjustments called for by this Section 3.</p>

<p align="justify">&nbsp;</p>

<p align="center">2</p>

</blockquote>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Adjustment of
Number of Shares</u></b>.&nbsp; Upon each
adjustment in the Warrant Price, the number of Shares purchasable hereunder
shall be adjusted, to the nearest whole share, to the product obtained by
multiplying the number of Shares purchasable immediately prior to such
adjustment in the Warrant Price by a fraction, the numerator of which shall be
the Warrant Price immediately prior to such adjustment and the denominator of
which shall be the Warrant Price immediately thereafter.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Conversion of
Shares</u></b>.&nbsp; In the event that all of
the authorized and outstanding Shares are redeemed or converted or reclassified
into other securities or property pursuant to the Company's Certificate of
Incorporation or otherwise, or the Shares otherwise ceases to exist, then, in
such case, the Holder of this Warrant, upon exercise hereof at any time after
the date on which the Shares are so redeemed or converted, reclassified or
ceases to exist (the &quot;Termination Date&quot;), shall receive, in lieu of the number
of Shares that would have been issuable upon such exercise immediately prior to
the Termination Date, the securities or property that would have been received
if this Warrant had been exercised in full and the Shares received thereupon
had been simultaneously converted immediately prior to the Termination Date,
all subject to further adjustment as provided in this Warrant.&nbsp; Additionally, the Warrant Price shall be
immediately adjusted to equal the quotient obtained by dividing (x) the
aggregate Warrant Price of the maximum number of Shares for which this Warrant
was exercisable immediately prior to the Termination Date by (y) the number of
Shares for which this Warrant is exercisable immediately after the Termination
Date, all subject to further adjustment as provided herein.</p>

</blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Notice of
Adjustments</u></b>.&nbsp; Whenever the
Warrant Price or the number of Shares purchasable hereunder shall be adjusted
pursuant to Section 3 hereof, the Company shall make a certificate signed by
its chief executive officer setting forth, in reasonable detail, the event
requiring the adjustment, the amount of the adjustment, the method by which
such adjustment was calculated, and the Warrant Price and the number of Shares
purchasable hereunder after giving effect to such adjustment, which shall be
sent pursuant to Section 12 hereof to the holder of this Warrant. </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Fractional
Shares</u></b>.&nbsp; No fractional Shares
will be issued in connection with any exercise hereunder, but in lieu of such
fractional Shares the Company shall make a cash payment therefor based on the
fair market value of the Shares on the date of exercise as reasonably
determined in good faith by the Company's Board of Directors.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Compliance
with Securities Act: Disposition of Warrant or Shares of Common Stock</u></b>.&nbsp; This Warrant may not be assigned or
transferred in whole or in part by the holder hereof.&nbsp; The holder of this Warrant, by acceptance
hereof, agrees that this Warrant, and the Shares to be issued upon exercise
hereof are being acquired for investment and that such holder will not offer,
sell or otherwise dispose of this Warrant, or any Shares to be issued upon
exercise hereof except under circumstances which will not result in a violation
of the Securities Act of 1933, as amended (the &quot;Act&quot;).&nbsp; This Warrant and all Shares issued upon
exercise of this Warrant (unless registered under the Act) shall be stamped or
imprinted with a legend in substantially the following form:</p>

<p align="justify">&nbsp;</p>

<p align="center">3</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<blockquote>
  <blockquote>

<p align="justify">&quot;THE SECURITIES EVIDENCED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE
SECURITIES LAWS.&nbsp; NO SALE OR DISPOSITION
MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION
STATEMENT RELATED THERETO OR COMPLIANCE WITH AN EXEMPTION FROM SUCH
REGISTRATION REQUIREMENTS&quot;. </p>

  </blockquote>
</blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Rights as
Stockholders; Information</u></b>.&nbsp; No
holder of this Warrant, as such, shall be entitled to vote or receive dividends
or be deemed the holder of Shares or any other securities of the Company which
may at any time be issuable on the exercise hereof for any purpose, nor shall
anything contained herein be construed to confer upon the holder of this
Warrant, as such, any of the rights of a stockholder of the Company or any
right to vote for the election of directors or upon any matter submitted to
stockholders at any meeting thereof, or to receive notice of meetings, or to
receive dividends or subscription rights or otherwise until this Warrant shall
have been exercised and the Shares purchasable upon the exercise hereof shall
have become deliverable, as provided herein.&nbsp;
Notwithstanding the foregoing, the Company will transmit to the holder
of this Warrant such information, documents and reports as are generally
distributed to the holders of any class or series of the securities of the
Company concurrently with the distribution thereof to the stockholders.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Right to
Convert Warrant into Shares; Net Issuance</u></b>.</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Right to
Convert</u></b>.&nbsp; In addition to and
without limiting the rights of the holder under the terms of this Warrant, the
holder shall have the right to convert this Warrant or any portion thereof (the
&quot;Conversion Right&quot;) into Shares as provided in this Section 8 at any time or
from time to time during the term of this Warrant.&nbsp; Upon exercise of the Conversion Right with
respect to a particular number of shares subject to this Warrant (the
&quot;Converted Warrant Shares&quot;), the Company shall deliver to the holder (without
payment by the holder of any exercise price or any cash or other consideration)
(X) that number of shares of fully paid and nonassessable Shares equal to the
quotient obtained by dividing the value of this Warrant (or the specified
portion hereof) on the Conversion Date (as hereinafter defined), which value
shall be determined by subtracting (A) the aggregate Warrant Price of the
Converted Warrant Shares immediately prior to the exercise of the Conversion Right
from (B) the aggregate fair market value of the Converted Warrant Shares
issuable upon exercise of this Warrant (or the specified portion hereof) on the
Conversion Date (as herein defined) by (Y) the fair market value of one Share
on the Conversion Date (as herein defined).</p>

<p align="justify">&nbsp;</p>

<p align="center">4</p>

</blockquote>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">Expressed as a formula, such conversion shall be computed as
follows:</p>

<p>X&nbsp; =&nbsp;&nbsp;
<u>B-A<br>
</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y</p>

<p>Where:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; = &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
number of Shares that may be issued to holder.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; Y
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
fair market value (FMV) of one Share.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
aggregate Warrant Price (i.e., Converted Warrant Shares x Warrant Price).</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; B
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The
aggregate FMV (i.e., FMV x Converted Warrant Shares).</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No fractional shares shall be issuable upon exercise of the
Conversion Right, and, if the number of shares to be issued determined in
accordance with the foregoing formula is other than a whole number, the Company
shall pay to the holder an amount in cash equal to the fair market value of the
resulting fractional share on the Conversion Date (as hereinafter defined).&nbsp; All references herein to an &quot;exercise&quot; of the
Warrant shall include an exchange pursuant to this Section 8.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Method of
Exercise</u></b>.&nbsp; The Conversion Right
may be exercised by the holder by the surrender of this Warrant at the
principal office of the Company together with a notice of exercise
substantially in the form attached hereto as Exhibit A-1, specifying that the
holder thereby intends to exercise the Conversion Right and indicating the
number of shares subject to this Warrant that are being surrendered (referred
to in subsection (a) hereof as the Converted Warrant Shares) in exercise of the
Conversion Right.&nbsp; Such conversion shall
be effective upon receipt by the Company of this Warrant together with the
aforesaid notice of exercise, or on such later date as is specified therein (the
&quot;Conversion Date&quot;), and, at the election of the holder hereof, may be made
contingent upon the closing of the sale of the Company's Common Stock to the
public in a public offering pursuant to a Registration Statement under the Act
(a &quot;Public Offering&quot;).&nbsp; Certificates for
the shares issuable upon exercise of the Conversion Right and, if applicable, a
new Warrant evidencing the balance of the shares remaining subject to this
Warrant, shall be issued as of the Conversion Date and shall be delivered to
the holder within thirty days following the Conversion Date.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Determination
of Fair Market Value</u></b>.&nbsp; For
purposes of this Section 8, &quot;fair market value&quot; of a Share as of a particular
date (the &quot;Determination Date&quot;) shall mean:</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If the Conversion Right is exercised in connection with
and contingent upon a Public Offering, and if the Company's Registration
Statement relating to such Public Offering (&quot;Registration Statement&quot;) has been
declared effective by the Securities and Exchange Commission, then the initial
&quot;Price to Public&quot; specified in the final prospectus with respect to such
offering.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If the Conversion Right is not exercised in connection
with and contingent upon a Public Offering, then as follows:</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If traded on a securities exchange or The Nasdaq Stock
Market, the fair market value of the Common Stock shall be deemed to be the
average of the closing or last reported sale prices of the Common Stock on such
exchange or market over the thirty day period ending five business days prior
to the Determination Date, and the fair market value of the Shares shall be
deemed to be such fair market value of the Common Stock;</p>

<p align="justify">&nbsp;</p>

<p align="center">5</p>

</blockquote>
<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If otherwise traded in an over-the-counter market, the
fair market value of the Common Stock shall be deemed to be the average of the
closing ask prices of the Common Stock over the thirty day period ending five
business days prior to the Determination Date, and the fair market value of the
Shares shall be deemed to be such fair market value of the Common Stock; and</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
If there is no public market for the Common Stock, then
fair market value shall be the price reasonably determined in good faith by the
Board of Directors of the Company.</p>

</blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Reservation
of Common Stock</u></b>.&nbsp; The Company
hereby covenants that at all times following the date hereof there shall be
reserved for issuance and delivery upon exercise of this Warrant such number of
Shares as are from time to time issuable upon exercise of this Warrant.&nbsp; The Company hereby further covenants that
from time to time following the date hereof, the Company will take all steps
necessary to amend its Certificate of Incorporation to provide sufficient
reserves of Shares issuable upon exercise of this Warrant.&nbsp; All such shares shall be duly authorized, and
when issued upon such exercise, shall be validly issued, fully paid and
non-assessable, free and clear of all liens, security interests, charges and
other encumbrances or restrictions on sale and free and clear of all preemptive
rights, except encumbrances or restrictions arising under federal or state
securities laws.&nbsp; </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Modification
and Waiver</u></b>.&nbsp; This Warrant and any
provision hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement of the same
is sought.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Market
Standoff</u></b>.&nbsp; The holder of this
Warrant hereby agrees not to sell, transfer or otherwise dispose of any part of
this Warrant or any shares acquired pursuant hereto during a period specified
by the representative of the underwriters of the Company's initial public
offering (not to exceed 180 days) following the effectiveness of such initial
public offering, and such holder further agrees that the Company may impose
stop-transfer instructions with respect to such securities during such period.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Notices</u></b>.&nbsp; Any notice, request, communication or other
document required or permitted to be given or delivered to the holder hereof or
the Company shall be delivered, or shall be sent by certified or registered
mail, postage prepaid, to each such holder at its address as shown on the books
of the Company or to the Company at the address indicated therefor on the
signature page of this Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Binding
Effect on Successors</u></b>.&nbsp; Until the
issuance of any new Warrant required to be issued under Section 3(a), this
Warrant shall be binding upon any corporation that issues securities in
exchange for securities of the class issuable upon exercise of this Warrant in
connection with any merger, consolidation or acquisition of all or
substantially all of the Company's assets, and all of the obligations of the
Company relating to the Shares issuable upon the exercise or conversion of this
Warrant shall survive the exercise, conversion and termination of this Warrant
and all of the covenants and agreements of the Company shall inure to the
benefit of the holder hereof. The Company will, at the time of the exercise or
conversion of this Warrant, in whole or in part, upon request of the holder
hereof but at the Company's expense, acknowledge in writing its continuing
obligation to the holder hereof in respect of any rights (including, without
limitation, any right to registration of the shares) to which the holder hereof
shall continue to be entitled after such exercise or conversion in accordance
with this Warrant; provided, that the failure of the holder hereof to make any
such request shall not affect the continuing obligation of the Company to the
holder hereof in respect of such rights.</p>

<p align="justify">&nbsp;</p>

<p align="center">6</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Lost Warrants
or Stock Certificates</u></b>.&nbsp; The
Company covenants to the holder hereof that, upon receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of this Warrant or any stock certificate and, in the case of any
such loss, theft or destruction, upon receipt of an indemnity reasonably
satisfactory to the Company, or in the case of any such mutilation upon
surrender and cancellation of such Warrant or stock certificate, the Company
will make and deliver a new Warrant or stock certificate, of like tenor, in
lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Descriptive Headings</u></b>.&nbsp; The descriptive headings of the several
paragraphs of this Warrant are inserted for convenience only and do not
constitute a part of this Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Governing Law</u></b>.&nbsp; This Warrant shall be construed and enforced
in accordance with, and the rights of the parties shall be governed by, the
internal laws of the State of California without regard to its conflicts of
laws principles.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Survival</u></b>.&nbsp; All agreements of the Company and the holder
hereof contained herein shall survive indefinitely until, by their respective
terms, they are no longer operative.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Remedies</u></b>.&nbsp; In case any one or more of the covenants and
agreements contained in this Warrant shall have been breached, the holders
hereof (in the case of a breach by the Company), or the Company (in the case of
a breach by a holder), may proceed to protect and enforce their or its rights
either by suit in equity and/or by action at law, including, but not limited
to, an action for damages as a result of any such breach and/or an action for
specific performance of any such covenant or agreement contained in this
Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Acceptance</u></b>.&nbsp; Receipt of this Warrant by the holder hereof
shall constitute acceptance of and agreement to the foregoing terms and
conditions.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>No Impairment
of Rights</u></b>.&nbsp; The Company will not,
by amendment of its Certificate of Incorporation or through any other means,
avoid or seek to avoid the observance or performance of any of the terms of
this Warrant, but will at all times in good faith assist in the carrying out of
all such terms and in the taking of all such action as may be necessary or
appropriate in order to protect the rights of the holder of this Warrant
against impairment.&nbsp; Without limiting the
generality of the foregoing, the Company (a) will not increase the par value of
any shares of stock issuable upon the exercise of this Warrant above the amount
payable therefor upon such exercise, and (b) will take all such action as may
be necessary or appropriate in order that the Company may validly and legally
issue fully paid and non-assessable Shares upon exercise of this Warrant.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Severability</u></b>.&nbsp; If any term, provision, covenant, or
restriction of this Warrant is held by a court of competent jurisdiction to be
invalid, void or unenforceable, the remainder of the terms, provisions,
covenants and restrictions of this Warrant shall remain in full force and
effect and shall in no way be affected, impaired or invalidated.</p>

<p align="justify">&nbsp;</p>

<p align="center">7</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<b><u>Notices of
Record Date</u></b>.&nbsp; In case:</p>

<blockquote>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the Company shall take a record of the holders of its
Common Stock for the purpose of entitling them to receive any dividend or other
distribution, or any right to subscribe for or purchase any shares of stock of
any class or any other securities or to receive any other right; or of any
consolidation or merger of the Company with or into another corporation, any
capital reorganization of the Company, any reclassification of the capital
stock of the Company, or any conveyance of all or substantially all of the
assets of the Company to another corporation in which holders of the Company's
stock are to receive stock, securities or property of another corporation; or</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of any voluntary dissolution, liquidation or winding-up
of the Company; or</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
of any redemption or conversion of all outstanding
Common Stock.</p>

</blockquote>

<p align="justify">then, and in each such case, the Company will mail or cause
to be mailed to the holder of this Warrant a notice specifying, as the case may
be, (i) the date on which a record is to be taken for the purpose of such
dividend, distribution or right, or (ii) the date on which such reorganization,
reclassification, consolidation, merger, conveyance, dissolution, liquidation,
winding-up, redemption or conversion is to take place, and the time, if any is
to be fixed, as of which the holders of record of Common Stock shall be
entitled to exchange their shares of Common Stock, for securities or other
property deliverable upon such reorganization, reclassification, consolidation,
merger, conveyance, dissolution, liquidation or winding-up.&nbsp; Such notice shall be delivered at least seven
(7) days prior to the date therein specified.</p>

<p align=left>Date
of Grant:&nbsp; September 28, 2002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p align=left><br>
ACKNOWLEDGED AND AGREED:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX,
INC.<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u><br>
</u>______________________________&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; _______________________________</p>

<p align=left>Signature&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patrick
Johnson&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p align=left>Ronald Coss&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CEO/President
<br>
&nbsp;</p>

<p align=left>&nbsp;</p>

<p align=center>8</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<b><br clear=all>
</b>

<p align="center"><b>EXHIBIT A</b></p>

<p align="center"><u><b>NOTICE OF EXERCISE</b></u></p>

<p>To:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX, INC.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned
hereby elects to purchase __________ shares of Common Stock of PRO-DEX, INC.
pursuant to the terms of the attached Warrant, and tenders herewith payment of
the purchase price of such shares in full.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please issue a
certificate or certificates representing said shares in the name of the
undersigned or in such other name or names as are specified below:</p>

<p align="center">______________________________<br>
(Name)<br>
<br>
<u>______________________________<br>
</u>(Address)</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned
represents that the aforesaid shares are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection
with, the distribution thereof and that the undersigned has no present
intention of distributing or reselling such shares.&nbsp; In support thereof, the undersigned has
executed an Investment Representation Statement attached hereto as Schedule 1.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature<br>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date</p>

<br clear=all>


<p align="center">9</p>


<hr color="#000080"><p style="page-break-after: always"></p>


<p align="center"><b>EXHIBIT A-1</b></p>

<p align="center"><u><b>NOTICE OF EXERCISE OF NET ISSUANCE CONVERSION RIGHTS</b></u></p>

<p>To:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX, INC.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned,
the registered holder of the Warrant delivered herewith (the &quot;Warrant&quot;), hereby
elects to exercise the Conversion Right (as defined in Section 8 of the
Warrant) as provided herein.&nbsp; __________
shares subject to the Warrant are being surrendered hereby in exercise of the
Conversion Right.&nbsp; The number of shares
to be issued pursuant to this exercise shall be determined by reference to the
formula in Section 8(a) of the Warrant, which requires the use of the &quot;fair market
value&quot; of the Company's stock.&nbsp; As of the
Determination Date (as defined in the Warrant), the &quot;fair market value&quot; of one
of the Shares shall be determined in the manner provided in Section 8(c) of the
Warrant, which amount has been determined by the undersigned (or agreed to by
the holder of the Warrant and PRO-DEX, INC.) to be $_____ per share.&nbsp; Therefore, ___________ shares are to be
issued to the undersigned pursuant to this exercise.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please issue a
certificate or certificates representing said shares in the name of the
undersigned or in such other name or names as are specified below:</p>

<p align="center">_______________________________<br>
(Name)<br>
<br>
_______________________________<br>
(Address)</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The undersigned
represents that the aforesaid shares are being acquired for the account of the
undersigned for investment and not with a view to, or for resale in connection
with, the distribution thereof and that the undersigned has no present
intention of distributing or reselling such shares.&nbsp; In support thereof, the undersigned has
executed an Investment Representation Statement attached hereto as Schedule l.</p>

<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Signature<br>
<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs
p;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Date</p>

<p align="center">

<br clear=all>


</p>


<hr color="#000080"><p style="page-break-after: always"></p>


<p align="center"><b>Schedule 1</b></p>

<p align="center"><u><b>INVESTMENT REPRESENTATION STATEMENT</b></u></p>

<p>Purchaser:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p>Company:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PRO-DEX,
INC.</p>

<p>Security:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p>Amount:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p>

<p>Date:&nbsp;&nbsp;&nbsp; </p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In connection with the purchase of the above-listed securities
(the &quot;Securities&quot;), the undersigned (the &quot;Purchaser&quot;) represents to the Company
as follows:</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser is
aware of the Company's business affairs and financial condition, and has
acquired sufficient information about the Company to reach an informed and
knowledgeable decision to acquire the Securities.&nbsp; The Purchaser is purchasing the Securities
for its own account for investment purposes only and not with a view to, or for
the resale in connection with, any &quot;distribution&quot; thereof for purposes of the
Securities Act of 1933, as amended (the &quot;Act&quot;).</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
understands that the Securities have not been registered under the Securities
Act in reliance upon a specific exemption therefrom, which exemption depends
upon, among other things, the bona fide nature of the Purchaser's investment
intent as expressed herein.&nbsp; In this
connection, the Purchaser understands that, in the view of the Securities and
Exchange Commission (&quot;SEC&quot;), the statutory basis for such exemption may be
unavailable if the Purchaser's representation was predicated solely upon a
present intention to hold these Securities for the minimum capital gains period
specified under tax statutes, for a deferred sale, for or until an increase or
decrease in the market price of the Securities, or for a period of one year or
any other fixed period in the future.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
further understands that the Securities must be held indefinitely unless
subsequently registered under the Act or unless an exemption from registration
is otherwise available.&nbsp; Moreover, the
Purchaser understands that the Company is under no obligation to register the
Securities except as set forth in the Warrant under which the Securities are
being acquired.&nbsp; In addition, the
Purchaser understands that the certificate evidencing the Securities will be
imprinted with the legend referred to in the Warrant under which the Securities
are being purchased.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser is
aware of the provisions of Rule 144 and 144A, promulgated under the Act, which,
in substance, permit limited public resale of &quot;restricted securities&quot; acquired,
directly or indirectly, from the issuer thereof (or from an affiliate of such
issuer), in a non-public offering subject to the satisfaction of certain
conditions, if applicable, including, among other things: The availability of
certain public information about the Company, the resale occurring not less
than one year after the party has purchased and paid for the securities to be
sold; the sale being made through a broker in an unsolicited &quot;broker's transaction&quot;
or in transactions directly with a market maker (as said term is defined under
the Securities Exchange Act of 1934, as amended) and the amount of securities
being sold during any three-month period not exceeding the specified
limitations stated therein.</p>

<hr color="#000080"><p style="page-break-after: always"></p>

<p align="justify">&nbsp;</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
further understands that at the time it wishes to sell the Securities there may
be no public market upon which to make such a sale, and that, even if such a
public market then exists, the Company may not be satisfying the current public
information requirements of Rule 144 and 144A, and that, in such event, the
Purchaser may be precluded from selling the Securities under Rule 144 and 144A
even if the one-year minimum holding period had been satisfied.</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Purchaser
further understands that in the event all of the requirements of Rule 144 and
144A are not satisfied, registration under the Act, compliance with Regulation
A, or some other registration exemption will be required; and that,
notwithstanding the fact that Rule 144 is not exclusive, the Staff of the SEC
has expressed its opinion that persons proposing to sell private placement
securities other than in a registered offering and otherwise than pursuant to
Rule 144 will have a substantial burden of proof in establishing that an exemption
from registration is available for such offers or sales, and that such persons
and their respective brokers who participate in such transactions do so at
their own risk.</p>



<p>Purchaser: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></p>

<p>Date:&nbsp;&nbsp;&nbsp; _______________,
____</p>





</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex991.htm
<TEXT>
<html>

<head>
<title>EXHIBIT 99.1</title>
</head>

<body>

<p>&nbsp;</p>




<p><b>EXHIBIT 99.1</b></p>



<p align=center>&nbsp;</p>

<p align=center><b>CERTIFICATIONS
OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER<br>
PURSUANT
TO 18 U.S.C. SECTION 1350, <br>
AS ADOPTED PURSUANT TO <br>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In connection with the
quarterly report on Form 10-Q of Quality Systems, Inc. (the &quot;Company&quot;) for the
quarterly period ended September 30, 2002 (the &quot;Report&quot;), the undersigned
hereby certifies in his capacity as Chief Executive Officer of the Company,
pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp; the Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
as amended; and</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp; the information contained in the Report
fairly presents, in all material respects, the financial condition and results
of operations of the Company.</p>



<p>Dated:
November 13, 2002&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div align="right">
  <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse" bordercolor="#111111" width="400" id="AutoNumber3">
    <tr>
      <td>By:<u> /s/ &nbsp;&nbsp; Patrick L. Johnson&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u>
      </td>
    </tr>
    <tr>
      <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patrick
L. Johnson</td>
    </tr>
    <tr>
      <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief
Executive Officer and President</td>
    </tr>
  </table>
</div>



<p>&nbsp;</p>



<p>&nbsp;</p>



<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In connection with the
quarterly report on Form 10-Q of Quality Systems, Inc. (the &quot;Company&quot;) for the
quarterly period ended September 30, 2002 (the &quot;Report&quot;), the undersigned
hereby certifies in his capacity as Chief Financial Officer of the Company,
pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1.&nbsp;&nbsp; the Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934,
as amended; and</p>

<p align="justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2.&nbsp;&nbsp; the information contained in the Report
fairly presents, in all material respects, the financial condition and results
of operations of the Company.</p>



<p>Dated:
November 13, 2002</p>

<div align="right">
  <table border="0" cellpadding="0" cellspacing="0" style="border-collapse: collapse" bordercolor="#111111" width="400" id="AutoNumber4">
    <tr>
      <td>By:<u> /s/ &nbsp;&nbsp; JEFFREY
J. RITCHEY&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u>
      </td>
    </tr>
    <tr>
      <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jeffrey
J. Ritchey</td>
    </tr>
    <tr>
      <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Financial Officer</td>
    </tr>
  </table>
</div>

</body>

</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
